<SEC-DOCUMENT>0001437749-26-014237.txt : 20260430
<SEC-HEADER>0001437749-26-014237.hdr.sgml : 20260430
<ACCEPTANCE-DATETIME>20260430163318
ACCESSION NUMBER:		0001437749-26-014237
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		27
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260430
DATE AS OF CHANGE:		20260430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UroGen Pharma Ltd.
		CENTRAL INDEX KEY:			0001668243
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38079
		FILM NUMBER:		26926242

	BUSINESS ADDRESS:	
		STREET 1:		9 HA'TA'ASIYA ST
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4365007
		BUSINESS PHONE:		972 9 770 7601

	MAIL ADDRESS:	
		STREET 1:		9 HA'TA'ASIYA ST
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4365007
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>urgn20260312_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:ecd="http://xbrl.sec.gov/ecd/2026" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2026" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:srt-types="http://fasb.org/srt-types/2017-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2026" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:urgn="http://www.urogen.com/20251231" xmlns:rr="http://xbrl.sec.gov/rr/2023" xmlns:country="http://xbrl.sec.gov/country/2026" xmlns:currency="http://xbrl.sec.gov/currency/2026" xmlns:exch="http://xbrl.sec.gov/exch/2026" xmlns:sic="http://xbrl.sec.gov/sic/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"><head>
	<title>urgn20260312_def14a.htm</title>


	<!-- Generated by ThunderDome Portal - 4/30/2026 1:10:34 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none;"><ix:header><ix:hidden>
<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="dei:AmendmentFlag" id="ixv-12294">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="dei:EntityCentralIndexKey" id="ixv-12295">0001668243</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="dei:DocumentType" id="c3">DEF 14A</ix:nonNumeric></ix:hidden>
<ix:references>
<link:schemaRef xlink:href="urgn-20251231.xsd" xlink:type="simple"/></ix:references>
<ix:resources>
<xbrli:context id="d_2025-01-01_2025-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2023-01-01_2023-12-31_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="NonApplicable"><xbrli:measure>thunderdome:item</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2023-01-01_2025-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2025-01-01_2025-12-31_RestatementDateAxis-RestatementDateAxis.domain-2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:RestatementDateAxis"><ecd:RestatementDateAxis.domain>2023-12-31</ecd:RestatementDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources>
</ix:header></div>
<div>&#160;</div>

<div>
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:c3"><b>SCHEDULE</b>&#160;<b>14A</b></span></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proxy Statement Pursuant to Section 14(a) of the</b><br/>
<b>Securities Exchange Act of 1934</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by the Registrant&#160;&#160;&#9746;</p>
			</td>
			<td style="vertical-align:top;width:6.5%;">&#160;</td>
			<td style="vertical-align:top;width:27.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by a Party other than the Registrant&#160;&#160;&#9744;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box:</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#9744;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Preliminary Proxy Statement</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Confidential, for Use of the Commission Only (as permitted by Rule</b>&#160;<b>14a</b>&#8209;<b>6(e)(2))</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">&#9746;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Definitive Proxy Statement</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Definitive Additional Materials</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting Material under &#167;240.14a&#8209;12</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="dei:EntityRegistrantName" id="c4">UROGEN PHARMA LTD.</ix:nonNumeric></b></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Name of Registrant as Specified In Its Charter)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>N/A</b></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Payment of Filing Fee (Check the appropriate box):</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9746;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No fee required</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fee paid previously with preliminary materials</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</div>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="urgn20240606_def14aimg001.jpg" src="urgn20240606_def14aimg001.jpg" style="width:403;height:143;"/></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UROGEN PHARMA LTD.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">400 Alexander Park Drive, Princeton, New Jersey 08540</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">April 30, 2026</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dear Shareholder,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">You are cordially invited to attend the 2026&#160;Annual Meeting of Shareholders of UroGen Pharma Ltd. (the &#8220;Company&#8221;) to be held on June 22, 2026&#160;at 10:00 a.m., Eastern Time. The annual meeting will be held in a completely virtual format. You can attend the annual meeting by visiting www.virtualshareholdermeeting.com/URGN2026, where you will be able to listen to the meeting live, submit questions and vote online. Shareholders attending the virtual meeting will be afforded the same rights and opportunities to participate as they would at an in-person meeting. We encourage you to attend online and participate. We recommend that you log in a few minutes before the annual meeting start time of 10:00 a.m.&#160;Eastern Time on June 22, 2026, to ensure you are logged in when the annual meeting begins.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">At the meeting, you will be asked to consider and vote on the proposals set forth in the proxy statement relating to the annual meeting.&#160;Whether or not you plan to virtually attend and vote your shares online at the meeting, it is important that your ordinary shares be represented and counted. Accordingly, after reading the proxy statement, please vote by proxy over the telephone or online by following the instructions included in the proxy materials; or complete, date, sign and return the enclosed proxy card. If you hold your shares in &#8220;street name&#8221; through a broker, bank or other intermediary, please vote in accordance with their instructions provided to you.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company has fixed the close of business on April 29, 2026&#160;as the record date for the determination of shareholders entitled to notice of, and to vote on the matters proposed at, the meeting and any adjournment or postponement thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Thank you for your continued support.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Very truly yours,</p>

			<div><img alt="lbsig.jpg" src="lbsig.jpg"/></div>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Liz Barrett</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President and Chief Executive Officer</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UROGEN PHARMA LTD.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">400 Alexander Park Drive</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Princeton, New Jersey 08540</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>To Be Held On June 22, 2026</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dear Shareholder:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">You are cordially invited to attend the 2026&#160;Annual Meeting of Shareholders of UroGen Pharma Ltd., a corporation organized under the laws of the State of Israel (the &#8220;Company&#8221;). The meeting will be held on June 22, 2026&#160;at 10:00 a.m.&#160;Eastern Time. The annual meeting will be held in a completely virtual format. You can attend the annual meeting by visiting www.virtualshareholdermeeting.com/URGN2026&#160;where you will be able to listen to the meeting live, submit questions and vote online during the meeting. Shareholders attending the virtual meeting will be afforded the same rights and opportunities to participate as they would at an in-person meeting. We encourage you to attend online and participate. We recommend that you log in a few minutes before the annual meeting start time of 10:00 a.m., Eastern Time on June 22, 2026, to ensure you are logged in when the annual meeting begins. We are holding the annual meeting for the following purposes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To elect to the Board of Directors the following seven nominees presented by the Board of Directors to hold office until our next annual meeting of shareholders: Arie Belldegrun, M.D.; Elizabeth Barrett; Cynthia M. Butitta; Stuart Holden,&#160;M.D.; James A. Robinson, Jr.; Leana S. Wen, M.D., M.Sc.; and Daniel G. Wildman;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law, 5759-1999 and the regulations promulgated thereunder;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve an amendment to the Company&#8217;s Amended and Restated Non-Employee Director and Officer Compensation Policy in relation to directors&#8217; and officers&#8217; insurance;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve an amendment to the Company&#8217;s 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 1,000,000&#160;shares;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers, as disclosed in the accompanying proxy statement;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company&#8217;s auditor until the Company's&#160;2027&#160;annual meeting of shareholders;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In accordance with Israeli law, to discuss the Company's audited financial statements for the fiscal year ended December&#160;31, 2025; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To conduct any other business properly brought before the annual meeting and any adjournment or postponement thereof.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">These items of business are more fully described in the accompanying proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The record date for the annual meeting is April 29, 2026. Only shareholders of record at the close of business on the record date are entitled to notice of and to vote at the annual meeting or any adjournment or postponement thereof, either by virtual attendance or by proxy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:46.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Important Notice Regarding the Availability of Proxy Materials for the Shareholders</b>&#8217;<b>&#160;Meeting to Be Held on June 22, 2026</b>&#160;<b>at 10:00 a.m., Eastern Time.</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The proxy statement and annual report to shareholders are available at www.proxyvote.com.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By Order of the Board of Directors,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Chris Degnan</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chris Degnan</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Princeton, New Jersey</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">April 30, 2026</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>You are cordially invited to attend the annual meeting virtually through a live webcast. Whether or not you expect to attend the annual meeting, please complete, date, sign and return the enclosed proxy card, or vote by proxy over the telephone or online as instructed in these proxy materials, as promptly as possible in order to ensure your representation at the annual meeting. Even if you have voted by proxy, you may still vote online at the annual meeting if you virtually attend the annual meeting. Please note, however, that if your shares are held of record by a broker, bank or other intermediary and you wish to vote at the annual meeting, you must obtain a legal proxy issued in your name or your control number from the holder of record. </b></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UROGEN PHARMA LTD.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>400 Alexander Park Drive</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Princeton, New Jersey 08540</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROXY STATEMENT</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FOR THE 2026</b>&#160;<b>ANNUAL MEETING OF SHAREHOLDERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>June 22, 2026</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Why am I receiving these materials?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We have sent you these proxy materials because the Board of Directors (sometimes referred to as the &#8220;Board&#8221;) of UroGen Pharma Ltd. (sometimes referred to as &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; or &#8220;UroGen&#8221;) is soliciting your proxy to vote at the 2026&#160;Annual Meeting of Shareholders (the &#8220;Annual Meeting&#8221;), or any adjournments or postponements of the Annual Meeting. You are invited to virtually attend the Annual Meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the Annual Meeting to vote your shares. Instead, you may simply complete, date, sign and return the enclosed proxy card, or vote by proxy over the telephone or online by following the instructions below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We intend to mail these proxy materials on or about May 11, 2026&#160;to all shareholders of record at the close of business on April 29, 2026&#160;(the &#8220;Record Date&#8221;) entitled to vote at the Annual Meeting.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How do I attend, participate in, and ask questions during the Annual Meeting online?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Annual Meeting will be a virtual meeting of shareholders, which will be conducted solely online via live webcast. You are entitled to attend the Annual Meeting if you are a shareholder of record as of the close of business on the Record Date or hold a valid proxy for the Annual Meeting. To be admitted to the Annual Meeting, you will need to visit www.virtualshareholdermeeting.com/URGN2026, and enter the 16 digit control number provided on your proxy card or voting instruction form. You will be able to submit questions during the Annual Meeting through www.virtualshareholdermeeting.com/URGN2026. There is no physical location for the Annual Meeting. The meeting will start at 10:00 a.m. Eastern Time on June 22, 2026. Online check-in will start approximately 15 minutes before the meeting. Shareholders attending the Annual Meeting will be afforded the same rights and opportunities to participate as they would at an in-person meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If you hold your shares through an intermediary, such as a bank or broker, you should contact such intermediary well in advance of the Annual Meeting if you have questions about obtaining your Control Number or proxy to vote. You may be required to provide proof of beneficial ownership, such as your most recent account statement as of the Record Date, a copy of the voting instruction form provided by your broker, bank, trustee, or nominee, or other similar evidence of ownership.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To help ensure that we have a productive and efficient meeting, and in fairness to all shareholders in attendance, the&#160;rules of conduct for the Annual Meeting are as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">You may submit questions and comments electronically through the meeting portal.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Only shareholders of record as of the Record Date and their proxy holders may submit questions or comments.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Please include your name and affiliation, if any, when submitting a question or comment.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Limit your remarks to one brief question or comment that is relevant to the Annual Meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Questions may be grouped by topic by our management.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Questions may also be ruled as out of order if they are, among other things, irrelevant to our business, related to pending or threatened litigation, disorderly, repetitious of statements already made, or in furtherance of the speaker&#8217;s own personal, political or business interests.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Be respectful of your fellow shareholders and Annual Meeting participants.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">No audio or video recordings of the Annual Meeting are permitted.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What if I cannot find my Control Number?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Please note that if you do not have your Control Number, you will be able to log in as a guest. To view the meeting webcast, visit www.virtualshareholdermeeting.com/URGN2026&#160;and register as a guest. If you log in as a guest, you will not be able to vote your shares or ask questions during the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If you are a beneficial owner (that is, you hold your shares in an account at a broker, bank or other intermediary), you will need to contact that broker, bank or other intermediary to obtain your Control Number prior to the Annual Meeting. Beneficial shareholders who did not receive a Control Number from their bank or brokerage firm, who wish to attend the meeting, should follow the instructions from their bank or brokerage firm, including any requirement to obtain a legal proxy. Most brokerage firms or banks allow a shareholder to obtain a legal proxy either online or by mail.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Who can vote at the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Only shareholders of record at the close of business on April 29, 2026&#160;will be entitled to vote at the Annual Meeting. On the Record Date, there were 48,721,701&#160;ordinary shares issued and outstanding. Each ordinary share entitles the holder to one vote with respect to each matter submitted to shareholders at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Shareholder of Record: Shares Registered in Your Name</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If on the Record Date your shares were registered directly in your name with our transfer agent, Computershare Trust Company, N.A. of 150 Royall Street, Canton, Massachusetts 02021, then you are a shareholder of record.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As a shareholder of record, you may vote online at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to ensure your vote is counted by voting by proxy over the telephone or online as instructed below, or vote by proxy using the enclosed proxy card.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Intermediary</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If on the Record Date your shares were not held in your name, but rather in an account at a brokerage firm, bank, dealer or other similar intermediary, then you are the beneficial owner of shares held in &#8220;street name&#8221; and these proxy materials are being forwarded to you by that intermediary. The intermediary holding your account is considered to be the shareholder of record for purposes of voting at the Annual Meeting. As a beneficial owner of your shares, you have the right to direct your broker, bank or other agent as to how to vote the shares in your account. You are also invited to virtually attend the Annual Meeting. You may vote prior to the Annual Meeting by logging in with your Control Number on your proxy card, voting instruction form or in the instructions you received via email at www.proxyvote.com. You may access the meeting and vote at the Annual Meeting by logging in with your Control Number at www.virtualshareholdermeeting.com/URGN2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What am I voting on?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This proxy statement describes the proposals on which we would like you, as a shareholder, to vote at the Annual Meeting. This proxy statement provides you with information on the proposals, as well as other information about us, so that you can make an informed decision as to whether and how to vote your shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At the Annual Meeting, shareholders will act upon the following six proposals:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.3%;">&#160;</td>
			<td style="vertical-align:top;width:9.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Proposal 1</p>
			</td>
			<td style="vertical-align:top;width:88.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To elect to the Board of Directors the following seven nominees presented by the Board of Directors to hold office until our next annual meeting of shareholders: Arie Belldegrun, M.D.; Elizabeth Barrett; Cynthia M. Butitta; Stuart Holden,&#160;M.D.; James A. Robinson, Jr.; Leana S. Wen, M.D., M.Sc.; and Daniel G. Wildman;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.3%;">&#160;</td>
			<td style="vertical-align:top;width:9.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Proposal 2</p>
			</td>
			<td style="vertical-align:top;width:88.4%;">To approve the amendment and restatement of the Articles of Association of the Company (as proposed to be amended and restated, the &#8220;Proposed Articles of Association&#8221;) to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law, 5759-1999 and the regulations promulgated thereunder (collectively, the &#8220;Companies Law&#8221;);</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.3%;">&#160;</td>
			<td style="vertical-align:top;width:9.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Proposal 3</p>
			</td>
			<td style="vertical-align:top;width:88.4%;">To approve an amendment to the Company&#8217;s Amended and Restated Non-Employee Director and Officer&#160;Compensation Policy in relation to directors&#8217; and officers&#8217; insurance (the &#8220;Compensation Policy Amendment&#8221;);</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.3%;">&#160;</td>
			<td style="vertical-align:top;width:9.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Proposal 4</p>
			</td>
			<td style="vertical-align:top;width:88.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve an&#160;amendment&#160;to the Company&#8217;s 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 1,000,000&#160;shares;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.3%;">&#160;</td>
			<td style="vertical-align:top;width:9.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Proposal 5</p>
			</td>
			<td style="vertical-align:top;width:88.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers, as disclosed in this&#160;proxy statement; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.2%;">&#160;</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Proposal 6</p>
			</td>
			<td style="vertical-align:top;width:88.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company&#8217;s auditor until the Company's 2027&#160;annual meeting of shareholders.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What if another matter is properly brought before the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of the date of this proxy statement, our Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of your proxyholder (one of the individuals named on your proxy card) to vote on those matters in accordance with their best judgment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How do I vote?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">With respect to&#160;each of the matters to be voted on, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Shareholder of Record: Shares Registered in Your Name</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If you are a shareholder of record, you may vote online at the Annual Meeting or vote by proxy in advance of the Annual Meeting over the telephone or online, or by completing, dating, signing and returning the enclosed proxy card. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend and vote at the Annual Meeting even if you have already voted by proxy. To vote <b><i>during</i></b>&#160;the Annual Meeting, if you are a shareholder of record as of the Record Date, follow the instructions at www.virtualshareholdermeeting.com/URGN2026. You will need to enter the Control Number found on your proxy card. &#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To vote <b><i>prior </i></b>to the Annual Meeting, you may vote by proxy by using the enclosed proxy card, by telephone or online, as described below:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To vote over the telephone, dial toll-free 1-800-690-6903&#160;using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and Control Number from the proxy card. Your telephone vote must be received by 11:59 p.m. Eastern Time on June 21, 2026&#160;to be counted.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To vote online, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the Control Number from the proxy card. Your internet vote must be received by 11:59 p.m. Eastern Time on June 21, 2026&#160;to be counted.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Intermediary</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If you are a beneficial owner of shares registered in the name of your broker, bank, or other intermediary, you should have received information containing voting instructions from that intermediary rather than from us. To vote <b><i>prior</i></b> to the Annual Meeting, simply follow the voting instructions provided by such intermediary to ensure that your vote is counted. You may access and vote <b><i>during </i></b>the Annual Meeting by logging in with your Control Number on your proxy card, voting instruction form or instructions you received via email at www.virtualshareholdermeeting.com/URGN2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:46.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Internet proxy voting will be provided to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions.</b>&#160;<b>However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies.</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How many votes do I have?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">On each matter to be voted upon, you have one vote for each ordinary share you owned as of the Record Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>What happens if I do not vote?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Shareholder of Record: Shares Registered in Your Name</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If you are a shareholder of record and do not vote online at the Annual Meeting or vote by proxy over the telephone or online, or by using the enclosed proxy card, your shares will not be voted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Intermediary</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If you are a beneficial owner of shares registered in the name of your broker, bank, or other intermediary (sometimes referred to as shares held in &#8220;street name&#8221;) and you do not provide instructions how to vote your shares, your broker, bank or other intermediary may still be able to vote your shares in its discretion. Under the rules that govern brokers, brokers, banks and other intermediaries that are subject to such rules, they may use their discretion to vote your &#8220;uninstructed&#8221; shares with respect to matters considered to be &#8220;routine,&#8221; but not with respect to &#8220;non-routine&#8221; matters.&#160;Proposals 1, 2, 3, 4 and 5 are considered to be non-routine, meaning that your broker, bank or other intermediary may not vote your shares on those proposals in the absence of your voting instructions. Proposal 6&#160;is considered to be a routine matter, meaning that if you do not return voting instructions to your broker, bank or other intermediary, your shares may be voted by such intermediary in its discretion on Proposal 6.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>What if I return a proxy card or otherwise vote but do not make specific choices?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>&#8220;For</b>&#8221;&#160;the election to the Board of Directors of the following seven nominees presented by the Board to hold office until our next annual meeting of shareholders: Arie Belldegrun, M.D.; Elizabeth Barrett; Cynthia M. Butitta; Stuart Holden,&#160;M.D.; James A. Robinson, Jr.; Leana S. Wen, M.D., M.Sc.; and Daniel G. Wildman.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>&#8220;For</b>&#8221;&#160;the approval of the Proposed Articles of Association.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>&#8220;For</b>&#8221;&#160;the approval of&#160;the Compensation Policy Amendment.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>&#8220;For</b>&#8221;&#160;the approval of an amendment&#160;to the Company&#8217;s 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 1,000,000&#160;shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;"><b>&#8220;For</b>&#8221;&#160;the advisory approval of the compensation of our named executive officers, as disclosed in this proxy statement.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>&#8220;For</b>&#8221;&#160;the approval of the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company&#8217;s independent auditor until the Company's 2027&#160;annual meeting of shareholders.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If any other matter is properly presented at the Annual Meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using their best judgment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Who is paying for this proxy solicitation?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Our directors and employees will not be paid any additional compensation for soliciting proxies. If we decide to engage a solicitation firm, we expect to pay customary fees not to exceed $15,000&#160;plus out-of-pocket expenses. We may also reimburse brokerage firms, banks and other nominees for the cost of forwarding proxy materials to beneficial owners.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What does it mean if I receive more than one set of proxy materials?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If you receive more than one set of proxy materials, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the proxy cards in the proxy materials to ensure that all of your shares are voted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Can I change my vote after submitting my proxy?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Shareholder of Record: Shares Registered in Your Name</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">You may submit another properly completed proxy card with a later date.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">You may grant a subsequent proxy by telephone or online.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">You may send a timely written notice that you are revoking your proxy to our Corporate Secretary at UroGen Pharma Ltd., 400 Alexander Park Drive, 4th&#160;Floor, Princeton, New Jersey 08540.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">You may virtually attend the Annual Meeting and vote online at the meeting. Simply attending the Annual Meeting will not, by itself, revoke your proxy. Even if you plan to attend the Annual Meeting, we recommend that you also vote by proxy over the telephone or online, or by using the enclosed proxy card so that your vote will be counted if you later decide not to attend the Annual Meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Your most current proxy card or telephone or online proxy is the one that is counted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Intermediary</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If your shares are held by your broker, bank or other intermediary, you should follow the instructions provided by your broker, bank or other intermediary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>When are shareholder proposals and director nominations due for next year</b>&#8217;<b>s annual meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the Companies Law, one or more shareholders holding at least 1% of the voting rights in the Company may request that the Board include a matter in the agenda of a general meeting of shareholders to be convened in the future (or 5% if the matter is the appointment or removal of a director), provided that it is appropriate to discuss such a matter at the general meeting. Our current amended and restated articles of association provide that any shareholder holding at least 1% of the outstanding voting rights may make such a request.&#160;If approved, shareholder proposals under the Proposed Articles of Association will tie eligibility to submit shareholder proposals to the requirements under the Companies Law. Under the Companies Law, eligible shareholders may be able to&#160;present proposals for consideration at the Annual Meeting by submitting their proposals in writing to the Company no later than April 24, 2026, provided that such proposal is appropriate for consideration by shareholders at the meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In addition to the requirements under the Companies Law, our articles of association specify additional procedural requirements for shareholder proposals. Under our articles of association, a proposal must be delivered, either in person or by certified mail, postage prepaid, and received by us, (i)&#160;in the case of a general meeting that is an annual meeting, no less than 60 days nor more than 120 days prior to the date of the first anniversary of the preceding year&#8217;s annual meeting, provided, however, that, in the event that the date of the annual general meeting is advanced more than 30 days prior to or delayed by more than 30 days after the anniversary of the preceding year&#8217;s annual general meeting, notice by the proposing shareholder, in order to be timely, must be received no earlier than the close of business 120 days prior to such annual general meeting and no later than the close of business on the later of 90 days prior to such annual general meeting or the 10th day following the day on which public announcement of the date of such annual general meeting is first made, and (ii)&#160;in the case of a general meeting that is an extraordinary meeting, no earlier than 120 days prior to such extraordinary general meeting and no later than the close of business on the later of 60 days prior to such extraordinary general meeting or the 10th day following the day on which public announcement of the date of such general meeting is first made, subject to applicable law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under our articles of association, any shareholder entitled under applicable law to make a shareholder proposal, as described above, may make such proposal only if a written notice of such shareholder&#8217;s intent to make such proposal shall have been given to the&#160;Company within the periods set out in the prior paragraph. Each such notice shall set forth: (i)&#160;the name and address of the shareholder making the request; (ii)&#160;a representation that the shareholder is a holder of shares of the Company entitled to vote at such meeting and intends to appear in person or by virtual attendance, as applicable, or by proxy at the meeting; (iii)&#160;a description of all arrangements or understandings between the shareholder and any other person or persons (naming such person or persons) in connection with the subject which is requested to be included in the agenda; (iv)&#160;a description of all Derivative Transactions (as defined in our articles of association) by the shareholder during the previous 12 month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms of, such transaction; and (v)&#160;a declaration that all the information that is required under the Companies Law and any other applicable law to be provided to the Company in connection with such subject, if any, has been provided. Furthermore, the Board, may, in its discretion, to the extent it deems necessary, request that the shareholder provide additional information necessary so as to include a subject in the agenda of a general meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In addition, shareholder proposals may be submitted for inclusion in a proxy statement under Rule&#160;14a-8 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Under Rule&#160;14a-8 of the Exchange Act, to be eligible for inclusion in the Company&#8217;s proxy materials for the 2027&#160;annual meeting of shareholders, shareholder proposals must be received by the Company no later than January 11, 2027, which is 120 days prior to the 12-month anniversary of the date this proxy statement is first released&#160;to&#160;shareholders with respect to the Annual Meeting, or if the date of next year&#8217;s annual meeting of shareholders is advanced by more than 30 days or delayed by more than 30 days from the anniversary of the Annual Meeting, a reasonable time before the Company begins to print and send its proxy materials. In addition, Rule&#160;14a-8 proposals must otherwise comply with the requirements of the rule. Additional requirements regarding shareholder proposals submitted for inclusion in the Company&#8217;s proxy materials for an annual general meeting of shareholders can be found in the articles of association, which is available as an exhibit to our Annual Report on Form 10-K for the year ended&#160;December&#160;31, 2025, as filed on March 2, 2026. Proposals should be addressed to: UroGen Pharma Ltd., 400 Alexander Park Drive, 4th Floor, Princeton, New Jersey 08540, Attention: Corporate Secretary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In addition to satisfying the foregoing requirements under our articles of association, to comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than our Board&#8217;s nominees must provide notice that sets forth any additional information required by Rule 14a-19 promulgated under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How are votes counted?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Votes will be counted by the inspector of election appointed for the Annual Meeting, who will separately count, for each proposal, votes &#8220;For&#8221; and &#8220;Against,&#8221; abstentions and, if applicable, broker non-votes. Abstentions&#160;and broker non-votes, if any, will have no effect on any proposal.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What are </b>&#8220;<b>broker non-votes</b>&#8221;<b>?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">When a beneficial owner of shares held in &#8220;street name&#8221; does not give instructions to his or her broker, bank or nominee holding the shares as to how to vote on a non-routine matter, the broker, bank or nominee cannot vote the shares. These unvoted shares are counted as &#8220;broker non-votes.&#8221; Proposals 1, 2, 3, 4 and 5&#160;are considered to be non-routine and we&#160;therefore, expect broker non-votes to exist in connection with those proposals.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>As a reminder, if you are a beneficial owner of shares held in </i>&#8220;<i>street name,</i>&#8221;<i> in order to ensure your shares are voted in the way you would prefer, you must provide voting instructions to your broker or nominee holding the shares by the deadline provided in the materials you receive from your broker or nominee.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How many votes are needed to approve each proposal?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On each proposal to be voted upon, shareholders have one vote for each ordinary share owned as of the Record Date. Votes will be counted by the inspector of election. The following table summarizes vote requirements and the effect of abstentions and broker non-votes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proposal</b><br/>
			<b>Number</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proposal Description</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Vote Required for</b><br/>
			<b>Approval</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Effect of </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Abstentions</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Effect of Broker </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Non-Votes</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The election to the Board of Directors of the following seven nominees presented by the Board: Arie Belldegrun, M.D.; Elizabeth Barrett; Cynthia M. Butitta; Stuart Holden,&#160;M.D.; James A. Robinson, Jr.; Leana S. Wen, M.D., M.Sc.; and Daniel G. Wildman.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>FOR</b>&#160;votes from the holders of a majority of shares present by virtual attendance or represented by proxy and voting on the election of directors.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 4.6%; text-align: center;">2</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">To approve the Proposed Articles of Association.</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;"><b>FOR</b>&#160;votes from the holders of a majority of shares present by virtual attendance or represented by proxy and voting on the matter.</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">None</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">None</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">To approve the Compensation Policy Amendment.</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>FOR</b>&#160;votes from the holders of a majority of shares present by virtual attendance or represented by proxy and voting on the matter, provided that certain conditions, as described below, are met.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To approve an amendment&#160;to the Company&#8217;s 2017 Equity Incentive Plan to&#160;increase the number of ordinary shares authorized for issuance under the plan by 1,000,000&#160;shares.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>FOR</b>&#160;votes from the holders of a majority of shares present by virtual attendance or represented by proxy and voting on the matter.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 4.6%; text-align: center;">5</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">Advisory approval of the compensation of the Company&#8217;s named executive officers.</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;"><b>FOR</b>&#160;votes from the holders of a majority of shares present by virtual attendance or represented by proxy and voting on the matter.</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">None</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">None</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">6</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company&#8217;s independent auditor until the Company's 2027&#160;annual meeting of shareholders.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:11.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>FOR</b>&#160;votes from the holders of a majority of shares present by virtual attendance or represented by proxy and voting on the matter.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">None</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Not applicable<sup style="vertical-align:top;line-height:120%;">(1)</sup></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This proposal is considered to be a &#8220;routine&#8221;&#160;matter. Accordingly, if you hold your shares in &#8220;street name&#8221;&#160;and do not provide voting instructions to your broker, bank or other intermediary that holds your shares, your broker, bank or other intermediary has discretionary authority to vote your shares on this proposal.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the Companies Law, the approval of Proposal 3&#160;requires the affirmative vote of the holders of the majority of the ordinary shares present in person (i.e., by virtual attendance) or represented by proxy and voting at the Annual Meeting on such proposal, excluding abstentions, provided that either: (i) such majority includes a majority of the ordinary shares voted by shareholders who are not &#8220;controlling shareholders&#8221; and who do not have a &#8220;personal interest&#8221; in the resolution under Proposal 3; or (ii) the total number of ordinary shares of shareholders who are not controlling shareholders and who do not have a personal interest in the resolution under Proposal 3&#160;who voted against the resolution does not exceed 2% of the voting rights of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the Companies Law, the term &#8220;<b><i>controlling shareholder</i></b>&#8221; means a shareholder who has the ability to direct the activities of the Company, other than by virtue of being an Office Holder (as such term is defined in the Companies Law). A shareholder is presumed to be a controlling shareholder if the shareholder holds 50% or more of the voting rights in the Company or has the right to appoint 50% or more of the directors of the Company or its chief executive officer (referred to in the Companies Law as the general manager). As of the date hereof, the Company is not aware of any shareholder who would be considered a controlling shareholder of the Company under the Companies Law for the purposes of the above-described special majority requirement for the approval of Proposal 3.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the Companies Law, a &#8220;<b><i>personal interest</i></b>&#8221; of a shareholder is defined as such shareholder&#8217;s personal interest in an act or a transaction of the Company, including (i)&#160;a personal interest of such shareholder&#8217;s relative, and (ii)&#160;a personal interest of a corporate body in which such shareholder or any of his or her relatives serves as a director or the chief executive officer, owns at least 5% of its issued share capital or its voting rights, or has the right to appoint a director or the chief executive officer, but excluding a personal interest arising solely from the holding of shares in the Company. A personal interest also includes the personal interest of a proxy holder voting shares, even if the proxy giver does not have a personal interest in the matter, and the personal interest of the proxy giver, whether or not the person voting the shares has discretion.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the Companies Law, the term &#8220;<b><i>relative</i></b>&#8221; means a spouse, sibling, parent, grandparent or descendant and the spouse&#8217;s sibling, parent or descendant; and the spouse of each of the foregoing persons.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the Companies Law, a voting shareholder is required to notify the Company whether or not such shareholder is a controlling shareholder or has a &#8220;personal interest&#8221; in the resolution under Proposal 3.&#160;Each shareholder voting by means of the enclosed proxy card or a voting instruction form, or via telephone or online, will be deemed to have confirmed that such shareholder is not a controlling shareholder and does not have a personal interest in the resolution. If you are a controlling shareholder or a shareholder who has a personal interest in the resolution, prior to voting, you should contact: Vincent Perrone&#160;at <span style="text-decoration: underline; ">vincent.perrone@urogen.com</span>. If you hold your shares in &#8220;street name&#8221; through a broker, bank or other intermediary and you are a controlling shareholder or have a personal interest in the resolution, you should notify the Company as stated above, and, in addition, you should advise your broker, bank or other intermediary of that status, and they in turn should notify the Company as described in the preceding sentence.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>What is the quorum requirement?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A quorum of shareholders is necessary to hold a valid annual meeting. A quorum will be present if at least two (2) shareholders who hold, in the aggregate, at least thirty-three and one-third percent (33 1/3%) of the voting rights in the Company are present at the Annual Meeting via virtual attendance or represented by proxy. On the Record Date, there were 48,721,701 shares outstanding and entitled to vote. Thus, the holders of at least 16,240,567&#160;shares must be present via virtual attendance or represented by proxy at the Annual Meeting to have a quorum. Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other intermediary) or if you vote online at the Annual Meeting. If within half an hour from the time appointed for the Annual Meeting a quorum is not present, the meeting shall stand adjourned to the same day in the next week, at the same time and place. Abstentions and broker non-votes will be treated as neither a vote &#8220;for&#8221; nor &#8220;against&#8221; any matter, although they will be counted in determining whether a quorum is present.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How can I find out the Annual Meeting voting results?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a current report on Form 8-K within four business days after the Annual Meeting, we intend to file a current report on Form 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional current report on Form 8-K to publish the final results.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>INFORMATION REGARDING THE BOARD OF DIRECTORS</b><br/>
<b>AND CORPORATE GOVERNANCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Board Leadership Structure</b>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Board has an independent Chair, Arie Belldegrun, M.D., who has authority, among other things, to preside over Board meetings, and shall have such powers and duties as may from time to time be assigned by the Board. Accordingly, the Chair has substantial ability to shape the work of the Board.&#160;We believe that separation of the positions of Chair and Chief Executive Officer reinforces the independence of the Board in its oversight of our business and affairs. In addition, we believe that having an independent Chair creates an environment that is more conducive to objective evaluation and oversight of management&#8217;s performance, increasing management accountability and improving the ability of our Board to monitor whether management&#8217;s actions are in our best interests and those of our shareholders. As a result, we believe that having an independent Chair can enhance the effectiveness of our Board as a whole.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Board Diversity</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">While we do not have a formal diversity policy in place, our Board monitors the mix of skills and experience of its directors to help ensure it has the necessary tools to perform its oversight function effectively. Our Board values diversity of viewpoints, backgrounds, and experiences, and believes such diversity is important in the selection of directors in order to enhance cognitive diversity and ensure quality of dialogue in the boardroom. Three of our directors are diverse by gender (3 directors) or race (1 director).</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Independence of the Board of Directors</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Applicable Nasdaq rules require a majority of a listed company&#8217;s directors to be comprised of independent directors within one year of listing. In addition, Nasdaq rules require that, subject to specified exceptions, each member of a listed company&#8217;s Audit, Compensation and Nominating and Corporate Governance Committees be independent and that Audit Committee members also satisfy independence criteria set forth in Rule&#160;10A-3 under the Exchange Act. The Board consults with the Company&#8217;s counsel to ensure that the Board&#8217;s independence determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in the pertinent listing standards of Nasdaq, as in effect from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Consistent with these considerations, the Board has determined that all of our directors, except Ms.&#160;Barrett, are independent directors, as defined under applicable Nasdaq listing standards. In making such determination, our Board considered the relationships that each non-employee director has with the Company and all other facts and circumstances that our Board deemed relevant in determining his or her independence, including the beneficial ownership of our capital stock by each non-employee director.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">There are no family relationships among any of our directors or executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Role of the Board in Risk Oversight</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">One of the key functions of our Board is informed oversight of our risk management process. Our Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various standing committees of our Board that address risks inherent in their respective areas of oversight. In particular, our Board is responsible for monitoring and assessing strategic risk exposure and our Audit Committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The Audit Committee is also responsible for overseeing our cybersecurity risk management processes, including oversight of risks from cybersecurity threats. The Compliance Committee is responsible for overseeing our implementation of compliance programs, policies and procedures that are designed to respond to the various compliance, legal and regulatory risks we may face, as well as making recommendations to the Board regarding compliance with such legal and regulatory risks. The Compliance Committee also assists the Audit Committee in fulfilling its oversight responsibility for the Company&#8217;s risk assessment and risk management activities relating to the integrity of our financial statements and is responsible for assisting our compliance officer in fulfilling his/her responsibilities. Our Compensation Committee monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. Our Nominating and Corporate Governance Committee monitors the effectiveness of our corporate governance practices and policies. Both the Board as a whole and the various standing committees receive periodic reports from the standing committees, as well as incidental reports as matters may arise. It is the responsibility of the committee chairs to report findings regarding material risk exposures to the Board as quickly as possible.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<div>&#160;</div>

<div>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Insider Trading Policy; Hedging Policy*</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We have <ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="c8" format="ixt:fixed-true">adopted</ix:nonNumeric> an insider trading policy (&#8220;Insider Trading Policy&#8221;) governing the purchase, sale, and/or other dispositions of the Company&#8217;s securities by directors, officers, and other employees of the Company that is designed to promote compliance with insider trading laws, rules and regulations, as well as procedures designed to further the foregoing purposes. A copy of our Insider Trading Policy is filed as an exhibit to the Form 10-K for our fiscal year ended December 31, 2025. In addition, it is the Company&#8217;s intent to comply with applicable laws and regulations relating to insider trading.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our Insider Trading Policy prohibits our directors, officers and employees, and generally any entities or family members of such individuals whose trading activities are controlled or influenced by any such persons, from engaging in short sales, transactions in put or call options, hedging transactions, margin accounts or other inherently speculative transactions with respect to our equity securities, which protects against short-term decision making.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>*</i>&#160;<i>The </i>&#8220;<i>Hedging Policy</i>&#8221;<i> disclosure is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended (the </i>&#8220;<i>Securities Act</i>&#8221;<i>) or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</i></p>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Meetings of the Board of Directors</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Board met six times in 2025. The Audit Committee met four times in 2025. The Compensation Committee met four times in 2025.&#160;The Nominating and Corporate Governance Committee met three times in 2025. The Compliance Committee met four&#160;times in 2025. Each Board and committee member attended at least 75% of the aggregate number of meetings of the Board and of the committees on which they served, held during the portion of the last fiscal year for which they were directors or committee members, respectively. The Company&#8217;s independent directors met four times in regularly scheduled executive sessions in 2025, at which only independent directors were present in compliance with applicable Nasdaq listing standards. Dr.&#160;Belldegrun, M.D., the Chair of the&#160;Board in 2025, presided over the executive sessions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Information Regarding our Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee and Compliance Committee </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee and Compliance Committee have authority to engage legal counsel or other experts or consultants, as each deems appropriate to carry out its responsibilities. Our Board has determined that each member of these committees meets the applicable Nasdaq rules and regulations regarding &#8220;independence&#8221; and each member is free of any relationship that would impair his or her individual exercise of independent judgment with regard to the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Audit Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Audit Committee consists of Ms. Butitta, Dr. Holden and Dr.&#160;Wen. Ms. Butitta serves as Chair of the Audit Committee.&#160;All members of our Audit Committee meet the requirements for financial literacy under the applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC") and Nasdaq. Our Board has determined that Ms. Butitta is an &#8220;audit committee financial expert&#8221; as such term is defined in the applicable SEC rules and has the requisite financial experience as defined by the Nasdaq listing standards. Each of the members of our Audit Committee is &#8220;independent&#8221; as such term is defined in Rule&#160;10A-3(b)(1) under the Exchange Act and satisfies the independent director requirements under the Nasdaq listing standards,&#160;including the standards specific to members of an audit committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Audit Committee charter sets forth the responsibilities of the Audit Committee consistent with the rules and regulations of the SEC and the Nasdaq listing standards, as well as the requirements for such committee under the Companies Law, including the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">oversight of our independent registered public accounting firm and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to the Board in accordance with Israeli law;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">recommending the engagement or termination of the person filling the office of our internal auditor; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">recommending the terms of audit and non-audit services provided by the independent registered public accounting firm for pre-approval by our Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Audit Committee provides assistance to our Board in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, internal control and legal compliance functions by pre-approving the services performed by our independent accountants and reviewing their reports regarding our accounting practices and systems of internal control over financial reporting. Our Audit Committee also oversees the audit efforts of our independent accountants and takes those actions that it deems necessary to satisfy itself that the auditors are independent of management.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Audit Committee is also responsible for overseeing our cybersecurity risk management processes, including oversight of risks from cybersecurity threats.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We believe that the composition and functioning of our Audit Committee complies with all applicable requirements of the Sarbanes-Oxley Act, and all applicable SEC and Nasdaq rules and regulations. We intend to comply with future requirements to the extent they become applicable to us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A copy of our Audit Committee charter is available for review on the &#8220;Investors &#8211; Governance&#8221; page of our website www.urogen.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Report of the Audit Committee of the Board of Directors*</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December&#160;31, 2025&#160;with management of the Company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the &#8220;PCAOB&#8221;) and the SEC. The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#8217; communications with the Audit Committee concerning independence and has discussed with the independent registered public accounting firm the accounting firm&#8217;s independence. Based on the foregoing, the Audit Committee has recommended to the Board that the audited financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Cynthia M. Butitta, Chair</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Stuart Holden, M.D.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Leana S. Wen, M.D., M.Sc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>*The material in this proxy statement is not </i>&#8220;<i>soliciting material,</i>&#8221;<i> is not deemed </i>&#8220;<i>filed</i>&#8221;<i> with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Compensation</b>&#160;<b>Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Compensation Committee consists of Dr. Belldegrun&#160;and Mr. Wildman. Mr. Wildman serves as Chair of the Compensation Committee. Each of these individuals is a non-employee director, as defined in Rule&#160;16b-3 promulgated under the Exchange Act. Our Board has determined that each of these individuals is &#8220;independent&#8221; as defined under the applicable listing standards of Nasdaq, including the standards specific to members of a compensation committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Compensation&#160;Committee is responsible for (i)&#160;recommending the compensation policy to our Board for its approval (and subsequent approval by our shareholders) and (ii)&#160;duties related to the compensation policy and to the compensation of our office holders, including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">recommending whether a compensation policy should continue in effect;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">recommending to the Board periodic updates to the compensation policy;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">assessing implementation of the compensation policy;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">determining whether to approve the terms of compensation of certain office holders which, according to the Companies Law, require the committee&#8217;s approval; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">determining whether the compensation terms of a candidate for the position of the chief executive officer of the Company needs to be brought to approval of the shareholders.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Compensation Committee charter sets forth the responsibilities of the Compensation Committee, which include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the responsibilities set forth in the compensation policy;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">reviewing and approving the granting of options and other incentive awards to the extent such authority is delegated by our Board; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">reviewing, evaluating and making recommendations regarding the compensation and benefits for our non-employee directors.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We believe that the composition and functioning of our Compensation Committee complies with all SEC and Nasdaq rules and regulations. We intend to comply with future requirements to the extent they become applicable to us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A copy of our Compensation Committee charter is available for review on the &#8220;Investors &#8211; Governance&#8221; page of our website&#160;www.urogen.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Nominating and Corporate Governance Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Our Nominating and Corporate Governance Committee consists of Mr. Robinson and Dr. Wen. Dr. Wen serves as Chair of the Nominating and Corporate Governance Committee. Each of these individuals is a non-employee director, as defined in Rule&#160;16b-3 promulgated under the Exchange Act. Our Board has determined that each of these individuals is &#8220;independent&#8221; as defined under the applicable listing standards of Nasdaq, including the standards specific to members of a nominating and corporate governance committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Nominating and Corporate Governance Committee is responsible for:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">overseeing our corporate governance functions on behalf of the Board;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">making recommendations to the Board regarding corporate governance issues;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">identifying and evaluating candidates to serve as our directors consistent with the criteria approved by the Board;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">reviewing and evaluating the performance of the Board;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">serving as a focal point for communication between director candidates, non-committee directors and our management;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">selecting or recommending to the Board for selection candidates to the Board; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">making other recommendations to the Board regarding affairs relating to our directors.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Nominating and Corporate Governance Committee does not intend to alter the way it evaluates candidates, based on whether or not the candidate was recommended by a shareholder. The Nominating and Corporate Governance Committee believes that it is in the best position to identify, review, evaluate and select qualified candidates for Board membership, based on the comprehensive criteria for Board membership approved by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Nominating and Corporate Governance Committee believes that the candidates for director, both individually and collectively, have the integrity, experience, judgment, commitment (including having sufficient time to devote to us and level of participation), skills, diversity, and expertise appropriate for us. In assessing the directors, both individually and collectively, the Nominating and Corporate Governance Committee considers our current needs and the needs of the Board, to maintain a balance of diversity of&#160;thought, knowledge, experience, capability, skills, viewpoints, and backgrounds. However, the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time. The Nominating and Corporate Governance Committee will consider director candidates recommended by shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">We believe that the composition and functioning of our Nominating and Corporate Governance Committee complies with all SEC and Nasdaq rules and regulations. We intend to comply with future requirements to the extent they become applicable to us.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A copy of our Nominating and Corporate Governance Committee charter is available for review on the &#8220;Investors &#8211; Governance&#8221; page of our website, www.urogen.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Compliance Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Compliance Committee consists of Dr. Holden, Mr. Robinson and Mr. Wildman, with Mr. Robinson serving as Chair of the committee.&#160;The Compliance Committee is responsible for the oversight of our non-financial compliance matters, including our overall compliance programs and their effectiveness, compliance policies and procedures, significant legal or regulatory compliance exposures of a compliance nature and material reports to or inquiries from government or regulatory agencies relating to compliance matters. The Compliance Committee charter sets forth the responsibilities of the Compliance Committee, which includes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">overseeing our implementation of compliance programs, policies and procedures that are designed to respond to the various compliance, legal and regulatory risks facing us;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">making recommendations to the Board regarding compliance with such legal and regulatory risks;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">assisting the Audit Committee as needed in fulfilling the Audit Committee&#8217;s oversight responsibility for our risk assessment and risk management activities relating to the integrity of our financial statements;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">assisting our compliance officer in fulfilling his/her responsibilities;&#160;and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">performing any other duties as directed by the Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Our Values</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="urgn20240606_def14aimg004.jpg" src="urgn20240606_def14aimg004.jpg" style="width:622;height:236;"/></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Environmental, Social &amp; Corporate Governance (</b>&#8220;<b>ESG</b>&#8221;<b>) Practices</b>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We are strongly committed to progress on ESG matters. As a company, we are committed to continued sustainable business operations, thoughtful social responsibility initiatives and maintaining governance structures that promote effective oversight. Our Board oversees and advises our management of our strategy, initiatives, risks, opportunities and reporting on ESG matters.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:9.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Environment</i></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<img alt="urgn20240606_def14aimg005.jpg" src="urgn20240606_def14aimg005.jpg" style="width:146;height:142;"/></p>
			</td>
			<td style="vertical-align:top;width:37%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Sustainability and Environmental Risk Management </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We understand our responsibility in operating our business in a sustainable manner. Just as we strive to understand and minimize the impact our business has on the environment; we have also committed to understanding and identifying the risks that climate change poses to our business. For example, as we continue to face the risk of disruptions caused by climate related events, we have evaluated the sufficiency of our physical distribution network, establishing distribution points and warehouses with our business partners to ensure our ability to deliver our products to patients.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Supply Chain</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our efforts also include developing and maintaining relationships with suppliers with a common focus on sustainability. Our business involves the use of hazardous materials and we and our third-party manufacturers and suppliers must comply with environmental laws and regulations<i>. </i>Our third-party subcontractors&#8217;&#160;and suppliers&#8217;&#160;activities involve the controlled storage, use, transportation and disposal of hazardous materials owned by us, including mitomycin, key components of our products and product candidates, and other hazardous compounds. As such, we engage with partners and suppliers with a framework for minimizing the environmental impact of their business, as well as their vulnerability to ongoing environmental and climate events. For example, our supplier for mitomycin contained in our approved products&#160;<i>Jelmyto</i><sup style="vertical-align:top;line-height:120%;">&#174;</sup>&#160;and <i>Zusduri&#8482;</i>, has ISO 14001 certification for its environmental management system aligning to ISO best practices.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:9.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Community</i></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<img alt="urgn20240606_def14aimg006.jpg" src="urgn20240606_def14aimg006.jpg" style="width:153;height:149;"/></p>
			</td>
			<td style="vertical-align:top;width:37%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Access to Care</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our mission is to build novel solutions to treat specialty cancers and urologic diseases because patients deserve better options. Our inventive approach combines innovative technology with new perspectives on traditional therapy to deliver breakthrough treatments.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We are committed to helping patients access our products&#160;<i>Jelmyto</i>&#160;and&#160;<i>Zusduri</i>. Our market access teams have laid the foundation for coverage and reimbursement, meeting multiple times with payors, and to date, the majority of large commercial plans have policies in place.&#160;Although <i>Jelmyto</i>&#160;has received Orphan Drug Designation from the FDA, it is offered under the 340b Drug Pricing Program to allow more patients the ability to access this treatment. Likewise, <i>Zusduri </i>is&#160;also offered under the 340b Drug Pricing Program.<i>&#160;</i>We also offer financial aid programs for eligible patients who have been prescribed <i>Jelmyto</i>&#160;and <i>Zusduri&#160;</i>and who need help managing the cost of treatment. For example, patients with commercial health insurance may qualify for the UroGen Support&#8482;&#160;Copay Program in which patients will pay as little as $50 per dose of <i>Jelmyto</i>&#160;and&#160;<i>Zusduri&#160;</i>for the cost of the drug. Additionally, patients without insurance may qualify for the UroGen Support Patient Assistance Program.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Additionally, we have entered into an arrangement with the Tanner Pharma Group ("Tanner"), a global provider of integrated specialty access solutions to launch named patient programs in select countries where <i>Jelmyto</i>&#160;is not commercially available. These named patient programs provide physicians with an appropriate mechanism to legally and ethically prescribe <i>Jelmyto </i>prior to its commercial availability.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Inclusivity</b>&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We strive to include perspectives from all walks of life, regardless of race, ethnicity, gender identity, sexual orientation, age, religion or disability.&#160;We believe our spectrum of backgrounds, identities, and abilities is what makes us stronger.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">With over 290 employees worldwide, we firmly believe every member of our team deserves to have their voice heard. We ensure transparency through an open-door policy and bringing&#160;together diverse perspectives from around our Company to build cross-departmental connection and collaboration.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:9.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Governance</i></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<img alt="urgn20240606_def14aimg007.jpg" src="urgn20240606_def14aimg007.jpg" style="width:150;height:167;"/></p>
			</td>
			<td style="vertical-align:top;width:37%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Ethics and Compliance</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As important as our mission, is how we conduct ourselves every day striving to achieve that mission on behalf of the patients that we collectively serve. That is why we are committed to conducting all aspects of our business consistent with the highest ethical standards and applicable laws and regulations that govern our industry, including and not limited to:</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">- Anti-kickback laws&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">- Medicare, Medicaid and the Medicaid Best Price Law&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">- Food, Drug, and Cosmetic Act and its implementing regulations&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">- The Pharmaceutical Research and Manufacturers of America Code on Interactions with&#160;Healthcare Professionals&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">- The Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As part of this commitment, we have adopted a Comprehensive Compliance Program (&#8220;CCP&#8221;) that is designed to prevent, detect and resolve potential compliance issues. Our CCP is designed to effectuate the principles and framework set forth in the &#8220;<i>Compliance Program Guidance for Pharmaceutical Manufacturers</i>&#8221;&#160;published&#160;by the U.S. Department of Health and Human Services Office of Inspector General in 2003 and the Pharmaceutical Research Manufacturers of America&#8217;s &#8220;<i>Code on Interactions with Healthcare Professionals.</i>&#8221;&#160;More information about our ethics and compliance program can be found at the&#160;&#8220;Who We Are&#8221;&#160;section of our website.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We have adopted a Corporate Code of Ethics and Conduct (the &#8220;Code of Conduct&#8221;) applicable to all of our employees, executive officers and directors. The Code of Conduct is available on our website at www.urogen.com. Our Audit Committee is responsible for monitoring the implementation of the Code of Conduct and must approve any material changes to or waivers of the Code of Conduct regarding our directors or executive officers, and disclosures made in the Company&#8217;s annual report in such regard. In addition, we intend to post on our website all disclosures that are required by law or the listing standards of the applicable stock exchange concerning any amendments to, or waivers from, any provision of the Code of Conduct.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Our Approach to Shareholder Engagement</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt;">We understand that engaging with our shareholders is a critical component of our overall governance strategy. Our approach is guided by our commitment to accountability, transparency, and responsiveness to our investors&#8217; needs and interests. We recognize that our shareholders play a critical role in our success and take their views seriously. Members of our management team and our Board regularly engage with many of our largest shareholders throughout the year to better understand their concerns, priorities and expectations. Our process for shareholder outreach and engagement occurs throughout the year.&#160;We hold an Annual General Meeting each year to provide our shareholders with an opportunity to meet with management and our board of directors, ask questions, and provide feedback on our business, commercial and development strategy. Following our Annual General Meeting, we review the voting results as well as reports published by Institutional Shareholder Services and Glass Lewis to gain an initial understanding of areas of focus. We&#160;reach out to shareholders to invite feedback and discussion to ensure an understanding of the areas of greatest interest to our shareholders. Beginning in January 2025, we actively sought feedback from investors representing over 80%&#160;of the Company&#8217;s total outstanding shares on issues such as executive compensation and governance to better inform our disclosures and address shareholder feedback. In addition, we conduct regular proactive outreach and accept inbound requests throughout the year, offering shareholders time with management, including but not limited to regular corporate updates and 1x1 meetings, reporting of quarterly financial results and operational updates, and presenting and meeting with shareholders at multiple industry and banking conferences. Over the 2025-2026&#160;cycle, areas of particular shareholder interest included the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Capital structure and ongoing capital requirements;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Commercial launch and ongoing commercialization of the Company&#8217;s products, <i>Jelmyto </i>and <i>Zusduri</i>;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Advancement of the Company&#8217;s pipeline including next generation mitomycin formulations (UGN-103 and UGN-104) and UGN-501; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">Competitive landscape in non-muscle invasive bladder cancer and low-grade upper tract urothelial cancer.</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Shareholder Communications with the Board </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Board expects that the views of our shareholders will be heard by the Board, its committees or individual directors, as applicable, and that appropriate responses be provided to shareholders on a timely basis. Shareholders wishing to formally communicate with the Board, any committee of the Board, the independent directors as a group or any individual director may send communications directly to us at UroGen Pharma Ltd. 400 Alexander Park Drive, 4th Floor, Princeton, New Jersey 08540, Attention: Corporate Secretary. All clearly marked written communications, other than unsolicited advertising or promotional materials, are logged and copied, and forwarded to the director(s) to whom the communication was addressed. Please note that the foregoing communication procedure does not apply to (i)&#160;shareholder proposals pursuant to Exchange Act Rule&#160;14a-8 and communications made in connection with such proposals or (ii)&#160;service of process or any other notice in a legal proceeding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL 1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ELECTION OF DIRECTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Our Board currently consists of seven directors. There are seven nominees for director this year, consisting of the following incumbent directors: Arie Belldegrun, M.D.;&#160;Elizabeth Barrett;&#160;Cynthia M. Butitta;&#160;Stuart Holden, M.D.; James A. Robinson, Jr.; Leana S. Wen, M.D., M.Sc.; and Daniel G. Wildman. Each director to be elected and qualified will hold office until our next annual meeting of shareholders and until his or her successor is elected, or, if sooner, until the director&#8217;s death, resignation or removal. Each of the nominees listed below is currently a director of the Company who was previously elected by the shareholders. It is the Company&#8217;s policy to invite director nominees to attend each annual meeting of shareholders. Three of our directors then serving on our Board attended the 2025&#160;annual meeting of shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Holders of proxies solicited by this proxy statement will vote the proxies received by them as directed on the proxy card or, if no direction is made, for the election of the Board&#8217;s seven nominees.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Each of the directors nominated by the Board has consented to serving as a nominee, being named in this proxy statement, and serving on the Board if elected. Each director elected at the Annual Meeting will be elected to serve until our next annual meeting of shareholders. If any nominee is unable or declines to serve as a director at the time of the Annual Meeting, the proxy holders may vote for any nominee designated by the present Board to fill the vacancy. The Company&#8217;s management has no reason to believe that any nominee will be unable to serve.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Nominees for Election</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our&#160;Nominating and Corporate Governance Committee and our Board seek to assemble a Board that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise and high-level management experience necessary to oversee and direct our business. To that end, our Board has identified and evaluated nominees in the broader context of our Board&#8217;s overall composition, with the goal of recruiting members who complement and strengthen the skills of other members and who also exhibit integrity, collegiality, sound business judgment and other qualities that our Board views as critical to effective functioning of our Board. The brief biographies below include information, as of the date of this proxy statement, regarding the specific and particular experience, qualifications, attributes or skills of each director or nominee that qualify such person to serve on our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b>&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Position Held With the Company</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Arie Belldegrun, M.D.</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">76</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chair of the Board</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Elizabeth Barrett</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">63</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President, Chief Executive Officer and Director</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cynthia M. Butitta</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">71</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stuart Holden, M.D.</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">83</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">James A. Robinson, Jr.</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">56</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Leana S. Wen, M.D., M.Sc.</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">43</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Daniel G. Wildman</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">69</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:21.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Arie Belldegrun, M.D.&#160;</i></b>has served as our Chair of the Board since December 2012. Dr. Belldegrun is a co-founder of Allogene Therapeutics, a public biopharmaceutical company, and has served as Executive Chairman of its board of directors since November 2017. From March 2014 until October 2017, Dr. Belldegrun served as the President and Chief Executive Officer of Kite Pharma, Inc. and as a member of its board of directors from June 2009 until October 2017. He was also a Director of Gingko Bioworks (from September 2021 to November 2024) and Chairman of Kronos Bio, Inc. (November 2017 to June 2025). Dr. Belldegrun currently serves as Chairman of Bellco Capital LLC (since 2004); Chairman and Partner of Two River (since June 2009); Co-chairman of Breakthrough Properties LLC and Breakthrough Services, L.L.C. (since April 2019);&#160;Co-chairman of Symbiotic Capital (since June 2023); and Director of ByHeart, Inc. (since October 2019). Dr. Belldegrun is also Senior Managing Director of Vida Ventures, LLC (since November 2017). Dr. Belldegrun is a Research Professor, holds the Roy and Carol Doumani Chair in Urologic Oncology, and is Founder and Director of the UCLA Institute of Urologic Oncology at the David Geffen School of Medicine at UCLA. Prior to joining UCLA, Dr. Belldegrun was at the National Cancer Institute/NIH as a research fellow in surgical oncology and immunotherapy under Dr. Steven A. Rosenberg. He completed his M.D. at the Hebrew University Hadassah Medical School in Jerusalem, his post-graduate studies in Immunology at the Weizmann Institute of Science, and his residency in urologic surgery at Harvard Medical School. He has authored several books on oncology and more than 500 scientific and medical papers related to urological cancers, immunotherapy, gene therapy and cancer vaccines. He is certified by the American Board of Urology and the American Association of Genitourinary Surgeons. Our Board believes Dr. Belldegrun&#8217;s business and medical knowledge and experience qualify him to serve on our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Elizabeth Barrett</i></b>&#160;has served as our President and Chief Executive Officer and as a director since January 2019. Prior to joining UroGen, Ms. Barrett served as the Chief Executive Officer of Novartis Oncology and a member of the Novartis Executive Committee since February 2018. Prior to Novartis, Ms. Barrett served at Pfizer Inc. in various leadership capacities, most recently as the Global President of Oncology and, before that, as President of Global Innovative Pharma for Europe, President of the Specialty Care Business Unit for North America, and Regional President of United States Oncology. Prior to Pfizer, Ms. Barrett was Vice President and General Manager of the Oncology Business Unit at Cephalon Inc. Ms. Barrett received an M.B.A. degree in Business Administration-Marketing from Saint Joseph&#8217;s University and a B.S. from the University of Louisiana. Ms. Barrett also served&#160;on the board&#160;of directors of Sage Therapeutics, Inc. (2019-2025) and currently serves on the board of directors of Allogene Therapeutics, Inc. (since 2021). Our Board believes Ms. Barrett&#8217;s service as our Chief Executive Officer and her leadership of both large organizations and growing businesses qualify&#160;her to serve on our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Cynthia M. Butitta</i></b>&#160;has served as our director since October 2017. Ms. Butitta served as Chief Financial Officer of Kite Pharma, Inc. from January 2014 to May 2016 and as its Chief Operating Officer from March 2014 to September 2017. From May 2011 to December 2012, she was Senior Vice President and Chief Financial Officer at NextWave Pharmaceuticals Inc., a specialty pharmaceutical company. Prior to that, Ms. Butitta served as Chief Operating Officer of Telik, Inc., a biopharmaceutical company, from March 2001 to December 2010 and as its Chief Financial Officer from August 1998 to December 2010. Ms. Butitta also served as Principal Accounting Officer of Telik, Inc. until December 2010.&#160;She has served as a Director of Autolus, Ltd., a biotechnology company, since March 2018; a board member of Olema Oncology since August 2020 and Century Therapeutics, Inc. from February 2021 to August 2025. Ms. Butitta received her B.S. degree with honors in Business and Accounting from Edgewood College in Madison, Wisconsin and her M.B.A. degree in Finance from the University of Wisconsin-Madison. Our Board believes Ms.&#160;Butitta&#8217;s financial knowledge and experience qualify her to serve on our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Stuart Holden, M.D.</i></b>&#160;has served as our director since December 2015. Dr.&#160;Holden has been the Chair of ProQuest Investments&#8217; Scientific Advisory Board since it was founded in 1998. Since May 2014, Dr.&#160;Holden has served as a member of the UCLA faculty as a Health Sciences Clinical Professor of Urology, Spielberg Family Chair in Urologic Oncology, in the Department of Urology at the UCLA David Geffen School of Medicine and Associate Director of the UCLA Institute of Urologic Oncology. Dr.&#160;Holden has worked in the field of prostate cancer for more than 36 years. Dr.&#160;Holden also serves as Medical Director of the Prostate Cancer Foundation since the foundation&#8217;s inception in 1993. Dr.&#160;Holden was the director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai Medical Center and the first holder of the Warschaw, Robertson, Law Families Chair in Prostate Cancer. Dr.&#160;Holden has served as a member of the board of directors of Telormedix SA from 2008 to 2017 and served as a member of the board of directors of Acurian, Inc. from 1999 through 2014. Dr.&#160;Holden also served on the Board of the American College of Medical Informatics from 1999 through 2006 and is currently on the board of Clarus Therapeutics, Inc. In addition, he was a founding partner at Tower Urology in Los Angeles. Dr.&#160;Holden received a B.S. degree from the University of Wisconsin-Madison and completed his medical degree and received his surgical training at Weill Cornell Medical College and the New York Hospital-Cornell University Medical College. He completed his urology residency at Emory University School of Medicine and fellowships in urology and developmental genetics at Memorial Sloan-Kettering Cancer Center. He also was awarded a clinical fellowship from the American Cancer Society. Our Board believes Dr.&#160;Holden&#8217;s medical knowledge and experience qualify him to serve on our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>James A. Robinson, Jr.</i></b> has served as our director since July 2023. Mr. Robinson currently serves as the President, Chief Executive Officer and member of the board directors of A2 Biotherapeutics, Inc. Prior to this role, he served as the Chief Executive Officer of Urovant Sciences, Inc. from March 2020 through June 2023 and has served as a member of Urovant&#8217;s board of directors from March 2019 through June 2023.&#160;Prior to Urovant Sciences, Mr. Robinson held the position of President and Chief Operating Officer at Paragon Biosciences, where he oversaw Paragon&#8217;s operations from April 2019 to March 2020. Previously, Mr. Robinson served as the President and Chief Operating Officer of Alkermes, where he was responsible for global commercial, new product planning, corporate planning, manufacturing, quality, human resources and business development functions. Prior to Alkermes, Mr. Robinson spent over twelve years at Astellas U.S., most recently as President, Americas Operations, where his responsibilities included all aspects of operations for North and South America. Prior to that, he was President of Astellas Pharma US, where he was responsible for leading the U.S. commercial organization. Prior to Astellas, Mr. Robinson spent thirteen years at Schering-Plough Pharmaceuticals, where his last role was Vice President, Hepatitis Sales and Managed Care. Mr. Robinson currently serves as an advisor to BridgeBio Pharma, Inc. and on the board of directors of Eledon Pharmaceuticals, Inc., a public&#160;biotechnology company,&#160;and Petauri Health, a private healthcare service company. Previously, Mr. Robinson served on the board of directors of Neos Therapeutics, Inc. prior to its acquisition by Aytu Biopharma, Inc. as well as the board of directors of Applied Genetic Technologies Corporation until its acquisition by Syncona LTD in November 2022. He also previously served on the board of directors of the Pharmaceutical Research and Manufacturers of America ("PhRMA") and served as Chairman of PhRMA&#8217;s State Committee. He is a founding member of MATTER. Mr. Robinson received a Bachelor of Science degree from DePaul University. Our Board believes Mr. Robinson&#8217;s broad business leadership experience, including his experience as an executive of commercial organizations, qualifies him to serve on our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Leana S. Wen, M.D., M.Sc.</i></b> has served as our director since August 2022. Dr. Wen is an emergency physician and has served as a faculty member&#160;at the George Washington University&#160;since September 2019. She has been a contributing columnist for The Washington Post since June 2020, writing on health policy and public health, and a health and medical expert for CNN since August 2020. From January 2015 to October 2018, she was the health commissioner for the city of Baltimore, where she led the nation&#8217;s oldest continuously operating health department to combat the opioid epidemic and improve maternal and child health. From 2013 to 2015, Dr. Wen served as director of patient-centered care research in the department of emergency medicine at George Washington University, and authored a critically-acclaimed book on patient advocacy. She is currently on the board of the Bipartisan Policy Center and the&#160;Baltimore Community Foundation, and chairs the advisory board of the Behavioral Health Group. She has also been a global health fellow at the World Health Organization, a consultant with the China Medical Board, and a nonresident senior fellow at the Brookings Institution. Dr. Wen also served as the President of Planned Parenthood from 2018 through 2019. She has been a member of more than ten nonprofit boards, including serving as the chair of Behavioral Health System Baltimore. Dr. Wen has also served on the board of directors of Glaukos Corporation since March 2021 and also serves on its audit committee. Dr. Wen&#8217;s work has been recognized by numerous professional organizations, including as one of Modern Healthcare&#8217;s Top 50 Physician-Executives and a member of the Council on Foreign Relationships. In 2019, she was named one of TIME magazine&#8217;s 100 Most Influential People and in 2022 as one of Modern Healthcare&#8217;s 100 Most Influential People in Healthcare. She holds a B.S. from California State University, Los Angeles, an M.D. from Washington University School of Medicine and two M.Sc.s from the University of Oxford, where she was a Rhodes Scholar. She completed her residency training at Brigham &amp; Women&#8217;s Hospital and Massachusetts General Hospital, where she was a clinical fellow at Harvard Medical School. Our Board believes Dr. Wen&#8217;s experience as a practicing physician, combined with her extensive experience working in governmental sectors, with innovative health companies, and serving on a public company board and audit committee and on nonprofit boards and foundations qualify her to serve on our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Daniel G. Wildman</i></b> has served as our director since November 2022. Mr. Wildman is Chairman of the Board of Progenerative Medical, Inc., a pre-commercial company translating clinically proven reduced pressure technology into medical treatments for orthopedic surgeries. He also serves on the board of directors of Nyxoah S.A.,&#160;Progenerative Medical, Inc. and&#160;PanTher Therapeutics, Inc. At Johnson &amp; Johnson, Mr. Wildman led&#160;the Digital Surgery Strategy initiative, where he was tasked with developing an integrated strategy for robotic surgery for the company. This strategy directly led to the 2019 acquisition of Auris Health, Inc. Prior to Digital Surgery, Mr. Wildman led&#160;Depuy Synthes Spine. In this role, he had overall responsibility for the second-largest spine surgery business in the world ($1.8B). He served in this capacity from August of 2015 to September of 2017, and during this period developed and implemented an integrated turn-around plan for the company. Previously, Mr. Wildman served as Worldwide President of Ethicon Biosurgery, a division of Ethicon, Inc. From 2003 to 2015 he led this global business dedicated to delivering innovative and life-saving solutions to surgeons via development and commercialization of biomaterial, biologic and combination products that changed the standard of care for intraoperative hemostasis. In this role, Mr. Wildman transitioned the company from Advanced Wound Care to Biosurgery through a combination of acquisitions, divestitures, and internal capability development, all focused on development and commercialization of meaningful innovations. The Biosurgery business at Ethicon continues to be one of the fastest growing companies in Johnson &amp; Johnson's portfolio. Prior to Johnson &amp; Johnson, Mr. Wildman spent 10 years with Boston Scientific Corporation in a variety of sales, marketing, operations and strategic planning roles of increasing responsibility. Mr. Wildman is an accomplished global leader. Throughout his career, he has earned a solid reputation for his strategic vision, motivational leadership, innovative technologies, ability to execute and his commitment to people development. Mr. Wildman received a Bachelor of Arts degree in Economics from St. Lawrence University in New York. Our Board believes Mr. Wildman&#8217;s business and executive experience qualify him to serve on our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Our Board unanimously recommends</b><br/>
<b>that you vote </b>&#8220;<b>FOR</b>&#8221;<b> each named nominee.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL 2</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TO APPROVE THE PROPOSED&#160;<span style="text-transform:uppercase">Articles of association</span></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Background</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">On March 19, 2026, our Board approved amending and restating the Articles of Association of the Company&#160;in the form attached hereto as Appendix A-1 to, among other things, tie eligibility for shareholder proposals to the requirements under the Companies Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Prior to March 2024, the Companies Law provided that one or more shareholders holding at least 1% of the voting rights in a company may request that the Board include a matter on the agenda of a general meeting of shareholders to be convened in the future, which is reflected in our existing Articles of Association (the &#8220;Existing Articles&#8221;). Under an amendment to regulations under the Companies Law that became effective in March 2024, for companies whose shares are listed for trade on an exchange outside of Israel such as us, a request that the Board include the appointment or removal of a director as a matter on the agenda of a general meeting of shareholders to be convened in the future requires that shareholders hold at least 5% of the voting rights in a company. As proposed to be amended and restated, among other things, the &#160;Proposed Articles of Association tie the right to request that a matter be included on the agenda of a shareholder meeting to the eligibility requirements under the Companies Law. This change also ensures that our Articles of Association remain consistent with any future changes to the Companies Law governing similar eligibility requirements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Proposed Articles of Association also make several other conforming and technical amendments and clarifications, including, but not limited to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Clarifying that our Board has authority to issue, in addition to options and warrants, &#8220;other securities&#8221;&#160;for the purchase of shares of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Proposed Articles of Association specify that no business shall be conducted at a shareholder meeting unless a quorum is present when the meeting proceeds to business, replacing the current formulation under the Existing Articles that requires a quorum at the time of voting on each resolution.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Existing Articles provide that our Board may dismiss our Chief Executive Officer, subject to any contract between our Chief Executive Officer and the Company. The Proposed Articles of Association remove this qualification, reflecting that while the Company may have contractual obligations to a departing Chief Executive Officer, those obligations do not limit our Board's corporate authority to dismiss our Chief Executive Officer.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Specifying<i>&#160;</i>which officers may only be appointed by our Board, and which officers may be appointed by our Chief Executive Officer.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Updating and reorganizing the indemnification, insurance and exculpation provisions for clarity and to reflect current Israeli law, including removing limitations that in any event apply by operation of law to insurance, indemnity, and exculpation and do not need to be expressly restated.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">All of the proposed amendments to the Existing Articles are shown in a marked version of the Proposed Articles of Association attached as Appendix&#160;A-2 to this proxy statement. The general description of the proposed amendments to the Existing Articles set forth above is qualified in its entirety by reference to the full text of the Proposed Articles of Association.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Proposed Resolution</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">It is proposed that at the Annual Meeting the following resolution be adopted:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8220;RESOLVED, that the amendment and restatement of the Articles of Association of UroGen Pharma Ltd., in the form attached as Appendix A-1 to UroGen Pharma Ltd.'s definitive proxy statement relating to its 2026 Annual Meeting of Shareholders, be, and hereby is, approved.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Our Board unanimously recommends</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>that you vote </b>&#8220;<b>FOR</b>&#8221;<b> the foregoing resolution.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL 3</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TO APPROVE<span style="text-transform:uppercase;">&#160;THE compensation policy&#160;AMENDMENT</span></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Background</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the Companies Law, companies incorporated under the laws of the State of Israel whose shares are listed for trading on a stock exchange or have been offered to the public in or outside of Israel, such as us, are required to adopt a policy governing the compensation of "office holders" (as defined in the Companies Law). Accordingly, we maintain a compensation policy for our non-employee directors and certain officers (the "Compensation Policy"), which our Board and shareholders adopted and approved in 2025. Under Israeli law, director and officer insurance is considered compensation, and therefore we are proposing certain related amendments to the Compensation Policy, as detailed below. On March 19, 2026, our Board, following the recommendation of our Compensation Committee, approved amending Section 2.2.3 of the Compensation Policy in the form attached hereto as Appendix B (the "Compensation Policy Amendment") and our shareholders are being asked to approve the Compensation Policy Amendment at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Compensation Policy Amendment, inter alia, (i) clarifies that the insurance, exculpation and indemnification arrangements are available to the Company's directors as well as its officers, and to the fullest extent permitted by applicable law, and (ii) specifies that the insurance arrangements (A) shall provide coverage in such amounts as shall be determined by the Compensation Committee and, if required by applicable law, the Board, (B) may include &#8220;run-off&#8221; or &#8220;tail&#8221; insurance and Public Offering of Securities Insurance (POSI) or similar insurance and the maximum period for &#8220;run-off&#8221; or &#8220;tail&#8221; insurance, and (C) shall be subject to the limitations that (1) the annual premium to be paid by the Company as well as the amount of the deductible for the Company shall be on market terms as of the date of the issuance of the policy and (2) the cost of the policy to the Company shall not have a material impact on the Company's profitability, assets or liabilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In recommending and approving the Compensation Policy Amendment, our Board and Compensation Committee considered that it was advisable to have the Compensation Policy clarify and specify the above matters consistent with market practice for Israeli-incorporated publicly traded companies. Under the Companies Law, subject to certain conditions, our Board may adopt the Compensation Policy Amendment even if it is not approved by the shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Proposed Resolution</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">It is proposed that at the Annual Meeting the following resolution be adopted:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8220;RESOLVED, that the amendment to the UroGen Pharma Ltd. Amended and Restated Non-Employee Director and Officer Compensation Policy, in the form attached as Appendix B to UroGen Pharma Ltd.'s definitive proxy statement relating to its 2026 Annual Meeting of Shareholders, be, and hereby is, approved.&#8221;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Our Board unanimously recommends</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>that you vote </b>&#8220;<b>FOR</b>&#8221;<b> the foregoing resolution.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL 4</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TO APPROVE AMENDMENTS&#160;TO THE COMPANY</b>&#8217;<b>S 2017 EQUITY INCENTIVE PLAN </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Background</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On March 19, 2026, our Board, following the recommendation of our Compensation Committee, amended the UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (the &#8220;2017 Plan&#8221;), subject to shareholder approval&#160;to increase the number of ordinary shares authorized for issuance under the 2017 Plan by 1,000,000 shares. We refer to the 2017 Plan, as amended on March 19, 2026, as the &#8220;Amended 2017 Plan&#8221; throughout this proxy statement. References in this proposal to our Board include the Compensation&#160;Committee of the Board, where applicable.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Why We Are Asking our Shareholders to Approve the Amended 2017 Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Currently, we maintain the 2017 Plan to grant stock options, restricted stock units, performance stock units and other stock awards in order to provide long-term incentives to our employees and directors. Approval of the Amended 2017 Plan by our shareholders will allow us to continue to grant stock options, restricted stock unit awards, performance stock units and other stock awards at levels determined appropriate by our Board or Compensation Committee. The Amended 2017 Plan allows us the potential to utilize a broad array of equity incentives and performance cash incentives in order to secure and retain the services of our employees and directors, and to provide long-term incentives that align the interests of our employees and directors with the interests of our shareholders.&#160;Our Board believes that the Amended 2017 Plan is an integral part of our long-term compensation philosophy, and the Amended 2017 Plan is necessary to continue providing the appropriate levels and types of equity compensation for our employees and directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Requested Shares</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to adjustment for certain changes in our capitalization, if this Proposal 4&#160;is approved by our shareholders, the aggregate number of ordinary shares that may be issued under the Amended 2017 Plan will not exceed the sum of (i) 1,400,000 shares initially reserved under the 2017 Plan, (ii) 250,167 shares added to the 2017 Plan pursuant to automatic increases pursuant to the provisions of the 2017 Plan,&#160;(iii) 1,900,000 shares added to the 2017 Plan in August 2018 pursuant to the approval of the Board and our shareholders, (iv) 400,000 shares added to the 2017 Plan in April 2020 pursuant to the approval of the Board and our shareholders, (v) 400,000 added to the 2017 Plan in March 2021 pursuant to the approval of the Board and subsequently approved by our shareholders on June 7, 2021, (vi) 400,000 shares added to the 2017 Plan in March 2022 pursuant to the approval of the Board and subsequently approved by our shareholders on June 8, 2022, (vii) 450,000 shares added to the 2017 Plan in July 2023 pursuant to approval of the Board and subsequently approved by our shareholders on September 7, 2023,&#160;(viii) 800,000 shares approved by the Board on June 14, 2024 and subsequently approved by our shareholders on August 6, 2024, (ix) 2,750,000 shares approved by the Board on June 30, 2025 and subsequently approved by our shareholders on August 26, 2025 and (x) 1,000,000 shares newly requested shares approved by the Board on March 19, 2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">We are hereby&#160;informing the SEC that, if the shareholders approve the Amended 2017 Plan, we intend to register the additional 1,000,000 shares that become authorized for issuance thereunder under a Registration Statement on Form S-8 prior to the end of 2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Why We Believe It</b>&#8217;<b>s Important to Vote to Approve the Amended 2017 Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Equity Awards Are an Important Part of Our Compensation Philosophy</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Board believes that our future success depends, in large part, on our ability to maintain a competitive position in retaining and motivating our overall employee base and&#160;key talent, including&#160;senior leadership. The Board believes that the issuance of equity awards is a key element underlying our ability to retain and motivate our employee base and&#160;key talent, including senior leadership, and aligns the longer-term interests of such personnel with those of our shareholders. The Amended 2017 Plan will allow us to continue to provide performance-based incentives to our eligible employees. Therefore, the Board believes that the Amended 2017 Plan is in the best interests of the Company and its shareholders and recommends a vote in favor of this Proposal 4.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>The Size of Our Share Reserve Request Is Reasonable</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of March 31, 2026, we had 1,888,694 shares available for grant under the 2017 Plan. If the Amended 2017 Plan is approved by our shareholders, we will have an additional 1,000,000&#160;shares available for grant after the Annual Meeting. We anticipate this to be a pool of shares necessary to provide a predictable amount of equity for retaining and motivating our employee base and&#160;key talent, including senior leadership. The size of our request is also reasonable in light of the equity granted to our employees and directors over the past year. If the Amended 2017 Plan is not approved by our shareholders, the existing 2017 Plan will continue in effect, but we will be limited in the grants that we will be able to make, which could place us in a disadvantageous position as compared with our competitors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>We Manage Our Equity Incentive Award Use Carefully, and Dilution Is Reasonable</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We continue to believe that equity awards such as stock options and restricted stock unit awards are a vital part of our overall compensation program. Our compensation philosophy reflects broad-based eligibility for equity incentive awards. However, we recognize that equity awards dilute existing shareholders, and, therefore, we must responsibly manage the growth of our equity compensation program. We are committed to effectively monitoring our equity compensation share reserve, including our &#8220;burn rate,&#8221; to ensure that we maximize shareholders&#8217; value by granting the appropriate number of equity incentive awards necessary to attract, reward, and retain employees and senior leadership. The tables below show our responsible overhang and burn rate percentages.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Overhang</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table provides certain additional information regarding our equity incentive program.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of March 31, 2026</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:39.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total number of ordinary shares subject to outstanding stock options</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2,390,854</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Weighted-average exercise price of outstanding stock options</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$25.42</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Weighted-average remaining term of outstanding stock options</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4.87 years</p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total number of ordinary shares subject to outstanding full value awards</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2,965,586</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total number of ordinary shares available for grant under the 2017 Equity Incentive Plan</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,888,694</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total number of shares of ordinary shares available for grant under all other equity incentive plans</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">164,098</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of April 29, 2026</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:39.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total number of ordinary shares outstanding<sup style="vertical-align:top;line-height:120%;">(1)</sup></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">50,337,223</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Per-share closing price of our ordinary shares&#160;as reported on Nasdaq Global Market</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$23.34<sup style="vertical-align:top;line-height:120%;">(2)</sup></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1) Represents ordinary shares outstanding plus 1,615,522&#160;ordinary shares that are subject to pre-funded warrants that we issued in our private placement financing in July&#160;2023 and in our underwritten public offering in June 2024,&#160;which pre-funded warrants are issued and outstanding as of April 29, 2026.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(2) Represents the closing price of our ordinary shares as reported on the Nasdaq Global Market on April 29, 2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Burn Rate</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table provides detailed information regarding the activity related to our equity incentive plans for fiscal years 2023-2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="10" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Fiscal Year</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2025</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2024</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:25.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total number of ordinary shares subject to stock options granted</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">122,500</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">238,614</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">530,000</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total number of ordinary shares subject to time-based full value awards granted</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">949,570</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">798,956</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">754,249</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total number of ordinary shares subject to performance-based full value awards earned</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">174,376</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">165,413</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">100,000</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Weighted-average number of ordinary shares outstanding</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">48,116,098<sup style="vertical-align:top;line-height:120%;">(2)</sup></td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">42,876,737<sup style="vertical-align:top;line-height:120%;">(2)</sup></td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">28,834,303<sup style="vertical-align:top;line-height:120%;">(1)</sup></td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Burn Rate</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2.59%</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">2.81%</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 5.6%; text-align: center;">4.80%</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">(1) Includes the impact of ordinary shares that are subject to pre-funded warrants that we issued in our private placement financing in July&#160;2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">(2) Includes the impact of ordinary shares that are subject to pre-funded warrants that we issued in our private placement financing in July 2023 and in our underwritten public offering in June 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Key Plan Features</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Amended 2017 Plan includes provisions that are designed to protect our shareholders&#8217; interests and to reflect corporate governance best practices including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Repricing is not allowed without shareholder approval</i>. The Amended 2017 Plan prohibits the repricing of outstanding stock options and stock appreciation rights and the cancelation of any outstanding stock options or stock appreciation rights that have an exercise or strike price greater than the then-current fair market value of our ordinary shares in exchange for cash or other stock awards under the Amended 2017 Plan without prior shareholder approval.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Shareholder approval is required for additional shares</i>. The Amended 2017 Plan does not contain an annual &#8220;evergreen&#8221;&#160;provision. The Amended 2017 Plan authorizes a fixed number of shares, so that shareholder approval is required to issue any additional shares, allowing our shareholders to have direct input on our equity compensation programs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>No liberal change in control provisions</i>. Our Amended 2017 Plan does not provide for single-trigger acceleration in the event of a change in control transaction.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>No liberal share recycling provisions</i>. Shares used to pay the exercise price of an award, or to satisfy the tax withholding obligations related to an award, will no longer be available for future grant under the Amended 2017 Plan.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>No dividends or dividend equivalents on unvested awards. </i>Dividends and dividend equivalents are subject to the same vesting provisions as the award to which they relate.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>No discounted stock options or stock appreciation rights</i>. All stock options and stock appreciation rights must have an exercise price equal to or greater than the fair market value of our ordinary shares on the date the stock option or stock appreciation right is granted.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Submission of amendments to the Amended 2017 Plan to shareholders.</i>&#160;The Amended 2017 Plan requires shareholder approval for material amendments to the Amended 2017 Plan, including, as noted above, any increase in the number of shares reserved for issuance under the Amended 2017 Plan.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Flexibility in designing equity compensation scheme.</i>&#160;The Amended 2017 Plan allows us to provide a broad array of equity incentives, including traditional option grants, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, other stock awards and performance cash awards. By providing this flexibility, we can quickly and effectively react to trends in compensation practices and continue to offer competitive compensation arrangements to attract and retain the talent necessary for the success of our business.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Broad</i>&#8209;<i>based eligibility for equity awards.</i>&#160;We grant equity awards to a large portion of our employees. By doing so, we tie our employees&#8217;&#160;interests with shareholder interests and motivate our employees to act as owners of the business.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Awards subject to forfeiture/clawback</i>. Awards granted under the Amended 2017 Plan will be subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, we may impose other clawback, recovery or recoupment provisions in an award agreement, including a reacquisition right in respect of previously acquired shares or other cash or property upon the occurrence of cause.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Administration by independent committee</i>. The Amended 2017 Plan will be administered by the members of our Compensation Committee, all of whom are &#8220;non-employee directors&#8221;&#160;within the meaning of Rule 16b-3 under the Exchange Act and &#8220;independent&#8221;&#160;within the meaning of the Nasdaq listing standards.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Description of the Amended 2017 Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The material features of the Amended 2017 Plan are described below. The following description of the Amended 2017 Plan is a summary only and is qualified in its entirety by reference to the complete text of the Amended 2017 Plan. Shareholders are urged to read the actual text of the Amended 2017 Plan in its entirety, which is attached hereto as Appendix C.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>General. </i>The Amended 2017 Plan provides for the grant of incentive stock options to our employees and for the grant of nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, performance cash awards, and other forms of stock awards to our employees, directors and consultants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Authorized Shares.</i> The maximum number of shares that may be issued under the Amended 2017 Plan is 9,750,167. The maximum number of ordinary shares that may be issued upon the exercise of incentive stock options under the Amended 2017 Plan is 5,600,000. Shares subject to awards granted under the Amended 2017 Plan that expire or terminate without being exercised in full, or that are paid out in cash rather than in shares, do not reduce the number of shares available for issuance under the Amended 2017 Plan. Additionally, shares issued pursuant to awards under the Amended 2017 Plan that we repurchase or that are forfeited become available for future grant under the Amended 2017 Plan. However, shares used to pay the exercise price of a stock award, or to satisfy the tax withholding obligations related to a stock award, are no longer available for future grant under the Amended 2017 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Plan Administration.</i> Our Board, or a duly authorized committee of our Board, administers the Amended 2017 Plan. Our Board may also delegate to one or more of our officers the authority to (1) designate employees (other than officers) to receive specified stock awards and (2) determine the number of shares subject to such stock awards. Under the Amended 2017 Plan, our Board has the authority to determine the terms of awards, including recipients, the exercise, purchase or strike price of stock awards, if any, the number of shares subject to each stock award, the fair market value of a share, the vesting schedule applicable to the awards, together with any vesting acceleration, the form of consideration, if any, payable upon exercise or settlement of the award and the terms of the award agreements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Section 162(m) Limits.</i> At such time as necessary for compliance with Section 162(m) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), no participant may be granted stock awards covering more than 500,000 of our ordinary shares under the Amended 2017 Plan during any calendar year pursuant to stock options, stock appreciation rights and other stock awards whose value is determined by reference to an increase over an exercise price or strike price of at least 100% of the fair market value of our ordinary shares on the date of grant. Additionally, no participant may be granted in a calendar year a performance stock award covering more than 500,000 of our ordinary shares or a performance cash award having a maximum value in excess of $3.0 million under the Amended 2017 Plan. These limitations were previously included in the 2017 Plan to allow us to grant compensation that would not be subject to the $1,000,000 annual limitation on the income tax deductibility of compensation paid to a covered executive officer imposed by Section 162(m) of the Code. As noted in the section of the "Executive Compensation"&#160;portion of this proxy statement entitled &#8220;Tax and Accounting Implications,&#8221; this exemption from Section 162(m)&#8217;s deduction limit for performance-based compensation has generally been repealed, effective for taxable years beginning after December 31, 2017. Despite this change in tax law, we have chosen to retain the limits in the Amended 2017 Plan. The presence of these limits (and other references to 162(m) in the Amended 2017 Plan) should not be taken to mean that the performance-based exemption will be applicable to awards under the Amended 2017 Plan, as it will indeed not be applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Stock Options.</i> Incentive stock options and nonstatutory stock options are granted pursuant to stock option agreements adopted by the plan administrator. The plan administrator determines the exercise price for stock options, within the terms and conditions of the Amended 2017 Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of a share on the date of grant. Options granted under the Amended 2017 Plan vest at the rate specified in the stock option agreement as determined by the plan administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Restricted Stock Unit Awards.</i> Restricted stock unit awards are granted pursuant to restricted stock unit award agreements adopted by the plan administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration that may be acceptable to our Board, or a duly authorized committee of our Board, and permissible under applicable law. A restricted stock unit award may be settled by cash, delivery of stock, a combination of cash and stock as deemed appropriate by the plan administrator or in any other form of consideration set forth in the restricted stock unit award agreement. Additionally, dividend equivalents may be credited in respect of shares covered by a restricted stock unit award. Except as otherwise provided in the applicable award agreement, restricted stock units that have not vested will be forfeited upon the participant&#8217;s cessation of continuous service for any reason.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Restricted Stock Awards.</i> Restricted stock awards are granted pursuant to restricted stock award agreements adopted by the plan administrator. A restricted stock award may be awarded in consideration for cash, check, bank draft or money order, past services to us or any other form of legal consideration that may be acceptable to our Board, or a duly authorized committee of our Board, and permissible under applicable law. The plan administrator determines the terms and conditions of restricted stock awards, including vesting and forfeiture terms. If a participant&#8217;s service relationship with us ceases for any reason, we may receive through a forfeiture condition or a repurchase right any or all of the shares held by the participant that have not vested as of the date the participant terminates service with us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Stock Appreciation Rights.</i> Stock appreciation rights are granted pursuant to stock appreciation grant agreements adopted by the plan administrator. The plan administrator determines the purchase price or strike price for a stock appreciation right, which generally cannot be less than 100% of the fair market value of a share on the date of grant. A stock appreciation right granted under the Amended 2017 Plan vests at the rate specified in the stock appreciation right agreement as determined by the plan administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Performance Awards.</i> The Amended 2017 Plan permits the grant of performance-based stock and cash awards. Our Compensation&#160;Committee may structure awards so that the stock or cash will be issued or paid only following the achievement of certain pre-established performance goals during a designated performance period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Other Stock Awards.</i> The plan administrator may grant other awards based in whole or in part by reference to our shares. The plan administrator will set the number of shares under the stock award and all other terms and conditions of such awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Changes to Capital Structure.</i> In the event there is a specified type of change in our capital structure, such as a stock split, reverse stock split or recapitalization, appropriate adjustments will be made to (1) the class and maximum number of shares reserved for issuance under the Amended 2017 Plan, (2) the class and maximum number of shares that may be issued upon the exercise of incentive stock options, (3) the class and maximum number of shares subject to stock awards that can be granted in a calendar year and (4) the class and number of shares and exercise price, strike price or purchase price, if applicable, of all outstanding stock awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Transactions.</i> The Amended 2017 Plan provides that in the event of certain specified significant transactions, including: (1) a sale of all or substantially all of our assets, (2) the sale or disposition of more than 50% of our outstanding securities, (3) the consummation of a merger or consolidation where we do not survive the transaction and (4) the consummation of a merger or consolidation where we do survive the transaction but our shares outstanding prior to such transaction are converted or exchanged into other property by virtue of the transaction, unless otherwise provided in an award agreement or other written agreement between us and the award holder, the administrator may take one or more of the following actions with respect to such stock awards: (1) arrange for the assumption, continuation or substitution of a stock award by a successor corporation, (2) arrange for the assignment of any reacquisition or repurchase rights held by us to a successor corporation, (3) accelerate the vesting, in whole or in part, of the stock award and provide for its termination prior to the transaction, (4) arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us, (5) cancel or arrange for the cancellation of the stock award prior to the transaction in exchange for a cash payment, if any, determined by the Board or (6) make a payment, in the form determined by the Board, equal to the excess, if any, of the value of the property the participant would have received upon exercise of the awards prior to the transaction over any exercise price payable by the participant in connection with the exercise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Transferability.</i> A participant may not transfer stock awards under the Amended 2017 Plan other than by will, the laws of descent and distribution or as otherwise provided under the Amended 2017 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Plan Amendment or Termination.</i> Our Board has the authority to amend, suspend or terminate the Amended 2017 Plan, provided that such action does not materially impair the existing rights of any participant without such participant&#8217;s written consent. Certain material amendments also require the approval of our shareholders. No incentive stock options may be granted after the tenth anniversary of the date our Board adopted the Amended 2017 Plan. No stock awards may be granted under the Amended 2017 Plan while it is suspended or after it is terminated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>U.S. Federal Income Tax Consequences</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The information set forth below is a summary only and does not purport to be complete. The information is based upon current federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any recipient may depend on his or her particular situation, each recipient should consult the recipient&#8217;s tax adviser regarding the federal, state, local, and other tax consequences of the grant or exercise of an award or the disposition of stock acquired as a result of an award. The Amended 2017 Plan is not qualified under the provisions of Section 401(a) of the Code and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Nonstatutory Stock Options</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Generally, there is no taxation upon the grant of a nonstatutory stock option if the stock option is granted with an exercise price equal to the fair market value of the underlying stock on the grant date. On exercise, an optionholder will recognize ordinary income equal to the excess, if any, of the fair market value on the date of exercise of the stock over the exercise price. If the optionholder is employed by us or one of our affiliates, that income will be subject to withholding taxes. We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the optionholder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Incentive Stock Options</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Amended 2017 Plan provides for the grant of stock options that qualify as &#8220;incentive stock options,&#8221; as defined in Section 422 of the Code. Under the Code, an optionholder generally is not subject to ordinary income tax upon the grant or exercise of an incentive stock option (&#8220;ISO&#8221;) (although, in certain circumstances, there may be an item of adjustment included for alternative minimum tax purposes). If the optionholder holds a share received on exercise of an ISO for more than two years from the date the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition of that share and the holder&#8217;s tax basis in that share will be long-term capital gain or loss. If, however, an optionholder disposes of a share acquired on exercise of an ISO before the end of the required holding period, which is referred to as a disqualifying disposition, the optionholder generally will recognize ordinary income in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date the ISO was exercised over the exercise price.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We are not allowed an income tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired on exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we are generally allowed a deduction in an amount equal to the ordinary income includible in income by the optionholder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Restricted Stock Awards</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30 days following his or her receipt of the stock award, to recognize ordinary income, as of the date the recipient receives the award, equal to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient for the stock. We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Restricted Stock Unit Awards</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Generally, the recipient of a stock unit structured to conform to the requirements of Section 409A of the Code or an exception to Section 409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair market value of our ordinary shares received over any amount paid by the recipient in exchange for our ordinary shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Stock Appreciation Rights</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We may grant under the Amended 2017 Plan stock appreciation rights separate from any other award or in tandem with other awards under the Amended 2017 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Where the stock appreciation rights are granted with a strike price equal to the fair market value of the underlying stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Section 162(m) Limitations</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Compensation of persons who are &#8220;covered employees&#8221; of the Company is subject to the tax deduction limits of Section 162(m) of the Code. The exemption from Section 162(m)&#8217;s deduction limit for performance-based compensation has generally been repealed, effective for taxable years beginning after December 31, 2017. Our Compensation&#160;Committee has reserved the right to grant compensation that is not tax deductible if it determines that doing so will better meet the Company&#8217;s goals and objectives. For more information about Section 162(m), please see &#8220;Tax and Accounting Implications&#8221; in the "Executive Compensation"&#160;section.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>New Plan Benefits</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company cannot currently determine the benefits or number of shares subject to awards that may be granted in the future to executive officers, directors, and employees under the Amended 2017 Plan. We do not presently have any arrangements, written or otherwise, to issue any of the newly available authorized shares under the Amended 2017 Plan, except as set forth below with respect to non-employee directors. As of March 31, 2026, we had 298&#160;employees, 20&#160;consultants and six non-employee directors who would be eligible to receive grants under the Amended 2017 Plan. Awards granted under the Amended 2017 Plan to our non-employee directors are not subject to set benefits or amounts under the terms of the Amended 2017 Plan itself. For additional information regarding our current compensation program for non-employee directors, please see below in the section entitled &#8220;Director Compensation.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Option Awards Granted Under the 2017 Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table sets forth, for each of the individuals and various groups indicated, the total number of ordinary shares subject to option awards that have been granted (even if not currently outstanding) under the 2017 Plan as of March 31, 2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>2017 Equity Incentive Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name and Position</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As of March 31, 2026</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of Shares underlying </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Option Awards<sup style="vertical-align:top;line-height:120%;">(1)</sup></b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Elizabeth Barrett, Chief Executive Officer</i></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:13.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">747,432</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;"><i>Mark Schoenberg, Chief Medical Officer</i></td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 13.9%; text-align: center;">100,564</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Jason Smith, General Counsel and Chief Compliance Officer</i></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:13.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">153,000</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">All current executive officers as a group</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:13.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,075,138</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">All current directors who are not executive officers as a group</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:13.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">500,000</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Each nominee for election as a director:</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:13.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 31%; padding-left: 9pt;">Arie Belldegrun, M.D.</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 13.9%; text-align: center;">130,000</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 31%; padding-left: 9pt;">Cynthia M. Butitta</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 13.9%; text-align: center;">130,000</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 31%; padding-left: 9pt;">Elizabeth Barrett</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 13.9%; text-align: center;">747,432</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 31%; padding-left: 9pt;">Stuart Holden, M.D.</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 13.9%; text-align: center;">90,000</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 31%; padding-left: 9pt;">James A. Robinson, Jr.</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 13.9%; text-align: center;">50,000</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 31%; padding-left: 9pt;">Leana S. Wen, M.D., M.Sc.</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 13.9%; text-align: center;">50,000</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 31%; padding-left: 9pt;">Daniel G. Wildman</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align: bottom; width: 13.9%; text-align: center;">50,000</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Each associate of any executive officers, current directors or director nominees</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:13.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Each other person who received or is to receive 5% of awards</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:13.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">-</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">All employees, including all current officers who are not executive officers, as a group <sup style="vertical-align:top;line-height:120%;">(2)</sup></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:13.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3,272,400</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The table above only includes stock options granted and does not include restricted stock awards or performance stock awards granted.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Amount represents the number of all stock option awards ever granted under the 2017 Plan, including to previous employees and officers who are not executive officers.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Securities Authorized for Issuance Under Equity Compensation Plans</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes our compensation plans under which our equity securities are authorized for issuance at December&#160;31, 2025:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:21.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Plan category</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of securities</b><br/>
			<b>to be issued upon</b><br/>
			<b>exercise of</b><br/>
			<b>outstanding options,</b><br/>
			<b>warrants and rights</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Weighted-average exercise</b><br/>
			<b>price of outstanding options,</b><br/>
			<b>warrants and rights<sup style="vertical-align:top;line-height:120%;">(3)</sup></b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of securities remaining</b><br/>
			<b>available for</b><br/>
			<b>future issuance under equity</b><br/>
			<b>compensation plans</b><br/>
			<b>(excluding securities</b><br/>
			<b>reflected in column (a))</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.3%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td colspan="2" style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(a)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td colspan="2" style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(b)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td colspan="2" style="vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(c)</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Equity compensation plans approved by security holders</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2,168,730</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$26.64</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3,185,216</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;text-indent:-9pt;">Equity compensation plans not approved by security holders<sup style="vertical-align:top;line-height:120%;">(1)</sup></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-variant: normal; text-align: center; margin: 0pt; font-size: 10pt;">252,124<sup style="vertical-align:top;line-height:120%;">(2)</sup></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$14.57</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">240,697</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2,420,854</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$25.38</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:double 3px #000000;vertical-align:bottom;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3,425,913</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
		</tr>

</tbody></table>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In May 2019, we adopted the UroGen Pharma Ltd. 2019 Inducement Plan (the &#8220;Inducement Plan&#8221;) without the approval of our security holders. Under the Inducement Plan, the Company was originally authorized to issue up to&#160;900,000&#160;ordinary shares pursuant to awards issued under the Inducement Plan.&#160;In December 2021, the Board approved a 300,000 share increase in the reserve of the Inducement Plan. In June 2024, the Board approved a 600,000 share increase in the reserve of the Inducement Plan. Our Inducement Plan provides for the grant of nonstatutory stock options, restricted stock unit awards, and other awards. The only persons eligible to receive awards under our Inducement Plan are individuals who satisfy the standards for inducement grants under Nasdaq Marketplace Rule 5635(c)(4) or 5635(c)(3) and the related guidance under Nasdaq IM&#160;5635-1,&#160;including individuals who were not previously an employee or director of the Company or are following a bona fide period of&#160;non-employment,&#160;in each case as an inducement material to such individual&#8217;s agreement to enter into employment with the Company.&#160;In addition, awards granted under our Inducement Plan must be approved by either a majority of the Company&#8217;s &#8220;independent directors&#8221;&#160;(as such term is defined in Nasdaq Marketplace Rule 5605(a)(2)) or the Compensation Committee, provided such committee comprises solely independent directors. The terms of our Inducement Plan are otherwise substantially similar to our Amended 2017 Plan (including with respect to the treatment of awards upon corporate transactions involving us or certain changes in our capitalization).</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of December 31, 2025, options to purchase 252,124&#160;ordinary shares and restricted stock units covering 440,314&#160;shares were outstanding under the Inducement Plan. All options granted under the Inducement Plan have a maximum term of ten years. The Inducement Plan, and awards thereunder, may be amended by the Board at any time or from time to time in accordance with the terms of the Inducement Plan and applicable law.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:3.3%;">&#160;</td>
			<td style="vertical-align:middle;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The weighted-average exercise price does not take into account the shares subject to outstanding restricted stock units which have no exercise price.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Proposed Resolutions</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">It is proposed that at the Annual Meeting the following resolution be adopted:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;RESOLVED, that the&#160;UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended, in the form attached as Appendix C&#160;to UroGen Pharma Ltd.&#8217;s definitive proxy statement relating to its 2026&#160;Annual Meeting of Shareholders, be, and hereby is, approved.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Our Board unanimously recommends</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>that you vote </b>&#8220;<b>FOR</b>&#8221;<b> the foregoing resolution.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>PROPOSAL 5</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>ADVISORY VOTE ON EXECUTIVE COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In accordance with the requirements of Section 14A of the Exchange Act and the related rules of the SEC, in 2025, our Board adopted a policy to solicit a non-binding advisory vote on the compensation of our named executive officers, commonly referred to as a &#8220;say-on-pay vote,&#8221; every year. This vote is not intended to address any specific item of compensation, but rather the overall compensation of the Company&#8217;s named executive officers and the philosophy, policies and practices described in this proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The compensation of the Company&#8217;s named executive officers subject to the vote is disclosed in the &#8220;Executive Compensation&#8221; section, including the compensation tables and the related narrative disclosure, contained in this proxy statement. As discussed in those disclosures, the Company believes that its compensation policies and decisions are focused on pay-for-performance principles and strongly aligned with our shareholders&#8217; interests, consistent with current market practices. Compensation of the Company&#8217;s named executive officers is designed to enable the Company to attract and retain talented and experienced executives to lead the Company successfully in a competitive environment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accordingly, the Board is asking the shareholders to indicate their support for the compensation of the Company&#8217;s named executive officers as described in this proxy statement by casting a non-binding advisory vote &#8220;FOR&#8221; the following resolution:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;RESOLVED, that the compensation paid to the Company&#8217;s named executive officers, as disclosed pursuant to Item 402 of Regulation&#160;S-K, including the compensation tables and narrative discussion, is hereby approved.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Our Board unanimously recommends</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>that you vote </b>&#8220;<b>FOR</b>&#8221;<b> the foregoing resolution.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Because the vote is advisory, it is not binding on the Board or the Company. Nevertheless, the views expressed by the shareholders, whether through this vote or otherwise, are important to management and the Board and, accordingly, the Board and the Compensation Committee intend to consider the results of this vote in making determinations in the future regarding executive compensation arrangements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We will conduct our next say-on-pay vote at our 2027&#160;annual meeting of shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL 6</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our Audit Committee has selected PricewaterhouseCoopers LLP (&#8220;PwC US&#8221;) as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2026&#160;and through our 2027&#160;annual meeting of shareholders. Israeli law requires that our shareholders shall confirm the appointment of our independent registered public accounting firm at the Annual Meeting.&#160;Representatives of PwC US are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If the shareholders fail to ratify the selection, the Audit Committee will consider retaining an alternate independent registered public accounting firm.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Principal Accountant Fees and Services</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The following table represents aggregate fees billed to us for the years ended December&#160;31, 2025&#160;and 2024, by PwC US.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" class="finTable" style="border-collapse: collapse; width: 75%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 12.5%; margin-right: 12.5%;">

		<tbody><tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="6" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Year Ended December 31,</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>2025</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>2024</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="6" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>(in thousands)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit Fees<sup style="vertical-align:top;line-height:120%;">(1)</sup></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">1,380</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">1,384</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">All Other Fees<sup style="vertical-align:top;line-height:120%;">(2)</sup></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">2</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">2</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">1,382</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">1,386</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&#160;</td>
		</tr>

</tbody></table>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 75%; margin-left: 12.5%; margin-right: 12.5%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 3px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: 28px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(1)</p>
			</td>
			<td style="vertical-align: top; width: 1476px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the years ended December 31, 2025 and 2024, the aggregate audit fees were for professional services rendered for audits (including audits of statutory financial statements), quarterly reviews of our consolidated financial statements, preparation of comfort letters and consents associated with registration statements.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 75%; margin-left: 12.5%; margin-right: 12.5%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(2)</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For the years ended December 31, 2025 and 2024, all other fees were for accounting research subscription services.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">All fees described above were pre-approved by the Audit Committee.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Pre-Approval Policies and Procedures</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Audit Committee must pre-approve all audit, audit-related and all permitted non-audit services, and related fees and terms, to be provided to the Company by the independent auditor under applicable law and regulations. Pre-approval may be given as part of the Audit Committee&#8217;s approval of the scope of the engagement of the independent auditor or on an individual, explicit, case-by-case basis before the independent auditor is engaged to provide each service. The pre-approval of services may be delegated to the Audit Committee&#8217;s Chairperson, but the decision must be reported to the full Audit Committee at its next scheduled meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Audit Committee has determined that the rendering of services other than audit services by PwC US is compatible with maintaining the principal accountant&#8217;s independence.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Proposed Resolutions</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">It is proposed that at the Annual Meeting the following resolution be adopted:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;RESOLVED, that the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm as the Company&#8217;s independent auditor until the 2027 Annual Meeting of Shareholders as described in the Company&#8217;s definitive proxy statement relating to its 2026&#160;Annual Meeting of Shareholders, be, and hereby is, approved.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Our Board unanimously recommends</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>that you vote </b>&#8220;<b>FOR</b>&#8221;<b> the foregoing resolution.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITY OWNERSHIP OF</b><br/>
<b>CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The following table sets forth certain information relating to the beneficial ownership of our ordinary shares as of March 31, 2026, by:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 27px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 776px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our outstanding ordinary shares;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">each of our directors and each nominee for director;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 56px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 1686px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">each of our named executive officers; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 14px;">&#160;</td>
			<td style="vertical-align: middle; width: 55px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 1686px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">all of our current directors and executive officers as a group.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Beneficial ownership is based upon 48,708,280&#160;ordinary shares issued and outstanding as of March 31, 2026&#160;and determined in accordance with the rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment power. Unless otherwise indicated, we believe that the persons or entities identified in this table have sole voting and investment power with respect to all shares shown beneficially owned by them, subject to applicable community property laws. Ordinary shares issuable upon vesting of outstanding equity awards that are exercisable or subject to vesting within 60 days after March 31, 2026&#160;are deemed beneficially owned and such shares are used in computing the percentage ownership of the person holding the awards but are not deemed outstanding for the purpose of computing the percentage ownership of any other person. The information contained in the following table is not necessarily indicative of beneficial ownership for any other purpose, and the inclusion of any shares in the table does not constitute an admission of beneficial ownership of those shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise noted below, the address of each shareholder, director and executive officer is c/o UroGen Pharma Ltd., 400 Alexander Park Drive, 4<sup style="vertical-align:top;line-height:120%;">th</sup>&#160;Floor, Princeton, New Jersey 08540.</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 77%; margin-left: 11.5%; margin-right: 11.5%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name of Beneficial Owner</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Ordinary Shares</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Percent</b></p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Greater than 5% Shareholders</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">RTW Investments, LP&#160;&#160;<sup style="vertical-align:top;line-height:120%;">(1)</sup></td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">4,865,957</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">9.9</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">%</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Paradigm BioCapital Advisors LP&#160;<sup style="vertical-align:top;line-height:120%;">(2)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">4,216,084</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">8.7</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">%</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Blackrock, Inc.<sup style="vertical-align:top;line-height:120%;">(3)</sup></td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">2,519,771</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">5.2</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">%</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Morgan Stanley&#160;<sup style="vertical-align:top;line-height:120%;">(4)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2,488,299</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">5.1</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">%</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Directors and Named Executive Officers</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Elizabeth Barrett&#160;<sup style="vertical-align:top;line-height:120%;">(5)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1,074,123</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2.2</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">%</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Mark Schoenberg&#160;<sup style="vertical-align:top;line-height:120%;">(6)</sup></td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">245,549</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">*</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Jason Smith&#160;<sup style="vertical-align:top;line-height:120%;">(7)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">204,326</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Arie Belldegrun, M.D.<sup style="vertical-align:top;line-height:120%;">(8)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">513,693</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1.1</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">%</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Cynthia M. Butitta&#160;<sup style="vertical-align:top;line-height:120%;">(9)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">129,500</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Stuart Holden, M.D.&#160;<sup style="vertical-align:top;line-height:120%;">(10)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">89,500</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Leana Wen, M.D., M.Sc.&#160;<sup style="vertical-align:top;line-height:120%;">(11)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">49,500</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Daniel G.&#160;Wildman&#160;<sup style="vertical-align:top;line-height:120%;">(12)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">49,500</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">James A. Robinson Jr.&#160;<sup style="vertical-align:top;line-height:120%;">(13)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">49,834</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">*</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 64%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">All current directors and executive officers as a group (10&#160;persons)&#160;<sup style="vertical-align:top;line-height:120%;">(14)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 20%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2,432,519</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">4.8</p>
			</td>
			<td style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">%</p>
			</td>
		</tr>

</tbody></table>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indicates beneficial ownership of less than 1% of the total ordinary shares outstanding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 1.59375px;">&#160;</td>
			<td style="vertical-align: top; width: 27px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align: top; width: 1727px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Represents ordinary shares beneficially owned as of September&#160;30, 2024, up to the beneficial ownership blocker described below, based on a Schedule 13G/A filed on November 14, 2024, by RTW Investments, LP ("RTW Investments").&#160;In such filing, RTW Investments lists its address as 40 10th Avenue, Floor 7, New York, New York 10014, and indicates that it has shared voting power with respect to 4,930,204&#160;ordinary shares, including 1,142,857 ordinary shares issuable upon exercise of warrants, and shared dispositive power with respect to 4,930,204&#160;ordinary shares, including 1,142,857 ordinary shares issuable upon exercise of warrants.&#160;The warrants are subject to a 9.99% beneficial ownership blocker. RTW Investments is the investment adviser to certain funds (the "RTW Funds") with respect to the ordinary shares and ordinary shares issuable upon exercise of the warrants directly held by the RTW Funds. Roderick Wong, M.D. is the Managing Partner and Chief Investment Officer of RTW Investments.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: 27px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align: top; width: 1728px;">Represents ordinary shares beneficially owned as of September 30, 2025 based on a Schedule 13G/A filed on November 14, 2025 by the following (the "Reporting Persons"): (1) Paradigm BioCapital Advisors LP (the "Adviser"); (2) Paradigm BioCapital Advisors GP LLC (the "Adviser GP"); (3) Senai Asefaw, M.D. ("Senai Asefaw"); and (4) Paradigm BioCapital International Fund Ltd. (the "Fund").&#160;The Fund is a private investment vehicle. The Fund and one or more separately managed accounts managed by the Adviser (the "Account") directly beneficially own the ordinary shares reported in the Schedule 13G/A. The Adviser is the investment manager of the Fund and the Account. The Adviser GP is the general partner of the Adviser. Senai Asefaw is the managing member of the Adviser GP. The Adviser, the Adviser GP and Senai Asefaw may be deemed to beneficially own the ordinary shares directly beneficially owned by the Fund and the Account. The principal business office of the Adviser, the Adviser GP and Senai Asefaw is 767 Third Avenue, 17th Floor, New York, NY 10017.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: 28px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="vertical-align: top; width: 1727px;">Represents ordinary shares beneficially owned as of March 31, 2026 based on a Schedule 13G filed on April 27, 2026 by&#160;BlackRock, Inc.&#160;In such filing, BlackRock, Inc.&#160;lists its address as BlackRock, Inc., 50 Hudson Yards, New York, NY 10001, and indicates that it has shared voting power with respect to 2,461,477 ordinary shares and shared dispositive power with respect to 2,519,771 ordinary shares.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 29px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="vertical-align: top; width: 1726px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Represents ordinary shares beneficially owned as of June 30, 2025, based on a Schedule 13G&#160;filed on August 6, 2025, by Morgan Stanley.&#160;In such filing, Morgan Stanley lists its address as 1585 Broadway, New York, NY 10036, and indicates that it has shared voting power with respect to&#160;2,488,299 ordinary shares for an aggregate of 2,488,299 ordinary shares beneficially owned, or that may be deemed to be beneficially owned, by certain operating units of Morgan Stanley and its subsidiaries and affiliates.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(5)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consists of 326,691&#160;ordinary shares and 747,432 ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(6)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consists of 144,985 ordinary shares and 100,564 ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(7)</p>
			</td>
			<td style="vertical-align: top; width: auto;">Consists of 51,326 ordinary shares and 153,000 ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(8)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consists of 408,693 ordinary shares and 105,000 ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(9)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consists of 2,000 ordinary shares and 127,500 ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: 28px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(10)</p>
			</td>
			<td style="vertical-align: top; width: 1725px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consists of 2,000 ordinary shares and 87,500&#160;ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: 29px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(11)</p>
			</td>
			<td style="vertical-align: top; width: 1725px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consists of 2,000 ordinary shares and 47,500 ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: 29px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(12)</p>
			</td>
			<td style="vertical-align: top; width: 1725px;">Consists of 2,000 ordinary shares and 47,500 ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: 28px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(13)</p>
			</td>
			<td style="vertical-align: top; width: 1725px;">Consists of 2,000 ordinary shares and 45,834 ordinary shares issuable upon exercise of options or upon settlement of restricted stock units within 60 days following March 31, 2026.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: 28px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(14)</p>
			</td>
			<td style="vertical-align: middle; width: 1727px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Includes the shares described in notes (4) through (12) and 26,994 ordinary shares (which includes 24,714 ordinary shares issuable upon the exercise of options or upon settlement of restricted stock units within 60 days of March 31, 2026) beneficially owned by an additional executive officer who is not named in the table above.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXECUTIVE OFFICERS OF THE COMPANY</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table sets forth information concerning our executive officers, including their ages, as of the date of this proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name of Executive Officer</b></p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:26.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Position(s)</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Elizabeth Barrett</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">63</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:26.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President, Chief Executive Officer and Director</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chris Degnan</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align: top; width: 2.7%; text-align: center;">46</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:26.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark P. Schoenberg, M.D.</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">68</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:26.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Medical Officer</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jason Smith</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:2.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">54</p>
			</td>
			<td style="vertical-align:top;width:0.4%;">&#160;</td>
			<td style="vertical-align:top;width:26.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">General Counsel and Chief Compliance Officer</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The biography of Ms. Barrett is set forth under the heading &#8220;Information Concerning Our Directors&#8221; above.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Chris Degnan</i></b>&#160;has served as our Chief Financial Officer since October 2024. Prior to joining UroGen, Mr. Degnan&#160;served as the Chief Financial Officer of&#160;Galera Therapeutics, Inc., a public, late-stage biopharmaceutical company focused on oncology, from October 2019 to August 2024. Prior to Galera, Mr. Degnan served as the Chief Financial Officer of&#160;Verrica Pharmaceuticals Inc., a public, biotechnology company focused on medical dermatology, from March 2018 to October 2019. Prior to Verrica, Mr. Degnan held roles of increasing responsibility at Endo International plc, a generics and specialty branded pharmaceutical company, beginning in November 2014. At Endo, Mr. Degnan&#160;most recently served as the Vice President of Finance, Corporate FP&amp;A and International Pharmaceuticals Segment Chief Financial Officer from December 2016 to March 2018. Prior to that, he served as the Vice President of Finance, Chief Financial Officer for Endo&#8217;s U.S. Branded Pharmaceuticals segment from March 2016 to December 2016, and as the Senior Finance Director, U.S. Branded Pharmaceuticals from November 2014 to March 2016. Prior to joining Endo, Mr. Degnan held roles of increasing responsibility at AstraZeneca plc, a global biopharmaceutical company, beginning in 2004. At AstraZeneca, Mr. Degnan&#160;most recently served as Senior Finance Director, U.S. Commercial Finance from July 2013 to November 2014. Mr. Degnan&#160;is a Certified Public Accountant in the State of Pennsylvania (voluntary inactive status) and holds a B.B.A. degree in Accountancy from the University of Notre Dame.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Mark P. Schoenberg, M.D.</i></b>&#160;has served as our Chief Medical Officer since December 2017 and, prior to that, served as our Medical Director since February 2016. Dr.&#160;Schoenberg has over 20 years of experience in clinical practice and research focused on the care of patients with all forms of bladder cancer. Since April 2014, Dr.&#160;Schoenberg has been University Professor and Chair of the Urology Department at The Montefiore Medical Center for The Albert Einstein College of Medicine of Yeshiva University. Prior to joining Montefiore, from 2005 to 2014, Dr.&#160;Schoenberg served as Director of Urologic Oncology and Bernard L. Schwartz Distinguished Professor of Urologic Oncology at Johns Hopkins Hospital. Dr.&#160;Schoenberg is also the past chair of the Medical Advisory Board of the Bladder Cancer Advocacy Network, the author of The Guide to Living with Bladder Cancer, co-editor of The Textbook of Bladder Cancer, a contributor to Campbell&#8217;s Urology and a past Senior Editor of the journal Seminars in Urologic Oncology. Dr.&#160;Schoenberg received his M.D. (Alpha Omega Alpha) from the University of Texas Health Sciences Center and completed his residency in General Surgery and Urology at the Hospital of The University of Pennsylvania, where he served as chief resident and urology instructor, before completing basic research and clinical urologic oncology fellowships at Johns Hopkins under the auspices of The American Cancer Society. Dr.&#160;Schoenberg is a fellow of the American College of Surgeons, as well as a member of the American Association of Cancer Research, the Society of Urologic Oncology and the American Urological Association.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Jason Smith</i></b>&#160;has served as our General Counsel, Chief Compliance Officer and Corporate Secretary since August 2020. Mr. Smith is responsible for leading our legal, intellectual property, and corporate compliance functions. Mr. Smith joined us from Pfizer&#160;Inc., where he served as Chief Counsel, Oncology from August 2016 to August 2020. Prior to Pfizer, Mr. Smith worked in the legal department at Wyeth in a variety of roles including as antitrust counsel, Global Product Counsel and Chief Counsel, U.S. Pharmaceuticals, leading a team of lawyers supporting the prescription pharmaceuticals businesses. Before joining Wyeth, Mr. Smith was an associate at Howrey, Simon, Arnold &amp; White in Washington, DC, in the antitrust and commercial litigation groups. Mr. Smith received his bachelor's degree in Economics, cum laude from Binghamton University and his juris doctor degree, with high honors, from George Washington University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXECUTIVE COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">We are a &#8220;smaller reporting company&#8221; under Item 10 of Regulation&#160;S-K&#160;promulgated under the Exchange Act and the following compensation disclosure is intended to comply with the requirements applicable to smaller reporting companies. Although the rules allow us to provide less detail about our executive compensation program than companies that are not smaller reporting companies, our Compensation Committee is committed to providing the information necessary to help shareholders understand its executive compensation-related decisions. Accordingly, this section includes supplemental narratives that describe our 2025&#160;compensation program for our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Overview</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our fundamental objective is to advance patient care while creating consistent long-term value for our shareholders. To accomplish this objective, we have established an overall compensation program intended to attract and retain highly qualified executives, incentivize achievement of our key performance goals in order to align our executives&#8217; interests with those of our shareholders and link pay to company performance. We take a holistic approach to assessing Company performance, and identify corporate objectives that align with our short- and long-term strategic priorities, and build towards creation of long-term, sustainable shareholder value.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our 2025&#160;corporate performance highlights include the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 784px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In June 2025, the FDA approved and the Company subsequently launched <i>Zusduri</i>, the first and only FDA-approved medicine for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 21px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 783px;"><i>Zusduri</i>&#160;achieved net sales of&#160;$15.8 million in 2025, reflecting the initial launch period ahead of the permanent J Code, which subsequently&#160;became effective on January 1, 2026, streamlining reimbursement procedures and supporting broader patient access.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 784px;"><i>Jelmyto </i>achieved net product sales of $94.0 million in 2025, representing year-over-year underlying demand sales growth of 7%.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 784px;">In February 2025, we acquired a next-generation investigational oncolytic virus, UGN-501 (formerly known as ICVB-1042).&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 784px;">In November 2025, we reported a 77.8% three-month complete response rate from the Phase 3 UTOPIA trial of UGN-103 and announced FDA agreement on the new drug application submission strategy for UGN-103 in recurrent&#160;low-grade intermediate-risk non-muscle invasive bladder cancer based on the UTOPIA trial.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 20px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 784px;">In 2025, the Company obtained additional U.S. patent method claims covering the use of <i>Jelmyto</i> and <i>Zusduri</i>. The Company also secured a second U.S. patent covering the Company&#8217;s <i>RTGel</i><sup style="vertical-align:top;line-height:120%;">&#174;</sup> technology with medac&#8217;s licensed proprietary lyophilized mitomycin formulation as used in UGN-103 and UGN-104.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="font-size: 10pt;">The following discussion describes our executive compensation process and policies. It provides qualitative information on the factors relevant to these decisions and the manner in which compensation is awarded to our named executive officers for the fiscal year ended December&#160;31, 2025, which consisted of our principal executive officer, our chief medical officer and our general counsel and chief compliance officer. These named executive officers were as follows:</div>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration: underline; ">Name</span></b></p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration: underline; ">Position(s)</span></b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Elizabeth Barrett&#160;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President and Chief Executive Officer</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark P. Schoenberg</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Medical Officer</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jason Smith</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">General Counsel and Chief Compliance Officer</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Objectives, Philosophy and Elements of Executive Compensation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our compensation program aims to achieve the following main objectives:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.6%;">&#160;</td>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">attract, retain and reward highly qualified executives;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.6%;">&#160;</td>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">provide incentives that motivate executives to achieve our key performance goals that create shareholder value;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.6%;">&#160;</td>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">align our executives&#8217;&#160;interests with those of our shareholders; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.6%;">&#160;</td>
			<td style="vertical-align:top;width:1.8%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">link pay to company performance.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Company&#8217;s executive compensation program is overseen by the Compensation Committee with the advice and support of an independent third-party compensation consultant. The following are key characteristics of the Company&#8217;s executive compensation program:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 21px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 861px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>A substantial portion of executive pay is tied to performance</b>.&#160;We structure a significant portion of our named executive officers&#8217;&#160;compensation to be variable. Annual cash performance bonuses and long-term equity compensation are dependent on achievement of corporate performance objectives and determined by the Compensation Committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 21px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 861px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Our executive bonuses are dependent on the Company and the officer achieving annually determined objectives</b>. As a smaller reporting company with significant development-stage activities, we take a holistic approach to evaluating the Company's performance. We measure performance against challenging objectives established at the beginning of each performance cycle. We establish a broad set of measurable performance objectives that align with our long-term strategic priorities and build towards lasting long-term value. Our annual performance-based bonus opportunities for all our named executive officers are determined by the Compensation Committee, and ultimately the Board, based upon the Company&#8217;s and the officer&#8217;s achievement of objectives determined on an annual basis by the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 21px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 861px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>We emphasize long-term equity incentives</b>. Equity awards are an integral part of our executive compensation program and comprise the primary &#8220;at-risk&#8221;&#160;portion of our named executive officer compensation package. During 2025, we granted our executive officers restricted stock units and performance stock units. These awards strongly align our executive officers&#8217;&#160;interests with those of our shareholders by providing a continuing financial incentive to maximize value for our shareholders and by encouraging our executive officers to remain in our long-term employ. Restricted stock units granted to our named executive officers in 2025&#160;vest in equal annual installments over three years from the vesting commencement date. Performance stock units granted to our executive officers in 2025&#160;vest&#160;upon the achievement of cumulative net product sales of&#160;<i>Jelmyto</i>&#160;and&#160;<i>Zusduri </i>as well as continued service, directly tying a&#160;substantial component of our executive officers' total compensation to performance against one of the primary potential drivers of long-term value creation for our shareholders.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 865px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Our Compensation Committee has retained Compensia, Inc. as an independent third-party compensation consultant for guidance in making compensation decisions</b>.&#160;The compensation consultant advises the Compensation Committee on market practices, including identifying a peer group of companies and their compensation practices, so that our Compensation Committee can regularly assess the Company&#8217;s individual and total compensation programs against these peer companies, the general marketplace and other industry data points.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 0%;">&#160;</td>
			<td style="vertical-align: middle; width: 17px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 865px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>We do not provide our executive officers with any excise tax gross ups</b>.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 0%;">&#160;</td>
			<td style="vertical-align: middle; width: 16px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 866px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>We have not repriced options</b>.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 0%;">&#160;</td>
			<td style="vertical-align: middle; width: 13px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 869px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>We do not provide executive fringe benefits or perquisites to our executives</b>.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our executive compensation program generally consists of, and is intended to strike a balance among, the following three principal components: base salary, annual performance-based bonuses and long-term incentive compensation. We provided signing bonuses to our executive officers when they joined the Company. We also provide our executive officers with benefits available to all our employees, including participation in employee benefit plans. The following chart summarizes the three main elements of compensation, their objectives and key features.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:6.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Element of</b><br/>
			<b>Compensation</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Objectives</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.2%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:10.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Key Features</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Base Salary<br/>
			<b>(fixed cash) </b>&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:7.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Provides financial stability and security through a fixed amount of cash for performing job responsibilities.</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:10.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Generally reviewed annually and determined based on a number of factors, including in part, market data provided by our independent compensation consultant.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.2%;">&#160;</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:7.4%;">&#160;</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:10.7%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Performance Bonus<br/>
			<b>(at-risk cash)</b>&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:7.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Motivates and rewards for attaining key annual Company and executive officer performance objectives.</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:10.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Target bonus amounts are generally reviewed annually and determined based upon positions that have similar impact on the organization and competitive bonus opportunities in our market. Bonus opportunities are dependent upon achievement of specific corporate performance objectives consistent with our strategic plan and individual performance objectives that relate to the officer&#8217;s role and expected contribution toward reaching our corporate goals, determined by the Board and communicated at the beginning of the year. Actual bonus amounts earned are determined at the end of the year, taking into account corporate and individual performance objectives.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.2%;">&#160;</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:7.4%;">&#160;</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:10.7%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Long-Term Incentive<br/>
			<b>(at-risk equity)</b>&#160;</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:7.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Motivates and rewards for long-term Company performance; aligns executives&#8217;&#160;interests with shareholder interests and changes in shareholder value.</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:10.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Equity opportunities are generally reviewed annually and may be granted during the first half of the year or as appropriate during the year for new hires, promotions, or other special circumstances, such as to encourage retention, or as a reward for significant achievement.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.2%;">&#160;</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:7.4%;">&#160;</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:10.7%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:6.2%;">&#160;</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:7.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Attracts highly qualified executives and encourages their continued employment over the long-term.</p>
			</td>
			<td style="vertical-align:top;width:0.2%;">&#160;</td>
			<td style="vertical-align:top;width:10.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Individual awards are determined based on a number of factors, including current corporate and individual performance and market data provided by our independent compensation consultant.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We focus on providing a competitive compensation package to our executive officers which provides short- and long-term incentives for the achievement of measurable Company and executive officer objectives. We believe that this approach provides an appropriate blend of short-term and long-term incentives to maximize shareholder value. We generally do not have any formal policies for allocating compensation among salary, performance bonus awards and equity grants, short-term and long-term compensation or among cash and non-cash compensation, although total annual cash bonus compensation to any individual is capped at 150% of such individual&#8217;s salary pursuant to our Compensation Policy. Our Compensation Committee uses its judgment to establish a total compensation program for each named executive officer that is a mix of current, short-term and long-term incentive compensation, and cash and non-cash compensation, that it believes is appropriate to achieve the goals of our executive compensation program and our corporate objectives. In 2025, our Actual CEO compensation was as follows:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<div style="text-align: center;">
<div><img alt="ceodirectcomp.jpg" src="ceodirectcomp.jpg"/></div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To ensure the alignment of our executive officer incentives with shareholder interests, we have historically structured a significant portion of the named executive officers&#8217; total target compensation with performance-based bonus opportunities and long-term incentive equity awards. Additionally, in 2025, half of the value of our CEO&#8217;s long-term incentive equity awards were in the form of performance stock units which vest based on a cumulative&#160;net product sales target of <i>Jelmyto</i>&#160;and&#160;<i>Zusduri</i>, directly tying a&#160;substantial component of our CEO&#8217;s total compensation to a primary driver&#160;of long-term value creation for our shareholders. Our CEO's&#160;total direct compensation for 2025&#160;was positioned at approximately the 20th&#160;percentile of our compensation peer group. Our non-CEO executives'&#160;total direct compensation for 2025&#160;was positioned at approximately the 15th&#160;percentile of our compensation peer group (see section titled "Use of Competitive Market Compensation Data" below for more detail on the selection of our compensation peer group).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>2025</b>&#160;<b>Say-on-Pay Results</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">At our 2025&#160;annual meeting of shareholders, we held a shareholder advisory vote on executive compensation, commonly referred to as a &#8220;say-on-pay&#8221; vote, which resulted in over&#160;89% of the total votes cast being in favor of the advisory proposal.&#160;We continue to assess and enhance our approach to executive compensation by seeking feedback from shareholders and reviewing the analyses of the Institutional Shareholder Services and Glass Lewis published reports. Our approach to aligning pay and performance focuses on maintaining a significant portion of executive&#8217;s annual total compensation based on evaluation of individual executives'&#160;performance against our corporate objectives.&#160;We take a holistic approach to assessing Company performance, undertake a robust goal-setting process to determine corporate objectives that align with our short- and long-term strategic priorities, and build towards creation of shareholder value.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We continually endeavor to align our executives'&#160;interests&#160;with those of our shareholders, and link pay to company performance. In 2025&#160;and 2026, we have included performance stock units&#160;as part of our officers&#8217; long-term incentive compensation, with vesting of these performance stock units upon achievement of a cumulative&#160;net product sales target of <i>Jelmyto</i>&#160;and&#160;<i>Zusduri </i>and receipt of U.S. regulatory approval for UGN-103, respectively, directly tying a&#160;substantial component of our officers&#8217; total compensation to the primary potential drivers of long-term value for the Company and our shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We expect to hold our next &#8220;say-on-pay&#8221; vote at our 2027&#160;annual meeting of shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Our Compensation Governance Structure</b>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Role of our Compensation Committee, Management and the Board</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Compensation Committee is appointed by the Board and has responsibilities related to the compensation of the Company&#8217;s directors, officers, and employees and the development and administration of the Company&#8217;s compensation plans. For details on the Compensation&#160;Committee&#8217;s oversight of the executive compensation program, see the section above titled &#8220;Compensation&#160;Committee."&#160;Our Compensation&#160;Committee consists solely of independent members of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Compensation Committee reviews all compensation paid to our executive officers, including our named executive officers. The Chief Executive Officer evaluates and provides to the Compensation&#160;Committee performance assessments and compensation recommendations. While the Chief Executive Officer discusses her recommendations with the Compensation Committee, she does not participate in the deliberations concerning her own compensation. More specifically, the Compensation Committee discusses and makes final recommendations to the Board with respect to executive compensation matters without the Chief Executive Officer present during discussions of the Chief Executive Officer&#8217;s compensation. From time to time, various other members of management and other employees as well as outside advisors or consultants may be invited by the Compensation Committee to make presentations, provide financial or other background information or advice or otherwise participate in the Compensation Committee meetings.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Compensation Committee meets periodically throughout the year to manage and evaluate our executive compensation program, and generally determines the principal components of compensation (base salary, performance bonus and equity awards) for our executive officers on an annual basis; however, decisions may occur at other times for new hires, promotions or other special circumstances as our Compensation&#160;Committee determines appropriate. The Compensation Committee does not delegate authority to approve executive officer compensation. The Compensation&#160;Committee does not maintain a formal policy regarding the timing of equity awards to our executive officers. The Compensation Committee will continue to monitor and evaluate our executive compensation program in light of our shareholders&#8217; views, before making any adjustments, and continue to consider the outcome of our say-on-pay votes and our shareholders&#8217; views when making future compensation decisions for our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Role of Compensation Consultant</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Compensation Committee has the sole authority to retain compensation consultants to assist in its evaluation of executive compensation, including the authority to approve the consultant&#8217;s reasonable fees and other retention terms. The Compensation&#160;Committee has retained Compensia, Inc. (&#8220;Compensia&#8221;), a management consulting firm that provides executive compensation and advisory services to compensation committees of life sciences companies, as its compensation consultant. A representative of Compensia attends meetings of the Compensation&#160;Committee at the invitation of the Committee. In addition, Compensia supported the selection of companies included in our compensation peer group, provided competitive market assessments of the compensation of our executive officers and non-employee director compensation programs, and provided support on other matters as requested by the Compensation&#160;Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Compensation Committee has analyzed whether the work of Compensia as compensation consultant raises any conflict of interest, taking into account relevant factors in accordance with SEC guidelines. Based on its analysis, our Compensation Committee determined that the work of Compensia and the individual compensation advisors employed by Compensia does not create any conflict of interest pursuant to the SEC rules and Nasdaq listing standards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Competitive Market Compensation Data</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Compensation Committee believes that it is important when making its compensation decisions to be informed as to the current practices of comparable public companies with which we compete for top talent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Working with Compensia, the Compensation Committee approved a group of companies that were identified as peers.&#160;Identification of peers included consideration of comparable market capitalization, revenues, investigational and/or in-line portfolio, number of employees as well as stage and maturity of the peer company.&#160;Compensia prepared and the Compensation&#160;Committee reviewed, a range of market data reference points with respect to base salary, performance bonuses, target total cash compensation (base salary and the annual target performance bonus), equity compensation, and total direct compensation (target total cash compensation and equity compensation) with respect to each of the named executive officers.&#160;The peer group that was identified and used in research that informed executive compensation for 2025&#160;included the following companies: Acrivon Therapeutics, Arcus Biosciences, Arvinas, Aura Biosciences, C4 Therapeutics, Day One Biopharmaceuticals, Erasca, IDEAYA Biosciences, iTeos Therapeutics, Kura Oncology, Olema Pharmaceuticals, Rigel Pharmaceuticals, Sutro Biopharma, Syndax Pharmaceuticals, Tango Therapeutics, Tyra Biosciences, Xencor and Y-mAbs Therapeutics.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">This benchmarking analysis found that overall target total direct compensation awarded in 2025&#160;was at approximately the 15<sup style="vertical-align:top;line-height:120%;">th</sup> percentile for our executive officers excluding the CEO and the 20<sup style="vertical-align:top;line-height:120%;">th</sup> percentile for the CEO. This analysis of 2025&#160;compensation and other research performed by Compensia is then used to inform the Compensation Committee&#8217;s determinations regarding executive compensation going forward.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Factors Used in Determining Executive Compensation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our Compensation Committee sets the compensation of our executive officers at levels they determine to be competitive and appropriate for each named executive officer, using their professional experience and judgment. Pay decisions are not made by use of a formulaic approach or benchmark; the Compensation&#160;Committee believes that executive pay decisions require consideration of a multitude of relevant factors which may vary from year to year. In making executive compensation decisions, the Compensation&#160;Committee generally takes into consideration the factors listed below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 19px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 863px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company performance and existing business needs</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 19px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 863px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Each named executive officer&#8217;s individual performance, scope of job function and the critical skill set of the named executive officer to the Company&#8217;s future performance</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 19px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 863px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The need to attract new talent to our executive team and retain existing talent in a highly competitive industry</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 19px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 863px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A range of market data reference points, as described above under &#8220;Use of Competitive Market Compensation Data&#8221;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 19px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 863px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Recommendations from consultants on compensation policy determinations for the executive officer group</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>2025</b>&#160;<b>Executive Compensation Summary</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Base Salary</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The base salaries of our executive officers are designed to compensate them for day-to-day services rendered during the fiscal year. Appropriate base salaries are used to recognize the experience, skills, knowledge and responsibilities required of each executive officer and to allow us to attract and retain individuals capable of leading us to achieve our business goals in competitive market conditions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The base salaries of our executive officers are reviewed at least annually by our Compensation Committee and adjustments are made to reflect Company and individual performance, as well as competitive market practices. Our Compensation Committee also takes into account subjective performance criteria, such as an executive officer&#8217;s ability to lead, organize and motivate others, develop the skills necessary to mature with us, set realistic goals to be achieved in his or her respective area, and recognize and pursue new business opportunities that enhance our growth and success. Our Compensation Committee does not apply specific formulas to determine increases, but instead makes an evaluation of each executive officer&#8217;s contribution to our long-term success. Annual adjustments to base salaries are effective as of March&#160;1 of each year, with mid-year adjustments to base salaries made under special circumstances, such as promotions or increased responsibilities, or to align certain base salaries with those of individuals in comparable positions at the companies in our compensation peer group.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The 2025&#160;base salaries for our named executive officers were as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Executive </b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Base</b><br/>
			<b>Salary</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Percentage</b><br/>
			<b>Increase</b><br/>
			<b>in Base</b><br/>
			<b>Salary from</b><br/>
			<b>December 2024</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Elizabeth Barrett</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$860,439</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.50%</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark Schoenberg</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$372,279</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.50%</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jason Smith</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$494,800</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.50%</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Annual Performance Bonus</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our named executive officers are eligible to receive performance-based cash bonuses, which are designed to provide appropriate incentives to our executive officers to achieve defined annual corporate goals and to reward them for individual performance towards these goals. The annual performance-based bonus that each named executive officer is eligible to receive is generally based on the extent to which we achieve the corporate objectives that the Board establishes each year. At the end of the year, the Board and Compensation Committee review the Company&#8217;s performance and approve the extent to which we achieved each of these corporate goals. Generally, the Board and Compensation Committee will assess each named executive officer&#8217;s individual contributions towards reaching our annual corporate goals and objectives but does not typically establish specific individual goals for our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The table below sets forth the targets for our named executive officers for 2025, as provided for in their respective employment agreements. The target percentage is paid as a percentage of such executive officer&#8217;s base salary. For example, if 100% of the Company&#8217;s performance goals are achieved, this would yield our Chief Executive Officer, Elizabeth Barrett, a cash incentive award of 75% of her base salary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 80%; margin-left: 10%; margin-right: 10%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 81%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Executive Officer</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Target</b><br/>
			<b>Percentage of</b><br/>
			<b>Base Salary</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 81%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Elizabeth Barrett</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">75%</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 81%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Mark Schoenberg</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><sup style="vertical-align:top;line-height:120%;">(1)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 81%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Jason Smith</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">50%</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 22px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align: middle; width: 784px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dr. Schoenberg&#8217;s annual target bonus is $225,000. Dr. Schoenberg is eligible to receive up to 150% of the annual target bonus based upon the achievement of the Company&#8217;s corporate objectives.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="font-size: 10pt;">In early 2025, the Compensation Committee finalized the corporate goals for the 2025&#160;performance year as described below. Our objective corporate goals were designed to be challenging to achieve and are directly aligned with our specific strategic goals, including advancing our development programs, our research function, our clinical activities, commercialization activities and certain corporate and financial goals, which we believe will create value for shareholders. The maximum possible corporate achievement for 2025&#160;was 150% of our 2025&#160;corporate goals (up to 100% for the core goals and 50% for the stretch goals). In early 2026, the Compensation Committee and the Board evaluated the accomplishments and performance of the Company against such corporate goals, including progress towards the goal in making their recommendations for the ultimate funding levels, and the Board made the following determinations regarding corporate performance achieved against the pre-established performance goals.</div>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 82%; margin-left: 9%; margin-right: 9%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 69%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Corporate Goal </b>&#8211;&#160;<b>Core</b></p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Weighting</b></p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Corporate</b><br/>
			<b>Achievement</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 69%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">FDA approval of&#160;<i>Zusduri</i></p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">50%</p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Achieved</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 69%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Achieve combined <i>Jelmyto/Zusduri</i> revenue target</p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">30% sliding scale</p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Not Achieved</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 69%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">UGN-103: last patient in by end of Q3 2025</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10%</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Achieved</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 69%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">UGN-104: first patient dosed by end of Q2 2025</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10%</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Not Achieved</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 82%; margin-left: 9%; margin-right: 9%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 67%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Corporate Goal </b>&#8211;&#160;<b>Stretch</b></p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 22%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Weighting</b></p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Corporate</b><br/>
			<b>Achievement</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 67%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Execute a strategic transaction: combination, aggregation, ex-US partnership, change-in-control</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 22%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">30%</p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Not Achieved</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 67%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Execute research collaboration: early-stage asset acquisition or in/out-license, commercial or development partnership</p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 22%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10%</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Achieved</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 67%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">FDA approval of <i>Zusduri</i></p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 22%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">10%</p>
			</td>
			<td style="vertical-align: middle; width: 0%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Achieved</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In January 2026,&#160;the Board reviewed and approved corporate cash incentives as set forth in the table below. The Compensation Committee or Board may, in its sole discretion, eliminate any individual cash incentive or reduce or increase the amount of compensation payable with respect to any individual cash incentive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 52%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="6" style="vertical-align: middle; width: 177px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>2025</b>&#160;<b>Target Annual Cash</b><br/>
			<b>Incentive</b></p>
			</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="6" style="vertical-align: middle; width: 13%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>2025</b>&#160;<b>Actual Annual Cash</b><br/>
			<b>Incentive Paid</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Named Executive Officer </b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>% of Base Salary</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 80px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>$</b></p>
			</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>% of Target Annual Cash Incentive</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>$</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Elizabeth Barrett</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">75%</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align: middle; width: 71px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">645,329</p>
			</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">80%</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">516,263</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark Schoenberg</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><sup style="vertical-align:top;line-height:120%;">(1)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align: middle; width: 71px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">225,000</p>
			</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">80%</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">180,000</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 52%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jason Smith</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">50%</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align: middle; width: 71px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">247,400</p>
			</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">80%</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">197,920</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">Dr. Schoenberg&#8217;s annual target bonus is $225,000. Dr. Schoenberg is eligible to receive up to 150% of the annual target bonus based upon the achievement of the Company&#8217;s corporate objectives.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Equity Awards</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In 2025, the Board, upon the recommendation of the Compensation Committee, approved the following grants of&#160;restricted stock units and performance stock units to our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 86%; margin-left: 7%; margin-right: 7%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 53%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Executive </b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Restricted&#160;</b><b>Stock units </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>(#</b>&#160;<b>shares)</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Performance Stock units </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>(# shares)</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 53%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Elizabeth Barrett</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">96,377</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">96,376</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 53%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Mark Schoenberg</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">20,000</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">20,000</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 53%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Jason Smith</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">10,000</p>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">10,000</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">All restricted stock units granted to our named executive officers above vest in equal annual installments over three years from the vesting commencement date, subject to the continued service of the named executive officer through each vesting date. Performance stock units vest as follows: 1/3rd upon the Company&#8217;s filing with the SEC&#160;of a quarterly report on Form 10-Q or annual report on Form 10-K showing the Company&#8217;s achievement of a target cumulative net product sales amount during a calendar year (the &#8220;Net Product Sales Milestone&#8221;); 1/3rd on January 31st of the calendar year immediately following the achievement of the Net Product Sales Milestone; and 1/3rd on the second January 31st following the achievement of the Net Product Sales Milestone, all subject to the applicable awardee&#8217;s continuous service as of each vesting date.&#160;The annual equity grants to our named executive officers are evaluated and approved by the Compensation Committee and the Board in the context of each named executive officer&#8217;s total compensation and take into account the market data provided by compensation consultants in addition to the individual officer&#8217;s responsibilities and performance. New hire equity grants to our named executive officers are evaluated and approved by the Compensation Committee and&#160;the Board based on competitive market data provided by compensation consultants as well as such officer&#8217;s experience and expected contributions. The Compensation Committee also takes into account the recommendations of the Chief Executive Officer with respect to appropriate grants and any particular individual circumstances, other than with respect her own grants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In&#160;December 2025,&#160;we amended certain RSU and PSU awards granted to our CEO to defer vesting until the end of&#160;2026. The modifications did&#160;not&#160;result in any incremental fair value at the modification dates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Other Features of Our Executive Compensation Program</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Agreements with Our Named Executive Officers</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We have entered into written employment agreements with each of our executive officers. Each of these employment agreements provides for &#8220;at will&#8221; employment and set forth the initial compensation arrangements for the executive officer, including an initial base salary, an annual cash opportunity, and an equity award recommendation. These agreements and the proprietary information and invention assignment agreements each executive officer executes upon commencing employment at the Company also set forth the rights and responsibilities of each party and include, among other rights and responsibilities, the prohibition on the executive officer from engaging directly or indirectly in competition with us, soliciting any of our employees, or disclosing our confidential information.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Below are descriptions of our employment agreements with our named executive officers. For a discussion of the severance payments and other benefits to be provided in connection with an involuntary termination of employment, including in connection with a change in control of the Company under the arrangements with our executive officers, please see &#8220;Severance and Change in Control Benefits&#8221; below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Elizabeth Barrett. </i>On January 3, 2019, we entered into an employment agreement with Ms. Barrett, which was amended in January 2021 to provide certain change in control benefits, as described in more detail below under &#8220;Severance and Change in Control Benefits.&#8221;&#160;Pursuant to her employment agreement, Ms. Barrett (i) received a signing bonus of $300,000 (subject to full repayment if she resigned without good reason, or the Company terminated her employment for cause, before January 3, 2020); (ii) received an initial annual base salary of $700,000; (iii) was eligible to receive an annual discretionary bonus for 2019 of up to 100% of her base salary, with 50% guaranteed; and (iv) is eligible to receive annual discretionary bonuses for years following 2020, with an annual target bonus of 50% of her base salary. In December 2023, the Board approved an increase in the annual bonus target from 50% to 75% to be effective starting with the 2024 performance year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to her employment agreement, Ms. Barrett was also initially granted a restricted stock unit covering 317,065 of our ordinary shares and an option to purchase 277,432 ordinary shares. Under the terms of an omnibus amendment of Ms. Barrett&#8217;s prior equity award agreements, executed in January 2021, the remainder of the unvested shares underlying both of these equity awards vested in full in January 2022, in lieu of the prior monthly vesting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Mark Schoenberg</i>. On January 23, 2020, we entered into a new employment agreement with Dr. Schoenberg, which was amended in January 2021 to provide certain change in control benefits, as described in more detail below under &#8220;Severance and Change in Control Benefits.&#8221;&#160;Pursuant to the terms of the agreement and Dr. Schoenberg&#8217;s reduced-time status, Dr. Schoenberg received an annual base salary of $205,000 for a 50% full-time equivalent role and is eligible to receive an annual target cash bonus of $225,000 with a maximum of 150% of such target bonus, subject to achievement of Company goals and objectives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">On March 15, 2021, the Compensation Committee approved an increase in the reduced-time capacity under the employment agreement from a 50% full-time equivalent role to a 75% full-time equivalent role as of January 1, 2021 and on March 17, 2021 our Board endorsed and approved the increase to 75% full-time equivalent. Dr. Schoenberg&#8217;s employment agreement was further amended in April 2021 to reflect the changes approved by the Board, pursuant to which he is entitled to an annual base salary of $307,500 effective January 1, 2021 through February 28, 2021 and beginning on March 1, 2021 and thereafter an annual base salary of $316,725 for a 75% full-time equivalent role.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Jason Smith.</i> On August 12, 2020, we entered into an employment agreement with Mr. Smith, which was amended in January 2021 to provide certain change in control benefits, as described in more detail below under &#8220;Severance and Change in Control Benefits.&#8221;&#160;Pursuant to the terms of the agreement, Mr. Smith (i) received a signing bonus of $100,000 (which was subject to full repayment if his employment with the Company had terminated&#160;for any reason before August 31, 2021),&#160;(ii) received&#160;an initial annual base salary of $425,000 and (iii) was&#160;eligible for a target annual cash bonus equal to 50% of his base salary. Mr. Smith was granted an initial new hire option to purchase 60,000 ordinary shares and 25,000 restricted stock units.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Severance and Change in Control Benefits</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our employment agreements with Ms. Barrett, Dr. Schoenberg&#160;and Mr. Smith provide that they are eligible for severance benefits upon certain involuntary terminations of employment, including in connection with a change in control, as described below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to their respective amended employment agreements, if the named executive officer's employment is terminated by the Company without cause, by the named executive officer for good reason, or due to the named executive officer&#8217;s death or disability (in the case of Ms. Barrett and Mr. Smith), then the named executive officer will be entitled to the following severance benefits: (i) continuing base salary payments for 6 months (or 12 months in the case of Ms. Barrett and up&#160;to 12 months in the case of Dr. Schoenberg); (ii) a prorated target annual bonus for the year of termination (to the extent earned based on company performance and with any individual performance component deemed achieved); (iii) any unpaid annual bonus earned with respect to the year preceding termination; (iv) the accelerated vesting of restricted shares and options held by the named executive officer at the time of such termination&#160;(in the case of Ms. Barrett, the portion of the award otherwise scheduled to vest within the 12 month period following termination; in the case of Dr. Schoenberg, 50% of the then-unvested award shall be deemed immediately vested and exercisable as of the termination date; and in the case of Mr. Smith, vesting will be accelerated by 1/12<sup style="vertical-align:top;line-height:120%;">th</sup>, such that 8.33% of the&#160;restricted shares and options will be deemed immediately vested and exercisable); and (v) COBRA payment reimbursement for up to 6 months for Mr. Smith, and 12 months in the case of Ms. Barrett&#160;following such termination.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">If there is a change in control and the named executive officer is terminated without cause or resigns for good reason, in either case within three months prior to, or 24 months following the effective date of the change in control, all three named executive officers will be entitled to 100% vesting and exercisability of all of his or her Company equity awards or other equity interests that are outstanding and unvested as of the termination or resignation date, and Ms. Barrett and Mr. Smith&#160;will be entitled to the following severance benefits, in lieu of the corresponding severance benefits described above: (i) a lump sum payment equal to the sum of (1) 12 months (18 months in the case of Ms. Barrett) of his or her then-current annual base salary and (2) 100% of his or her current target annual bonus; and (ii) the amount of any COBRA premium payments made by the named executive officer during the 12 months (or 18 months in the case of Ms. Barrett) following such termination.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Payment of the severance benefits described in the preceding paragraphs is subject to the named executive officer signing and not revoking a separation agreement and release of claims in a form satisfactory to us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>Other Benefits</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our named executive officers are eligible to participate in our employee benefit plans, including our medical, dental, vision, group life, disability and accidental death and dismemberment insurance plans, in each case on the same basis as all of our other employees. We provided a 401(k) plan to all of our U.S. employees, including our named executive officers. We do not generally provide perquisites or personal benefits to our named executive officers. We do, however, pay the premiums for term life insurance and disability insurance for all of our employees, including our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Tax and Accounting Implications</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under Financial Accounting Standard Board ASC Topic 718 (&#8220;ASC Topic 718&#8221;), we are required to estimate and record an expense for each award of equity compensation over the vesting period of the award. We record share-based compensation expense on an ongoing basis according to ASC Topic 718.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under Section 162(m) of the Code, compensation paid to each of our &#8220;covered employees&#8221; that exceeds $1 million per taxable year is generally non-deductible. Although the Compensation Committee will continue to consider tax implications as one factor in determining executive compensation, it also looks at other factors in making its decisions and retains the flexibility to provide compensation for our named executive officers in a manner consistent with the goals of our executive compensation program and our best interests, and the best interests of our shareholders, which may include providing for compensation that is not deductible by us due to the deduction limit under Section 162(m) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31_RestatementDateAxis-RestatementDateAxis.domain-2023-12-31" name="ecd:ErrCompAnalysisTextBlock" id="c9" escape="true">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Clawbacks</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">As a public company, if we are required to restate our financial results due to our material noncompliance with any financial reporting requirements under the federal securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, certain covered officers, including the Chief Executive Officer and Chief Financial Officer, may be legally required to reimburse our Company for any cash bonus or other incentive-based or equity-based compensation they receive in accordance with the provisions of section 304 of the Sarbanes-Oxley Act of 2002.&#160;Additionally, we have adopted an incentive compensation recoupment policy (&#8220;Clawback Policy&#8221;) to comply with Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder and Nasdaq Listing Rule 5608. For more information, see the full text of our Clawback Policy, which is filed as an exhibit to our 2023 Annual Report on Form 10-K.</p>
</ix:nonNumeric>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Risk Analysis of Our Compensation Policies and Practices</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The Compensation&#160;Committee has reviewed the Company&#8217;s compensation policies and practices, in consultation with Compensia and outside Company counsel, to assess whether they encourage employees to take inappropriate risks. After reviewing and assessing the Company&#8217;s compensation philosophy, terms and practices, including the mix of fixed and variable, short and long-term incentives and overall pay, incentive plan structures, and the checks and balances built into, and oversight of, each plan and practice, the Compensation Committee determined that any risks arising from our compensation policies and practices for our employees are not reasonably likely to have a material adverse effect on our Company as a whole. The Compensation Committee believes that the mix and design of the elements of executive compensation do not encourage management to assume excessive risks; the mix of short-term compensation (in the form of salary and annual bonus, if any, which is based on a variety of performance factors), and long-term compensation (in the form of options to purchase our ordinary shares and restricted stock units) prevents undue focus on short-term results and helps align the interests of the Company&#8217;s executive officers with the interests of our shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;"><b>2025</b>&#160;<b>Summary Compensation Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The following table sets forth all of the compensation awarded to, earned by or paid to our named executive officers during the years indicated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 19%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name and Principal Position</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Year</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Salary</b><br/>
			<b>($)</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Bonus</b><br/>
			<b>($) </b><b><sup style="vertical-align:top;line-height:120%;">(1)</sup></b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Stock</b><br/>
			<b>Awards</b><br/>
			<b>($) </b><b><sup style="vertical-align:top;line-height:120%;">(2)</sup></b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Option</b><br/>
			<b>Awards</b><br/>
			<b>($)</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-Equity</b><br/>
			<b>Incentive </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Plan</b><br/>
			<b>Compensation</b><br/>
			<b>($) </b><b><sup style="vertical-align:top;line-height:120%;">(3)</sup></b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>All Other</b><br/>
			<b>Compensation</b><br/>
			<b>($) </b><b><sup style="vertical-align:top;line-height:120%;">(4)</sup></b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total ($)</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 19%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Elizabeth Barrett</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">855,590</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">774,066</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2,122,211</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">516,263</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">42,494</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4,310,624</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 19%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Chief Executive Officer</i></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2024</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">826,013</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2,751,111</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">529,981</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">42,753</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4,149,858</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 19%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark Schoenberg</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">369,607</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">167,500</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">440,400</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">&#8212;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">180,000</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13,133</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1,170,640</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 19%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Chief Medical&#160;</i><i>Officer</i></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2024</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">354,240</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">314,000</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">&#8212;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">202,500</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8,145</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">878,885</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 19%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jason Smith</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">492,011</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">198,960</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">220,200</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">197,920</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">89,527</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1,198,618</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 19%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>General Counsel and Chief Compliance Officer</i></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2024</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">475,003</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">518,100</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">203,179</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 2%;">&#160;</td>
			<td style="vertical-align: middle; width: 11%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">79,182</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1,275,464</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Represents discretionary bonuses paid to the named executive officer for the applicable year. Discretionary bonuses earned in&#160;2025&#160;were approved by the Board based on assessment of overall achievements in the business and individual performance, including the accomplishments noted in our 2025&#160;corporate performance highlights, above.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Represents the aggregate grant-date fair value of the restricted stock units and performance stock units awarded to the named executive officer for the applicable year, calculated in accordance with ASC Topic 718 and does not take into account estimated forfeitures, which value is based on the closing market price of our ordinary shares on the date of grant.&#160;The grant date fair value of the restricted stock units is based on the closing market price of the Company&#8217;s ordinary shares on the date of the grant. The grant date fair value and the maximum potential value of the performance stock units are the same and are based on the closing market price of our ordinary shares on the date of grant.&#160;The assumptions used in the calculation of these amounts are included in Note 17 to the consolidated financial statements appearing in&#160;our Form&#160;10-K for the year ended December 31, 2025, filed with the SEC on March 2, 2026.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 0%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For more information, see &#8220;Annual Performance Bonus&#8221;&#160;above.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The amounts reported in this column represent the value of Company-paid life insurance, Company contributions to 401(k) plans,&#160;tax reimbursements payments and other Company paid health, dental, disability and insurance premiums. In 2025, amounts for Ms. Barrett included Company contributions to 401(k) plans of 14,000 and Company paid health insurance premiums of 26,598; amounts for Dr. Schoenberg included tax reimbursement payments of 11,807; and&#160;amounts for Mr. Smith included&#160;Company contributions to 401(k) plans of 14,000, tax reimbursement payments of 16,491 and Company paid health insurance premiums of 57,578.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2025&#160;Outstanding Equity Awards at Fiscal Year End Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The following table shows for the fiscal year ended December&#160;31, 2025, certain information regarding outstanding equity awards at fiscal year-end for our named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 90%; margin-left: 5%; margin-right: 5%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Option Awards</b></p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Stock Awards</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b>&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Grant Date</b></p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Number of</b></p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Number of</b></p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Number</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Market</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Equity</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Equity</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Securities</b></p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Securities</b></p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>of Shares</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Value of</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Incentive</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Incentive</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Underlying</b></p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Underlying</b></p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Option </b></p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Option </b></p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>of Stock</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Shares of</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Plan</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Plan</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Unexercised</b></p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Unexercised</b></p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Exercise </b></p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Expiration </b></p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>that have</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Stock that</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Awards:</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Awards:</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options (#)</b></p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options (#)</b></p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Price ($) </b></p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Date </b></p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>not</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>have not</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Number of</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Market or</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Exercisable </b></p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Unexercisable</b></p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><sup style="vertical-align:top;line-height:120%;">(2)</sup></b></p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Vested (#)</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Vested ($)</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Unearned</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Payout</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><sup style="vertical-align:top;line-height:120%;">(1)</sup></b></p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><sup style="vertical-align:top;line-height:120%;">(3)</sup></b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Shares, units or other rights that have not Vested (#)</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Value of Unearned Shares, Units or Other Rights that have not Vested ($)</b><b><sup style="vertical-align:top;line-height:120%;">(4)</sup></b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Elizabeth Barrett</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/3/2019</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">277,432</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">47.57</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/3/2029</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2020</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">45,000</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">29.41</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2030</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2021</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">13,334</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;312,282</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2021</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">150,000</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">22.07</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2031</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2022</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;150,000</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">7.72</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2032</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2023</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">75,000</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1,756,500</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2023</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">83,333</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">41,667</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">10.39</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2033</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">975,841</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">9/7/2023</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">100,000</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">2,342,000</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2024</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">87,615</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2,051,943</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2024</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">87,615</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">2,051,943</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2025</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">96,377</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">2,257,149</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2025</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">96,376</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">2,257,126</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Mark P. Schoenberg</b></td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/20/2016</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">5.00</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/20/2023</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">12/7/2017</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">15,000</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">39.26</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">12/7/2027</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/26/2019</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">7,500</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">42.50</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/26/2029</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/26/2019</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2020</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">15,000</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">29.41</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2030</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">1/31/2021</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">21,000</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">22.07</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2031</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2021</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2022</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">12,064</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">7.72</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2032</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2022</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2023</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">3,334</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">78,082</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2023</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">20,000</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10,000</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10.39</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2033</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">234,200</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">6/8/2023</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10,000</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">234,200</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">9/7/2023</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1,667</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">39,041</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2024</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">6,667</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">156,141</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">1/31/2025</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">20,000</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">468,400</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2025</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">20,000</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">468,400</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Jason Smith</b></p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">10/1/2020&#160;</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;60,000</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">19.66</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">10/1/2030</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2021</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;8,000</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">22.07</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2031</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">6/5/2021</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;15,000</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">17.98</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">6/5/2031</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2022</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2022</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;30,000</p>
			</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">7.72</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2032</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2023</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;6,667</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;156,141</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2023</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">26,666</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;13,334</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">10.39</p>
			</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2033</p>
			</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#8212;</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;312,282</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">9/7/2023</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">3,334</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;78,082</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2024</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">11,000</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">257,620</p>
			</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">1/31/2024</p>
			</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8212;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2025</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10,000</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">234,200</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 17%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1/31/2025</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 37px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 60px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10,000</td>
			<td style="vertical-align: middle; width: 8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">234,200</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Options granted to Ms. Barrett, Dr. Schoenberg and&#160;Mr. Smith vest in equal annual installments over three years from the vesting commencement date.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Options to purchase our ordinary shares were granted with a per share exercise price equal to the fair market value of one ordinary share on the date of grant, as determined in good faith by our Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">RSU and option grants with amounts that have not yet vested vest in equal annual installments over three years from the grant date.&#160;Market value is based on the Company's share price as of December 31, 2025.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: auto;">&#160;</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="vertical-align: top; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Represents performance stock units&#160;which vest (and have now vested), (i) upon the earlier of the receipt of U.S. regulatory approval for <i>Zusduri</i>&#160;in the three years following the grant or the occurrence of a change in control, (ii) the achievement of the&#160;first&#160;commercial sale of <i>Zusduri</i>&#160;in the United States following receipt of regulatory approval, or (iii) upon the achievement of cumulative net product sales of&#160;<i>Jelmyto</i>&#160;and&#160;<i>Zusduri </i>as well as continued service.&#160;Market value is based on the Company's share price as of December 31, 2025.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:AwardTmgMnpiDiscTextBlock" id="c12" escape="true">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"><b>Policies&#160;and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" id="c15"><ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:AwardTmgMnpiCnsdrdFlag" id="c16" format="ixt:fixed-false"><ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:AwardTmgPredtrmndFlag" id="c17" format="ixt:fixed-false"><ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:MnpiDiscTimedForCompValFlag" id="c18" format="ixt:fixed-false">From time to time, the Company grants stock options to its employees, including the named executive officers. In 2025, we did not grant any stock options, stock appreciation rights or similar instruments with option-like features to our named executive officers. Historically, the Company has generally granted new-hire option awards to our executive officers on or shortly following the executive&#8217;s employment start date. For other new hires, new-hire option awards are generally granted in the first week of the month following the new hire&#8217;s employment start date. Promotion option grants are generally granted in the month following the promotion date. Our non-employee directors receive automatic grants of initial and annual stock compensation awards which may be in the form of stock options or a combination of stock options and RSU's, at the time of a director&#8217;s initial appointment or election to the Board and at the time of each annual meeting of the Company&#8217;s shareholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under the heading, &#8220;Director Compensation-Non-Employee Director Compensation Policy,&#8221; below. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. Because we have a practice of generally granting new-hire and&#160;promotion options as described above, the Board and the Compensation Committee generally do not take material non-public information (&#8220;MNPI&#8221;) into account when determining the timing or terms of awards, and they do not seek to time the award of stock options in relation to the Company&#8217;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></p>
</ix:nonNumeric>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 402(v) Pay Versus Performance </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The disclosure included in this section is prescribed by SEC rules and does not necessarily align with how the Company or the Compensation Committee view the link between the Company&#8217;s performance and named executive officer pay. This disclosure is intended to comply with the requirements of Item&#160;402(v) of Regulation S-K applicable to &#8220;smaller reporting companies.&#8221; For additional information about our pay for performance compensation philosophy and how we seek to align executive compensation with the Company&#8217;s performance, refer to &#8220;Executive Compensation.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In accordance with Item&#160;402(v) of Regulation S-K, we provide the following disclosure regarding executive compensation for our principal executive officer (&#8220;PEO&#8221;) and non-PEO named executive officers and Company performance for the fiscal years listed below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:PvpTableTextBlock" id="c19" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Required Tabular Disclosure of Pay Versus Performance</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The amounts set forth below under the headings &#8220;Compensation Actually Paid to PEO&#8221; and &#8220;Average Compensation Actually Paid for Non-PEO Named Executive Officers"&#160;have been calculated in a manner consistent with Item 402(v) of Regulation S-K. Use of the term &#8220;compensation actually paid&#8221; (&#8220;CAP&#8221;) is required by the SEC&#8217;s rules and as a result of the calculation methodology required by the SEC, such amounts differ from compensation actually received by the individuals and the compensation decisions described in the &#8220;Executive Compensation&#8221; section above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Year</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary Compensation Table Total for PEO<sup style="vertical-align:top;line-height:120%;">(1)</sup></b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation Actually Paid to PEO<sup style="vertical-align:top;line-height:120%;">(2)</sup></b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average Summary Compensation Table Total for Non-PEO Named Executive Officers</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average</b>&#160;<b>Compensation Actually Paid for Non-PEO Named Executive Officers<sup style="vertical-align:top;line-height:120%;">(3)</sup></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.6%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-variant: normal; text-align: center; margin: 0pt; font-size: 10pt;">&#160;</p>

			<div style="font-size: 10pt; text-align: center;"><b>Value of Initial Fixed $100 Investment Based on Total Shareholder Return</b></div>

			<div style="font-size: 11.1111px; text-align: center;"><sup style="vertical-align:top;line-height:120%;"><b>(4)</b></sup></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Net Income (Loss)</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 4.5%; text-align: center;">2025</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;"><ix:nonFraction id="c22" contextRef="d_2025-01-01_2025-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">4,310,624</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;"><ix:nonFraction id="c23" contextRef="d_2025-01-01_2025-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">11,841,327</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;"><ix:nonFraction id="c24" contextRef="d_2025-01-01_2025-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,184,629</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;"><ix:nonFraction id="c25" contextRef="d_2025-01-01_2025-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,083,905</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 7.6%; text-align: center;">$<ix:nonFraction id="c26" contextRef="d_2025-01-01_2025-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">264.04</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.5%; text-align: center;">$(<ix:nonFraction id="c27" contextRef="d_2025-01-01_2025-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">153,494,000</ix:nonFraction>)</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2024</p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonFraction id="c28" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">4,149,858</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonFraction id="c29" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,943,517</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonFraction id="c30" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,231,158</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonFraction id="c31" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">913,979</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: 7.6%; text-align: center;">$<ix:nonFraction id="c32" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">120.07</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.5%; text-align: center;">$(<ix:nonFraction id="c33" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">126,874,000</ix:nonFraction>)</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;"><ix:nonFraction id="c34" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">4,639,590</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;"><ix:nonFraction id="c35" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">6,316,189</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;"><ix:nonFraction id="c36" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,434,365</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;"><ix:nonFraction id="c37" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,958,801</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 7.6%; text-align: center;">$<ix:nonFraction id="c38" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">169.11</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: 8.5%; text-align: center;">$(<ix:nonFraction id="c39" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">102,244,000</ix:nonFraction>)</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</ix:nonNumeric>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:AdjToPeoCompFnTextBlock" id="c40" escape="true">
<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="c41" escape="true">
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 6.9%;">(1)</td>
			<td style="vertical-align:top;width:auto;"><ix:nonNumeric contextRef="d_2023-01-01_2025-12-31" name="ecd:PeoName" id="c43">Elizabeth Barrett</ix:nonNumeric>, our President and Chief Executive Officer, was our PEO for each year reported</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">(2)</td>
			<td style="vertical-align:top;width:auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">The non-PEO named executive officers, for each year reported were as follows:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2025:&#160;Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith,&#160;our General Counsel and Chief Compliance Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2024: Chris Degnan, our Chief Financial Officer; Jason Smith, our General Counsel and Chief Compliance Officer; and Don Kim, our former Chief Financial Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2023: Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith, our General Counsel and Chief Compliance Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">(3)</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For fiscal year 2025, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2025, computed in accordance with Item 402(v) of Regulation S-K:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">(<ix:nonFraction id="c44" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">2,122,211</ix:nonFraction>)</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">(<ix:nonFraction id="c45" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">660,600</ix:nonFraction>)</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;"><ix:nonFraction id="c46" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-</ix:nonFraction></td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c47" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c48" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">4,514,275</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c49" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,405,200</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c50" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c51" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c52" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">5,144,729</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c53" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">809,218</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c54" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">23,910</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c55" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">244,734</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c56" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c57" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c58" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c59" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c60" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c61" contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c62" contextRef="d_2025-01-01_2025-12-31_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">7,530,704</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c63" contextRef="d_2025-01-01_2025-12-31_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,798,552</ix:nonFraction></p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;">For fiscal year 2024, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:</p>
&#160;

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c64" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">2,751,111</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c65" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">1,071,230</ix:nonFraction>)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;"><ix:nonFraction id="c66" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-</ix:nonFraction></td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c67" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">695,294</ix:nonFraction>)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c68" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,866,200</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c69" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,267,052</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c70" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c71" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c72" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">1,401,192</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c73" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">459,291</ix:nonFraction>)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c74" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">79,762</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c75" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">7,227</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c76" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c77" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c78" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c79" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c80" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c81" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c82" contextRef="d_2024-01-01_2024-12-31_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">2,206,341</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c83" contextRef="d_2024-01-01_2024-12-31_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">951,536</ix:nonFraction>)</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;">For fiscal year 2023, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c84" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">2,464,250</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c85" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">896,250</ix:nonFraction>)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c86" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">836,533</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(<ix:nonFraction id="c87" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">468,459</ix:nonFraction>)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c88" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">3,982,234</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c89" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,885,051</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c90" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c91" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c92" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">859,009</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c93" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">286,886</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c94" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">136,140</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c95" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">241,644</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c96" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c97" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c98" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c99" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c100" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c101" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="0">-&#160;&#160;&#160;</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c102" contextRef="d_2023-01-01_2023-12-31_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,676,600</ix:nonFraction></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><ix:nonFraction id="c103" contextRef="d_2023-01-01_2023-12-31_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,048,873</ix:nonFraction></p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">(4)</p>
			</td>
			<td style="vertical-align:top;width:43.8%;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">Total shareholder return (&#8220;TSR&#8221;) is calculated as the difference between the Company&#8217;s share price at the beginning and the end of the measurement period, divided by the Company&#8217;s share price at the beginning of the measurement period.</p>
			</td>
		</tr>

</tbody></table>
</ix:nonNumeric></ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="c104" escape="true">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Relationship Between Compensation Actually Paid and Company Total Shareholder Return</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our non-PEO named executive officers, and the Company&#8217;s TSR over the three most recently completed fiscal years.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;">
<div><img alt="tsrgraph.jpg" src="tsrgraph.jpg"/></div>
</div>
</ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2025-01-01_2025-12-31" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="c107" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Relationship Between Compensation Actually Paid and Net Loss </i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our non-PEO named executive officers, and our net loss during the three most recently completed fiscal years.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;">
<div><img alt="netincomegraph.jpg" src="netincomegraph.jpg"/></div>
</div>

<div style="text-align: center;">&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>The information provided above under the </i>&#8220;<i>Item 402(v) Pay Versus Performance</i>&#8221;<i> heading will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div></ix:exclude>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</ix:nonNumeric>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DIRECTOR COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-Employee Director Compensation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table sets forth in summary form information concerning the compensation that we paid or was earned or awarded during the year ended December&#160;31, 2025&#160;to each of our non-employee directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 402px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name </b></p>
			</td>
			<td style="vertical-align: middle; width: 11px;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 93px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Fees Earned or</b><br/>
			<b>Paid in Cash</b><br/>
			<b>($)</b></p>
			</td>
			<td style="vertical-align: middle; width: 7px;">&#160;</td>
			<td style="vertical-align: middle; width: 6px;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 82px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Option</b><br/>
			<b>Awards</b><br/>
			<b>($) </b><b><sup style="vertical-align:top;line-height:120%;">(1)</sup></b></p>
			</td>
			<td style="vertical-align: middle; width: 9px;">&#160;</td>
			<td style="vertical-align: middle; width: 82px;"><b>Stock</b><br/>
			<b>Awards</b><br/>
			<b>($) <sup style="vertical-align:top;line-height:120%;">(2)</sup></b></td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td colspan="2" style="vertical-align: middle; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total</b><br/>
			<b>($)</b></p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 402px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Arie Belldegrun, M.D.<sup style="vertical-align:top;line-height:120%;">(2)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 11px;">&#160;</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 87px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">200,000</p>
			</td>
			<td style="vertical-align: middle; width: 7px;">&#160;</td>
			<td style="vertical-align: middle; width: 6px;">&#160;</td>
			<td style="vertical-align: middle; width: 8px;">&#160;</td>
			<td style="vertical-align: middle; width: 73px;">337,486</td>
			<td style="vertical-align: middle; width: 9px;">&#160;</td>
			<td style="vertical-align: middle; width: 82px;">&#160;-</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 12%;">537,486</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 402px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cynthia M. Butitta <sup style="vertical-align:top;line-height:120%;">(3)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 11px;">&#160;</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 87px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">65,000</p>
			</td>
			<td style="vertical-align: middle; width: 7px;">&#160;</td>
			<td style="vertical-align: middle; width: 6px;">&#160;</td>
			<td style="vertical-align: middle; width: 8px;">&#160;</td>
			<td style="vertical-align: middle; width: 73px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">168,743</p>
			</td>
			<td style="vertical-align: middle; width: 9px;">&#160;</td>
			<td style="vertical-align: middle; width: 82px;">&#160;156,000</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">389,743</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 402px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stuart Holden, M.D.&#160;<sup style="vertical-align:top;line-height:120%;">(4)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 11px;">&#160;</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 87px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">57,500</p>
			</td>
			<td style="vertical-align: middle; width: 7px;">&#160;</td>
			<td style="vertical-align: middle; width: 6px;">&#160;</td>
			<td style="vertical-align: middle; width: 8px;">&#160;</td>
			<td style="vertical-align: middle; width: 73px;">168,743</td>
			<td style="vertical-align: middle; width: 9px;">&#160;</td>
			<td style="vertical-align: middle; width: 82px;">&#160;156,000</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">382,243</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 402px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Leana Wen, M.D., M.Sc.&#160;<sup style="vertical-align:top;line-height:120%;">(5)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 11px;">&#160;</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 87px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">67,500</p>
			</td>
			<td style="vertical-align: middle; width: 7px;">&#160;</td>
			<td style="vertical-align: middle; width: 6px;">&#160;</td>
			<td style="vertical-align: middle; width: 8px;">&#160;</td>
			<td style="vertical-align: middle; width: 73px;">168,743</td>
			<td style="vertical-align: middle; width: 9px;">&#160;</td>
			<td style="vertical-align: middle; width: 82px;">&#160;156,000</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">392,243</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 402px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Daniel G. Wildman (Wildman Ventures LLC) <sup style="vertical-align:top;line-height:120%;">(6)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 11px;">&#160;</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 87px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">71,522</p>
			</td>
			<td style="vertical-align: middle; width: 7px;">&#160;</td>
			<td style="vertical-align: middle; width: 6px;">&#160;</td>
			<td style="vertical-align: middle; width: 8px;">&#160;</td>
			<td style="vertical-align: middle; width: 73px;">168,743</td>
			<td style="vertical-align: middle; width: 9px;">&#160;</td>
			<td style="vertical-align: middle; width: 82px;">&#160;156,000</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">396,265</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 402px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">James A. Robinson, Jr. <sup style="vertical-align:top;line-height:120%;">(7)</sup></p>
			</td>
			<td style="vertical-align: middle; width: 11px;">&#160;</td>
			<td style="vertical-align: middle; width: 5px;">&#160;</td>
			<td style="vertical-align: middle; width: 87px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">58,478</p>
			</td>
			<td style="vertical-align: middle; width: 7px;">&#160;</td>
			<td style="vertical-align: middle; width: 6px;">&#160;</td>
			<td style="vertical-align: middle; width: 8px;">&#160;</td>
			<td style="vertical-align: middle; width: 73px;">168,743</td>
			<td style="vertical-align: middle; width: 9px;">&#160;</td>
			<td style="vertical-align: middle; width: 82px;">&#160;156,000</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">383,221</p>
			</td>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 49px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align: middle; width: 1708px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The amounts reported in this column do not reflect the amounts that may actually be received by our non-employee directors. Instead, these amounts reflect the aggregate grant date fair value of options to purchase our ordinary shares, and restricted stock units granted to our non-employee directors during the fiscal year ended December 31, 2025, as computed in accordance with ASC Topic 718. Assumptions used in the calculation of these amounts are included in Note 17&#160;to the consolidated financial statements appearing in our Form 10-K for the year ended December 31, 2025, filed with the SEC on March 2, 2026. As required by SEC rules, the amounts reported exclude the impact of estimated forfeitures related to service-based vesting conditions. Our non-employee directors who have received shares will only realize compensation with regard to these options to the extent the market price of our ordinary shares is greater than the exercise price of such options.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Aggregate number of option awards and restricted stock units outstanding held by Dr. Belldegrun at December 31, 2025&#160;were 95,000 and none, respectively.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Aggregate number of option awards and restricted stock units outstanding held by Ms. Butitta at December 31, 2025&#160;were 122,500 and 6,000, respectively.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Aggregate number of option awards and restricted stock units outstanding held by Dr. Holden at December 31, 2025&#160;were 82,500 and 6,000, respectively.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(5)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Aggregate number of option awards and restricted stock units outstanding held by Dr. Wen at December 31, 2025&#160;were 42,500&#160;and 6,000, respectively.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 19px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(6)</p>
			</td>
			<td style="vertical-align: middle; width: 823px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Aggregate number of option awards and restricted stock units outstanding held by Mr. Wildman at December 31, 2025&#160;were 42,500&#160;and 6,000, respectively.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(7)</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Aggregate number of option awards and restricted stock units outstanding held by Mr. Robinson at December 31, 2025&#160;were 37,500&#160;and 6,000, respectively.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Non-Employee Director Compensation Policy</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The cash fees paid to or earned by our directors in 2025, as reflected in the table above, were paid pursuant to our non-employee director compensation policy. Pursuant to our non-employee director compensation policy, each of our directors who is not an employee of our company, which is currently all directors other than Ms.&#160;Barrett, is eligible to receive compensation for service on our Board and committees of our Board. Our non-employee director compensation policy is contained within the Compensation Policy. Under our non-employee director compensation policy, each non-employee member of our Board is entitled to receive a cash retainer in the following amounts for service in each specified role:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Annual Board Service Retainer</span>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 32px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 1220px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chair of the Board: $195,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align: middle; width: 32px;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: middle; width: 1220px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">All other eligible directors: $45,000</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Annual Committee Member Service Retainer (in addition to Board Service Retainer)</span>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Member of the Audit Committee: $7,500</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Member of the Compensation Committee: $5,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Member of the Nominating and Corporate Governance Committee: $5,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Member of the Compliance Committee: $5,000</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Annual Committee Chair Service Retainer (in addition to Committee Member Service Retainer)</span>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chair of the Audit Committee: $20,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chair of the Compensation&#160;Committee: $15,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chair of the Nominating and Corporate Governance Committee: $15,000</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chair of the Compliance Committee: $15,000</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the current non-employee director compensation policy, each non-employee director is also entitled to receive either (i) an initial option grant to purchase 40,000 of our ordinary shares or (ii) an option to purchase 20,000 ordinary shares and 16,000 restricted stock units, and an annual grant of&#160;either (i) an option to purchase 20,000 of our ordinary shares or (ii) an option to purchase 10,000 of our ordinary shares and 8,000 restricted stock units on the date of each annual shareholders meeting of the Company, contingent upon their continued service as a non-employee member of the Board. If a director joins the Board between annual meetings, the annual grant awarded at his/her first annual meeting will be pro-rated based on the duration of service leading up to the meeting date: (i)&#160;for service between 0 (zero) and 90 (ninety) days &#8211; no grant; (ii)&#160;for service between 91 (ninety-one) and 180 (one hundred eighty) days &#8211; 50% of the grant set forth above; and (iii)&#160;for service of at least 181 (one hundred eighty-one) days &#8211; 100% of the grant set forth above.&#160;The exercise price per share of each stock option granted under the non-employee director compensation policy will be equal to 100% of the fair market value of the underlying ordinary share on the date of grant. The initial option grants and restricted stock unit grant&#160;vest in equal quarterly installments over a period of three&#160;years. The annual option grants and restricted stock unit grants vest in equal quarterly installments over a period of one year. Additionally, a grant in excess of the initial grant may be applied as an inducement for eligible or prospective non-employee directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">In 2025, we adopted a restricted stock unit deferral program which allows our non-employee directors to defer settlement of restricted stock units granted to such non-employee director under the Compensation Policy (as it may be amended from time to time) until the earlier of (i) the date that is 30 days following the date on which the director ceases to serve as a member of the Board and (ii) a change of control of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Our non-employee directors also received reimbursement of their actual out-of-pocket costs and expenses incurred in connection with attending Board meetings.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TRANSACTIONS WITH RELATED PERSONS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Certain Related-Person Transactions</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Described below are all transactions occurring since January&#160;1, 2024&#160;to which we were a party and in which (i)&#160;the amounts involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years, and (ii)&#160;a director, executive officer, holder of more than 5% of our outstanding ordinary shares, or any member of such person&#8217;s immediate family had or will have a direct or indirect material interest, other than (a) the equity and other compensation agreements that are described under &#8220;Executive Compensation&#8221; and &#8220;Director Compensation&#8221; and compensation to other executive officers that would have been disclosed in the &#8220;Executive Compensation&#8221; section if any such executive officer had been a&#160;named executive officer, and (b) such transactions that are not required to be described under this item pursuant to the instructions to Item 404(a) of Regulation S-K. We believe the terms obtained or consideration that we paid or received, as applicable, in connection with the transactions described below were comparable to terms available or the amounts that would be paid or received, as applicable, in arm&#8217;s-length transactions with unrelated third parties.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">On&#160;February 14, 2025, the Company entered into an Asset Purchase Agreement (the &#8220;Agreement&#8221;) with IconOVir Bio, Inc. (&#8220;IconOVir&#8221;), pursuant to which the Company purchased and acquired certain assets of IconOVir, including the product candidate ICVB-1042&#160;and certain contracts, intellectual property rights, regulatory applications, submissions and registrations, and data and other rights related thereto, and assumed certain liabilities and obligations of IconOVir arising under certain contracts of IconOVir acquired by the Company. As consideration for the acquired assets, the Company (i)&#160;issued 374,843 ordinary shares of the Company (the &#8220;Company Shares&#8221;) to IconOVir, which represents a purchase price of $4.0&#160;million divided by the volume-weighted average closing price of the Company Shares on The Nasdaq Stock Market over the 30 consecutive trading days ending on (and including) the trading day immediately prior to the closing of the acquisition, (ii)&#160;agreed to pay IconOVir a&#160;one-time&#160;payment of $15.0&#160;million in cash upon the achievement of a cumulative aggregate worldwide net sales milestone for all products, including combination products, that incorporate or comprise ICVB-1042 (&#8220;ICVB Products&#8221;), (iii) agreed to pay IconOVir a low, single-digit percentage royalty, on an ICVB&#160;Product-by-ICVB&#160;Product basis, on the annual, worldwide net sales of such ICVB Product during the royalty term, subject to certain reductions as set forth in the Agreement, and (iv)&#160;agreed to assume certain immaterial liabilities arising under certain acquired contracts ((i), (ii), (iii), and (iv)&#160;collectively, the &#8220;Purchase Price&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Entities affiliated with Arie Belldegrun, M.D., the Chair of the Board of Directors of the Company, held certain promissory notes of IconOVir that&#160;may&#160;entitle such entities to receive, in the aggregate, approximately&#160;28.3% of the Purchase Price.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Indemnification agreements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our articles of association permit us to exculpate, indemnify and insure each of our directors and executive officers to the fullest extent permitted by the Companies Law. We have entered into indemnification agreements with each of our directors and executive officers, undertaking to indemnify them to the fullest extent permitted by Israeli law, to the extent that these liabilities are not covered by insurance. We have also obtained Directors and Officers insurance for each of our executive officers and directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Policies and Procedures for Transactions with Related Persons</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">We adopted a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. For purposes of our policy only, a &#8220;related person transaction&#8221; is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any related person are, were or will be participants in which the amount involved exceeds the lesser of $120,000 and 1% of the average of our total assets at year-end for the last two completed fiscal years. Transactions involving compensation for services provided to us as an employee or director that are approved by the Compensation Committee are not covered by this policy. A &#8220;related person&#8221; is any executive officer, director or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned or controlled by such persons.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to our Audit Committee or, if Audit Committee approval would be inappropriate, to another independent body of our Board, for review, consideration and approval or ratification. The presentation must include a description of, among other things, the material facts, interests, direct and indirect, of the related persons, benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant shareholder to enable us to identify any existing or potential related-person transactions and to effectuate the terms of the policy. In addition, under our Code of Conduct, our employees and directors have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. In considering related person transactions, our Audit Committee, or other independent body of our Board, is required to take into account the relevant available facts and circumstances including, but not limited to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the risks, costs and benefits to us;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the impact on a director&#8217;s independence in the event that the related person is a director, immediate family member of a director or an entity with which a director is affiliated;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the availability of other sources for comparable services or products; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:6.7%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The policy requires that, in determining whether to approve, ratify or reject a related person transaction, our Audit Committee, or other independent body of our Board, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our shareholders, as our Audit Committee, or other independent body of our Board, determines in the good faith exercise of its discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>HOUSEHOLDING OF PROXY MATERIALS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Annual Meeting materials with respect to two or more shareholders sharing the same address by delivering a single set of Annual Meeting materials addressed to those shareholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for shareholders and cost savings for companies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This year, a number of brokers with account holders who are shareholders will be &#8220;householding&#8221; our proxy materials. A single set of Annual Meeting materials will be delivered to multiple shareholders sharing an address unless contrary instructions have been received from the affected shareholders. Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate set of Annual Meeting materials, please notify your broker or UroGen at (646) 768-9780&#160;or by mail to UroGen Pharma Ltd., Attention: Corporate Secretary, 400 Alexander Park Drive, 4th Floor, Princeton, New Jersey 08540. Shareholders who currently receive multiple copies of the Annual Meeting materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>DISCUSSION OF AUDITED CONSOLIDATED FINANCIAL STATEMENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Members of our management will be available at the Annual Meeting to discuss our audited consolidated financial statements for the fiscal year ended December 31, 2025, a copy of which is included in our Annual Report on Form 10-K for the year ended&#160;December&#160;31, 2025, as filed with the SEC on March 2, 2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OTHER MATTERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Board, at the time of the preparation of this proxy statement, knows of no other matters to come before the Annual Meeting other than that referred to herein. If any other matters should properly come before the Annual Meeting, the persons named in the proxy card will have discretionary authority to vote all proxies in accordance with his or her best judgment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By Order of the Board</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">/s/ Chris Degnan</span></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chris Degnan</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">April 30, 2026</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>A copy of the Company</b>&#8217;<b>s Annual Report to the SEC on Form 10-K for the fiscal year ended December 31, 2025</b>&#160;<b>is available without charge upon written request to: UroGen Pharma Ltd., Attention: Corporate Secretary, 400 Alexander Park Drive, 4th Floor, Princeton, New Jersey 08540.</b></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;"><b>APPENDIX A-1</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;"><b>PROPOSED ARTICLES OF ASSOCIATION</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>ARTICLES OF ASSOCIATION</b>&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>OF</b>&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>UROGEN PHARMA LTD.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>A COMPANY LIMITED BY SHARES</b>&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>UNDER THE COMPANIES LAW, 5759-1999</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>INTERPRETATION</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In these Articles, unless the context requires otherwise, the following capitalized terms shall have the meanings set opposite them:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Articles</b>&#8221;&#160;means these Articles of Association, as may be amended from time to time;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Board</b>&#8221;&#160;means the board of directors of the Company;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Business Day</b>&#8221;&#160;means any day other than a Saturday, Sunday and any day on which banks in Israel are closed or on which the NASDAQ is closed;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Chairman of the Board</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">16.4</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Companies Law</b>&#8221;&#160;means the Israeli Companies Law, 5759-1999, as amended from time to time, including the regulations promulgated thereunder, or any other law which may come in its stead, including all amendments made thereto;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Company</b>&#8221;&#160;means UroGen Pharma Ltd.;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Compensation Committee</b>&#8221;&#160;has the meaning set out in the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Derivative Transaction</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">12.7</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;External Director</b>&#8221;&#160;has the meaning set out in the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.10.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;General Meeting</b>&#8221;&#160;means either an annual or an extraordinary meeting of the shareholders;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.11.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Incapacitated Person</b>&#8221;&#160;means any person whose capacity to effect legal action was denied or restricted by a court of competent jurisdiction or pursuant to the laws of the jurisdiction applicable to him and a bankrupt person in respect of whom no rehabilitation has been granted;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.12.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;NASDAQ</b>&#8221;&#160;means the Nasdaq Stock Market;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.13.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Nominees</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">15.2</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.14.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Office</b>&#8221;&#160;means the registered office of the Company at that time;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.15.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Office Holder</b>&#8221;&#160;has the meaning set out in the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align: top; width: 44px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.16 .</p>
			</td>
			<td style="vertical-align: top; width: 1580px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Ordinary Shares</b>&#8221;&#160;means ordinary shares of the Company with a nominal value of NIS 0.01 each;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.17.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Proposal Request</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">12.5</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.18.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Proposing Shareholder</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article 12.5</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.19.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Register</b>&#8221;&#160;means the register of shareholders administered in accordance with the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.20.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Rights</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">24.9</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.21.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;SEC</b>&#8221;&#160;means the U.S. Securities and Exchange Commission;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.22.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Special Fund</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article 24.9</span>; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:98pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.23.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;U.S. Rules</b>&#8221;&#160;means the applicable rules of the NASDAQ and U.S.&#160;&#160;securities laws, regulations and rules, as amended from time to time.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Reference to &#8220;<i>writing</i>&#8221;, &#8220;<i>written</i>&#8221;&#160;or similar expressions in these Articles means handwriting, typewriting, photography, telex, email, other electronic form or any other legible form of writing. Reference to a &#8220;person&#8221;&#160;or &#8220;persons&#8221;&#160;shall also include corporations, companies, cooperative societies, partnerships, trusts of any kind or any other body of persons, whether incorporated or otherwise.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of this <span style="text-decoration: underline; ">Article 1</span>&#160;and unless the context necessitates another meaning, terms and expressions in these Articles which have been defined in the Companies Law shall have the meanings ascribed to them therein.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.4.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Words in the singular shall also include the plural, and vice versa.&#160;&#160;Words in the masculine shall include the feminine and vice versa.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.5.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The captions to articles in these Articles are intended for the convenience of the reader only, and no use shall be made thereof in the interpretation of these Articles.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>LIMITED LIABILITY</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The Company is a company with limited liability and therefore each shareholder&#8217;s liability for the Company&#8217;s obligations shall be limited to the payment of the nominal value of the shares held by such shareholder, subject to the provisions of the Companies Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>OBJECTIVES</b>&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The Company&#8217;s objectives are to engage in any lawful activity.&#160; The Company may donate a reasonable amount of money for any purpose that the Board finds appropriate, even if the donation is not for business considerations or for the purpose of achieving profits for the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>REGISTERED OFFICE</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The Office shall be at such place as decided by the Board from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>AUTHORIZED SHARE CAPITAL</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The authorized share capital of the Company shall consist of NIS 1,000,000 (one million New Israeli Shekels) divided into 100,000,000 (one hundred million) Ordinary Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>RIGHTS ATTACHING TO THE ORDINARY SHARES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Ordinary Shares shall rank <i>pari passu</i>&#160;between them in all respects.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Ordinary Shares in respect of which all calls have been fully paid shall confer on the holders thereof the right to attend and to vote at General Meetings of the Company, both annual as well as extraordinary meetings. Each Ordinary Share shall confer on its holder one vote at a General Meeting of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Ordinary Shares shall confer on a holder thereof the right to receive a dividend, to participate in a distribution of bonus shares and to participate in the distribution of the assets of the Company upon its winding-up, pro rata to the nominal amount paid up on the shares or credited as paid up in respect thereof, and without reference to any premium which may have been paid in respect thereof.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>MODIFICATION OF CLASS RIGHTS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to applicable law, if at any time the share capital of the Company is divided into different classes of shares and unless the terms of issue of such class of shares otherwise stipulate, the rights attaching to any class of shares (including rights prescribed in the terms of issue of the shares) may be altered, modified or canceled by a resolution passed at a separate class meeting of the shareholders of that class.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The provisions contained in these Articles with regard to General Meetings shall apply, <i>mutatis mutandis</i>&#160;as the case may be, to every class meeting of the holders of each such class of the Company&#8217;s shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise provided by these Articles, the increase of an authorized class of shares, or the issuance of additional shares thereof out of the authorized and unissued share capital, shall not be deemed, for purposes of this <span style="text-decoration: underline; ">Article 7</span>, to modify or abrogate the rights attached to previously issued shares of such class or of any other class.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>UNISSUED SHARE CAPITAL</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The unissued shares in the capital of the Company shall be under the control of the Board (and, to the full extent permitted by law, any committee designated thereby), which shall be entitled to issue or otherwise grant the same to such persons under such restrictions and conditions as it shall deem fit, whether for consideration or otherwise, and whether for consideration in cash or for consideration which is not in cash, above their nominal value or at a discount, all on such conditions, in such manner and at such times as the Board (or such committee) shall deem fit, subject to the provisions of the Companies Law.&#160;&#160;The Board (or such committee) shall be entitled, <i>inter alia</i>, to differentiate between shareholders with regard to the amounts of calls in respect of the allotment of shares (to the extent that there are calls) and with regard to the time for payment thereof.&#160;&#160;The Board (or such committee) may also issue options or warrants or other securities for the purchase of shares of the Company and prescribe the manner of the exercise of such options or warrants or other securities, including the time and price for such exercise and any other provision which is relevant to the method for distributing the issued shares of the Company amongst the purchasers thereof.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to prescribe the times for the issue of shares of the Company and the conditions therefor and any other matter which may arise in connection with the issue thereof.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In every case of a rights offering, the Board shall be entitled, in its discretion, to resolve any problems and difficulties arising or that are likely to arise in regard to fractions of rights, and without prejudice to the generality of the foregoing, the Board shall be entitled to specify that no shares shall be allotted in respect of fractions of rights, or that fractions of rights shall be sold and the net proceeds shall be paid to the persons entitled to the fractions of rights, or, in accordance with a decision by the Board, to the benefit of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:31pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>INCREASE OF CAPITAL; ALTERATIONS TO CAPITAL</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company may, from time to time, by a resolution of the shareholders at a General Meeting, increase its share capital by way of the creation of new shares, whether or not all the existing shares have been issued up to the date of the resolution, whether or not it has been decided to issue same, and whether or not calls have been made on all the issued shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The increase of share capital shall be in such amount and divided into shares of such nominal value, and with such restrictions and conditions and with such rights and privileges as the resolution dealing with the creation of the shares prescribes, and if no provisions are contained in the resolution, then as the Board shall prescribe.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise stated in the resolution approving the increase of the share capital, the new shares shall be subject to those provisions in regard to issue, allotment, alteration of rights, payment of calls, liens, forfeiture, transfer, transmission and other provisions which apply to the shares of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company may, subject to any applicable provisions of the Companies Law:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">consolidate its issued or unissued share capital, or any part thereof, including into shares of a per share par value which is larger, equal to or smaller than the per share par value of its existing shares;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">sub-divide its issued or unissued share capital, in whole or in part, into shares of a smaller or the same par value of the existing shares and without prejudice to the foregoing, one or more of the shares so created may be granted any preferred or deferred rights or any special rights with regard to dividends, participation in assets upon winding-up, voting and so forth, subject to the provisions of these Articles;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">reduce its share capital; or</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cancel any shares which on the date of passing of the resolution have not been issued and to reduce its share capital by the amount of such shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.5.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In the event of any of the actions described in <span style="text-decoration: underline; ">Article 9.4</span>&#160;above, the Board shall be entitled to prescribe arrangements necessary in order to resolve any difficulty arising or that are likely to arise in connection with such consolidation or other action, including to (i) allot, in contemplation of or subsequent to such consolidation or other action, shares or fractional shares sufficient to preclude or remove fractional share holdings; (ii) redeem, subject to applicable law, such shares or fractional shares sufficient to preclude or remove fractional share holdings; (iii) round up, round down or round to the nearest whole number, any fractional shares resulting from the consolidation or from any other action which may result in fractional shares; or (iv) cause the transfer of fractional shares by certain shareholders to other shareholders thereof so as to most expediently preclude or remove any fractional shareholdings, and, cause the transferees of such fractional shares to pay the transferors thereof the fair value thereof, and the Board is hereby authorized to act in connection with such transfer, as agent for the transferors and transferees of any such fractional shares, with full power of substitution, for the purposes of implementing the provisions of this <span style="text-decoration: underline; ">Article 9.5</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>SHARE CERTIFICATES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Uncertificated Shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise determined by the Board, the shares shall not be certificated.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certificated Shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 80pt;">To the extent shares are certificated:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Share certificates evidencing title to the shares of the Company shall be issued under the seal or rubber stamp of the Company or the Company&#8217;s name stamped or printed, together with the signatures of two members of the Board, or one director together with the Chief Executive Officer, the Chief Financial Officer or any other person designated by the Board. The Board shall be entitled to decide that the signatures be effected in any mechanical or electronic form, provided that the signature shall be effected under the supervision of the Board in such manner as it prescribes.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every shareholder shall be entitled, free of charge, to one certificate in respect of all the shares of a single class registered in his name in the Register.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company shall not refuse a request by a shareholder to obtain several certificates in place of one certificate, unless such request is, in the opinion of the Board, unreasonable.&#160;&#160;Where a shareholder has sold or transferred some of his shares, he shall be entitled, free of charge, to receive a certificate in respect of his remaining shares, provided that the previous certificate is delivered to the Company before the issuance of a new certificate.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every share certificate shall specify the number of shares in respect of which such certificate is issued and may also specify the amounts which have been paid up in respect of each such share.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A share certificate registered in the names of two (2) or more persons shall be delivered to one of the joint holders, and the Company shall not be obliged to issue more than one certificate to all the joint holders of shares and the delivery of such certificate to one (1) of the joint holders shall be deemed to be delivery to all of them.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If a share certificate should be lost, destroyed or defaced, the Company shall be entitled to issue a new certificate in its place, provided that the certificate is delivered to it and destroyed by it, or it is proved to the satisfaction of the Board that the certificate was lost or destroyed and security has been received to its satisfaction in respect of any possible damages and after payment of such amount as the Board shall prescribe.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No person shall be recognized by the Company as having any right to a share unless such person is the registered owner of the shares in the Register.&#160;&#160;The Company shall not be bound by and shall not recognize any right or privilege pursuant to the laws of equity, or a fiduciary relationship or a chose in action, future or partial, in any share, or a right or privilege to a fraction of a share, or (unless these Articles otherwise direct) any other right in respect of a share, except the absolute right to the share as a whole, where same is vested in the owner registered in the Register.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>TRANSFER AND TRANSMISSION OF SHARES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No transfer of shares shall be registered unless a proper instrument of transfer is delivered to the Company or, in the case of shares registered with a transfer agent, delivered to such transfer agent or to such other place specified for this purpose by the Board.&#160;&#160;Subject to the provisions of these Articles, an instrument of transfer of a share in the Company shall be signed by the transferor and the transferee.&#160;&#160;Notwithstanding anything to the contrary herein, shares registered in the name of The Depository Trust Company (or other entity providing similar functions) or its nominee shall be transferrable in accordance with the policies and procedures of The Depository Trust Company (or other entity providing similar functions). The Board may approve other methods of recognizing the transfer of shares in order to facilitate the trading of the Company&#8217;s shares on the NASDAQ or on any other stock exchange.&#160;&#160;The transferor shall be deemed to remain the holder of the share up until the time the name of the transferee is registered in the Register in respect of the transferred share.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insofar as the circumstances permit, the instrument of transfer of a share shall be substantially in the form set out below, or in any other form that the Board may approve.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 161pt;">I _______________, I.D.&#160; _______________ of _______________ (the &#8220;<b>Transferor</b>&#8221;), in consideration for an amount of _______________ (in words) paid to me by _______________ I.D.&#160; _______________ of _______________ (hereinafter: the &#8220;<b>Transferee</b>&#8221;), hereby transfer to the Transferee _______________ ______________ shares of nominal value NIS _______________ each, marked with the numbers _______________ to _______________ (inclusive) of UroGen Pharma Ltd., to be held by the Transferee, the assignee of his rights and his successors-in title, under all the same conditions under which I held same prior to the signing of this instrument, and I, the Transferee, hereby agree to accept the aforementioned shares in accordance with the above mentioned conditions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 81pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 81pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 81pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 161pt;">In witness whereof we have hereunto signed this _____ day of _______ 20__.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 81pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 161pt;">Transferor _______________ Transferee _______________</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 81pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 161pt;">Witnesses to Signature ______________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company may close the transfer registers and the Register for such period of time as the Board shall deem fit.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every instrument of transfer shall be submitted to the Office or to such other place as the Board shall prescribe, for purposes of registration, together with the share certificates to be transferred, or if no such certificate was issued, together with a letter of allotment of the shares to be transferred, and such other proof as the Board may demand in regard to the transferor&#8217;s right of title or his right to transfer the shares.&#160;&#160;The Board shall have the right to refuse to recognize an assignment of shares until the appropriate securities under the circumstances have been provided, as shall be determined by the Board in a specific case or from time to time in general.&#160;&#160;Instruments of transfer which serve as the basis for transfers that are registered shall remain with the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every instrument of transfer shall relate to one class of shares only, unless the Board shall otherwise agree.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The executors of the will or administrator of a deceased shareholder&#8217;s estate (such shareholder not being one of a joint owners of a share) or, in the absence of an administrator of the estate or executor of the will, the persons specified in <span style="text-decoration: underline; ">Article 11.7</span>&#160;below, shall be entitled to demand that the Company recognize them as owners of rights in the share.&#160;&#160;The provisions of <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">11.4</span>&#160;above shall apply, mutatis mutandis, also in regard to this Article.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In the case of the death of one of the holders of a share registered in the names of two or more persons, the Company shall recognize only the surviving owners as persons having rights in the share.&#160;&#160;However, the aforementioned shall not be construed as releasing the estate of a deceased joint shareholder from any and all undertakings in respect of the shares.&#160;&#160;Any person who shall become an owner of shares following the death of a shareholder shall be entitled to be registered as owner of such shares after having presented to an officer of the Company to be designated by the Chief Executive Officer an inheritance order or probation order or order of appointment of an administrator of estate and any other proof as required - if these are sufficient in the opinion of such officer - testifying to such person&#8217;s right to appear as shareholder in accordance with these Articles, and which shall testify to his title to such shares.&#160;&#160;The provisions of <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">11.4</span>&#160;above shall apply, <i>mutatis mutandis</i>, also in regard to this Article.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The receiver or liquidator of a shareholder who is a company or the trustee in bankruptcy or the official receiver of a shareholder who is bankrupt, upon presenting appropriate proof to the satisfaction of an officer of the Company to be designated by the Chief Executive Officer that such shareholder has the right to appear in this capacity and which testifies to such shareholder&#8217;s title, may, with the consent of the Board (the Board shall not be obligated to give such consent) be registered as the owner of such shares.&#160;&#160;Furthermore, such shareholder may assign such shares in accordance with the rules prescribed in these Articles.&#160;&#160;The provisions of <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">11.4</span>&#160;above shall apply, <i>mutatis mutandis</i>, also in regard to this Article.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A person entitled to be registered as a shareholder following assignment pursuant to these Articles shall be entitled, if approved by the Board and to the extent and under the conditions prescribed by the Board, to dividends and any other monies paid in respect of the shares, and shall be entitled to give the Company confirmation of the payments; <i>however</i>, he shall not be entitled to be present or to vote at any General Meeting of the Company or, subject to the provisions of these Articles, to make use of any rights of shareholders, until he has been registered as owner of such shares in the Register.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>GENERAL MEETING</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">An annual General Meeting shall be held at such time and at such place as the Board shall determine either within or outside the State of Israel.&#160;&#160;Such annual General Meeting shall be called an annual meeting, and all other meetings of the shareholders shall be called extraordinary meetings.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may call an extraordinary meeting whenever it sees fit to do so, at such time and at such place as the Board shall determine either within or outside the State of Israel.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[INTENTIONALLY OMITTED]</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company is not required to give notice of a General Meeting, subject to any mandatory provision of the Companies Law or other applicable law or regulation.&#160;&#160;Subject to the mandatory provisions of the Companies Law or other applicable law or regulation, in counting the number of days of prior notice given, the day of publication of the notice shall not be counted, but the day of the meeting shall be counted.&#160;&#160;The notice shall specify those items and contain such information as shall be required by the Companies Law and any other applicable law and regulations.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any shareholder or shareholders of the Company that have the right under the Companies Law to request that a certain matter be included on the agenda of a General Meeting to be held in the future (a &#8220;<b>Proposing Shareholder</b>&#8221;) may submit such a request in accordance with and subject to the Companies Law and these Articles, provided that the matter is appropriate to be considered at the relevant General Meeting and the request is timely made (a &#8220;<b>Proposal Request</b>&#8221;).&#160;&#160;Subject to any requirements under the Companies Law, to be considered timely and appropriate for the agenda of the relevant General Meeting, a Proposal Request must be delivered, either in person or by certified mail, postage prepaid, and received at the Office, (i) in the case of a General Meeting that is an annual meeting, no less than sixty (60) days nor more than one-hundred twenty (120) days prior to the date of the first anniversary of the preceding year&#8217;s annual meeting, <i>provided, however</i>, that, in the event that the date of the annual meeting is advanced more than thirty (30) days prior to or delayed by more than thirty (30) days after the anniversary of the preceding year&#8217;s annual meeting, notice by the Proposing Shareholder, in order to be timely and appropriate for the agenda of the relevant General Meeting, must be received no earlier than the close of business one-hundred twenty (120) days prior to such annual meeting and no later than the close of business on the later of ninety (90) days prior to such annual meeting or the tenth (10<sup style="vertical-align:top;line-height:120%;">th</sup>) day following the day on which public announcement of the date of such meeting is first made, and (ii) in the case of a General Meeting that is an extraordinary meeting, no earlier than one-hundred twenty (120) days prior to such extraordinary meeting and no later than the close of business on the later of sixty (60) days prior to such extraordinary meeting or the tenth (10<sup style="vertical-align:top;line-height:120%;">th</sup>) day following the day on which public announcement of the date of such meeting is first made, subject to applicable law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A Proposal Request shall also set forth: (i) the name and address of the Proposing Shareholder making the request; (ii) a representation that the Proposing Shareholder is a holder of shares of the Company entitled to vote at such meeting and intends to appear in person or by proxy at the meeting; (iii) a description of all arrangements or understandings between the Proposing Shareholder and any other person or persons (naming such person or persons) in connection with the subject which is requested to be included in the agenda; (iv) a description of all Derivative Transactions (as defined below) by the Proposing Shareholder during the previous twelve (12) month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms of, such Derivative Transactions; and (v) a declaration that all the information that is required under the Companies Law and any other applicable law to be provided to the Company in connection with such subject, if any, has been provided.&#160;&#160;Furthermore, the Board, may, in its discretion, to the extent it deems necessary, request that the Proposing Shareholder(s) provide additional information necessary so as to include a subject in the agenda of a General Meeting, as the Board may reasonably require.&#160;&#160;The information required pursuant to this <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">12.6</span>&#160;shall be updated as of the date the Proposing Shareholder submits the Proposal Request.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A &#8220;<b>Derivative Transaction</b>&#8221;&#160;means any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proposing Shareholder or any of its affiliates or associates, whether of record or beneficial: (a) the value of which is derived in whole or in part from the value of any class or series of shares or other securities of the Company, (b) which otherwise provides any direct or indirect opportunity to gain or share in any gain derived from a change in the value of securities of the Company, (c) the effect or intent of which is to mitigate loss, manage risk or benefit of security value or price changes, or (d) which provides the right to vote or increase or decrease the voting power of such Proposing Shareholder, or any of its affiliates or associates, with respect to any shares or other securities of the Company, which agreement, arrangement, interest or understanding may include, without limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement to borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proposing Shareholder in the shares or other securities of the Company held by any general or limited partnership, or any limited liability company, of which such Proposing Shareholder is, directly or indirectly, a general partner or managing member.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">13.9</span>&#160;below, in the event that the Company has established that an adjourned meeting shall be held on such date which is earlier or later than the date provided for in Section 78(b) of the Companies Law, such date shall be included in the notice.&#160;&#160;The Company may add additional places for shareholders to review the full text of the proposed resolutions, including an internet site.&#160;&#160;The notice shall be provided in the manner prescribed in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">27</span>.&#160;&#160;In no event shall the public announcement of an adjournment or postponement of a General Meeting commence a new time period (or extend any time period) for the giving of a Proposal Request as described above.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to any requirements under the Companies Law, nominations of persons for election to the Board may only be made at an extraordinary meeting if directors are to be elected at such meeting (a) by or at the direction of the Board, or (b) by a Proposing Shareholder who is entitled to vote at the meeting and who complies with the notice procedures set forth in <span style="text-decoration: underline; ">Articles </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">12.5 and </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">12.6</span>&#160;above.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PROCEEDINGS AT GENERAL MEETING</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No business shall be conducted at a General Meeting unless a quorum is present when the meeting proceeds to business.&#160;&#160;Except in cases where it is otherwise stipulated, a quorum shall be constituted when there are personally present, or represented by proxy, at least two (2) shareholders who hold, in the aggregate, at least thirty-three and one-third percent (33 1/3%) of the voting rights in the Company.&#160;&#160;A proxy may be deemed to be two (2) or more shareholders pursuant to the number of shareholders such proxy represents.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If within half an hour from the time appointed for the meeting, a quorum is not present, without there being an obligation to notify the shareholders to that effect, the meeting shall be adjourned to the same day in the following week, at the same hour and at the same place or to an earlier or later time and date if so specified in the notice of the meeting, unless such day shall fall on a statutory holiday (either in Israel or in the United States), in which case the meeting will be adjourned to the first Business Day afterwards.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If the original meeting was convened upon requisition under Section 63, 64 or 65 of the Companies Law, then one or more shareholders, present in person or by proxy and holding the number of shares required for making a requisition under Section 63 of the Companies Law, shall constitute a quorum at the adjourned meeting, but in any other case any shareholder or shareholders present in person or by proxy shall constitute a quorum at the adjourned meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Chairman of the Board, or any other person appointed for this purpose by the Board, shall preside at every General Meeting.&#160;&#160;If within fifteen (15) minutes from the time appointed for the meeting, the designated chairman for the meeting shall not be present, then any of the following may preside as chairman of the General Meeting (and in the following order): any director, the Chief Executive Officer, the Chief Financial Officer, the Secretary of the Company, or any person designated by the foregoing.&#160;&#160;If none of the foregoing persons is present, willing and able to act as chairman for the meeting, then the shareholders present at the meeting (in person or by proxy) shall elect one of their number to serve as chairman of the meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Except as required under the Companies Law or these Articles, any resolution of the shareholders shall be adopted by a majority of the voting power present and voting on such resolution at the applicable General Meeting, in person or by proxy.&#160;&#160;Each shareholder shall be entitled to the number of votes to which such shareholder is entitled on the basis of the number of Ordinary Shares held by such shareholder and shall vote all of the Ordinary Shares or any part thereof at his sole discretion.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Where a poll has been demanded, the chairman of the meeting shall be entitled - but not obliged - to accede to the demand.&#160;&#160;Where the chairman of the meeting has decided to hold a poll, such poll shall be held in such manner, at such time and at such place as the chairman of the meeting directs, either immediately or after an interval or postponement, or in any other way, and the results of the vote shall be deemed to be the resolution at the meeting at which the poll was demanded.&#160;&#160;A person demanding a poll may withdraw his demand prior to the poll being held.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A demand for the holding of a poll shall not prevent the continued business of the meeting on all other questions apart of the question in respect of which a poll was demanded.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The announcement by the chairman of the meeting that a resolution has been passed unanimously or by a particular majority, or has been rejected, and a note recorded to that effect in the Company&#8217;s minute book, shall serve as prima facie proof of such fact, and there shall be no necessity for proving the number of votes or the proportion of votes given for or against the resolution, unless otherwise required under applicable law and regulation.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The chairman of a General Meeting at which a quorum is present may, with the consent of holders of a majority of the voting power represented in person and by proxy and voting on the question of adjournment, adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting as originally called.&#160;&#160;Subject to these Articles, it shall not be necessary to give any notice of an adjournment unless the meeting is adjourned for more than twenty-one (21) days, in which case notice thereof shall be given in the manner required for the meeting as originally called.&#160;&#160;Where a General Meeting has been adjourned without changing its agenda, to a date which is not more than twenty-one (21) days, notices shall be given for the new date, as early as possible, and by no later than seventy-two (72) hours before the General Meeting. The Board may postpone or adjourn a General Meeting prior to its commencement.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>VOTES OF SHAREHOLDERS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The voting rights of every shareholder entitled to vote at a General Meeting shall be as set forth in <span style="text-decoration: underline; ">Article 6.2</span>&#160;of these Articles.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In the case of joint shareholders, the vote of the senior joint holder, given personally or by proxy, shall be accepted, to the exclusion of the vote of the remaining joint shareholders, and for these purposes the senior of the joint shareholders shall be the person amongst the joint holders whose name appears first in the Register.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A shareholder who is an Incapacitated Person may vote solely through his guardian or other person who fulfills the function of such guardian and who was appointed by a court or other competent authority, and any guardian or other person as aforesaid shall be entitled to vote by way of a proxy, or in such manner as the court or other competent authority directs.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any corporation which is a shareholder of the Company shall be entitled, by way of resolution of its board of directors or another organ which manages said corporation, to appoint such person which it deems fit, whether or not such person is a shareholder of the Company, to act as its representative at any General Meeting of the Company or at a meeting of a class of shares in the Company which such corporation is entitled to attend and to vote thereat, and the appointed as aforesaid shall be entitled, on behalf of the corporation whom he represents, to exercise all of the same powers and authorities which the corporation itself could have exercised had it been a natural person holding shares of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every shareholder who is entitled to attend and vote at a General Meeting of the Company shall be entitled to appoint a proxy.&#160;&#160;A proxy can be appointed by more than one shareholder and vote in different ways on behalf of each principal.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The instrument appointing a proxy shall be in writing signed by the person making the appointment or by his authorized representative, and if the person making the appointment is a corporation, the power of attorney shall be signed in the manner in which the corporation signs on documents which bind it, and a certificate of an attorney with regard to the authority of the signatories to bind the corporation shall be attached thereto.&#160;&#160;The proxy need not be a shareholder of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The instrument appointing a proxy, or a copy thereof certified by an attorney, shall be lodged at the Office, or at such other place as the Board shall specify, not less than forty-eight (48) hours prior to the General Meeting at which the proxy intends to vote based on such instrument of proxy (or such shorter period as the notice of the General Meeting shall specify).&#160;&#160;Notwithstanding the above, the chairman of the meeting shall have the right to waive the time requirement provided above with respect to all instruments of proxies and to accept any and all instruments of proxy until the beginning of a General Meeting.&#160;&#160;A document appointing a proxy shall be valid for every adjourned meeting of the General Meeting to which the document relates.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every instrument appointing a proxy, whether for a meeting specifically indicated, or otherwise, shall, as far as circumstances permit, be substantially in the following form, or in any other form approved by the Board:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 152pt;">I ______________ of ______________ being a shareholder holding shares in UroGen Pharma Ltd., hereby appoint Mr.&#160; ______________ of ______________ or failing him, Mr.&#160; ______________ of ______________, or failing him, Mr.&#160; ______________ of ______________, to vote in my name, place and stead at the (ordinary/extraordinary) General Meeting of the Company to be held on the ____ of ______ 20__, and at any adjourned meeting thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 152pt;">In witness whereof I have hereto set my hand on the _____ day of _____.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No shareholder shall be entitled to vote at a General Meeting unless he has paid all of the calls and all of the amounts due from him, for the time being, in respect of his shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:62pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.10.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A vote given in accordance with the instructions contained in an instrument appointing a proxy shall be valid notwithstanding the death or bankruptcy of the appointer, or the revocation of the proxy, or the transfer of the share in respect of which the vote was given as aforesaid, unless notice in writing of the death, revocation or transfer is received at the Office, or by the chairman of the meeting, prior to such vote.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:62pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.11.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the Companies Law, an instrument appointing a proxy shall be deemed revoked (i) upon receipt by the Company or the chairman of the meeting, subsequent to receipt by the Company of such instrument, of written notice signed by the person signing such instrument or by the shareholder appointing such proxy revoking the appointment thereunder (or the authority pursuant to which such instrument was signed) or of an instrument appointing a different proxy, provided such notice of revocation or instrument appointing a different proxy were so received at the place and within the time for delivery of the instrument revoked thereby as referred to in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">14.7</span>&#160;hereof, or (ii) if the appointing shareholder is present in person at the meeting for which such instrument of proxy was delivered, upon receipt by the chairman of such meeting of written notice from such shareholder of the revocation of such appointment, or if and when such shareholder votes at such meeting.&#160;&#160;A vote cast in accordance with an instrument appointing a proxy shall be valid notwithstanding the revocation or purported revocation of the appointment, or the presence in person or vote of the appointing shareholder at a meeting for which it was rendered, unless such instrument of appointment was deemed revoked in accordance with the foregoing provisions of this <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">14.11</span>&#160;at or prior to the time such vote was cast.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>THE BOARD OF DIRECTORS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The prescribed number of directors of the Company shall be between five (5) and nine (9) (including the External Directors, if any), as may be fixed from time to time by the Board.&#160;&#160;Any director shall be eligible for re-election upon termination of his term of office, subject to applicable law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Prior to every annual General Meeting of the Company, the Board (or a duly authorized committee of the Board) may select, via a resolution adopted by a majority of the Board (or such committee), the persons to be proposed to the shareholders for election as directors at such annual General Meeting for service until the next annual General Meeting (the &#8220;<b>Nominees</b>&#8221;).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Nominees shall be elected by a resolution at the annual General Meeting at which they are subject to election.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every director, other than External Directors (if any), shall hold office until the end of the next annual General Meeting following the annual General Meeting at which he was elected, unless his office is vacated in accordance with <span style="text-decoration: underline; ">Articles </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">15.7 or </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">16.5</span>&#160;below.&#160;&#160;If, at an annual General Meeting, no Nominees are proposed by either the Board or shareholders, or if no Nominees are elected, the directors then in office shall continue to hold office until the convening of a General Meeting at which Nominees shall be proposed and elected.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If the office of a director shall be vacated, or if the number of incumbent directors is less than the maximum prescribed by <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">15.1</span>&#160;above, leaving one or more available offices unfilled, the Board shall be entitled to appoint another director in each office that has become or remains vacated, and such Board-appointed director (or directors) shall hold office until replaced in the manner set out in <span style="text-decoration: underline; ">Article 15.4</span>&#160;above.&#160;&#160;This <span style="text-decoration: underline; ">Article 15.5</span>&#160;shall not apply to a vacated office of an External Director, which may be filled only in accordance with <span style="text-decoration: underline; ">Article 15.9</span>&#160;below, unless the minimum number of External Directors required under the Companies Law are in office at that time or the Company otherwise is not required to appoint an External Director to such office in accordance with the Companies Law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The directors in their capacity as such shall be entitled to receive remuneration as shall be determined in compliance with the Companies Law.&#160;&#160;The conditions (including remuneration) of the terms of office of members of the Board shall be decided by the Board or any duly authorized committee thereof, subject to the Companies Law.&#160;&#160;The remuneration of directors may be fixed as an overall payment or other consideration, or as a payment or other consideration in respect of attendance at meetings of the Board or a committee thereof, or a combination of both.&#160;&#160;In addition to his remuneration, each director shall be entitled to be reimbursed, retroactively or in advance, in respect of his reasonable expenses connected with performing his functions and services as a director.&#160;&#160;Such entitlement shall be determined in accordance with, and shall be subject to, a specific resolution or policy adopted by the Board regarding such matter and in accordance with the requirements of applicable law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law with regard to External Directors and subject to <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">15.4</span>&#160;above and <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">16.5</span>&#160;below, the office of a member of the Board shall be vacated in any one of the following events:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he resigns his office by way of a letter signed by him, lodged at the Office;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he is declared bankrupt;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he becomes insane or unsound of mind;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">upon his death;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he is prevented by applicable law from serving as a director of the Company;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if the Board terminates his office in accordance with Section 231 of the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if a court order is given in accordance with Section 233 of the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he is removed from office by a resolution at a General Meeting adopted by a majority of the voting power in the Company; or</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if his period of office has terminated in accordance with the provisions of these Articles.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If the office of a member of the Board should be vacated, the remaining members of the Board shall be entitled to continue to act for all purposes for as long as their number does not fall below the minimum, as prescribed in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">15.1</span>&#160;above, without limiting their right to fill any vacancy at any time in accordance with <span style="text-decoration: underline; ">Article 15.5</span>&#160;above.&#160;&#160;Should their number fall below the aforesaid minimum, the remaining directors shall not be entitled to act, except for the appointment of additional directors, or for the purpose of calling a General Meeting for the appointment of additional directors, or for the purpose of calling a General Meeting for the appointment of a new Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The office of an External Director shall be vacated and an External Director may be removed and replaced only in accordance with the provisions for vacation of office, removal and appointment of External Directors under the Companies Law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>OTHER PROVISIONS REGARDING DIRECTORS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to any mandatory provisions of applicable law, a director shall not be disqualified by virtue of his office from holding another office in the Company or in any other company in which the Company is a shareholder or in which it has any other form of interest, or of entering into a contract with the Company, either as seller or buyer or otherwise.&#160;&#160;Likewise, no contract made by the Company or on its behalf in which a director has any form of interest may be nullified and a director shall not be obliged to account to the Company for any profit deriving from such office, or resulting from such contract, merely by virtue of the fact that he serves as a director or by reason of the fiduciary relationship thereby created, but such director shall be obliged to disclose to the Board the nature of any such interest at the first opportunity.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A general notice to the effect that a director is a shareholder or has any other form of interest in a particular firm or a particular company and that he must be deemed to have an interest in any business with such firm or company shall be deemed to be adequate disclosure for purposes of this Article in relation to such director, and after such general notice has been given, such director shall not be obliged to give special notice in relation to any particular business with such firm or such company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law and these Articles, the Company shall be entitled to enter into a transaction in which an Office Holder of the Company has a personal interest, directly or indirectly, and may enter into any contract or otherwise transact any business with any third party in which contract or business an Office Holder has a personal interest, directly or indirectly.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board by regular majority shall elect one (1) of its members to serve as chairman of the Board (the &#8220;<b>Chairman of the Board</b>&#8221;). The Chief Executive Officer of the Company shall not serve as Chairman of the Board, unless permitted under applicable law.&#160;&#160;The office of Chairman of the Board shall be vacated if the Board by regular majority determines to dismiss the Chairman of the Board prior to the end of his term of office, or in each of the cases mentioned in <span style="text-decoration: underline; ">Articles </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">15.7</span>&#160;above and <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">16.5</span>&#160;below.&#160;&#160;The Board may also elect one (1) of its members to serve as Vice Chairman of the Board, who shall have such duties and authorities as the Board may assign to him.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If, in a General Meeting, by a resolution adopted by a majority of the voting power in the Company, any director is dismissed prior to the end of his term of office, the Board shall be entitled to appoint another individual in his place as a director.&#160;&#160;The individual so appointed shall hold such office only for that period of time during which the director who was replaced would have held office. This <span style="text-decoration: underline; ">Article 16.5</span>&#160;shall not apply to External Directors (if any), who shall be appointed and removed in accordance with the Companies Law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A director shall not be obliged to hold any share in the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PROCEEDINGS OF THE BOARD OF DIRECTORS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall convene for a meeting at least once every calendar quarter.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may meet in order to exercise its powers pursuant to Section 92 of the Companies Law, including without limitation to supervise the Company&#8217;s affairs, and it may, subject to the provisions of the Companies Law, adjourn its meetings and regulate its proceedings and operations as it deems fit.&#160;&#160;It may also prescribe the quorum required for the conduct of business.&#160;&#160;Until otherwise decided by the Board, a quorum shall be constituted if a majority of the directors holding office for the time being are present when the meeting proceeds to business.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Should a director or directors be barred from being present and voting at a meeting of the Board pursuant to Section 278 of the Companies Law, the quorum shall be a majority of the directors entitled to be present and to vote at the meeting of the Board when the meeting proceeds to business.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any director, the Chief Executive Officer in the event stipulated in Section 122 of the Companies Law or the auditor of the Company in the event stipulated in Section 169 of the Companies Law, may, at any time, demand the convening of a meeting of the Board.&#160;&#160;The Chairman of the Board shall be obliged, on such demand, to call such meeting within a reasonable time from receipt of a request by the director, the Chief Executive Officer or the auditor of the Company soliciting such a meeting, provided that proper notice pursuant to <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">17.5</span>&#160;is given.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every director shall be entitled to receive notice of meetings of the Board, and such notice may be in writing, sent to the last address (whether physical or electronic) or facsimile number given by the director for purposes of receiving notices, <i>provided</i>&#160;that the notice shall be given at least a reasonable amount of time prior to the meeting and in no event less than twenty four (24) hours prior notice, unless the urgency of the matter to be discussed at the meeting reasonably requires a shorter notice period as determined by the Chairman of the Board or the Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every meeting of the Board at which a quorum is present shall have all the powers and authorities vested for the time being in the Board.&#160;&#160;Any matter considered by the Board shall be decided by a simple majority of the directors attending such meeting and voting on such matter.&#160;&#160;In the case of an equality of votes of the Board, the Chairman of the Board shall not have a second or casting vote, and the proposal shall be deemed to be defeated.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If the Chairman of the Board is not present within thirty (30) minutes after the time appointed for the meeting, the directors present shall elect one of their members to preside at such meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may adopt resolutions, without actually convening a meeting of the Board, provided that all the directors entitled to participate in the meeting and to vote on the subject brought for decision agree thereto.&#160;&#160;If resolutions are made as stated in this <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">17.8</span>, the Chairman of the Board shall record minutes of the decisions stating the manner of voting of each director on the subjects brought for decision, as well as the fact that all the directors agreed to take the decision without actually convening.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may hold meetings by use of any means of communication, on condition that all participating directors can hear each other at the same time.&#160;&#160;In the case of a resolution passed by way of a telephone call or any such other means of communication, a copy of the text of the resolution shall be sent, as soon as possible thereafter, to the directors.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>GENERAL POWERS OF THE BOARD OF DIRECTORS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The supervision of the Company&#8217;s affairs shall be in the hands of the Board, which shall be entitled to exercise all of the powers and authorities and to perform any act and deed which the Company is entitled to exercise and to perform in accordance with these Articles, and in respect of which there is no mandatory provision or requirement in the Companies Law or in binding rules and regulations of the United States that such powers and authorities be exercised or performed by the shareholders in a General Meeting or by a committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may, from time to time, in its absolute discretion, borrow or secure any amounts of money required by the Company for the conduct of its business.&#160;&#160;The Board shall be entitled to raise or secure the repayment of an amount obtained by it, in such way and on such conditions and times as it deems fit.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to issue documents of undertaking, such as options, debentures or debenture stock, whether linked or redeemable, convertible debentures or debentures convertible into other securities, or debentures which carry a right to purchase shares or to purchase other securities, or any mortgage, pledge, collateral or other charge over the property of the Company and its undertaking, in whole or in part, whether present or future, including the uncalled share capital or the share capital which has been called but not yet paid.&#160;&#160;The deeds of undertaking, debentures of various types or other forms of collateral security may be issued at a discount, at a premium or otherwise and with such preferential or deferred or other rights, as the Board shall, from time to time, decide.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may, from time to time, set aside any amount(s) out of the profits of the Company as a reserve or reserves for any purpose(s) which the Board, in its absolute discretion, shall deem fit, including without limitation, capitalization and distribution of bonus shares, and may invest any sum so set aside in any manner and from time to time deal with and vary such investments and dispose of all or any part thereof and employ any such reserve or any part thereof in the business of the Company without being bound to keep the same separate from other assets of the Company, and may subdivide or re-designate any reserve or cancel the same or apply the funds therein for other purposes, all as the Board may from time to time think fit.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">19.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>BOARD COMMITTEES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">19.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may, as it deems fit and subject to any applicable law, delegate to a committee certain of its powers and authorities, in whole or in part, as it deems appropriate.&#160;&#160;The curtailment or revocation of the powers and authorities of a committee by the Board shall not invalidate a prior act of such committee or an act taken in accordance with its instructions, which would have been valid had the powers and authorities of the committee not been altered or revoked by the Board.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">19.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The meetings and proceedings of every such committee which is comprised of two (2) or more members shall be conducted in accordance with the provisions contained in these Articles in regard to the conduct of meetings and proceedings of the Board to the extent that the same are suitable for such committee, and so long as no provisions have been adopted in replacement thereof by the Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">20.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>RATIFICATION OF ACTIONS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">20.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the Companies Law, all acts taken in good faith by the Board or a committee or by an individual acting as a member thereof shall be valid even if it is subsequently discovered that there was a defect in the appointment of the Board, the committee or the member, as the case may be, or that the members, or one of them, was or were disqualified from being appointed as a director(s) or to a committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">20.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board or any committee may ratify any act the performance of which at the time of the ratification was within the scope of the authority of the Board or the relevant committee.&#160;&#160;The General Meeting shall be entitled to ratify any act taken by the Board or any committee without authority or which was tainted by some other defect.&#160;&#160;From the time of the ratification, every act ratified as aforesaid, shall be treated as though lawfully performed from the outset.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">21.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>SIGNING POWERS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">21.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to any other resolution on the subject passed by the Board, the Company shall be bound only pursuant to a document in writing bearing its seal or its rubber stamp or its printed or stamped name, and the signature of whomever may be authorized by the Board, which shall be entitled to empower any person, either alone or jointly with another, even if he is not a shareholder or a director, to sign and act in the name and on behalf of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">21.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to prescribe separate signing power in regard to different businesses of the Company and in respect of the limit of the amounts in respect of which various persons shall be authorized to sign.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>CHIEF EXECUTIVE OFFICER</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall, from time to time, appoint a Chief Executive Officer and subject to the provisions of the Companies Law delineate his powers and authorities and his remuneration and the Board may dismiss him or replace him at any time it deems fit.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A Chief Executive Officer need not be a director or shareholder.&#160;&#160;Subject to the provisions of any contract between the Chief Executive Officer and the Company, if the Chief Executive Officer is also a director, all of the same provisions with regard to appointment, resignation and removal from office shall apply to the Chief Executive Officer in his capacity as a director, as applicable to the Company&#8217;s other directors who are not External Directors.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled from time to time, subject to the provisions of the Companies Law, to delegate to the Chief Executive Officer for the time being such of the powers it has pursuant to these Articles as it deems appropriate.&#160;&#160;The Board shall be entitled to grant such powers for such period, for such purposes, on such conditions and with such restrictions as it deems appropriate, and it shall be entitled to grant such powers without renouncing the powers and authorities of the Board in such regard.&#160;&#160;The Board may revoke, annul and alter such delegated powers and authorities, in whole or in part, at any time.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of any applicable law, the remuneration of the Chief Executive Officer shall be fixed from time to time by the Board (and, so long as required by the Companies Law, shall be approved by the Compensation Committee and by the shareholders unless exempted from shareholders&#8217;&#160;approval) and such remuneration may be in the form of a fixed salary or commissions or a participation in profits, or combination thereof, or in any other manner which may be decided by the Board and approved according to this <span style="text-decoration: underline; ">Article 22.4</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:26pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">23.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>SECRETARY, OFFICE-HOLDERS, CLERKS AND REPRESENTATIVES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">23.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled, from time to time, to appoint, or, unless determined otherwise by the Board, the Chief Executive Officer, either alone or together with other persons designated by the Board, shall be entitled to appoint Office Holders (other than (i) directors and (ii) &#8220;officers&#8221;&#160;as defined under Rule 16a-1(f) of the U.S. Securities and Exchange Act of 1934, as amended (&#8220;<b>Section 16 Officers</b>&#8221;)); a Secretary for the Company; employees and agents to such permanent, temporary or special positions; and to specify and change their titles, authorities and duties, and to set,&#160;&#160;their salaries, bonuses and other compensation.&#160;&#160;Salaries, bonuses and compensation of Office Holders who are not directors or Section 16 Officers shall be determined and approved by the Chief Executive Officer, or in such other manner as may be permitted from time to time under the Companies Law.&#160;&#160;The Board, or, unless determined otherwise by the Board, the Chief Executive Officer, either alone or together with other persons designated by the Board, shall be entitled at any time, in its, his or their (as applicable) sole and absolute discretion, to terminate the services of one of more of the foregoing persons (excluding, for clarity, directors and Section 16 Officers).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">23.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board and the Chief Executive Officer may from time to time and at any time, subject to their powers under these Articles and the Companies Law, empower any person to serve as representative of the Company for such purposes and with such powers and authorities, instructions and discretions for such period and subject to such conditions as the Board or the Chief Executive Officer, as the case may be, shall deem appropriate.&#160;&#160;The Board or Chief Executive Officer may grant such person, inter alia, the power to further delegate the authority, powers and discretions vested in him, in whole or in part.&#160;&#160;The Board or the Chief Executive Officer, as the case may be, may revoke, annul, vary or change any such power or authority, or all such powers or authorities collectively.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:32pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>DIVIDENDS, BONUS SHARES, FUNDS AND CAPITALIZATION OF FUNDS AND PROFITS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may decide on the payment of a dividend or on the distribution of bonus shares.&#160;&#160;A dividend in cash or bonus shares shall be paid or distributed, as the case may be, equally to the holders of the Ordinary Shares registered in the Register, pro rata to the nominal amount of capital paid up or credited as paid up on par value of the shares, without reference to any premium which may have been paid thereon.&#160;&#160;However, whenever the rights attached to any shares or the terms of issue of the shares do not provide otherwise, an amount paid on account of a share prior to the payment thereof having been called, or prior to the due date for payment thereof, and on which the Company is paying interest, shall not be taken into account for purposes of this Article as an amount paid-up on account of the share.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Except where determined otherwise in accordance with <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">11.9</span>, only a person whose name, on the date determined by the Board for entitlement to the dividend (&#8220;<b>Record Date</b>&#8221;), was registered in the Register as the owner of the shares shall be entitled to dividends.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless other instructions are given, it shall be permissible to pay any dividend by way of a check or payment order to be sent by post to the registered address of the shareholder or the person entitled thereto, or in the case of joint shareholders being registered, to the shareholder whose name appears first in the Register in relation to the joint shareholding.&#160;&#160;Every such check shall be made in favor of the person to whom it is sent.&#160;&#160;A receipt by the person whose name, on the Record Date, was registered in the Register as the owner of the shares, or in the case of joint holders, by one of the joint holders, shall serve as a discharge with regard to all the payments made in connection with such share.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to invest any dividend which has not been claimed for a period of one (1) year after having been declared, or to make use thereof in any other way for the benefit of the Company until such time as it is claimed.&#160;&#160;A dividend or other beneficial rights in respect of shares shall not bear interest, and the Company shall not be obliged to pay interest or linkage in respect of an unclaimed dividend.&#160;&#160;The payment by the Board of any unclaimed dividend into a separate account shall not make the Company a trustee in respect thereof, and any dividend unclaimed after a period of seven (7) years from the date of declaration of such dividend shall be forfeited and shall revert to the Company, provided, however, that the Board may, at its discretion, cause the Company to pay any such dividend, or any part thereof, to a person who would have been entitled thereto had the same not reverted to the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise specified in the terms of issue of shares or securities convertible into, or which grant a right to purchase, shares, any shares that are fully paid-up or credited as paid-up shall at any time confer on their holders the right to participate in the full dividends and in any other distribution for which the determining date for the right to receive the same is the date at which the aforesaid shares were fully paid-up or credited as fully paid-up, as the case may be, or subsequent to such date.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to deduct from any dividend or other beneficial rights, all amounts of money which the holder of the share in respect of which the dividend is payable or in respect of which the other beneficial rights were given, may owe to the Company in respect of such share, whether or not the due date for payment thereof has arrived.&#160;&#160;The Board shall be entitled to retain any dividend or bonus shares or other beneficial rights in respect of a share in relation to which the Company has a lien, and to utilize any such amount or the proceeds received from the sale of any bonus shares or other beneficial rights, for the discharge of the debts or liabilities in respect of which the Company has a lien.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may decide that a dividend is to be paid, in whole or in part, by way of a distribution of assets of the Company in kind, including by way of debentures of the Company, or shares or debentures of any other company, or in any other way.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may decide that any portion of the amounts standing for the time being to the credit of any capital fund (including a fund created as a result of a revaluation of the assets of the Company), or which are held by the Company as profits available for distribution, shall be capitalized subject to and in accordance with the provisions of the Companies Law and of these Articles, and serve for the payment up in full (either at par or with a premium as prescribed by the Company) of shares which have not yet been issued or of debentures of the Company, which shall then be allotted and distributed amongst the shareholders as fully paid-up shares or debentures, pro rata to each shareholder&#8217;s entitlement under these Articles.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In every case that the Company issues bonus shares by way of a capitalization of profits or funds at a time at which securities issued by the Company are in circulation and confer on the holders thereof rights to convert the same into shares in the share capital of the Company, or options to purchase shares in the share capital of the Company (such rights of conversion or options shall henceforth be referred to as the &#8220;<b>Rights</b>&#8221;), the Board shall be entitled (in a case that the Rights or part thereof shall not be otherwise adjusted in accordance with the terms of their issue) to transfer to a special fund designated for the distribution of bonus shares in the future (to be called by any name that the Board may decide on and which shall henceforth be referred to as the &#8220;<b>Special Fund</b>&#8221;) an amount equivalent to the nominal amount of the share capital to which some or all of the Rights holders would have been entitled as a result of the issue of bonus shares, had they exercised their Rights prior to the determining date for the right to receive bonus shares, including rights to fractions of bonus shares, and in the case of a second or additional distribution of bonus shares in respect of which the Company acts pursuant to this Article, including entitlement stemming from a previous distribution of bonus shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:68pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.10.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In the case of the allotment of shares by the Company as a consequence of the exercise of entitlement by the owners of shares in those cases in which the Board has made a transfer to the Special Fund in respect of the Rights pursuant to <span style="text-decoration: underline; ">Article 24.9</span>&#160;above, the Board shall allot to each such shareholder, in addition to the shares to which he is entitled by virtue of having exercised his rights, such number of fully paid-up shares the nominal value of which is equivalent to the amount transferred to the Special Fund in respect of his rights, by way of a capitalization to be effected by the Board of an appropriate amount out of the Special Fund.&#160;&#160;The Board shall be entitled to decide on the manner of dealing with rights to fractions of shares in its sole discretion.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:68pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.11.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If after any transfer to the Special Fund has been made the Rights should lapse, or the period should end for the exercise of Rights in respect of which the transfer was effected without such Rights being exercised, then any amount which was transferred to the Special Fund in respect of the aforesaid unexercised Rights shall be released from the Special Fund, and the Company may deal with the amount so released in any manner it would have been entitled to deal therewith had such amount not been transferred to the Special Fund.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:68pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For the implementation of any resolution regarding a distribution of shares or debentures by way of a capitalization of profits as aforesaid, the Board may:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Resolve any difficulty which arises or may arise in regard to the distribution in such manner as it deems fit and may take all of the steps that it deems appropriate in order to overcome such difficulty.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Issue certificates in respect of fractions of shares, or decide that fractions of less than an amount to be decided by the Board shall not be taken into account for purposes of adjusting the rights of the shareholders or may sell the fractions of shares and pay the net proceeds to the persons entitled thereto.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sign, or appoint a person to sign, on behalf of the shareholders on any contract or other document which may be required for purposes of giving effect to the distribution, and, in particular, shall be entitled to sign or appoint a person who shall be entitled to appoint and submit a contract or other document as referred to in Section 291 of the Companies Law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Make any arrangement or other scheme which is required in the opinion of the Board in order to facilitate the distribution.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:68pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.13.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled, as it deems appropriate and expedient, to appoint trustees or nominees for those registered shareholders who have failed to notify the Company of a change of their address and who have not applied to the Company in order to receive dividends, shares or debentures out of capital, or other benefits during the aforesaid period.&#160;&#160;Such trustees or nominees shall be appointed for the use, collection or receipt of dividends, shares or debentures out of capital and rights to subscribe for shares which have not yet been issued and which are offered to the shareholders but they shall not be entitled to transfer the shares in respect of which they were appointed, or to vote on the basis of holding such shares.&#160;&#160;In all of the terms and conditions governing such trusts and the appointment of such nominees it shall be stipulated by the Company that upon the first demand by a beneficial holder of a share being held by the trustee or nominee, such trustee or nominee shall be obliged to return to such shareholder the share in question and all of those rights held by it on the shareholder&#8217;s behalf (all as the case may be).&#160;&#160;Any act or arrangement effected by any such nominees or trustee and any agreement between the Board and a nominee or trustee shall be valid and binding in all respects.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:32pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">25.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>COMPANY RECORDS AND REGISTERS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">25.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company shall comply with all the provisions of the Companies Law in regard to the recording of charges and the keeping and maintaining of a register of directors, the Register and register of charges.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">25.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any book, register and record that the Company is obliged to keep in accordance with the Companies Law or pursuant to these Articles shall be recorded in a regular book, or by digital, electronic or other means, as the Board shall decide.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">25.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to and in accordance with the provisions of Sections 138 and 139 of the Companies Law, the Company may cause supplementary registers to be kept in any place outside Israel as the Board may deem fit, and, subject to all applicable requirements of the Companies Law, the Board may from time to time adopt such rules and procedures as it may deem fit in connection with the keeping of such supplementary registers.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:32pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>BOOKS OF ACCOUNT</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall keep proper books of account in accordance with the provisions of the Companies Law.&#160;&#160;The books of account shall be kept at the Office, or at such other place or places as the Board shall deem appropriate, and shall at all times be open to the inspection of members of the Board.&#160;&#160;A shareholder of the Company who is not a member of the Board shall not have the right to inspect any books or accounts or documents of the Company, unless such right has been expressly granted to him by the Companies Law, or if he has been permitted to do so by the Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">At least once each year the accounts of the Company and the correctness of the statement of income and the balance sheet shall be audited and confirmed by an independent auditor.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company shall, in an annual General Meeting, appoint an independent auditor who shall hold such position until the next annual General Meeting, or for a term beyond the aforesaid, provided that such term shall not extend beyond the third (3rd) annual General Meeting following the annual General Meeting at which such independent auditor was appointed, and his appointment, remuneration and rights and duties shall be subject to the provisions of the Companies Law, provided, however, that in exercising its authority to fix the remuneration of the auditor, the shareholders in an annual General Meeting may, by a resolution, act (and in the absence of any action in connection therewith shall be deemed to have so acted) to authorize the Board (with right of delegation to a Committee thereof or to management) to fix such remuneration subject to such criteria or standards, if any, as may be provided in such resolution, and if no such criteria or standards are so provided, such remuneration shall be fixed in an amount commensurate with both the volume and nature of the services rendered by the auditor.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the extent required by the Companies Law, the auditor shall be entitled to receive notices of every General Meeting of the Company and to attend such meetings and to express his opinions on all matters pertaining to his function as the auditor of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law and the U.S. Rules, any act carried out by the auditor of the Company shall be valid as against any person doing business in good faith with the Company, notwithstanding any defect in the appointment or qualification of the auditor.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the extent required by the Companies Law, it shall appoint an internal auditor possessing the authorities set forth in the Companies Law.&#160;&#160;The internal auditor of the Company shall present all of its proposed work plans to the Board or to the audit committee of the Board, as determined by the Board from time to time, and the Board or audit committee (as applicable) shall have the authority to approve them, subject to any modifications in its discretion. Until such time as the Board determines otherwise, the work plan shall be submitted to the audit committee of the Board and approved by it, subject to any modifications in its discretion.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:32pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTICES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company may serve any written notice or other document on a shareholder by way of delivery by hand, by facsimile transmission, by email or other electronic transmission, or by dispatch by prepaid registered mail to his address as recorded in the Register, or if there is no such recorded address, to the address given by him to the Company for the sending of notices to him.&#160;&#160;Notwithstanding the foregoing or any other provision to the contrary contained herein, notices or any other information or documents required to be delivered to a shareholder shall be deemed to have been duly delivered if submitted, published, filed or lodged in any manner prescribed by applicable law.&#160;&#160;With respect to the manner of providing such notices or other disclosures, the Company may distinguish between the shareholders listed on its regular Registry and those listed in any &#8220;additional registry&#8221;, as defined in Section 138(a) of the Companies Law, administered by a transfer agent or stock exchange registration company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any shareholder may serve any written notice or other document on the Company by way of delivery by hand at the Office, by facsimile or email transmission to the Company or by dispatch by prepaid registered mail to the Company at the Office.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any notice or document which is delivered or sent to a shareholder in accordance with these Articles shall be deemed to have been duly delivered and sent in respect of the shares held by him (whether in respect of shares held by him alone or jointly with others), notwithstanding the fact that such shareholder has died or been declared bankrupt at such time (whether or not the Company knew of his death or bankruptcy), and shall be deemed to be sufficient delivery or dispatch to heirs, trustees, administrators or transferees and any other persons (if any) who have a right in the shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any such notice or other document shall be deemed to have been served:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case of mailing, forty-eight (48) hours after it has been posted, or when actually received by the addressee if sooner than forty-eight (48) hours after it has been posted;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case of overnight air courier, on the next day following the day sent, with receipt confirmed by the courier, or when actually received by the addressee if sooner;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case of personal delivery, when actually tendered in person to such shareholder;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case of facsimile or other electronic transmission (including email), upon transmission, provided that the notice or other document shall not be deemed served if the sender receives an automatic system-generated response that such facsimile or other electronic transmission was undeliverable or not delivered; or</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case a notice is, in fact, received by the addressee, when received, notwithstanding that it was defectively addressed or failed, in some other respect, to comply with the provisions of this <span style="text-decoration: underline; ">Article 27.4</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any shareholder whose address is not described in the Register, and who shall not have designated in writing an address for the receipt of notices, shall not be entitled to receive any notice from the Company.&#160;&#160;In the case of joint holders of a share, the Company shall be entitled to deliver a notice by dispatch to the joint holder whose name stands first in the Register in respect of such share.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Whenever it is necessary to give notice of a particular number of days or a notice for another period, the day of delivery shall be counted in the number of calendar days or the period, unless otherwise specified.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Notwithstanding anything to the contrary contained herein, notice by the Company of a General Meeting, containing the information required to be set forth in such notice under these Articles, which is published, within the time otherwise required for giving notice of such meeting, in either or several of the following manners shall be deemed to be notice of such meeting duly given or service of such materials on the date of such publication:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.7.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">on the Company&#8217;s website; and/or</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.7.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in a report or a schedule filed with, or furnished to, the SEC.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:32pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>INSURANCE, INDEMNITY AND EXCULPATION</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law, the Company shall be entitled to enter into a contract to insure all or part of the liability of an Office Holder of the Company, imposed on him in consequence of an act which he has performed by virtue of being an Office Holder, in respect of any of the following:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The breach of a duty of care to the Company or to any other person;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The breach of a duty of loyalty to the Company, provided that the Office Holder acted in good faith and had reasonable grounds for believing that the action would not adversely affect the best interests of the Company;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A pecuniary liability imposed on him in favor of any other person; or</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any other circumstances arising under the law with respect to which the Company may, or will be able to, insure an Office Holder.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law, the Company shall be entitled to indemnify an Office Holder of the Company, to the fullest extent permitted by applicable law.&#160;&#160;Subject to the provisions of the Companies Law, the Company may retroactively to indemnify an Office Holder with respect to the following liabilities and expenses, <i>provided</i>, in each of the below cases, that such liabilities or expenses were incurred by such Office Holder in connection with an action performed by such Office Holder in his capacity as an Office Holder of the Company:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">a monetary liability imposed on him in favor of a third party in any judgment, including any settlement confirmed as judgment and an arbitrator&#8217;s award which has been confirmed by the court;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">reasonable litigation expenses, including legal fees, paid for by the Office Holder, in an investigation or proceeding conducted against such Office Holder by an agency authorized to conduct such investigation or proceeding, and which investigation or proceeding: (i) concluded without the filing of an indictment (as defined in the Companies Law) against such Office Holder and without a monetary liability having been imposed against such Office Holder in lieu of a criminal proceeding (as defined in the Companies Law); or (ii) concluded without the filing of an indictment against such Office Holder but with a monetary liability having been imposed against such Office Holder in lieu of a criminal proceeding for an offense that does not require proof of criminal intent; or (iii) involves financial sanction;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">reasonable litigation expenses, including legal fees, paid for by the Office Holder, or which the Office Holder is obligated to pay under a court order or ruling, in a proceeding brought against the Office Holder by the Company, or on its behalf, or by a third party, or in a criminal proceeding in which the Office Holder is found innocent, or in a criminal proceeding in which the Office Holder was convicted of an offense that does not require proof of criminal intent; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:109pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">any other event, occurrence or circumstances in respect of which the Company may lawfully indemnify an Office Holder of the Company (including, without limitation, indemnification with respect to the matters referred to under Section 56h(b)(1) of the Israeli Securities Law, 5728-1968, as amended, and Section 50P(b)(2) of the Israeli Economic Competition Law 5748-1988).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company may undertake to indemnify an Office Holder as aforesaid in Articles 28.2.1, 28.2.2, 28.2.3 and 28.2.4 prospectively, provided that, with respect to the matters set forth in <span style="text-decoration: underline; ">Article </span><span style="text-decoration: underline; ">&#8206;</span><span style="text-decoration: underline; ">28.2.1</span>, any indemnification undertaking with respect to the foregoing shall be limited (a) to events which, in the opinion of the Board, are foreseeable in light of the Company&#8217;s actual operations at the time of granting the indemnification undertaking, and (b) to an amount or by criteria determined by the Board to be reasonable in the given circumstances, and (c) the events that in the opinion of the Board are foreseeable in light of the Company&#8217;s actual operations at the time of granting the indemnification undertaking are listed in the indemnification undertaking together with the amount or criteria determined by the Board to be reasonable in the given circumstances.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law including the receipt of all approvals as required therein or under any applicable law, the Company may, to the maximum extent permitted by the Companies Law, exempt and release, including in advance, any Office Holder from any liability for damages arising out of a breach of a duty of care towards the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any amendment to the Companies Law or other applicable law adversely affecting the right of any Office Holder to be indemnified or insured pursuant to <span style="text-decoration: underline; ">Articles 28.1, 28.2, 28.3 and 28.4</span>&#160;and any amendments to such Articles shall be prospective in effect, and shall not affect the Company&#8217;s obligation or ability to indemnify or insure an Office Holder for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The provisions of <span style="text-decoration: underline; ">Articles 28.1, 28.2, 28.3 and 28.4</span>&#160;are not intended, and shall not be interpreted so as to restrict the Company, in any manner, in respect of the procurement of insurance or in respect of indemnification or exculpation, in favor of any person who is not an Office Holder, including, without limitation, any employee, agent, consultant or contractor of the Company who is not an Office Holder; or any Office Holder to the extent that such insurance and/or indemnification is not specifically prohibited under law.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:32pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">29.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>WINDING-UP AND REORGANIZATION</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">29.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;Should the Company be wound up and assets of the Company remain available for distribution after covering all the Company&#8217;s outstanding liabilities, such assets shall be distributed among the shareholders pro rata to the nominal value of the paid-up capital on the shares held by each of them.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:73pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">29.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Upon the sale of the Company&#8217;s assets, the Board may, or in the case of a liquidation, the liquidators may, if authorized to do so by a resolution of the Company, accept fully or partly paid-up shares, or securities of another company, Israeli or non-Israeli, whether in existence at such time or about to be formed, in order to purchase the property of the Company, or part thereof, and to the extent permitted under the Companies Law, the Board may (or in the case of a liquidation, the liquidators may) distribute the aforesaid shares or securities or any other property of the Company among the shareholders without realizing the same, or may deposit the same in the hands of trustees for the shareholders, and the General Meeting by a resolution may decide, subject to the provisions of the Companies Law, on the distribution or allotment of cash, shares or other securities, or the property of the Company and on the valuation of the aforesaid securities or property at such price and in such manner as the shareholders at such General Meeting shall decide, and all of the shareholders shall be obliged to accept any valuation or distribution determined as aforesaid and to waive their rights in this regard, except, in a case in which the Company is about to be wound-up and is in the process of liquidation, for those legal rights (if any) which, according to the provisions of the Companies Law, may not be changed or modified.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:32pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">30.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>TRANSLATION AND BINDING EFFECT</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">These Articles may be translated into Hebrew and/or into other languages.&#160; Notwithstanding the aforesaid, the English version of these Articles shall be binding upon the Company, its shareholders and/or any third party and shall supersede any translation thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>* * *</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>APPENDIX A-2</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;"><b>PROPOSED ARTICLES OF ASSOCIATION MARKED TO SHOW CHANGES TO EXISTING ARTICLES</b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>ARTICLES OF ASSOCIATION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>OF</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>UROGEN PHARMA LTD.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>A COMPANY LIMITED BY SHARES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>UNDER THE COMPANIES LAW, 5759-1999</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:39pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>INTERPRETATION</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In these Articles, unless the context requires otherwise, the following capitalized terms shall have the meanings set opposite them:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:111pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Articles</b>&#8221;&#160;means these Articles of Association, as may be amended from time to time;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:111pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Board</b>&#8221;&#160;&#160;means <span style="text-decoration: line-through; ">all of </span>the <span style="text-decoration: underline; ">board of</span> directors of the Company<span style="text-decoration: line-through; "> holding office pursuant to these Articles, including alternates, substitutes or proxies</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:111pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Business Day</b>&#8221;&#160;means any day other than a Saturday, Sunday and any day on which banks in Israel are closed or on which the NASDAQ is closed;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 149px;">&#160;</td>
			<td style="vertical-align: top; width: 33px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.4.</p>
			</td>
			<td style="vertical-align: top; width: 551px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Chairman of the Board</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article&#160;</span><span style="text-decoration: underline; ">16.4</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:111pt;">&#160;</td>
			<td style="vertical-align: top; width: 35px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.5.</p>
			</td>
			<td style="vertical-align: top; width: 550px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Companies Law</b>&#8221;<span style="text-decoration: underline; ">&#160;means</span>&#160;the Israeli Companies Law, 5759-1999, as amended from time to time, including the regulations promulgated thereunder, or any other law which may come in its stead, including all amendments made thereto;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 149px;">&#160;</td>
			<td style="vertical-align: top; width: 36px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.6.</p>
			</td>
			<td style="vertical-align: top; width: 548px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Company</b>&#8221;&#160;means UroGen Pharma Ltd.;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 150px;">&#160;</td>
			<td style="vertical-align: top; width: 34px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.7.</p>
			</td>
			<td style="vertical-align: top; width: 549px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Compensation Committee</b>&#8221;&#160;has the meaning set out in the Companies&#160;Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 151px;">&#160;</td>
			<td style="vertical-align: top; width: 36px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.1.8.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Derivative Transaction</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; "><span style="text-decoration: line-through; ">&#160;12.5</span></span><span style="text-decoration: line-through; ">;</span><span style="text-decoration: underline; ">&#160;12.7</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 153px;">&#160;</td>
			<td style="vertical-align: top; width: 37px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.9</span></p>
			</td>
			<td style="vertical-align: top; width: 543px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration: line-through; ">&#8220;Effective Time</span></b>&#8221;<span style="text-decoration: line-through; ">&#160;means the closing of the initial underwritten public&#160;offering of the Ordinary Shares (as defined below), at which time these Articles shall first</span> <span style="text-decoration: line-through; ">become effective;</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 152px;">&#160;</td>
			<td style="vertical-align: top; width: 29px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.10</span><span style="text-decoration: underline; ">1.1.9.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;External Director</b>&#8221;&#160;has the meaning set out in the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 153px;">&#160;</td>
			<td style="vertical-align: top; width: 38px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.11</span><span style="text-decoration: underline; ">1.1.10.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;General Meeting</b>&#8221;&#160;means either an annual or an extraordinary meeting of the shareholders;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 154px;">&#160;</td>
			<td style="vertical-align: top; width: 38px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.12</span><span style="text-decoration: underline; ">1.1.11.</span></p>
			</td>
			<td style="vertical-align: top; width: 541px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Incapacitated Person</b>&#8221;&#160;means any person whose capacity to effect legal action was denied or restricted by a court of competent jurisdiction or pursuant to the laws of the jurisdiction applicable to him and a bankrupt person in respect of whom no rehabilitation has been granted;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 153px;">&#160;</td>
			<td style="vertical-align: top; width: 33px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.13</span><span style="text-decoration: underline; ">11.1.2.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;NASDAQ</b>&#8221;&#160;means the <span style="text-decoration: line-through; ">NASDAQ Global or Capita</span><span style="text-decoration: underline; "><span style="text-decoration: line-through; ">l</span>Nasdaq Stock </span>Market<span style="text-decoration: underline; ">;</span></p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.14</span><span style="text-decoration: underline; ">1.1.13.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Nominees</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;15.2</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.15</span><span style="text-decoration: underline; ">1.1.14.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Office</b>&#8221;&#160;means the registered office of the Company at that time;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.16</span><span style="text-decoration: underline; ">1.1.15.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Office Holder</b>&#8221;&#160;has the meaning set out in the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.17</span><span style="text-decoration: underline; ">1.1.16.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Ordinary Shares</b>&#8221;&#160;means ordinary shares of the Company with a&#160;nominal value of NIS 0.01 each;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.18</span><span style="text-decoration: underline; ">1.1.17.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Proposal Request</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article 1</span><span style="text-decoration: underline; ">2.5</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.19</span><span style="text-decoration: underline; ">1.1.18.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Proposing Shareholder</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article 12.5</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 150px;">&#160;</td>
			<td style="vertical-align: top; width: 16px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.20</span><span style="text-decoration: underline; ">1.1.19.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Register</b>&#8221;&#160;means the register of shareholders administered in accordance with the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.21</span><span style="text-decoration: underline; ">1.1.20.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Rights</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;24.9</span>;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.22</span><span style="text-decoration: underline; ">1.1.21.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;SEC</b>&#8221;&#160;<span style="text-decoration: underline; ">means </span>the U.S. Securities and Exchange Commission;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:113pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.23</span><span style="text-decoration: underline; ">1.1.22.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;Special Fund</b>&#8221;&#160;has the meaning set out in <span style="text-decoration: underline; ">Article24.9</span>;<span style="text-decoration: underline; ">&#160;and</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 150px;">&#160;</td>
			<td style="vertical-align: top; width: 16px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">1.1.24</span><span style="text-decoration: underline; ">1.1.23.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&#8220;U.S. Rules</b>&#8221;&#160;means the applicable rules of the NASDAQ and U.S. securities laws, regulations and rules, as amended from time to time<span style="text-decoration: line-through; ">; and</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Reference to &#8220;<i>writing</i>&#8221;, &#8220;<i>written</i>&#8221;&#160;or similar expressions in these Articles means handwriting, typewriting, photography, telex, email<span style="text-decoration: underline; ">, other electronic form</span>&#160;or any other legible form of writing. Reference to a &#8220;person&#8221;&#160;or &#8220;persons&#8221;&#160;shall also include corporations, companies, cooperative societies, partnerships, trusts of any kind or any other body of persons, whether incorporated or otherwise.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of this <span style="text-decoration: underline; ">Article1</span>&#160;and unless the context necessitates another meaning, terms and expressions in these Articles which have been defined in the Companies Law shall have the meanings ascribed to them therein.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.4.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Words in the singular shall also include the plural, and vice versa. Words in the masculine shall include the feminine and vice versa.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1.5.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The captions to articles in these Articles are intended for the convenience of the reader only, and no use shall be made thereof in the interpretation of these Articles.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:39pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>LIMITED LIABILITY</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">The Company is a <span style="text-decoration: underline; ">company with </span>limited liability<span style="text-decoration: line-through; "> company</span> and therefore each shareholder&#8217;s liability for the Company&#8217;s obligations shall be limited to the payment of the nominal value of the shares held by such shareholder, subject to the provisions of the Companies Law.</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:39pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>OBJECTIVES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">The Company&#8217;s objectives are to engage in any lawful activity.&#160;The Company may donate a reasonable amount of money for any purpose that the Board finds appropriate, even if the donation is not for business considerations or for the purpose of achieving profits for the Company.</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:42pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>REGISTERED OFFICE</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">The <span style="text-decoration: line-through; ">registered office</span><span style="text-decoration: underline; ">Office</span> shall be at such place as decided by the Board from time to time.</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:39pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>AUTHORIZED SHARE CAPITAL</b></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 63pt;">The authorized share capital of the Company shall consist of NIS 1,000,000 (one million New Israeli Shekels) divided into 100,000,000 (one hundred million) Ordinary Shares.</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:39pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>RIGHTS ATTACHING TO THE ORDINARY SHARES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 100px;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>
			</td>
			<td style="vertical-align: top; width: 28px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Ordinary Shares shall rank <i>pari passu </i>between them in all respects.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Ordinary Shares in respect of which all calls have been fully paid shall confer on the holders thereof the right to attend and to vote at General Meetings of the Company, both annual as well as extraordinary meetings. Each Ordinary Share shall confer on its holder one vote at a General Meeting of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">6.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Ordinary Shares shall confer on a holder thereof the right to receive a dividend, to participate in a distribution of bonus shares and to participate in the distribution of the assets of the Company upon its winding-up, pro rata to the nominal amount paid up on the shares or credited as paid up in respect thereof, and without reference to any premium which may have been paid in respect thereof.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:39pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>MODIFICATION OF CLASS RIGHTS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to applicable law, if at any time the share capital of the Company is divided into different classes of shares and unless the terms of issue of such class of shares otherwise stipulate, the rights attaching to any class of shares (including rights prescribed in the terms of issue of the shares) may be altered, modified or canceled by a resolution passed at a separate class meeting of the shareholders of that class.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The provisions contained in these Articles with regard to General Meetings shall apply, <i>mutatis mutandis </i>as the case may be, to every class meeting of the holders of each such class of the Company&#8217;s shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">7.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise provided by these Articles, the increase of an authorized class of shares, or the issuance of additional shares thereof out of the authorized and unissued share capital, shall not be deemed, for purposes of this <span style="text-decoration: underline; ">Article7</span>, to modify or abrogate the rights attached to previously issued shares of such class or of any other class.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:39pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>UNISSUED SHARE CAPITAL</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;The unissued shares in the capital of the Company shall be under the control of the Board (and, to the full extent permitted by law, any committee designated thereby), which shall be entitled to issue or otherwise grant the same to such persons under such restrictions and conditions as it shall deem fit, whether for consideration or otherwise, and whether for consideration in cash or for consideration which is not in cash, above their nominal value or at a discount, all on such conditions, in such manner and at such times as the Board <span style="text-decoration: underline; ">(or such</span>&#160;<span style="text-decoration: underline; ">committee)</span>&#160;shall deem fit, subject to the provisions of the Companies Law. The Board<span style="text-decoration: underline; ">&#160;(or such</span>&#160;<span style="text-decoration: underline; ">committee)</span>&#160;shall be entitled, <i>inter alia</i>, to differentiate between shareholders with regard to the amounts of calls in respect of the allotment of shares (to the extent that there are calls) and with regard to the time for payment thereof. The Board <span style="text-decoration: underline; ">(or such committee)</span>&#160;may also issue options or warrants<span style="text-decoration: underline; ">&#160;or other securities</span>&#160;for the purchase of shares of the Company and prescribe the manner of the exercise of such options or warrants<span style="text-decoration: underline; ">&#160;or other securities</span>, including the time and price for such exercise and any other provision which is relevant to the method for distributing the issued shares of the Company amongst the purchasers thereof.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to prescribe the times for the issue of shares of the Company and the conditions therefor and any other matter which may arise in connection with the issue thereof.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">8.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In every case of a rights offering, the Board shall be entitled, in its discretion, to resolve any problems and difficulties arising or that are likely to arise in regard to fractions of rights, and without prejudice to the generality of the foregoing, the Board shall be entitled to specify that no shares shall be allotted in respect of fractions of rights, or that fractions of rights shall be sold and the net proceeds shall be paid to the persons entitled to the fractions of rights, or, in accordance with a decision by the Board, to the benefit of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:39pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>INCREASE OF CAPITAL; ALTERATIONS TO CAPITAL</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.1.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company may, from time to time, by a resolution of the shareholders at a General Meeting, increase its share capital by way of the creation of new shares, whether or not all the existing shares have been issued up to the date of the resolution, whether or not it has been decided to issue same, and whether or not calls have been made on all the issued shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The increase of share capital shall be in such amount and divided into shares of such nominal value, and with such restrictions and conditions and with such rights and privileges as the resolution dealing with the creation of the shares prescribes, and if no provisions are contained in the resolution, then as the Board shall prescribe.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise stated in the resolution approving the increase of the share capital, the new shares shall be subject to those provisions in regard to issue, allotment, alteration of rights, payment of calls, liens, forfeiture, transfer, transmission and other provisions which apply to the shares of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">By resolution of the shareholders in a General Meeting, theT</span><span style="text-decoration: underline; ">he</span>&#160;Company may, subject to any applicable provisions of the Companies Law:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:111pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">consolidate its <span style="text-decoration: line-through; ">existing </span><span style="text-decoration: underline; ">issued or unissued </span>share capital, or any part thereof, <span style="text-decoration: underline; ">including </span>into shares of a <span style="text-decoration: underline; ">per share par value which is </span>larger<span style="text-decoration: line-through; ">&#160;denomination </span><span style="text-decoration: underline; ">, equal to</span>&#160;<span style="text-decoration: underline; ">or smaller </span>than the <span style="text-decoration: underline; ">per share par value of its </span>existing shares;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:111pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">sub-divide its <span style="text-decoration: underline; ">issued or unissued </span>share capital, in whole or in part, into shares of&#160;a&#160;smaller&#160;<span style="text-decoration: line-through; ">denomination than the nominal </span><span style="text-decoration: underline; ">or&#160;the same par</span>&#160;value of the existing shares and without prejudice to the foregoing, one or more of the shares so created may be granted any preferred or deferred rights or any special rights with regard to dividends, participation in assets upon winding-up, voting and so forth, subject to the provisions of these Articles;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 149px;">&#160;</td>
			<td style="vertical-align: top; width: 32px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">reduce its share capital; or</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:111pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.4.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cancel any shares which on the date of passing of the resolution have not been issued and to reduce its share capital by the amount of such shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">9.5.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In the event <span style="text-decoration: line-through; ">that the Company</span>&#8217;<span style="text-decoration: line-through; ">s shareholders shall adopt </span><span style="text-decoration: underline; ">of </span>any of the <span style="text-decoration: line-through; ">resolutions</span><span style="text-decoration: underline; ">actions</span>&#160;described in <span style="text-decoration: underline; ">Article9.4</span>&#160;above, the Board shall be entitled to prescribe arrangements necessary in order to resolve any difficulty arising or that are likely to arise in connection with such <span style="text-decoration: line-through; ">resolutions, </span><span style="text-decoration: underline; ">consolidation or other action,</span> including<span style="text-decoration: line-through; ">, in the event of a consolidation, it shall be entitled</span>&#160;to&#160;(i) allot, in contemplation of or subsequent to such consolidation or other action, shares or fractional shares sufficient to preclude or remove fractional share holdings; (ii) redeem, <span style="text-decoration: line-through; ">in the case of redeemable shares, and </span>subject to applicable law, such shares or fractional shares sufficient to preclude or remove fractional share holdings; (iii) round up, round down or round to the nearest whole number, any fractional shares resulting from the consolidation or from any other action which may result in fractional shares; or (iv) cause the transfer of fractional shares by certain shareholders to other shareholders thereof so as to most expediently preclude or remove any fractional shareholdings, and, cause the transferees of such fractional shares to pay the transferors thereof the fair value thereof, and the Board is hereby authorized to act in connection with such transfer, as agent for the transferors and transferees of any such fractional shares, with full power of substitution, for the purposes of implementing the provisions of this <span style="text-decoration: underline; ">Article9.5</span>.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>SHARE CERTIFICATES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Uncertificated Shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:118pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1.11.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise determined by the Board, the shares shall not be certificated.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:118pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">10.1.2.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">Subject to Article 25.3 hereinbelow, the Company shall maintain a</span></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">&#8220;Primary Register</span>&#8221;<span style="text-decoration: line-through; ">, as such term is defined under Section 138(b) of the Companies Law, at the</span> <span style="text-decoration: line-through; ">Office and an </span>&#8220;<span style="text-decoration: line-through; ">Additional Register</span>&#8221;<span style="text-decoration: line-through; ">, as such term is defined under Section 138(a) of the</span> <span style="text-decoration: line-through; ">Companies Law.</span></p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certificated Shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt;">To the extent shares are certificated:</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Share certificates evidencing title to the shares of the Company shall be issued under the seal or rubber stamp of the Company<span style="text-decoration: line-through; ">, and</span><span style="text-decoration: underline; ">&#160;or the Company</span><span style="text-decoration: underline; ">&#8217;</span><span style="text-decoration: underline; ">s name stamped</span>&#160;<span style="text-decoration: underline; ">or printed,</span>&#160;together with the signatures of two members of the Board, or one director together with the Chief Executive Officer, the Chief Financial Officer or any other person designated by the Board. The Board shall be entitled to decide that the signatures be effected in any mechanical or electronic form, provided that the signature shall be effected under the supervision of the Board in such manner as it prescribes.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every shareholder shall be entitled, free of charge, to one certificate in respect of all the shares of a single class registered in his name in the Register.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The <span style="text-decoration: line-through; ">Board</span><span style="text-decoration: underline; ">Company</span>&#160;shall not refuse a request by a shareholder to obtain several certificates in place of one certificate, unless such request is, in the opinion of the Board, unreasonable. <span style="text-decoration: underline; ">&#160;</span>Where a shareholder has sold or transferred some of his shares, he shall be entitled, free of charge, to receive a certificate in respect of his remaining shares, provided that the previous certificate is delivered to the Company before the issuance of a new certificate.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every share certificate shall specify the number of <span style="text-decoration: line-through; ">the </span>shares in respect of which such certificate is issued and <span style="text-decoration: underline; ">may </span>also<span style="text-decoration: underline; ">&#160;specify</span>&#160;the amounts which have been paid up in respect of each<span style="text-decoration: underline; ">&#160;such</span>&#160;share.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A share certificate registered in the names of two (2) or more persons shall be delivered to one of the joint holders, and the Company shall not be obliged to issue more than one certificate to all the joint holders of shares and the delivery of such certificate to one (1) of the joint holders shall be deemed to be delivery to all of them.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If a share certificate should be lost, destroyed or defaced, the <span style="text-decoration: line-through; ">Board</span><span style="text-decoration: underline; ">Company</span>&#160;shall be entitled to issue a new certificate in its place, provided that the certificate is delivered to it and destroyed by it, or it is proved to the satisfaction of the Board that the certificate was lost or destroyed and security has been received to its satisfaction in respect of any possible damages and after payment of such amount as the Board shall prescribe.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No person shall be recognized by the Company as having any right to a share unless such person is the registered owner of the shares in the Register. The Company shall not be bound by and shall not recognize any right or privilege pursuant to the laws of equity, or a fiduciary relationship or a chose in action, future or partial, in any share, or a right or privilege to a fraction of a share, or (unless these Articles otherwise direct) any other right in&#160;respect of a share, except the absolute right to the share as a whole, where same is vested in the owner registered in the Register.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>TRANSFER AND TRANSMISSION OF SHARES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;No transfer of shares shall be registered unless a proper instrument of transfer is delivered to the Company or, in the case of shares registered with a transfer agent, delivered to such transfer agent or to such other place specified for this purpose by the Board. Subject to the provisions of these Articles, an instrument of transfer of a share in the Company shall be signed by the transferor and the transferee. Notwithstanding anything to the contrary herein, shares registered in the name of The Depository Trust Company <span style="text-decoration: underline; ">(or other entity providing</span>&#160;<span style="text-decoration: underline; ">similar functions) </span>or its nominee shall be transferrable in accordance with the policies and procedures of The Depository Trust Company.<span style="text-decoration: underline; ">&#160;(or other entity providing similar functions).</span>&#160;The Board may approve other methods of recognizing the transfer of shares in order to facilitate the trading of the Company&#8217;s shares on the NASDAQ or on any other stock exchange. The transferor shall be deemed to remain the holder of the share up until the time the name of the transferee is registered in the Register in respect of the transferred share.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insofar as the circumstances permit, the instrument of transfer of a share shall be substantially in the form set out below, or in any other form that the Board may approve.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 152pt;">I _______________, I.D.&#160; _______________ of _______________ (the &#8220;<b>Transferor</b>&#8221;), in consideration for an amount of _______________ (in words) paid to me by _______________ I.D.&#160; _______________ of _______________ (hereinafter: the &#8220;<b>Transferee</b>&#8221;), hereby transfer to the Transferee _______________ ______________ shares of nominal value NIS _______________ each, marked with the numbers _______________ to _______________ (inclusive) of UroGen Pharma Ltd., to be held by the Transferee, the assignee of his rights and his successors-in title, under all the same conditions under which I held same prior to the signing of this instrument, and I, the Transferee, hereby agree to accept the aforementioned shares in accordance with the above mentioned conditions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 152pt;">In witness whereof we have hereunto signed this _____ day of _______ 20__.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 152pt;">Transferor _______________ Transferee _______________</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 152pt;">Witnesses to Signature ______________</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company may close the transfer registers and the Register for such period of time as the Board shall deem fit.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every instrument of transfer shall be submitted to the Office or to such other place as the Board shall prescribe, for purposes of registration, together with the share certificates to be transferred, or if no such certificate was issued, together with a letter of allotment of the shares to be transferred, and such other proof as the Board may demand in regard to the transferor&#8217;s right of title or his right to transfer the shares. The Board shall have&#160;the right to refuse to recognize an assignment of shares until the appropriate securities under the circumstances have been provided, as shall be determined by the Board in a specific case or from time to time in general. Instruments of transfer which serve as the basis for transfers that are registered shall remain with the Company.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every instrument of transfer shall relate to one class of shares only, unless the Board shall otherwise agree.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The executors of the will or administrator of a deceased shareholder&#8217;s estate (such shareholder not being one of a joint owners of a share) or, in the absence of an administrator of the estate or executor of the will, the persons specified in <span style="text-decoration: underline; ">Article11.7</span>&#160;below, shall be entitled to demand that the Company recognize them as owners of rights in the share. The provisions of <span style="text-decoration: underline; ">Article&#160;</span><span style="text-decoration: underline; ">11.4</span>&#160;above shall apply, mutatis mutandis, also in regard to this Article.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In the case of the death of one of the holders of a share registered in the names of two or more persons, the Company shall recognize only the surviving owners as persons having rights in the share. However, the aforementioned shall not be construed as releasing the estate of a deceased joint shareholder from any and all undertakings in respect of the shares. Any person who shall become an owner of shares following the death of a shareholder shall be entitled to be registered as owner of such shares after having presented to an officer of the Company to be designated by the Chief Executive Officer an inheritance order or probation order or order of appointment of an administrator of estate and any other proof as required - if these are sufficient in the opinion of such officer - testifying to such person&#8217;s right to appear as shareholder in accordance with these Articles, and which shall testify to his title to such shares. The provisions of <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">11.4</span>&#160;above shall apply, <i>mutatis mutandis</i>, also in regard to this Article.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The receiver or liquidator of a shareholder who is a company or the trustee in bankruptcy or the official receiver of a shareholder who is bankrupt, upon presenting appropriate proof to the satisfaction of an officer of the Company to be designated by the Chief Executive Officer that such shareholder has the right to appear in this capacity and which testifies to such shareholder&#8217;s title, may, with the consent of the Board (the Board shall not be obligated to give such consent) be registered as the owner of such shares. Furthermore, such shareholder may assign such shares in accordance with the rules prescribed in these Articles. The provisions of <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">11.4</span>&#160;above shall apply, <i>mutatis mutandis</i>, also in regard to this Article.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">11.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A person entitled to be registered as a shareholder following assignment pursuant to these Articles shall be entitled, if approved by the Board and to the extent and under the conditions prescribed by the Board, to dividends and any other monies paid in respect of the shares, and shall be entitled to give the Company confirmation of the payments; <i>however</i>, he shall not be entitled to be present or to vote at any General Meeting of the Company or, subject to the provisions of these Articles, to make use of any rights of shareholders, until he has been registered as owner of such shares in the Register.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>GENERAL MEETING</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">A</span><span style="text-decoration: underline; ">An </span><span style="text-decoration: underline; ">annual</span>&#160;General Meeting shall be held at <span style="text-decoration: line-through; ">least once every year, not later</span>&#160;<span style="text-decoration: line-through; ">than fifteen (15) months after the last General Meeting, at </span>such time and at such place as the Board shall determine either within or outside the State of Israel. Such<span style="text-decoration: underline; ">&#160;annual</span>&#160;General Meeting shall be called an annual meeting, and all other meetings of the shareholders shall be called extraordinary meetings.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">12.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may call an extraordinary meeting whenever it sees fit to do so<span style="text-decoration: underline; ">, at such time and at such place as the Board shall determine either within or outside the State of</span> <span style="text-decoration: underline; ">Israel</span>.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><span style="text-decoration: line-through; ">12.3</span>&#160;&#160;<span style="text-decoration: line-through; "> The Board shall be obliged to call an extraordinary meeting upon a requisition</span> <span style="text-decoration: line-through; ">in writing in accordance with the Companies Law.</span></p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">12.3.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">[INTENTIONALLY OMITTED]</span></p>
			</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">&#160;</td>
			<td style="vertical-align:top;">&#160;</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">12.4.&#160;</td>
			<td style="vertical-align:top;">The Company <span style="text-decoration: line-through; ">shall provide prior notice in regard to the holding of an annual</span> <span style="text-decoration: line-through; ">meeting or an extraordinary meeting in accordance with the requirements of these Articles, and</span><span style="text-decoration: underline; ">is</span> <span style="text-decoration: underline; ">not required to give notice of a General Meeting, subject to any mandatory provision of</span> the Companies Law<span style="text-decoration: underline; "> or other applicable law or regulation</span>. Subject to the <span style="text-decoration: underline; ">mandatory</span> provisions of the Companies Law<span style="text-decoration: underline; "> or other applicable law or regulation</span>, in counting the number of days of prior notice given, the day of publication of <span style="text-decoration: underline; ">the </span>notice shall not be counted, but the day of the meeting shall be counted. The notice shall specify those items and contain such information as shall be required by the Companies Law and any other applicable law and regulations.</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">&#160;</td>
			<td style="vertical-align:top;">&#160;</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">12.5.</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Any shareholder <span style="text-decoration: line-through; ">holding at least 1% (one percent) of the outstanding voting rights</span> <span style="text-decoration: line-through; ">requesting to add an item to</span><span style="text-decoration: underline; ">or shareholders of the Company that have the right under the</span> <span style="text-decoration: underline; ">Companies Law to request that a certain matter be included on</span> the agenda of a General Meeting <span style="text-decoration: underline; ">to be held in the future </span>(a &#8220;<b>Proposing Shareholder</b>&#8221;) may submit such a request in accordance with <span style="text-decoration: underline; ">and subject to </span>the Companies Law <span style="text-decoration: underline; ">and these Articles, provided that the matter is appropriate</span> <span style="text-decoration: underline; ">to be considered at the relevant General Meeting and the request is timely made </span>(a &#8220;<b>Proposal Request</b>&#8221;). Subject to any requirements under the Companies Law, to be considered timely and <span style="text-decoration: line-through; ">thereby be added to such agenda</span><span style="text-decoration: underline; ">appropriate for the agenda of the relevant General Meeting</span>, a Proposal Request must be delivered, either in person or by certified mail, postage prepaid, and received at the Office, (i) in the case of a General Meeting that is an annual meeting, no less than sixty (60) days nor more than one-hundred twenty (120) days prior to the date of the first anniversary of the preceding year&#8217;s annual meeting, <i>provided, however</i>, that, in the event that the date of the annual meeting is advanced more than thirty (30) days prior to or delayed by more than thirty (30) days after the anniversary of the preceding year&#8217;s annual meeting, notice by the Proposing Shareholder, in order to be timely<span style="text-decoration: underline; "> and appropriate for the agenda of the relevant General</span> <span style="text-decoration: underline; ">Meeting</span>, must be received no earlier than the close of business one-hundred twenty (120) days prior to such annual meeting and no later than the close of business on the later of ninety (90) days prior to such annual meeting or the tenth (10<sup style="vertical-align:top;line-height:120%;">th</sup>) day following the day on which public announcement of the date of such meeting is first made, and (ii) in the case of a General Meeting that is an extraordinary meeting, no earlier than one-hundred twenty (120) days prior to such extraordinary meeting and no later than the close of business on the later of sixty (60) days prior to such extraordinary meeting or the tenth (10<sup style="vertical-align:top;line-height:120%;">th</sup>) day following the day on which public announcement of the date of such meeting is first made, subject to applicable law.</p>
			</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">&#160;</td>
			<td style="vertical-align:top;">&#160;</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">12.6.&#160;</td>
			<td style="vertical-align:top;">A Proposal Request shall also set forth: (i) the name and address of the Proposing Shareholder making the request; (ii) a representation that the Proposing Shareholder is a holder of shares of the Company entitled to vote at such meeting and intends to appear in person or by proxy at the meeting; (iii) a description of all arrangements or understandings between the Proposing Shareholder and any other person or persons (naming such person or persons) in connection with the subject which is requested to be included in the agenda; (iv) a description of all Derivative Transactions (as defined below) by the Proposing Shareholder during the previous twelve (12) month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms of, such&#160;Derivative Transactions; and (v) a declaration that all the information that is required under the Companies Law and any other applicable law to be provided to the Company in connection with such subject, if any, has been provided. Furthermore, the Board, may, in its discretion, to the extent it deems necessary, request that the Proposing Shareholder(s) provide additional information necessary so as to include a subject in the agenda of a General Meeting, as the Board may reasonably require. <span style="text-decoration: underline; ">&#160;</span>The information required pursuant to this <span style="text-decoration: underline; ">Article&#160;</span><span style="text-decoration: underline; ">12.6</span> shall be updated as of the date the Proposing Shareholder submits the Proposal Request.</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">&#160;</td>
			<td style="vertical-align:top;">&#160;</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">12.7.</td>
			<td style="vertical-align:top;">A &#8220;<b>Derivative Transaction</b>&#8221; means any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proposing Shareholder or any of its affiliates or associates, whether of record or beneficial: (a) the value of which is derived in whole or in part from the value of any class or series of shares or other securities of the Company, (b) which otherwise provides any direct or indirect opportunity to gain or share in any gain derived from a change in the value of securities of the Company, (c) the effect or intent of which is to mitigate loss, manage risk or benefit of security value or price changes, or (d) which provides the right to vote or increase or decrease the voting power of such Proposing Shareholder, or any of its affiliates or associates, with respect to any shares or other securities of the Company, which agreement, arrangement, interest or understanding may include, without limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement to borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proposing Shareholder in the shares or other securities of the Company held by any general or limited partnership, or any limited liability company, of which such Proposing Shareholder is, directly or indirectly, a general partner or managing member.</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">&#160;</td>
			<td style="vertical-align:top;">&#160;</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">12.8<span style="text-decoration: underline; ">.</span></td>
			<td style="vertical-align:top;">Subject to <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">13.9</span> below, in the event that the Company has established that an adjourned meeting shall be held on such date which is <span style="text-decoration: underline; ">earlier or </span>later than the date provided for in Section 78(b) of the Companies Law, such <span style="text-decoration: line-through; ">later</span> date shall be included in the notice. The Company may add additional places for shareholders to review the full text of the proposed resolutions, including an internet site. <span style="text-decoration: underline; ">&#160;</span>The notice shall be provided in the manner prescribed in <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">27. </span>&#160;In no event shall the public announcement of an adjournment or postponement of a General Meeting commence a new time period (or extend any time period) for the giving of a <span style="text-decoration: line-through; ">shareholder</span>&#8217;<span style="text-decoration: line-through; ">s noticeP</span><span style="text-decoration: underline; ">roposal Request</span> as described above.</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">&#160;</td>
			<td style="vertical-align:top;">&#160;</td>
		</tr>
		<tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">12.9.&#160;</td>
			<td style="vertical-align:top;">Subject to any requirements under the Companies Law, nominations of persons for election to the Board may only be made at an extraordinary meeting if directors are to be elected at such meeting (a) by or at the direction of the Board, or (b) by <span style="text-decoration: line-through; ">any shareholdera</span> <span style="text-decoration: underline; ">Proposing Shareholder</span> who is entitled to vote at the meeting and who complies with the notice procedures set forth in <span style="text-decoration: underline; "><span style="text-decoration: line-through; ">Article 12.6</span></span><span style="text-decoration: underline; ">Articles 12.5 and 12.6</span> above.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PROCEEDINGS AT GENERAL MEETING</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-size: 10pt; font-variant: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">13.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-size: 10pt; font-variant: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">No business shall be conducted at a General Meeting unless a quorum is present, <span style="text-decoration: line-through; ">and no resolution shall be passed unless a quorum is present at the time the </span><span style="text-decoration: underline; ">&#160;when the meeting proceeds to business.</span><span style="text-decoration: line-through; ">resolution is voted</span>&#160;<span style="text-decoration: line-through; ">on.</span>&#160;Except in cases where it is otherwise stipulated, a quorum shall be constituted when there are personally present, or represented by proxy, at least two (2) shareholders who hold, in the aggregate, at least thirty-three and one-third percent (33 1/3%) of the voting rights in the Company. A proxy may be deemed to be two (2) or more shareholders pursuant to the number of shareholders <span style="text-decoration: line-through; ">he</span><span style="text-decoration: underline; ">such proxy</span>&#160;represents.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.2.&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If within half an hour from the time appointed for the meeting, a quorum is not present, without there being an obligation to notify the shareholders to that effect, the meeting shall be adjourned to the same day in the following week, at the same hour and at the same place or to <span style="text-decoration: line-through; ">a</span><span style="text-decoration: underline; ">an earlier or</span> later time and date if so specified in the notice of the meeting, unless such day shall fall on a statutory holiday (either in Israel or in the United States), in which case the meeting will be adjourned to the first Business Day afterwards.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;If the original meeting was convened upon requisition under Section 63<span style="text-decoration: underline; ">, 64 or</span>&#160;<span style="text-decoration: underline; ">65</span>&#160;of the Companies Law,<span style="text-decoration: underline; ">&#160;then</span>&#160;one or more shareholders, present in person or by proxy and holding the number of shares required for making <span style="text-decoration: line-through; ">such</span><span style="text-decoration: underline; ">a</span>&#160;requisition<span style="text-decoration: underline; ">&#160;under Section 63 of the</span>&#160;<span style="text-decoration: underline; ">Companies Law</span>, shall constitute a quorum at the adjourned meeting, but in any other case any <span style="text-decoration: line-through; ">two (2)</span><span style="text-decoration: underline; ">sha<span style="text-decoration: underline; ">r</span>eholder or</span>&#160;shareholders present in person or by proxy shall constitute a quorum at the adjourned meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Chairman of the Board, or any other person appointed for this purpose by the Board, shall preside at every General Meeting. If within fifteen (15) minutes from the time appointed for the meeting, the designated chairman for the meeting shall not be present, <span style="text-decoration: underline; ">then any of the following may preside as chairman of the</span>&#160;<span style="text-decoration: underline; ">General Meeting (and in the following order): any director, the Chief Executive Officer, the</span>&#160;<span style="text-decoration: underline; ">Chief Financial Officer, the Secretary of the Company, or any person designated by the</span>&#160;<span style="text-decoration: underline; ">foregoing. If none of the foregoing persons is present, willing and able to act as chairman for</span>&#160;<span style="text-decoration: underline; ">the meeting, then</span> the shareholders present at the meeting<span style="text-decoration: underline; "> (in person or by proxy)</span>&#160;shall elect one of their number to serve as chairman of the meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Except as required under the Companies Law or these Articles, any resolution of the shareholders shall be adopted by a majority of the voting power present and voting on such resolution at the applicable General Meeting, in person or by proxy. Each shareholder shall be entitled to the number of votes to which such shareholder is entitled on the basis of the number of Ordinary Shares held by such shareholder and shall vote all of the Ordinary Shares or any part thereof at his sole discretion.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 87px;">&#160;</td>
			<td style="vertical-align: top; width: 32px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.6.</p>
			</td>
			<td style="vertical-align: top; width: 614px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Where a poll has been demanded, the chairman of the meeting shall be entitled - but not obliged - to accede to the demand. Where the chairman of the meeting has decided to hold a poll, such poll shall be held in such manner, at such time and at such place as the chairman of the meeting directs, either immediately or after an interval or postponement, or in any other way, and the results of the vote shall be deemed to be the resolution at the meeting at which the poll was demanded. A person demanding a poll may withdraw his demand prior to the poll being held.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A demand for the holding of a poll shall not prevent the continued business of the meeting on all other questions apart of the question in respect of which a poll was demanded.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The announcement by the chairman of the meeting that a resolution has been passed unanimously or by a particular majority, or has been rejected, and a note recorded to that effect in the Company&#8217;s minute book, shall serve as prima facie proof of such fact, and there shall be no necessity for proving the number of votes or the proportion of votes given for or against the resolution, unless otherwise required under applicable law and regulation.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">13.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The chairman of a General Meeting at which a quorum is present may, with the consent of holders of a majority of the voting power represented in person and by proxy and voting on the question of adjournment, adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting as originally called. Subject to these Articles, it shall not be necessary to give any notice of an adjournment unless the meeting is adjourned for more than twenty-one (21) days, in which case notice thereof shall be given in&#160;the manner required for the meeting as originally called. Where a General Meeting has been adjourned without changing its agenda, to a date which is not more than twenty-one (21) days, notices shall be given for the new date, as early as possible, and by no later than seventy-two&#160;(72) hours before the General Meeting.<span style="text-decoration: underline; "> The Board may postpone or adjourn a General Meeting</span> <span style="text-decoration: underline; ">prior to its commencement.</span></p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>VOTES OF SHAREHOLDERS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The voting rights of every shareholder entitled to vote at a General Meeting shall be as set forth in <span style="text-decoration: underline; ">Article 6.2</span>&#160;of these Articles.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In the case of joint shareholders, the vote of the senior joint holder, given personally or by proxy, shall be accepted, to the exclusion of the vote of the remaining joint shareholders, and for these purposes the senior of the joint shareholders shall be the person amongst the joint holders whose name appears first in the Register.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A shareholder who is an Incapacitated Person may vote solely through his guardian or other person who fulfills the function of such guardian and who was appointed by a court or other competent authority, and any guardian or other person as aforesaid shall be entitled to vote by way of a proxy, or in such manner as the court or other competent authority directs.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any corporation which is a shareholder of the Company shall be entitled, by way of resolution of its board of directors or another organ which manages said corporation, to appoint such person which it deems fit, whether or not such person is a shareholder of the Company, to act as its representative at any General Meeting of the Company or at a meeting of a class of shares in the Company which such corporation is entitled to attend and to vote thereat, and the appointed as aforesaid shall be entitled, on behalf of the corporation whom he represents, to exercise all of the same powers and authorities which the corporation itself could have exercised had it been a natural person holding shares of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every shareholder who is entitled to attend and vote at a General Meeting of the Company shall be entitled to appoint a proxy. A proxy can be appointed by more than one shareholder and vote in different ways on behalf of each principal.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The instrument appointing a proxy shall be in writing signed by the person making the appointment or by his authorized representative, and if the person making the appointment is a corporation, the power of attorney shall be signed in the manner in which the corporation signs on documents which bind it, and a certificate of an attorney with regard to the authority of the signatories to bind the corporation shall be attached thereto. The proxy need not be a shareholder of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The instrument appointing a proxy, or a copy thereof certified by an attorney, shall be lodged at the Office, or at such other place as the Board shall specify, not less than forty-eight (48) hours prior to the General Meeting at which the proxy intends to vote based on such instrument of proxy.<span style="text-decoration: underline; ">&#160;(or such shorter period as the notice of the General Meeting shall&#160;specify).</span>&#160;Notwithstanding the above, the chairman of the meeting shall have the right to waive the time requirement provided above with respect to all instruments of proxies and to accept any and all instruments of proxy until the beginning of a General Meeting. A document appointing a proxy shall be valid for every adjourned meeting of the General Meeting to which the document relates.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every instrument appointing a proxy, whether for a meeting specifically indicated, or otherwise, shall, as far as circumstances permit, be substantially in the following form, or in any other form approved by the Board:</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 152pt;">I ______________ of ______________ being a shareholder holding shares in UroGen Pharma Ltd., hereby appoint Mr.&#160; ______________ of ______________ or failing him, Mr.&#160; ______________ of ______________, or failing him, Mr.&#160; ______________ of ______________, to vote in my name, place and stead at the (ordinary/extraordinary) General Meeting of the Company to be held on the ____ of ______ 20__, and at any adjourned meeting thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 152pt;">In witness whereof I have hereto set my hand on the _____ day of _____.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 82px;">&#160;</td>
			<td style="vertical-align: top; width: 33px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.9.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No shareholder shall be entitled to vote at a General Meeting unless he has paid all of the calls and all of the amounts due from him, for the time being, in respect of his shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:62pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.10.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A vote given in accordance with the instructions contained in an instrument appointing a proxy shall be valid notwithstanding the death or bankruptcy of the appointer, or the revocation of the proxy, or the transfer of the share in respect of which the vote was given as aforesaid, unless notice in writing of the death, revocation or transfer is received at the Office, or by the chairman of the meeting, prior to such vote.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:62pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">14.11.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the Companies Law, an instrument appointing a proxy shall be deemed revoked (i) upon receipt by the Company or the chairman of the meeting, subsequent to receipt by the Company of such instrument, of written notice signed by the person signing such instrument or by the shareholder appointing such proxy <span style="text-decoration: line-through; ">canceling</span><span style="text-decoration: underline; ">revoking</span>&#160;the appointment thereunder (or the authority pursuant to which such instrument was signed) or of an instrument appointing a different proxy, provided such notice of <span style="text-decoration: line-through; ">cancellation</span><span style="text-decoration: underline; ">revocation</span>&#160;or instrument appointing a different proxy were so received at the place and within the time for delivery of the instrument revoked thereby as referred to in <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">14.7</span>&#160;hereof, or (ii) if the appointing shareholder is present in person at the meeting for which such instrument of proxy was delivered, upon receipt by the chairman of such meeting of written notice from such shareholder of the revocation of such appointment, or if and when such shareholder votes at such meeting. A vote cast in accordance with an instrument appointing a proxy shall be valid notwithstanding the revocation or purported <span style="text-decoration: line-through; ">cancellation</span><span style="text-decoration: underline; ">revocation</span>&#160;of the appointment, or the presence in person or vote of the appointing shareholder at a meeting for which it was rendered, unless such instrument of appointment was deemed revoked in accordance with the foregoing provisions of this <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">14.11</span>&#160;at or prior to the time such vote was cast.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>THE BOARD OF DIRECTORS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The prescribed number of directors of the Company shall be between five (5) and nine (9) (including the External Directors, if any), as may be fixed from time to time by <span style="text-decoration: line-through; ">a</span>&#160;<span style="text-decoration: line-through; ">two-thirds (2/3) majority of the then incumbent directors</span>.<span style="text-decoration: underline; ">the Board. </span>&#160;Any director shall be eligible for re-election upon termination of his term of office, subject to applicable law.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Prior to every annual General Meeting of the Company, the Board (or a duly authorized committee of the Board) may select, via a resolution adopted by a majority of the Board (or such committee), <span style="text-decoration: line-through; ">a number of</span><span style="text-decoration: underline; ">the</span>&#160;persons to be proposed to the shareholders for election as directors at such annual General Meeting for service until the next annual General Meeting (the &#8220;<b>Nominees</b>&#8221;).</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Nominees shall be elected by a resolution at the annual General Meeting at which they are subject to election.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every director, other than External Directors,<span style="text-decoration: underline; ">&#160;(if any),</span>&#160;shall hold office until the end of the next annual General Meeting following the annual General Meeting at which he was elected, unless his office is vacated in accordance with <span style="text-decoration: underline; ">Articles</span><span style="text-decoration: underline; ">&#160;15.7 or</span>&#160;<span style="text-decoration: underline; ">16.5 </span>below. &#160;If, at an annual General Meeting, no Nominees are proposed by either the Board or shareholders, or if no Nominees are elected, the directors then in office shall continue to hold office until the convening of a General Meeting at which Nominees shall be proposed and elected.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;If the office of a director shall be vacated, or if the number of incumbent directors is less than the maximum prescribed by <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">15.1</span>&#160;above, leaving one or more available offices unfilled, the <span style="text-decoration: line-through; ">majority of the remaining incumbent members of the</span>&#160;Board shall be entitled to appoint another director in <span style="text-decoration: line-through; ">place of </span>each <span style="text-decoration: line-through; ">director whose </span>office<span style="text-decoration: underline; ">&#160;that</span>&#160;has become or remains vacated, and such Board-appointed director (or directors) shall hold office until replaced in the manner set out in <span style="text-decoration: underline; ">Article</span><span style="text-decoration: line-through; ">&#160;</span><span style="text-decoration: underline; ">15.4</span>&#160;above. This <span style="text-decoration: underline; ">Article15.5</span>&#160;shall not apply to a vacated office of an External Director, which may be filled only in accordance with <span style="text-decoration: underline; ">Article15.9</span>&#160;below, unless <span style="text-decoration: line-through; ">there are two (2) or more</span><span style="text-decoration: underline; ">the minimum number of</span>&#160;External Directors <span style="text-decoration: underline; ">required under the Companies Law are </span>in office at that time <span style="text-decoration: line-through; ">in addition to the vacated office</span><span style="text-decoration: underline; ">or the Company otherwise is not required to appoint an</span> <span style="text-decoration: underline; ">External Director to such office in accordance with the Companies Law</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;The directors in their capacity as such shall be entitled to receive remuneration as shall be determined in compliance with the Companies Law. <span style="text-decoration: underline; ">&#160;</span>The conditions (including remuneration) of the terms of office of members of the Board shall be decided by the Board or any duly authorized committee thereof, <span style="text-decoration: line-through; ">but the same shall be valid only if ratified in the manner</span>&#160;<span style="text-decoration: line-through; ">required under</span><span style="text-decoration: underline; ">subje<span style="text-decoration: underline; ">ct </span>to</span>&#160;the Companies Law. The remuneration of directors may be fixed as an overall payment or other consideration, or as a payment or other consideration in respect of attendance at meetings of the Board or a committee thereof, or a combination of both. <span style="text-decoration: underline; ">&#160;</span>In addition to his remuneration, each director shall be entitled to be reimbursed, retroactively or in advance, in respect of his reasonable expenses connected with performing his functions and services as a director. Such entitlement shall be determined in accordance with, and shall be subject to, a specific resolution or policy adopted by the Board regarding such matter and in accordance with the requirements of applicable law.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;Subject to the provisions of the Companies Law with regard to External Directors and subject to <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">15.4</span>&#160;above and <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">16.5</span>&#160;below, the office of a member of the Board shall be vacated in any one of the following events:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 139px;">&#160;</td>
			<td style="vertical-align: top; width: 29px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.1.&#160;</p>
			</td>
			<td style="vertical-align: top; width: 569px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he resigns his office by way of a letter signed by him, lodged at the Office;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he is declared bankrupt;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he becomes insane or unsound of mind;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">upon his death;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he is prevented by applicable law from serving as a director of the&#160;Company;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if the Board terminates his office in accordance with Section 231 of the&#160;Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if a court order is given in accordance with Section 233 of the Companies Law;</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if he is removed from office by a resolution at a General Meeting adopted by a majority of the voting power in the Company; or</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.7.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">if his period of office has terminated in accordance with the provisions of these Articles.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If the office of a member of the Board should be vacated, the remaining members of the Board shall be entitled to continue to act for all purposes for as long as their number does not fall below the minimum, as prescribed in <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">15.1</span>&#160;above, without limiting their right to fill any vacancy at any time in accordance with <span style="text-decoration: underline; ">Article&#160;15.5</span>&#160;above. Should their number fall below the aforesaid minimum, the<span style="text-decoration: underline; ">&#160;remaining</span>&#160;directors shall not be entitled to act, except for the appointment of additional directors, or for the purpose of calling a General Meeting for the appointment of additional directors, or for the purpose of calling a General Meeting for the appointment of a new Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">15.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The office of an External Director shall be vacated and an External Director may be removed and replaced only in accordance with the provisions for vacation of office, removal and appointment of External Directors under the Companies Law.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>OTHER PROVISIONS REGARDING DIRECTORS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to any mandatory provisions of applicable law, a director shall not be disqualified by virtue of his office from holding another office in the Company or in any other company in which the Company is a shareholder or in which it has any other form of interest, or of entering into a contract with the Company, either as seller or buyer or otherwise. Likewise, no contract made by the Company or on its behalf in which a director has any form of interest may be nullified and a director shall not be obliged to account to the Company for any profit deriving from such office, or resulting from such contract, merely by virtue of the fact that he serves as a director or by reason of the fiduciary relationship thereby created, but such director shall be obliged to disclose to the Board the nature of any such interest at the first opportunity.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;A general notice to the effect that a director is a shareholder or has any other form of interest in a particular firm or a particular company and that he must be deemed to have an interest in any business with such firm or company shall be deemed to be adequate disclosure for purposes of this Article in relation to such director, and after such general notice has been given, such director shall not be obliged to give special notice in relation to any particular business with such firm or such company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law and these Articles, the Company shall be entitled to enter into a transaction in which an Office Holder of the Company has a personal interest, directly or indirectly, and may enter into any contract or otherwise transact any business with any third party in which contract or business an Office Holder has a personal interest, directly or indirectly.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;The Board by regular majority shall elect one (1) of its members to serve as chairman <span style="text-decoration: underline; ">of the Board</span>&#160;(the &#8220;<b>Chairman of the Board</b>&#8221;<span style="text-decoration: line-through; ">), </span><i><span style="text-decoration: line-through; ">provided </span></i><span style="text-decoration: line-through; ">that, subject to the provisions</span>&#160;<span style="text-decoration: line-through; ">of Section 121(c) of the Companies Law, the</span>&#8221;<span style="text-decoration: line-through; ">)</span><span style="text-decoration: underline; "><span style="text-decoration: line-through; ">. </span></span><span style="text-decoration: underline; ">The</span>&#160;Chief Executive Officer of the Company shall not serve as Chairman of the Board<span style="text-decoration: underline; ">., unless permitted under applicable law. </span>&#160;The office of Chairman of the Board shall be vacated if the Board by regular majority determines to dismiss the Chairman of the Board prior to the end of his term of office, or in each of the cases mentioned in <span style="text-decoration: underline; ">Articles</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">15.7</span>&#160;above and <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">16.5</span>&#160;below. The Board may also elect one (1) of its members to serve as Vice Chairman<span style="text-decoration: underline; ">&#160;of the Board</span>, who shall have such duties and authorities as the Board may assign to him.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 102px;">&#160;</td>
			<td style="vertical-align: top; width: 13px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">16.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;<span style="text-decoration: line-through; ">Subject to the relevant provisions of the Companies Law, the Company may</span><span style="text-decoration: underline; ">If</span>, in a General Meeting, by a resolution adopted by a majority of the voting power in the Company, <span style="text-decoration: line-through; ">dismiss</span>&#160;any director <span style="text-decoration: underline; ">is dismissed</span>&#160;prior to the end of his term of office, <span style="text-decoration: line-through; ">and</span>&#160;the Board shall be entitled<span style="text-decoration: line-through; ">, by regular majority,</span>&#160;to appoint another individual in his place as a director. The individual so appointed shall hold such office only for that period of time during which the director <span style="text-decoration: line-through; ">whom he replaces</span><span style="text-decoration: underline; ">who was replaced</span>&#160;would have held office. This <span style="text-decoration: underline; ">Article16.5</span>&#160;shall not apply to External Directors,<span style="text-decoration: underline; ">&#160;(if any),</span>&#160;who shall be appointed and removed in accordance with the Companies Law.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-size: 10pt; font-variant: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">16.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-size: 10pt; font-variant: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">A director shall not be obliged to hold any share in the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>
			</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PROCEEDINGS OF THE BOARD OF DIRECTORS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 100px;">&#160;</td>
			<td style="vertical-align: top; width: 28px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall convene for a meeting at least once every calendar quarter.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;The Board may meet in order to exercise its powers pursuant to Section 92 of the Companies Law, including without limitation to supervise the Company&#8217;s affairs, and it may, subject to the provisions of the Companies Law, adjourn its meetings and regulate its proceedings and operations as it deems fit. It may also prescribe the quorum required for the conduct of business. Until otherwise decided by the Board, a quorum shall be constituted if a majority of the directors holding office for the time being are present<span style="text-decoration: underline; ">&#160;when the meeting</span>&#160;<span style="text-decoration: underline; ">proceeds to business</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;Should a director or directors be barred from being present and voting at a meeting of the Board pursuant to Section 278 of the Companies Law, the quorum shall be a majority of the directors entitled to be present and to vote at the meeting of the Board<span style="text-decoration: underline; ">&#160;when the</span>&#160;<span style="text-decoration: underline; ">meeting proceeds to business</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;Any director, the Chief Executive Officer <span style="text-decoration: underline; ">in the event stipulated in Section 122</span>&#160;<span style="text-decoration: underline; ">of the Companies Law</span>&#160;or the auditor of the Company in the event stipulated in Section 169 of the Companies Law, may, at any time, demand the convening of a meeting of the Board. The Chairman of the Board shall be obliged, on such demand, to call such meeting within a reasonable time from receipt of a request by the director, the Chief Executive Officer or the auditor of the Company soliciting such a meeting, provided that proper notice pursuant to <span style="text-decoration: underline; ">Article</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">17.5</span>&#160;is given.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every director shall be entitled to receive notice of meetings of the Board, and such notice may be in writing<span style="text-decoration: line-through; ">&#160;or by facsimile, or electronic mail</span>, sent to the last address (whether physical or electronic) or facsimile number given by the director for purposes of receiving notices, <i>provided </i>that the notice shall be given at least a reasonable amount of time prior to the meeting and in no event less than twenty four (24) hours prior notice, unless the urgency of the matter to be discussed at the meeting reasonably requires a shorter notice period <span style="text-decoration: underline; ">as determined by the Chairman of the Board or the Board</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Every meeting of the Board at which a quorum is present shall have all the powers and authorities vested for the time being in the Board. Any matter <span style="text-decoration: line-through; ">discussed in a meeting and</span> <span style="text-decoration: line-through; ">brought up for decision by the Chairman of the</span><span style="text-decoration: underline; ">considered by the</span> Board shall be decided by a simple majority of the directors attending such meeting and voting on such matter. In the case of an equality of votes of the Board, the Chairman of the Board shall not have a second or casting vote, and the proposal shall be deemed to be defeated.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If the Chairman of the Board is not present within thirty (30) minutes after the time appointed for the meeting, the directors present shall elect one of their members to preside at such meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may adopt resolutions, without actually convening a meeting of the&#160;Board, provided that all the directors entitled to participate in the meeting and to vote on the subject brought for decision agree thereto. If resolutions are made as stated in this <span style="text-decoration: underline; ">Article&#160;17.8</span>, the Chairman of the Board shall record minutes of the decisions stating the manner of voting of each director on the subjects brought for decision, as well as the fact that all the directors agreed to take the decision without actually convening.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 106px;">&#160;</td>
			<td style="vertical-align: top; width: 9px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">17.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may hold meetings by use of any means of communication, on condition that all participating directors can hear each other at the same time. In the case of a resolution passed by way of a telephone call or any such other means of communication, a copy of the text of the resolution shall be sent, as soon as possible thereafter, to the directors.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>GENERAL POWERS OF THE BOARD OF DIRECTORS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The supervision of the Company&#8217;s affairs shall be in the hands of the Board, which shall be entitled to exercise all of the powers and authorities and to perform any act and deed which the Company is entitled to exercise and to perform in accordance with these Articles, and in respect of which there is no mandatory provision or requirement in the Companies Law or in binding rules and regulations of the United States that such powers and authorities be exercised or performed by the shareholders in a General Meeting or by a committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may, from time to time, in its absolute discretion, borrow or secure any amounts of money required by the Company for the conduct of its business. The Board shall be entitled to raise or secure the repayment of an amount obtained by it, in such way and on such conditions and times as it deems fit.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to issue documents of undertaking, such as options, debentures or debenture stock, whether linked or redeemable, convertible debentures or debentures convertible into other securities, or debentures which carry a right to purchase shares or to purchase other securities, or any mortgage, pledge, collateral or other charge over the property of the Company and its undertaking, in whole or in part, whether present or future, including the uncalled share capital or the share capital which has been called but not yet paid. The deeds of undertaking, debentures of various types or other forms of collateral security may be issued at a discount, at a premium or otherwise and with such preferential or deferred or other rights, as the Board shall, from time to time, decide.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">18.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may, from time to time, set aside any amount(s) out of the profits of the Company as a reserve or reserves for any purpose(s) which the Board, in its absolute discretion, shall deem fit, including without limitation, capitalization and distribution of bonus shares, and may invest any sum so set aside in any manner and from time to time deal with and vary such investments and dispose of all or any part thereof and employ any such reserve or any part thereof in the business of the Company without being bound to keep the same separate from other assets of the Company, and may subdivide or re-designate any reserve or cancel the same or apply the funds therein for other purposes, all as the Board may from time to time think fit.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">19.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>BOARD COMMITTEES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">19.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may, as it deems fit and subject to any applicable law, delegate to a committee certain of its powers and authorities, in whole or in part, as it deems appropriate. The curtailment or revocation of the powers and authorities of a committee by the Board shall not invalidate a prior act of such committee or an act taken in accordance with its instructions, which would have been valid had the powers and authorities of the committee not been altered or revoked by the Board.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">19.2.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The meetings and proceedings of every such committee which is comprised of two (2<span style="text-decoration: line-through; ">)/or a higher minimum number of members required under the Companies Law (or</span>&#160;<span style="text-decoration: line-through; ">applicable U.S. regulations that the Company has elected to follow in lieu of the Companies</span>&#160;<span style="text-decoration: line-through; ">law),</span>) or more members shall be conducted in accordance with the provisions contained in these Articles in regard to the conduct of meetings and proceedings of the Board to the extent that the same are suitable for such committee, and so long as no provisions have been adopted in replacement thereof by the Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">20.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>RATIFICATION OF ACTIONS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">20.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the Companies Law, all acts taken in good faith by the Board or a committee or by an individual acting as a member thereof shall be valid even if it is subsequently discovered that there was a defect in the appointment of the Board, the committee or the member, as the case may be, or that the members, or one of them, was or were disqualified from being appointed as a director(s) or to a committee.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">20.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;The Board or any committee may ratify any act the performance of which at the time of the ratification was within the scope of the authority of the Board or the relevant committee. The General Meeting shall be entitled to ratify any act taken by the Board or any committee without authority or which was tainted by some other defect. From the time of the ratification, every act ratified as aforesaid, shall be treated as though lawfully performed from the outset.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">21.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>SIGNING POWERS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">21.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to any other resolution on the subject passed by the Board, the Company shall be bound only pursuant to a document in writing bearing its seal or its rubber stamp or its printed <span style="text-decoration: underline; ">or stamped </span>name, and the signature of whomever may be authorized by the Board, which shall be entitled to empower any person, either alone or jointly with another, even if he is not a shareholder or a director, to sign and act in the name and on behalf of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">21.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to prescribe separate signing power in regard to different businesses of the Company and in respect of the limit of the amounts in respect of which various persons shall be authorized to sign.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>CHIEF EXECUTIVE OFFICER</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall, from time to time, appoint a Chief Executive Officer and subject to the provisions of the Companies Law delineate his powers and authorities and his remuneration<span style="text-decoration: line-through; ">. Subject to any contract between the Chief Executive Officer and the Company,</span>&#160;<span style="text-decoration: underline; ">and&#160;the</span> Board may dismiss him or replace him at any time it deems fit.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A Chief Executive Officer need not be a director or shareholder. Subject to the provisions of any contract between the Chief Executive Officer and the Company, if the Chief Executive Officer is also a director, all of the same provisions with regard to appointment, resignation and removal from office shall apply to the Chief Executive Officer in his capacity as a director, as applicable to the Company&#8217;s other directors<span style="text-decoration: underline; ">&#160;who are not External Directors</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.3.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled from time to time<span style="text-decoration: underline; ">, subject to the provisions of the</span>&#160;<span style="text-decoration: underline; ">Companies Law,</span>&#160;to delegate to the Chief Executive Officer for the time being such of the powers it has pursuant to these Articles as it deems appropriate. The Board shall be entitled to grant such powers for such period, for such purposes, on such conditions and with such restrictions as it deems appropriate, and it shall be entitled to grant such powers without renouncing the powers and authorities of the Board in such regard. The Board may revoke, annul and alter such delegated powers and authorities, in whole or in part, at any time.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">22.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of any applicable law, the remuneration of the Chief Executive Officer shall be fixed from time to time by the Board (and, so long as required by the Companies Law, shall be approved by the Compensation Committee and by the shareholders unless exempted from shareholders&#8217;&#160;approval) and such remuneration may be in the form of a fixed salary or commissions or a participation in profits, or combination thereof, or in any other manner which may be decided by the Board and approved according to this <span style="text-decoration: underline; ">Article22.4</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">23.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>SECRETARY, OFFICE-HOLDERS, CLERKS AND REPRESENTATIVES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">23.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;The Board shall be entitled, from time to time, to appoint, or<span style="text-decoration: line-through; "> to delegate to the Chief</span> <span style="text-decoration: line-through; ">Executive Officer, either alone or together with other persons designated by the Board, the ability</span> <span style="text-decoration: line-through; ">to appoint Office Holders (other than directors), a Secretary for the Company, employees and</span> <span style="text-decoration: line-through; ">agents to such permanent, temporary or special positions, and to specify and change their titles,</span> <span style="text-decoration: line-through; ">authorities and duties, and may set, or delegate to</span><span style="text-decoration: underline; ">, unless determined otherwise by the Board,</span> the Chief Executive Officer, either alone or together with other persons designated by the Board, <span style="text-decoration: line-through; ">the</span> <span style="text-decoration: line-through; ">ability to set</span><span style="text-decoration: underline; ">shall be entitled to appoint Office Holders (other than (i) directors and (ii) </span><span style="text-decoration: underline; ">&#8220;</span><span style="text-decoration: underline; ">officers</span><span style="text-decoration: underline; ">&#8221;</span> <span style="text-decoration: underline; ">as defined under Rule 16a-1(f) of the U.S. Securities and Exchange Act of 1934, as amended</span> <span style="text-decoration: underline; ">(</span><span style="text-decoration: underline; ">&#8220;</span><b><span style="text-decoration: underline; ">Section 16 Officers</span></b><span style="text-decoration: underline; ">&#8221;</span><span style="text-decoration: underline; ">)); a Secretary for the Company; employees and agents to such permanent,</span> <span style="text-decoration: underline; ">temporary or special positions; and to specify and change their titles, authorities and duties, and to</span> <span style="text-decoration: underline; ">set, their</span> salaries, bonuses and other compensation<span style="text-decoration: line-through; "> of any employee or agent who is not an Office</span> <span style="text-decoration: line-through; ">Holder</span>. Salaries, bonuses and compensation of Office Holders who are not directors <span style="text-decoration: underline; ">or Section</span> <span style="text-decoration: underline; ">16 Officers </span>shall be determined and approved by the Chief Executive Officer, or in such other manner as may be <span style="text-decoration: line-through; ">required</span><span style="text-decoration: underline; ">permitted</span> from time to time under the Companies Law. The Board, or, <span style="text-decoration: underline; ">unless determined otherwise by the Board,</span> the Chief Executive Officer, either alone or together with other persons designated by the Board<span style="text-decoration: line-through; "> (in the case of any Office Holder who is not a director, employee or agent appointed by the Board), shall be</span><span style="text-decoration: underline; ">, shall be</span> entitled at any time, in its, his or their (as applicable) sole and absolute discretion, to terminate the services of one of more of the foregoing persons (<span style="text-decoration: line-through; ">in the case of a director, however, subject to compliance with </span><span style="text-decoration: underline; "><span style="text-decoration: line-through; ">Article 16.5</span></span> <span style="text-decoration: line-through; ">above), subject to any other requirements under applicable law</span><span style="text-decoration: underline; ">excluding, for clarity, directors and</span> <span style="text-decoration: underline; ">Section 16 Officers).</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">23.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;The Board and the Chief Executive Officer may from time to time and at any time, subject to their powers under these Articles and the Companies Law, empower any person to serve as representative of the Company for such purposes and with such powers and authorities, instructions and discretions for such period and subject to such conditions as the Board or the Chief Executive Officer, as the case may be, shall deem appropriate. The Board or Chief Executive Officer may grant such person, inter alia, the power to further delegate the authority, powers and discretions vested in him, in whole or in part. The Board or the Chief Executive Officer, as the case may be, may revoke, annul, vary or change any such power or authority, or all such powers or authorities collectively.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>DIVIDENDS, BONUS SHARES, FUNDS AND CAPITALIZATION OF FUNDS AND PROFITS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">Unless otherwise permitted by the Companies Law, no dividends shall be paid</span>&#160;<span style="text-decoration: line-through; ">other than out of the Company</span>&#8217;<span style="text-decoration: line-through; ">s profits available for distribution as set forth in the Companies</span>&#160;<span style="text-decoration: line-through; ">Law. </span>The Board may decide on the payment of a dividend or on the distribution of bonus shares.&#160;A dividend in cash or bonus shares shall be paid or distributed, as the case may be, equally to the holders of the Ordinary Shares registered in the Register, pro rata to the nominal amount of capital paid up or credited as paid up on par value of the shares, without reference to any premium which may have been paid thereon. However, whenever the rights attached to any shares or the terms of issue of the shares do not provide otherwise, an amount paid on account of a share prior to the payment thereof having been called, or prior to the due date for payment thereof, and on which the Company is paying interest, shall not be taken into account for purposes of this Article as an amount paid-up on account of the share.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">Only</span><span style="text-decoration: underline; ">Except where determined otherwise in accordance with Article 11.9, only</span>&#160;a person whose name, on the date determined by the Board for entitlement to the dividend (&#8220;<b>Record Date</b>&#8221;), was registered in the Register as the owner of the shares shall be entitled to dividends.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless other instructions are given, it shall be permissible to pay any dividend by way of a check or payment order to be sent by post to the registered address of the shareholder or the person entitled thereto, or in the case of joint shareholders being registered, to the shareholder whose name appears first in the Register in relation to the joint shareholding. Every such check shall be made in favor of the person to whom it is sent.&#160;A receipt by the person whose name, on the Record Date, was registered in the Register as the owner of the shares, or in the case of joint holders, by one of the joint holders, shall serve as a discharge with regard to all the payments made in connection with such share.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to invest any dividend which has not been claimed for a period of one (1) year after having been declared, or to make use thereof in any other way for the benefit of the Company until such time as it is claimed. A dividend or other beneficial rights in respect of shares shall not bear interest, and the Company shall not be obliged to pay interest or linkage in respect of an unclaimed dividend. <span style="text-decoration: underline; ">&#160;</span>The payment by the Board of any unclaimed dividend into a separate account shall not make the Company a trustee in respect thereof, and any dividend unclaimed after a period of seven (7) years from the date of declaration of such dividend shall be forfeited and shall revert to the Company, provided, however, that the Board may, at its discretion, cause the Company to pay any such dividend, or any part thereof, to a person who would have been entitled thereto had the same not reverted to the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unless otherwise specified in the terms of issue of shares or securities convertible into, or which grant a right to purchase, shares, any shares that are fully paid-up or credited as paid-up shall at any time confer on their holders the right to participate in the full dividends and in any other distribution for which the determining date for the right to receive the same is the date at which the aforesaid shares were fully paid-up or credited as fully paid-up, as the case may be, or subsequent to such date.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled to deduct from any dividend or other beneficial rights, all amounts of money which the holder of the share in respect of which the dividend is payable or in respect of which the other beneficial rights were given, may owe to the Company in respect of such share, whether or not the due date for payment thereof has arrived. The Board shall be entitled to retain any dividend or bonus shares or other beneficial rights in respect of a share in relation to which the Company has a lien, and to utilize any such amount or the proceeds received from the sale of any bonus shares or other beneficial rights, for the discharge of the debts or liabilities in respect of which the Company has a lien.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may decide that a dividend is to be paid, in whole or in part, by way of a distribution of assets of the Company in kind, including by way of debentures of the Company, or shares or debentures of any other company, or in any other way.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.8.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board may decide that any portion of the amounts standing for the time being to the credit of any capital fund (including a fund created as a result of a revaluation of the assets of the Company), or which are held by the Company as profits available for distribution, shall be capitalized subject to and in accordance with the provisions of the Companies Law and of these Articles, and serve for the payment up in full (either at par or with&#160;a premium as prescribed by the Company) of shares which have not yet been issued or of debentures of the Company, which shall then be allotted and distributed amongst the shareholders as fully paid-up shares or debentures, pro rata to each shareholder&#8217;s entitlement under these Articles.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.9.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In every case that the Company issues bonus shares by way of a capitalization of profits or funds at a time at which securities issued by the Company are in circulation and confer on the holders thereof rights to convert the same into shares in the share capital of the Company, or options to purchase shares in the share capital of the Company (such rights of conversion or options shall henceforth be referred to as the &#8220;<b>Rights</b>&#8221;), the Board shall be entitled (in a case that the Rights or part thereof shall not be otherwise adjusted in accordance with the terms of their issue) to transfer to a special fund designated for the distribution of bonus shares in the future (to be called by any name that the Board may decide on and which shall henceforth be referred to as the &#8220;<b>Special Fund</b>&#8221;) an amount equivalent to the nominal amount of the share capital to which some or all of the Rights holders would have been entitled as a result of the issue of bonus shares, had they exercised their Rights prior to the determining date for the right to receive bonus shares, including rights to fractions of bonus shares, and in the case of a second or additional distribution of bonus shares in respect of which the Company acts pursuant to this Article, including entitlement stemming from a previous distribution of bonus shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:62pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.10.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In the case of the allotment of shares by the Company as a consequence of the exercise of entitlement by the owners of shares in those cases in which the Board has made a transfer to the Special Fund in respect of the Rights pursuant to <span style="text-decoration: underline; ">Article24.</span><span style="text-decoration: underline; "><span style="text-decoration: line-through; ">8</span></span><span style="text-decoration: underline; ">9</span>&#160;above, the Board shall allot to each such shareholder, in addition to the shares to which he is entitled by virtue of having exercised his rights, such number of fully paid-up shares the nominal value of which is equivalent to the amount transferred to the Special Fund in respect of his rights, by way of a capitalization to be effected by the Board of an appropriate amount out of the Special Fund. The Board shall be entitled to decide on the manner of dealing with rights to fractions of shares in its sole discretion.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:62pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.11.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If after any transfer to the Special Fund has been made the Rights should lapse, or the period should end for the exercise of Rights in respect of which the transfer was effected without such Rights being exercised, then any amount which was transferred to the Special Fund in respect of the aforesaid unexercised Rights shall be released from the Special Fund, and the Company may deal with the amount so released in any manner it would have been entitled to deal therewith had such amount not been transferred to the Special Fund.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:62pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For the implementation of any resolution regarding a distribution of shares or debentures by way of a capitalization of profits as aforesaid, the Board may:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Resolve any difficulty which arises or may arise in regard to the distribution in such manner as it deems fit and may take all of the steps that it deems appropriate in order to overcome such difficulty.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Issue certificates in respect of fractions of shares, or decide that fractions of less than an amount to be decided by the Board shall not be taken into account for purposes of adjusting the rights of the shareholders or may sell the fractions of shares and pay the net proceeds to the persons entitled thereto.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sign, or appoint a person to sign, on behalf of the shareholders on any contract or other document which may be required for purposes of giving effect to the distribution, and, in particular, shall be entitled to sign or appoint a person who shall be entitled to appoint and submit a contract or other document as referred to in Section 291 of the&#160;Companies Law.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.12.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Make any arrangement or other scheme which is required in the opinion of the Board in order to facilitate the distribution.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:62pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">24.13.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall be entitled, as it deems appropriate and expedient, to appoint trustees or nominees for those registered shareholders who have failed to notify the Company of a change of their address and who have not applied to the Company in order to receive dividends, shares or debentures out of capital, or other benefits during the aforesaid period. Such trustees or nominees shall be appointed for the use, collection or receipt of dividends, shares or debentures out of capital and rights to subscribe for shares which have not yet been issued and which are offered to the shareholders but they shall not be entitled to transfer the shares in respect of which they were appointed, or to vote on the basis of holding such shares. In all of the terms and conditions governing such trusts and the appointment of such nominees it shall be stipulated by the Company that upon the first demand by a beneficial holder of a share being held by the trustee or nominee, such trustee or nominee shall be obliged to return to such shareholder the share in question and all of those rights held by it on the shareholder&#8217;s behalf (all as the case may be). Any act or arrangement effected by any such nominees or trustee and any agreement between the Board and a nominee or trustee shall be valid and binding in all respects.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">25.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>COMPANY RECORDS AND REGISTERS</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">25.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The <span style="text-decoration: line-through; ">BoardCompany</span>&#160;shall comply with all the provisions of the Companies Law in regard to the recording of charges and the keeping and maintaining of a register of directors, the Register and register of charges.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">25.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any book, register and record that the Company is obliged to keep in accordance with the Companies Law or pursuant to these Articles shall be recorded in a regular book, or by digital, electronic or other means, as the Board shall decide.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">25.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to and in accordance with the provisions of Sections 138 and 139 of the Companies Law, the Company may cause supplementary registers to be kept in any place outside Israel as the Board may deem fit, and, subject to all applicable requirements of the Companies Law, the Board may from time to time adopt such rules and procedures as it may deem fit in connection with the keeping of such supplementary registers.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>BOOKS OF ACCOUNT</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board shall keep proper books of account in accordance with the provisions of the Companies Law. The books of account shall be kept at the Office, or at such other place or places as the Board shall deem appropriate, and shall at all times be open to the inspection of members of the Board. A shareholder of the Company who is not a member of the Board shall not have the right to inspect any books or accounts or documents of the Company, unless such right has been expressly granted to him by the Companies Law, or if he has been permitted to do so by the Board<span style="text-decoration: line-through; ">&#160;or by the shareholders based on a resolution adopted at a General Meeting</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">At least once each year the accounts of the Company and the correctness of the statement of income and the balance sheet shall be audited and confirmed by an independent auditor.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company shall, in an annual General Meeting, appoint an independent auditor who shall hold such position until the next annual General Meeting, or for a term beyond the aforesaid, provided that such term shall not extend beyond the third (3rd) annual General Meeting following the annual General Meeting at which such independent auditor was appointed, and his appointment, remuneration and rights and duties shall be subject to the provisions of the Companies Law, provided, however, that in exercising its authority to fix the remuneration of the auditor, the shareholders in an annual General Meeting may, by a resolution, act (and in the absence of any action in connection therewith shall be deemed to have so acted) to authorize the Board <span style="text-decoration: underline; ">(with right of delegation to a Committee thereof or to</span> <span style="text-decoration: underline; ">management) </span>to fix such remuneration subject to such criteria or standards, if any, as may be provided in such resolution, and if no such criteria or standards are so provided, such remuneration shall be fixed in an amount commensurate with both the volume and nature of the services rendered by the auditor.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">The</span><span style="text-decoration: underline; ">To the extent required by the Companies Law, the</span>&#160;auditor shall be entitled to receive notices of every General Meeting of the Company and to attend such meetings and to express his opinions on all matters pertaining to his function as the auditor of the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law and the U.S. Rules, any act carried out by the auditor of the Company shall be valid as against any person doing business in good faith with the Company, notwithstanding any defect in the appointment or qualification of the auditor.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">26.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">For as long as the Company is a public company, as defined in</span><span style="text-decoration: underline; ">To the extent</span>&#160;<span style="text-decoration: underline; ">required by</span>&#160;the Companies Law, it shall appoint an internal auditor possessing the authorities set forth in the Companies Law. The internal auditor of the Company shall present all of its proposed work plans to the <span style="text-decoration: underline; ">Board or to the </span>audit committee of the Board, <span style="text-decoration: line-through; ">which</span><span style="text-decoration: underline; ">asdetermined</span>&#160;<span style="text-decoration: underline; ">by the Board from time to time, and the Board or audit committee (as applicable)</span>&#160;shall have the authority to approve them<span style="text-decoration: underline; ">,</span> subject to any modifications in its discretion. <span style="text-decoration: underline; ">Until such time as</span>&#160;<span style="text-decoration: underline; ">the Board determines otherwise, the work plan shall be submitted to the audit committee of the</span>&#160;<span style="text-decoration: underline; ">Board and approved by it, subject to any modifications in its discretion.</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOTICES</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;The Company may serve any written notice or other document on a shareholder by way of delivery by hand, by facsimile transmission<span style="text-decoration: line-through; "> or</span><span style="text-decoration: underline; ">, by email or other electronic</span>&#160;<span style="text-decoration: underline; ">transmission or</span>&#160;by dispatch by prepaid registered mail to his address as recorded in the Register, or if there is no such recorded address, to the address given by him to the Company for the sending of notices to him. Notwithstanding the foregoing or any other provision to the contrary contained herein, notices or any other information or documents required to be delivered to a shareholder shall be deemed to have been duly delivered if submitted, published, filed or lodged in any manner prescribed by applicable law. With respect to the manner of providing such notices or other disclosures, the Company may distinguish between the shareholders listed on its regular Registry and those listed in any &#8220;additional registry&#8221;, as defined in Section 138(a) of the Companies Law, administered by a transfer agent or stock exchange registration company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any shareholder may serve any written notice or other document on the Company by way of delivery by hand at the Office, by facsimile or email transmission to the Company or by dispatch by prepaid registered mail to the Company at the Office.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any notice or document which is delivered or sent to a shareholder in accordance with these Articles shall be deemed to have been duly delivered and sent in respect of the shares held by him (whether in respect of shares held by him alone or jointly with others), notwithstanding the fact that such shareholder has died or been declared bankrupt at such time (whether or not the Company knew of his death or bankruptcy), and shall be deemed to be sufficient delivery or dispatch to heirs, trustees, administrators or transferees and any other persons (if any) who have a right in the shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:78pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any such notice or other document shall be deemed to have been served:</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case of mailing, forty-eight (48) hours after it has been posted, or when actually received by the addressee if sooner than forty-eight (48) hours after it has been posted;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case of overnight air courier, on the next day following the day sent, with receipt confirmed by the courier, or when actually received by the addressee if sooner;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 138px;">&#160;</td>
			<td style="vertical-align: top; width: 35px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.3.&#160;</p>
			</td>
			<td style="vertical-align: top; width: 560px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case of personal delivery, when actually tendered in person to such&#160;shareholder;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width: 139px;">&#160;</td>
			<td style="vertical-align: top; width: 35px;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.4.&#160;</p>
			</td>
			<td style="vertical-align: top; width: 559px;">&#160;in the case of facsimile or other electronic transmission (including email), <span style="text-decoration: line-through; ">the next day following the date on which</span><span style="text-decoration: underline; ">upon transmission, provided that the notice or other</span> <span style="text-decoration: underline; ">document shall not be deemed served if</span> the sender receives <span style="text-decoration: underline; ">an </span>automatic <span style="text-decoration: line-through; ">electronic confirmation</span> <span style="text-decoration: line-through; ">by the recipient</span>&#8217;<span style="text-decoration: line-through; ">s facsimile machine or computer or other device that such notice was received by</span> <span style="text-decoration: line-through; ">the addressee; or </span><span style="text-decoration: underline; ">system-generated response that such facsimile or other electronic transmission</span> <span style="text-decoration: underline; ">was undeliverable or not delivered; or</span></td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.4.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">in the case a notice is, in fact, received by the addressee, when received, notwithstanding that it was defectively addressed or failed, in some other respect, to comply with the provisions of this <span style="text-decoration: underline; ">Article27.4</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any shareholder whose address is not described in the Register, and who shall not have designated in writing an address for the receipt of notices, shall not be entitled to receive any notice from the Company. In the case of joint holders of a share, the Company shall be entitled to deliver a notice by dispatch to the joint holder whose name stands first in the Register in respect of such share.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Whenever it is necessary to give notice of a particular number of days or a notice for another period, the day of delivery shall be counted in the number of calendar days or the period, unless otherwise specified.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">27.7.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Notwithstanding anything to the contrary contained herein, notice by the Company of a General Meeting, containing the information required to be set forth in such notice under these Articles, which is published, within the time otherwise required for giving notice of such meeting, in<span style="text-decoration: underline; ">&#160;either or several of the following manners shall be deemed to be</span>&#160;<span style="text-decoration: underline; ">notice of such meeting duly given or service of such materials on the date of such publication</span>:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:115pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">27.7.1.&#160;</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">on the Company&#8217;s website; and/or</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:115pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">27.7.2.&#160;</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; "><span style="text-decoration: underline; ">in a re</span>port or a schedule filed with, or furnished to, the SEC.</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">27.7.1.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">&#160;&#160;the Company&#8217;s website shall be deemed to be notice of such meeting&#160;duly given, for the purposes of these Articles, to any shareholder whose address as registered in the Register (or as designated in writing for the receipt of notices and other documents) is located in the State of Israel; and</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">27.7.2.</span></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: line-through; ">&#160;&#160;&#160;one (1) notification by international wire service press release and&#160;furnishing of such release on Form 6-K to the SEC shall be deemed to be notice of such meeting duly given, for the purposes of these Articles, to any shareholder whose address as registered in the Register (or as designated in writing for the receipt of notices and other documents) is located outside the State of Israel.</span></p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:115pt;">&#160;</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>INSURANCE, INDEMNITY AND EXCULPATION</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law, the Company shall be entitled to enter into a contract to insure all or part of the liability of an Office Holder of the Company,&#160;imposed on him in consequence of an act which he has performed by virtue of being an Office Holder, in respect of any of the following:</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;The breach of a duty of care to the Company or to any other person, <span style="text-decoration: line-through; ">other than with respect to a distribution and excluding a breach committed intentionally or recklessly (other than a breach arising out negligent conduct);;</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The breach of a duty of loyalty to the Company, provided that the Office Holder acted in good faith and had reasonable grounds for believing that the action would not adversely affect the best interests of the Company;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">A pecuniary liability imposed on him in favor of any other person<span style="text-decoration: line-through; ">&#160;in</span>&#160;<span style="text-decoration: line-through; ">respect of an act done in his capacity as an Office Holder</span><span style="text-decoration: underline; "><span style="text-decoration: line-through; ">.</span></span><span style="text-decoration: underline; ">; or</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.1.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any other circumstances arising under the law with respect to which the Company may, or will be able to, insure an Office Holder.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law, the Company shall be entitled to indemnify an Office Holder of the Company, to the fullest extent permitted by applicable law. Subject to the provisions of the Companies Law, <span style="text-decoration: line-through; ">including the receipt of all approvals as</span>&#160;<span style="text-decoration: line-through; ">required therein or under any applicable law, </span>the Company may<span style="text-decoration: line-through; ">&#160;resolve</span>&#160;retroactively to indemnify an Office Holder with respect to the following liabilities and expenses, <i>provided</i>, in each of the below cases, that such liabilities or expenses were incurred by such Office Holder in <span style="text-decoration: underline; ">connection with an action performed by </span>such Office <span style="text-decoration: line-through; ">Holder</span>&#8217;<span style="text-decoration: line-through; ">s</span><span style="text-decoration: underline; ">Holder in his</span>&#160;capacity as an Office Holder of the Company:</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;&#160;&#160;&#160;&#160;a monetary liability imposed on him in favor of a third party in any judgment, including any settlement confirmed as judgment and an arbitrator&#8217;s award which has been confirmed by the court<span style="text-decoration: line-through; ">, in respect of an act performed by the Office Holder by virtue of&#160;the Office Holder being an Office Holder of the Company; <i>provided, however</i>, that: (a) any indemnification undertaking with respect to the foregoing shall be limited (i) to events which, in the opinion of the Board, are foreseeable in light of the Company&#8217;s actual operations at the time of the granting of the indemnification undertaking, and (ii) to an amount or by criteria determined by the Board to be reasonable in the given circumstances; and (b) the events that in the opinion of the Board are foreseeable in light of the Company&#8217;s actual operations at the time of the granting of the indemnification undertaking are listed in the indemnification undertaking together with the amount or criteria determined by the Board to be reasonable in the given circumstances;</span><span style="text-decoration: underline; ">;</span></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">reasonable litigation expenses, including legal fees, paid for by the Office Holder, in an investigation or proceeding conducted against such Office Holder by an agency authorized to conduct such investigation or proceeding, and which investigation or proceeding: (i) concluded without the filing of an indictment (as defined in the Companies Law) against such Office Holder and without a monetary liability having been imposed against such Office Holder in lieu of a criminal proceeding (as defined in the Companies Law); <span style="text-decoration: underline; ">or </span>(ii) concluded without the filing of an indictment against such Office Holder but with a monetary liability having been imposed against such Office Holder in lieu of a criminal proceeding for an offense that does not require proof of criminal intent; or (iii) involves financial sanction;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">reasonable litigation expenses, including legal fees, paid for by the Office Holder, or which the Office Holder is obligated to pay under a court order<span style="text-decoration: underline; ">&#160;or ruling</span>, in a proceeding brought against the Office Holder by the Company, or on its behalf, or by a third party, or in a criminal proceeding in which the Office Holder is found innocent, or in a criminal proceeding in which the Office Holder was convicted of an offense that does not require proof of criminal intent; and</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:103pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.2.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;any other event, occurrence or circumstances in respect of which the Company may lawfully indemnify an Office Holder of the Company (including, without limitation, indemnification with respect to the matters referred to under Section 56h(b)(1) of the Israeli Securities Law, 5728-1968, as amended<span style="text-decoration: underline; ">, and Section 50P(b)(2) of the Israeli</span>&#160;<span style="text-decoration: underline; ">Economic Competition Law 5748-1988</span>).</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.3.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company may undertake to indemnify an Office Holder as aforesaid<span style="text-decoration: line-through; ">: (i)</span> <span style="text-decoration: underline; ">in</span> <span style="text-decoration: underline; ">Articles 28.2.1, 28.2.2, 28.2.3 and 28.2.4</span> prospectively, provided that<span style="text-decoration: line-through; "> the</span><span style="text-decoration: underline; ">, with respect to the</span> <span style="text-decoration: underline; ">matters set forth in Article 28.2.1, any indemnification</span> undertaking <span style="text-decoration: line-through; ">is</span><span style="text-decoration: underline; ">with respect to the foregoing</span> <span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">shall be</span> limited <span style="text-decoration: line-through; ">to categories of</span><span style="text-decoration: underline; ">(a) to</span> events which, in the opinion of the Board<span style="text-decoration: line-through; "> can be foreseen</span> <span style="text-decoration: line-through; ">when the</span><span style="text-decoration: underline; ">, are foreseeable in light of the Company</span><span style="text-decoration: underline; ">&#8217;</span><span style="text-decoration: underline; ">s actual operations at the time of granting the</span> <span style="text-decoration: underline; ">indemnification</span> undertaking<span style="text-decoration: line-through; "> to indemnify is given</span>, and <span style="text-decoration: underline; ">(b) </span>to an amount <span style="text-decoration: line-through; ">set</span><span style="text-decoration: underline; ">or by criteria</span> <span style="text-decoration: underline; ">determined</span> by the Board <span style="text-decoration: line-through; ">as</span><span style="text-decoration: underline; ">to be</span> reasonable <span style="text-decoration: line-through; ">under</span><span style="text-decoration: underline; ">in</span> the <span style="text-decoration: underline; ">given</span> circumstances, and (<span style="text-decoration: line-through; ">ii) retroactively. </span><span style="text-decoration: underline; ">c) the events that in the opinion of the Board are foreseeable in light of the Company</span><span style="text-decoration: underline; ">&#8217;</span><span style="text-decoration: underline; ">s actual</span> <span style="text-decoration: underline; ">operations at the time of granting the indemnification undertaking are listed in the indemnification</span> <span style="text-decoration: underline; ">undertaking together with the amount or criteria determined by the Board to be reasonable in the</span> <span style="text-decoration: underline; ">given circumstances.</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.4.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subject to the provisions of the Companies Law including the receipt of all approvals as required therein or under any applicable law, the Company may, to the maximum extent permitted by the Companies Law, exempt and release, <span style="text-decoration: underline; ">including </span>in advance, any Office Holder from any liability for damages arising out of a breach of a duty of care towards the Company.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.5.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Any amendment to the Companies Law <span style="text-decoration: underline; ">or other applicable law </span>adversely affecting the right of any Office Holder to be indemnified or insured pursuant to <span style="text-decoration: underline; ">Articles28.1,</span>&#160;<span style="text-decoration: underline; ">28.2, 28.3 and 28.4</span>&#160;and any amendments to such Articles shall be prospective in effect, and shall not affect the Company&#8217;s obligation or ability to indemnify or insure an Office Holder for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:67pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28.6.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The provisions of <span style="text-decoration: underline; ">Articles 28.1, 28.2, 28.3 and 28.4</span>&#160;are not intended, and shall not be interpreted so as to restrict the Company, in any manner, in respect of the procurement of insurance or in respect of indemnification or exculpation, in favor of any person who is not an Office Holder, including, without limitation, any employee, agent, consultant or contractor of the Company who is not an Office Holder; or any Office Holder to the extent that such insurance and/or indemnification is not specifically prohibited under law.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">29.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>WINDING-UP AND REORGANIZATION</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">29.1.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Should the Company be wound up and assets of the Company remain available for distribution after covering all the Company&#8217;s outstanding liabilities, such assets shall be distributed among the shareholders pro rata to the nominal value of the paid-up capital on the shares held by each of them.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:75pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">29.2.&#160;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Upon the sale of the Company&#8217;s assets, the Board may, or in the case of a liquidation, the liquidators may, if authorized to do so by a resolution of the Company, accept fully or partly paid-up shares, or securities of another company, Israeli or non-Israeli, whether in existence at such time or about to be formed, in order to purchase the property of the Company, or part thereof, and to the extent permitted under the Companies Law, the Board may (or in the case of a liquidation, the liquidators may) distribute the aforesaid shares or securities or any other property of the Company among the shareholders without realizing the same, or may deposit the same in the hands of trustees for the shareholders, and the General Meeting by a resolution may decide, subject to the provisions of the Companies Law, on the&#160;distribution or allotment of cash, shares or other securities, or the property of the Company and on the valuation of the aforesaid securities or property at such price and in such manner as the shareholders at such General Meeting shall decide, and all of the shareholders shall be obliged to accept any valuation or distribution determined as aforesaid and to waive their rights in this regard, except, in a case in which the Company is about to be wound-up and is in the process of liquidation, for those legal rights (if any) which, according to the provisions of the Companies Law, may not be changed or modified.</p>
			</td>
		</tr>

</tbody></table>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="width:34pt;">&#160;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">30.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">TRANSLATION AND BINDING EFFECT</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">These Articles may be translated into Hebrew and/or into other languages. Notwithstanding the aforesaid, the English version of these Articles shall be binding upon the Company, its shareholders and/or any third party and shall supersede any translation thereof.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>* * *</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>APPENDIX B</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>COMPENSATION POLICY AMENDMENT</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">2.2.3&#160;&#160;&#160;&#160;&#160; Insurance, Exculpation and Indemnification. The directors and officers of the Company shall be entitled to benefit from the insurance, exculpation and indemnification arrangements to the fullest extent permitted by applicable law, to be approved from time to time by the Company, pursuant to the provisions of the Articles of Association of the Company and applicable law. The insurance arrangements shall provide coverage in such amounts as shall be determined by the Compensation Committee of the Company, and, if required by applicable law, the Board, and may include &#8220;run-off&#8221; (a/k/a &#8220;tail&#8221;) provisions for a period of up to the later of (i) 10 years after the termination of their services with the Company, and (ii) the resolution of existing claims, and such insurance arrangements may also include Public Offering of Securities Insurance (POSI) or similar insurance. The insurance arrangements (which may also cover the liability of any controlling shareholders of the Company and their relatives (within the meanings of such terms in the Companies Law), in their capacity as directors and officers of the Company) shall be subject to the following limitations, which shall be determined by the Compensation Committee of the Company, and, if required by applicable law, the Board: (i) the annual premium to be paid by the Company as well as the amount of the deductible for the Company shall be on market terms as of the date of the issuance of the policy; and (ii) the cost of the policy to the Company shall not have a material impact on the Company&#8217;s profitability, assets or liabilities.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;"><b>APPENDIX C</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>UroGen Pharma Ltd.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>2017 Equity Incentive Plan</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: center;"><b>UroGen Pharma Ltd.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>2017 Equity Incentive Plan</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Adopted by the Board of Directors: March 29, 2017 and May 3, 2017</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Approved by the Stockholders: April 19, 2017</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>IPO Date/Effective Date: May 9, 2017</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Amended by the Board of Directors: August 29, 2018</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Amended by the Board of Directors: April 26, 2020</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Approved by the Stockholders: June 8, 2020</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Amended by the Board of Directors: March 17, 2021</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Approved by the Stockholders: June 7, 2021</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Amended by the Board of Directors: March 7, 2022</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Approved by the Stockholders: June 8, 2022</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Amended by the Board of Directors: July 31, 2023</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Approved by the Stockholders: September 7, 2023</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Amended by the Board of Directors: June 14, 2024</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Approved by the Stockholders: August 6, 2024</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Amended by the Board of Directors: June 30, 2025</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Approved by the Stockholders: August 26, 2025</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Amended by the Board of Directors: March 19, 2026</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>[Approved by the Stockholders: June 22, 2026]</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>1.</b>&#160;&#160;&#160;&#160;<b>GENERAL</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Eligible Award Recipients.</b> Employees, Directors and Consultants are eligible to receive Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Available Awards.</b> The Plan provides for the grant of the following types of Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards, (vi) Performance Stock Awards, (vii) Performance Cash Awards, and (viii) Other Stock Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(c)</b>&#160;&#160;&#160;&#160;<b>Purpose.</b> The Plan, through the grant of Awards, is intended to help the Company secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate, and provide a means by which the eligible recipients may benefit from increases in value of the Ordinary Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>2.</b>&#160;&#160;&#160;&#160;<b>ADMINISTRATION</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Administration by Board.</b> The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section 2(c).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Powers of Board.</b> The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">i.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">To determine: (A) who will be granted Awards; (B) when and how each Award will be granted; (C) what type of Award will be granted; (D) the provisions of each Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive cash or Ordinary Shares under the Award; (E) the number of Ordinary Shares subject to, or the cash value of, an Award; and (F) the Fair Market Value applicable to a Stock Award.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">ii.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for administration of the Plan and Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement or in the written terms of a Performance Cash Award, in a manner and to the extent it will deem necessary or expedient to make the Plan or Award fully effective.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 2px; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align: middle; width: 29px;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">iii.</p>
			</td>
			<td style="vertical-align: middle; width: 914px;">To settle all controversies regarding the Plan and Awards granted under it.</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; margin: 0pt 0pt 0pt 9pt; font-family: &quot;Times New Roman&quot;;">iv.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; margin: 0pt 0pt 0pt 9pt; font-family: &quot;Times New Roman&quot;;">To accelerate, in whole or in part, the time at which an Award may be exercised or vest (or the time at which cash or Ordinary Shares may be issued in settlement thereof).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">v.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or an Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#8217;s rights under the Participant&#8217;s then-outstanding Award without the Participant&#8217;s written consent.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">vi.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or bringing the Plan or Awards granted under the Plan into compliance with the requirements for Incentive Stock Options or ensuring that they are exempt from, or compliant with, the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law. If required by applicable law or listing requirements (taking into account any permissible and effective opting out by the Company from such requirements), and except as provided in Section 9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan that (A) materially increases the number of Ordinary Shares available for issuance under the Plan, (B) materially expands the class of individuals eligible to receive Awards under the Plan, (C) materially increases the benefits accruing to Participants under the Plan, (D) materially reduces the price at which Ordinary Shares may be issued or purchased under the Plan, (E) materially extends the term of the Plan, or (F) materially expands the types of Awards available for issuance under the Plan. Except as otherwise provided in the Plan or an Award Agreement, no amendment of the Plan will materially impair a Participant&#8217;s rights under an outstanding Award without the Participant&#8217;s written consent.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">vii.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of (A) Section 162(m) of the Code regarding the exclusion of performance-based compensation from the limit on corporate deductibility of compensation paid to Covered Employees, (B) Section 422 of the Code regarding &#8220;incentive stock options&#8221;&#160;and/or (C) Rule 16b-3.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">viii.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; <i>provided, however,</i>&#160;that a Participant&#8217;s rights under any Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant, and (B) such Participant consents in writing. Notwithstanding the foregoing, (1) a Participant&#8217;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#8217;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Awards without the affected Participant&#8217;s consent (A) to maintain the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (B) to change the terms of an Incentive Stock Option, if such change results in impairment of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (C) to clarify the manner of exemption from, or to bring the Award into compliance with, Section 409A of the Code; and/or (D) to comply with other applicable laws or listing requirements.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">ix.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: auto; padding-left: 9pt;">&#160;</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">x.</p>
			</td>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are not United States nationals or who are employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt;"><b>(c)</b>&#160;&#160;&#160;&#160;<b>Delegation to Committee.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><b>(i) General.</b> The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;"><b>(ii) Section 162(m) and Rule 16b-3 Compliance.</b> The Committee may consist solely of two or more Outside Directors, in accordance with Section 162(m) of the Code, or solely of two or more Non-Employee Directors, in accordance with Rule 16b-3.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(d)</b>&#160;&#160;&#160;&#160;<b>Delegation to an Officer.</b> The Board may delegate to one (1) or more Officers the authority to do one or both of the following (i) designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other Stock Awards) and, to the extent permitted by applicable law, the terms of such Awards, and (ii) determine the number of Ordinary Shares to be subject to such Stock Awards granted to such Employees; <i>provided, however</i>,<i> </i>that the Board resolutions regarding such delegation will specify the total number of Ordinary Shares that may be subject to the Stock Awards granted by such Officer and that such Officer may not grant a Stock Award to himself or herself. Any such Stock Awards will be granted on the form of Stock Award Agreement most recently approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) to determine Fair Market Value.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(e)</b>&#160;&#160;&#160;&#160;<b>No Repricing of Awards.</b> Neither the Board nor any Committee will have the authority to (i) reduce the exercise or strike price of any outstanding Option or SAR or (ii) cancel any outstanding Option or SAR that has an exercise or strike price (per share) greater than the then-current Fair Market Value of the Ordinary Shares in exchange for cash or other Stock Awards under the Plan, unless the shareholders of the Company have approved such an action within twelve (12) months prior to such an event.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(f)</b>&#160;&#160;&#160;&#160;<b>Effect of Board</b>&#8217;<b>s Decision.</b> All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>3.</b>&#160;&#160;&#160;&#160;<b>SHARES SUBJECT TO THE PLAN</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Share Reserve. </b>Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate number of Ordinary Shares that may be issued pursuant to Stock Awards from and after the Effective Date will not exceed 9,750,167&#160;shares (the &#8220;<b><i>Share Reserve</i></b>&#8221;). For clarity, the Share Reserve in this Section 3(a)&#160;is a limitation on the number of Ordinary Shares that may be issued pursuant to the Plan. Accordingly, this Section 3(a)&#160;does not limit the granting of Stock Awards except as provided in Section 7(a). Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c) or, if applicable, NYSE Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Reversion of Shares to the Share Reserve. </b>If a Stock Award or any portion thereof (i) expires or otherwise terminates without all of the shares covered by such Stock Award having been issued or (ii) is settled in cash (<i>i.e.</i>, the Participant receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of Ordinary Shares that may be available for issuance under the Plan and the Ordinary Shares relating to such Stock Award (or portion thereof) will again become available for issuance under the Plan. If any Ordinary Shares issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited or repurchased will revert to and again become available for issuance under the Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(c) Shares Not Available for Subsequent Issuance. </b>The following shares will not become available again for issuance under the Plan: (A) any shares that are reacquired or withheld (or not issued) by the Company to satisfy the exercise, strike or purchase price of a Stock Award granted under the Plan (including any shares subject to such award that are not delivered because such award is exercised through a reduction of shares subject to such award (<i>i.e</i>., &#8220;net exercised&#8221;)); (B) any shares that are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with a Stock Award granted under the Plan; (C) any shares repurchased by the Company on the open market with the proceeds of the exercise, strike or purchase price of a Stock Award; and (D) in the event that a Stock Appreciation Right is settled in shares, the gross number of shares subject to such award.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(d)</b>&#160;&#160;&#160;&#160;<b>Incentive Stock Option Limit. </b>Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, the aggregate maximum number of Ordinary Shares that may be issued pursuant to the exercise of Incentive Stock Options will be 5,600,000 Ordinary Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(e)</b>&#160;&#160;&#160;&#160;<b>Section 162(m) Limitations</b>. Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, at such time as the Company may be subject to the applicable provisions of Section 162(m) of the Code, the following limitations shall apply.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">(i) A maximum of 500,000 Ordinary Shares subject to Options, SARs and Other Stock Awards whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the Fair Market Value on the date the Stock Award is granted may be granted to any one Participant during any one calendar year. Notwithstanding the foregoing, if any additional Options, SARs or Other Stock Awards whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the Fair Market Value on the date the Stock Award are granted to any Participant during any calendar year, compensation attributable to the exercise of such additional Stock Awards will not satisfy the requirements to be considered &#8220;qualified performance-based compensation&#8221; under Section 162(m) of the Code unless such additional Stock Award is approved by the Company&#8217;s stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">(ii) A maximum of 500,000 Ordinary Shares subject to Performance Stock Awards may be granted to any one Participant during any one calendar year (whether the grant, vesting or exercise is contingent upon the attainment during the Performance Period of the Performance Goals).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">(iii) A maximum of $3.0 million may be granted as a Performance Cash Award to any one Participant during any one calendar year.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>(f)</b>&#160;&#160;&#160;&#160;<b>Source of Shares.</b> Except as otherwise provided herein,&#160;the stock issuable under the Plan will be shares of authorized but unissued or reacquired Ordinary Shares, including shares repurchased by the Company on the open market or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>4.</b>&#160;&#160;&#160;&#160;<b>ELIGIBILITY</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Eligibility for Specific Stock Awards</b>. Incentive Stock Options may be granted only to employees of the Company or a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code). Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; <i>provided, however</i>, that Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405 of the Securities Act, unless (i) the stock underlying such Stock Awards is treated as &#8220;service recipient stock&#8221; under Section 409A of the Code (for example, because the Stock Awards are granted pursuant to a corporate transaction such as a spin off transaction), (ii) the Company, in consultation with its legal counsel, has determined that such Stock Awards are otherwise exempt from Section 409A of the Code, or (iii) the Company, in consultation with its legal counsel, has determined that such Stock Awards comply with the distribution requirements of Section 409A of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Ten Percent Stockholders.</b> A Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five years from the date of grant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>5.</b>&#160;&#160;&#160;&#160;<b>PROVISIONS RELATING TO OPTIONS AND STOCK APPRECIATION RIGHTS</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Each Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for Ordinary Shares purchased on exercise of each type of Option. If an Option is not specifically designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory Stock Option. The provisions of separate Options or SARs need not be identical; <i>provided, however</i>, that each Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Term.</b> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of ten years from the date of its grant or such shorter period specified in the Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Exercise Price.</b> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, the exercise or strike price of each Option or SAR will be not less than 100% of the Fair Market Value of the Ordinary Shares subject to the Option or SAR on the date the Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value of the Ordinary Shares subject to the Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Section 409A and, if applicable, Section 424(a) of the Code. Each SAR will be denominated in Ordinary Shares equivalents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(c)</b>&#160;&#160;&#160;&#160;<b>Purchase Price for Options.</b> The purchase price of Ordinary Shares acquired pursuant to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment. The permitted methods of payment are as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(i) by cash, check, bank draft or money order payable to the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(ii) pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iii) by delivery to the Company (either by actual delivery or attestation) of Ordinary Shares;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iv) if an Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of Ordinary Shares issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; <i>provided, however</i>, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Ordinary Shares will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A) shares issuable upon exercise are used to pay the exercise price pursuant to the &#8220;net exercise,&#8221; (B) shares are delivered to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(v) in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(d)</b>&#160;&#160;&#160;&#160;<b>Exercise and Payment of a SAR.</b> To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of Ordinary Shares equal to the number of Ordinary Share equivalents in which the Participant is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike price of the number of Ordinary Share equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation distribution may be paid in Ordinary Shares, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Award Agreement evidencing such SAR.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(e)</b>&#160;&#160;&#160;&#160;<b>Transferability of Options and SARs.</b> The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability of Options and SARs will apply:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(i) Restrictions on Transfer.</b> An Option or SAR will not be transferable except by will or by the laws of descent and distribution (or pursuant to subsections (ii) and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant. The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(i) Domestic Relations Orders.</b> Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations Section 1.421-1(b)(2). If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(iii) Beneficiary Designation.</b> Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, on the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Ordinary Shares or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#8217;s estate will be entitled to exercise the Option or SAR and receive the Ordinary Shares or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(f)</b>&#160;&#160;&#160;&#160;<b>Vesting Generally.</b> The total number of Ordinary Shares subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to any Option or SAR provisions governing the minimum number of Ordinary Shares as to which an Option or SAR may be exercised.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(g)</b>&#160;&#160;&#160;&#160;<b>Termination of Continuous Service.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Award as of the date of termination of Continuous Service) within the period of time ending on the earlier of (i) the date which occurs ninety (90) days following the termination of the Participant&#8217;s Continuous Service (or such longer or shorter period specified in the applicable Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR will terminate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(h)</b>&#160;&#160;&#160;&#160;<b>Extension of Termination Date.</b> If the exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance of Ordinary Shares would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements, and (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. In addition, unless otherwise provided in a Participant&#8217;s Award Agreement, if the sale of any Ordinary Shares received on exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause) would violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the expiration of the period of days or months (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the sale of the Ordinary Shares received upon exercise of the Option or SAR would not be in violation of the Company&#8217;s insider trading policy, or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(i)</b>&#160;&#160;&#160;&#160;<b>Disability of Participant.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date which occurs 12 months following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(j)</b>&#160;&#160;&#160;&#160;<b>Death of Participant.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if (i) a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii) the Participant dies within the period (if any) specified in the Award Agreement for exercisability after the termination of the Participant&#8217;s Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death, but only within the period ending on the earlier of (i) the date which occurs 18 months following the date of death (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of such Option or SAR as set forth in the Award Agreement. If, after the Participant&#8217;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR (as applicable) will terminate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(k)</b>&#160;&#160;&#160;&#160;<b>Termination for Cause.</b> Except as explicitly provided otherwise in a Participant&#8217;s Award Agreement or other individual written agreement between the Company or any Affiliate and the Participant, if a Participant&#8217;s Continuous Service is terminated for Cause, the Option or SAR will terminate immediately upon such Participant&#8217;s termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the date of such termination of Continuous Service.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(l)</b>&#160;&#160;&#160;&#160;<b>Non-Exempt Employees</b>. If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any Ordinary Shares until at least six months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i) if such non-exempt Employee dies or suffers a Disability, (ii) upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii) upon a Change in Control, or (iv) upon the Participant&#8217;s retirement (as such term may be defined in the Participant&#8217;s Award Agreement in another agreement between the Participant and the Company, or, if no such definition, in accordance with the Company's then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. To the extent permitted and/or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under any other Stock Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Section 5(l) will apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>6.</b>&#160;&#160;&#160;&#160;<b>PROVISIONS OF STOCK AWARDS OTHER THAN OPTIONS AND SARS.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Restricted Stock Awards.</b> Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. To the extent consistent with the Company&#8217;s articles of association, at the Board&#8217;s election, Ordinary Shares may be (x) held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted Stock Award lapse; or (y) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. Each Restricted Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 17pt;"><b>(i) Consideration.</b> A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to the Company, (B) past services to the Company or an Affiliate, or (C) any other form of legal consideration (including future services) that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 17pt;"><b>(ii) Vesting. </b>Ordinary Shares awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 17pt;"><b>(iii) Termination of Participant</b>&#8217;<b>s Continuous Service.</b> If a Participant&#8217;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the Ordinary Shares held by the Participant that have not vested as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 17pt;"><b>(iv) Transferability.</b> Rights to acquire Ordinary Shares under the Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Ordinary Shares awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 17pt;"><b>(v) Dividends. </b>A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the same vesting and forfeiture restrictions as apply to the shares subject to the Restricted Stock Award to which they relate; provided, however, that (i) no dividends may be paid with respect to any such shares before the date such shares have vested under the terms of such Restricted Stock Award Agreement, (ii) any dividends that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of such Restricted Stock Award Agreement (including, but not limited to, any vesting conditions), and (iii) any dividends that are credited with respect to any such shares will be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Restricted Stock Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Restricted Stock Unit Awards. </b>Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(i) Consideration.</b> At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Ordinary Shares subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the Participant for each share of Ordinary Shares subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(ii) Vesting. </b>At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(iii) Payment</b>. A Restricted Stock Unit Award may be settled by the delivery of Ordinary Shares, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(iv) Additional Restrictions. </b>At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the Ordinary Shares (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(v) Dividend Equivalents. </b>Dividend equivalents may be credited in respect of Ordinary Shares covered by a Restricted Stock Unit Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement; provided, however, that (i) no dividend equivalents may be paid with respect to any such shares before the date such shares have vested under the terms of such Restricted Stock Unit Award Agreement, (ii) any dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of such Restricted Stock Unit Award Agreement (including, but not limited to, any vesting conditions), and (iii) any dividend equivalents that are credited with respect to any such shares will be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Restricted Stock Unit Award Agreement</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(vi) Termination of Participant</b>&#8217;<b>s Continuous Service. </b>Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#8217;s termination of Continuous Service.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(c)</b>&#160;&#160;&#160;&#160;<b>Performance Awards</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(i) Performance Stock Awards</b>. A Performance Stock Award is a Stock Award (covering a number of shares not in excess of that set forth in Section 3(d) above) that is payable (including that may be granted, may vest or may be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award may but need not require the Participant&#8217;s completion of a specified period of Continuous Service. The length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Committee (or, if not required for compliance with Section 162(m) of the Code, the Board), in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Award Agreement, the Board or the Committee may determine that cash may be used in payment of Performance Stock Awards.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(ii) Performance Cash Awards</b>. A Performance Cash Award is a cash award (for a dollar value not in excess of that set forth in Section 3(d) above) that is payable contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Cash Award may also require the completion of a specified period of Continuous Service. At the time of grant of a Performance Cash Award, the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Committee (or, if not required for compliance with Section 162(m) of the Code, the Board), in its sole discretion. The Board or the Committee may specify the form of payment of Performance Cash Awards, which may be cash or other property, or may provide for a Participant to have the option for his or her Performance Cash Award, or such portion thereof as the Board or the Committee may specify, to be paid in whole or in part in cash or other property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(iii) Board and Committee Discretion</b>. The Board and the Committee retain the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;"><b>(iv) Section 162(m) Compliance</b>. Unless otherwise permitted in compliance with the requirements of Section 162(m) of the Code with respect to an Award intended to qualify as &#8220;performance-based compensation&#8221; thereunder, the Committee will establish the Performance Goals applicable to, and the formula for calculating the amount payable under, the Award no later than the earlier of (a) the date which occurs 90 days after the commencement of the applicable Performance Period, and (b) the date on which 25% of the Performance Period has elapsed, and in any event at a time when the achievement of the applicable Performance Goals remains substantially uncertain. Prior to the payment of any compensation under an Award intended to qualify as &#8220;performance-based compensation&#8221; under Section 162(m) of the Code, the Committee will certify the extent to which any Performance Goals and any other material terms under such Award have been satisfied (other than in cases where such Performance Goals relate solely to the increase in the value of the Ordinary Shares). Notwithstanding satisfaction of, or completion of any Performance Goals, the number of Ordinary Shares, Options, cash or other benefits granted, issued, retainable and/or vested under an Award on account of satisfaction of such Performance Goals may be reduced by the Committee on the basis of such further considerations as the Committee, in its sole discretion, will determine.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(d)</b>&#160;&#160;&#160;&#160;<b>Other Stock Awards</b>. Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Ordinary Shares, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair Market Value of the Ordinary Shares at the time of grant) may be granted either alone or in addition to Stock Awards provided for under Section 5&#160;and the preceding provisions of this Section 6. Subject to the provisions of the Plan, the Board will have sole and complete authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of Ordinary Shares (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>7.</b>&#160;&#160;&#160;&#160;<b>COVENANTS OF THE COMPANY</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Availability of Shares.</b> The Company will keep available at all times the number of Ordinary Shares reasonably required to satisfy then-outstanding Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Securities Law Compliance.</b> The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Stock Awards and to issue and sell Ordinary Shares upon exercise of the Stock Awards; <i>provided, however</i>, that this undertaking will not require the Company to register under the Securities Act the Plan, any Stock Award or any Ordinary Shares issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Ordinary Shares under the Plan, the Company will be relieved from any liability for failure to issue and sell Ordinary Shares upon exercise of such Stock Awards unless and until such authority is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Ordinary Shares pursuant to the Award if such grant or issuance would be in violation of any applicable securities law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(c)</b>&#160;&#160;&#160;&#160;<b>No Obligation to Notify or Minimize Taxes. </b>The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising such Stock Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>8.</b>&#160;&#160;&#160;&#160;<b>MISCELLANEOUS</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Use of Proceeds from Sales of Ordinary Shares. </b>Proceeds from the sale of Ordinary Shares pursuant to Awards will constitute general funds of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Corporate Action Constituting Grant of Awards.</b> Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(c)</b>&#160;&#160;&#160;&#160;<b>Stockholder Rights.</b> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any Ordinary Shares subject to an Award unless and until (i) such Participant has satisfied all requirements for exercise of, or the issuance of Ordinary Shares under, the Award pursuant to its terms, and (ii) the issuance of the Ordinary Shares subject to such Award has been entered into the books and records of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(d)</b>&#160;&#160;&#160;&#160;<b>No Employment or Other Service Rights.</b> Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the articles of association of the Company or an Affiliate, and any applicable provisions of the corporate law of the jurisdiction in which the Company or the Affiliate is incorporated, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(e)</b>&#160;&#160;&#160;&#160;<b>Change in Time Commitment.</b> In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(f)</b>&#160;&#160;&#160;&#160;<b>Incentive Stock Option Limitations.</b> To the extent that the aggregate Fair Market Value (determined at the time of grant) of Ordinary Shares with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(g)</b>&#160;&#160;&#160;&#160;<b>Investment Assurances.</b> The Company may require a Participant, as a condition of exercising or acquiring Ordinary Shares under any Award, (i) to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that such Participant is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Award; and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring Ordinary Shares subject to the Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise distributing the Ordinary Shares. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A) the issuance of the shares upon the exercise or acquisition of Ordinary Shares under the Award has been registered under a then currently effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Ordinary Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(h)</b>&#160;&#160;&#160;&#160;<b>Withholding Obligations.</b> Unless prohibited by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to an Award by any of the following means or by a combination of such means: (i) causing the Participant to tender a cash payment; (ii) withholding Ordinary Shares from the Ordinary Shares issued or otherwise issuable to the Participant in connection with the Award; <i>provided, however, </i>that no Ordinary Shares are withheld with a value exceeding the minimum amount of tax required to be withheld by law (or such lesser amount as may be necessary to avoid classification of the Stock Award as a liability for financial accounting purposes); (iii) withholding cash from an Award settled in cash; (iv) withholding payment from any amounts otherwise payable to the Participant; or (v) by such other method as may be set forth in the Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(i)</b>&#160;&#160;&#160;&#160;<b>Electronic Delivery</b>. Any reference herein to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(j)</b>&#160;&#160;&#160;&#160;<b>Deferrals.</b> To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Ordinary Shares or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(k)</b>&#160;&#160;&#160;&#160;<b>Compliance with Section 409A of the Code. </b>Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section 409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the Ordinary Shares are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#8217;s &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(l)</b>&#160;&#160;&#160;&#160;<b>Clawback/Recovery</b>. All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired Ordinary Shares or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>9. <span style="text-transform:uppercase;">Adjustments upon Changes in Ordinary Shares; Other Corporate Events.</span></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(a)</b>&#160;&#160;&#160;&#160;<b>Capitalization Adjustments</b>. In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), (iii) the class(es) and maximum number of securities that may be awarded to any person pursuant to Sections 3(d), and (iv) the class(es) and number of securities and price per share of stock subject to outstanding Stock Awards. The Board will make such adjustments, and its determination will be final, binding and conclusive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(b)</b>&#160;&#160;&#160;&#160;<b>Dissolution or Liquidation</b>. Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding Ordinary Shares not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the Ordinary Shares subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service; <i>provided, however</i>, that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(c)</b>&#160;&#160;&#160;&#160;<b>Transactions.</b> The following provisions shall apply to Stock Awards in the event of a Transaction unless otherwise provided in the instrument evidencing the Stock Award or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of a Stock Award. In the event of a Transaction, then, notwithstanding any other provision of the Plan, the Board shall take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the Transaction:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(i)&#160;arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Transaction);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(ii) arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Ordinary Shares issued pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iii) accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised) to a date prior to the effective time of such Transaction as the Board shall determine (or, if the Board shall not determine such a date, to the date that is five days prior to the effective date of the Transaction), with such Stock Award terminating if not exercised (if applicable) at or prior to the effective time of the Transaction;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iv) arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock Award;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(v) cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(vi) make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the Transaction, over (B) any exercise price payable by such holder in connection with such exercise. For clarity, this payment may be zero ($0) if the value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of Ordinary Shares in connection with the Transaction is delayed as a result of escrows, earn outs, holdbacks or other contingencies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">The Board need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants. The Board may take different actions with respect to the vested and unvested portions of a Stock Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(d)</b>&#160;&#160;&#160;&#160;<b>Change in Control.</b> A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>10. <span style="text-transform:uppercase;">Plan Term; Earlier Termination or Suspension of the Plan.</span></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of (i) the date the Plan is adopted by the Board (the &#8220;<b><i>Adoption Date</i></b>&#8221;), or (ii) the date the Plan is approved by the stockholders of the Company. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>11. <span style="text-transform:uppercase;">Existence of the Plan; Timing of First Grant or Exercise.</span></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The Plan will come into existence on the Adoption Date; <i>provided, however</i>, that no Award may be granted prior to the IPO Date (that is, the Effective Date). In addition, no Stock Award will be exercised (or, in the case of a Restricted Stock Award, Restricted Stock Unit Award, Performance Stock Award, or Other Stock Award, no Stock Award will be granted) and no Performance Cash Award will be settled unless and until the Plan has been approved by the stockholders of the Company, which approval will be within 12 months after the date the Plan is adopted by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>12. <span style="text-transform:uppercase;">Choice of Law.</span></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The Plan, all determinations made and actions taken pursuant hereto and, except as provided below or in an applicable subplan, each Award Agreement to a Participant shall be governed by the laws of the State of Israel, excluding matters that are subject to tax laws, regulations and rules, or conflicts or choice of law rule or principles, of any specific jurisdiction, which shall be governed by the respective laws, regulations and rules of such jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>13. <span style="text-transform:uppercase;">Definitions</span>. </b>As used in the Plan, the following definitions will apply to the capitalized terms indicated below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(a)&#160;</b>&#8220;<b><i>Affiliate</i></b>&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 of the Securities Act. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(b)&#160;</b>&#8220;<b><i>Award</i></b>&#8221; means a Stock Award or a Performance Cash Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(c)&#160;</b>&#8220;<b><i>Award Agreement</i></b>&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of an Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(d)&#160;</b>&#8220;<b><i>Board</i></b>&#8221; means the Board of Directors of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(e)&#160;</b>&#8220;<b><i>Capitalization Adjustment</i></b>&#8221; means any change that is made in, or other events that occur with respect to, the Ordinary Shares subject to the Plan or subject to any Stock Award after the Adoption Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(f)&#160;</b>&#8220;<b><i>Cause</i></b>&#8221;<b><i> </i></b>will have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events: (i)&#160;such Participant&#8217;s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof; (ii) such Participant&#8217;s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (iii)&#160;such Participant&#8217;s intentional, material violation of any contract or agreement between the Participant and the Company or of any statutory duty owed to the Company; (iv)&#160;such Participant&#8217;s unauthorized use or disclosure of the Company&#8217;s confidential information or trade secrets; or (v)&#160;such Participant&#8217;s gross misconduct. The determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Company, in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(g)</b>&#160;&#8220;<b><i>Change in Control</i></b>&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(i) any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of securities of the Company directly from the Company, (B)&#160;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, (C) on account of the acquisition of securities of the Company by any individual who is, on the Adoption Date, either an executive officer or a Director (either, a &#8220;<b><i>Legacy Investor</i></b>&#8221;) and/or any entity in which a Legacy Investor has a direct or indirect interest (whether in the form of voting rights or participation in profits or capital contributions) of more than 50% (collectively, the &#8220;<b><i>Legacy Entities</i></b>&#8221;) or on account of the Legacy Entities continuing to hold shares that come to represent more than 50% of the combined voting power of the Company&#8217;s then outstanding securities as a result of the conversion of any class of the Company&#8217;s securities into another class of the Company&#8217;s securities having a different number of votes per share pursuant to the conversion provisions set forth in the Company&#8217;s articles of association; or (D) solely because the level of Ownership held by any Exchange Act Person (the &#8220;<b><i>Subject Person</i></b>&#8221;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(ii) there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; <i>provided, however</i>, that a merger, consolidation or similar transaction will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the surviving Entity or its parent are owned by the Legacy Entities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iii) there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; <i>provided, however</i>, that a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the acquiring Entity or its parent are owned by the Legacy Entities;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iv) the stockholders of the Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company will otherwise occur, except for a liquidation into a parent corporation; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(v) individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#8220;<b><i>Incumbent</i></b>&#160;<b><i>Board</i></b>&#8221;) cease for any reason to constitute at least a majority of the members of the Board; <i>provided, however,</i> that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Notwithstanding the foregoing definition or any other provision of the Plan, the term Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company and the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant will supersede the foregoing definition with respect to Awards subject to such agreement; <i>provided, however</i>, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition will apply.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(h)&#160;</b>&#8220;<b><i>Code</i></b>&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(i)&#160;</b>&#8220;<b><i>Committee</i></b>&#8221; means a committee of one or more Directors to whom authority has been delegated by the Board in accordance with Section 2(c).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b><i>&#160;</i>(j)<i>&#8220;Company</i></b>&#8221; means UroGen Pharma Ltd., an Israeli corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(k)&#160;</b>&#8220;<b><i>Consultant</i></b>&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan.<b><i> </i></b>Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(l)<i> &#8220;Continuous Service</i></b>&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service; <i>provided, however</i>,<i> </i>that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. In addition, to the extent required for exemption from or compliance with Section 409A of the Code, the determination of whether there has been a termination of Continuous Service will be made, and such term will be construed, in a manner that is consistent with the definition of &#8220;separation from service&#8221; as defined under Treasury Regulation Section 1.409A-1(h) (without regard to any alternative definition thereunder).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(m)&#160;</b>&#8220;<b><i>Corporate Transaction</i></b>&#8221; the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(i) a sale<b> </b>or other disposition of all or substantially all, as determined by the Board, in its sole discretion, of the consolidated assets of the Company and its Subsidiaries;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(ii) a sale or other disposition of more than 50% of the outstanding securities of the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iii) a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iv) a merger, consolidation or similar transaction following which the Company is the surviving corporation but the Ordinary Shares outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(n)&#160;</b>&#8220;<b><i>Covered Employee</i></b>&#8221; will have the meaning provided in Section 162(m)(3) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(o)&#160;</b>&#8220;<b><i>Director</i></b>&#8221; means a member of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(p)&#160;</b>&#8220;<b><i>Disability</i></b>&#8221; means, with respect to a Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(q)&#160;</b>&#8220;<b><i>Effective Date</i></b>&#8221; means the IPO Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(r)&#160;</b>&#8220;<b><i>Employee</i></b>&#8221; means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(s)&#160;</b>&#8220;<b><i>Entity</i></b>&#8221; means a corporation, partnership, limited liability company or other entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(t)&#160;</b>&#8220;<b><i>Exchange Act</i></b>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(u)&#160;</b>&#8220;<b><i>Exchange Act Person</i></b>&#8221;<b><i> </i></b>means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v) any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(v)&#160;</b>&#8220;<b><i>Fair Market Value</i></b>&#8221; means, as of any date, the value of the Ordinary Shares determined as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(i) If the Ordinary Shares are listed on any established stock exchange or traded on any established market, the Fair Market Value of an Ordinary Share will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Ordinary Shares) on the date of determination, as reported in a source the Board deems reliable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(ii) Unless otherwise provided by the Board, if there is no closing sales price for the Ordinary Shares on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 26pt;">(iii) In the absence of such markets for the Ordinary Shares, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(w)&#160;</b>&#8220;<b><i>Incentive Stock Option</i></b>&#8221; means an option granted pursuant to Section 0 of the Plan that is intended to be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(x)&#160;</b>&#8220;<b><i>IPO Date</i></b>&#8221; means the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Ordinary Shares, pursuant to which the Ordinary Shares are priced for the initial public offering.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(y)&#160;</b>&#8220;<b><i>Non-Employee Director</i></b>&#8221;<b> </b>means a Director who either (i) is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;<b><i>Regulation S-K</i></b>&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item&#160;404(b) of Regulation S-K; or (ii) is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule 16b-3.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(z)&#160;</b>&#8220;<b><i>Nonstatutory Stock Option</i></b>&#8221; means any Option granted pursuant to Section 5&#160;of the Plan that does not qualify as an Incentive Stock Option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(aa)&#160;</b>&#8220;<b><i>Officer</i></b>&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(bb)&#160;</b>&#8220;<b><i>Option</i></b>&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase Ordinary Shares granted pursuant to the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(cc)&#160;</b>&#8220;<b><i>Option Agreement</i></b>&#8221; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(dd)&#160;</b>&#8220;<b><i>Optionholder</i></b>&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(ee)&#160;</b>&#8220;<b><i>Ordinary Shares</i></b>&#8221; means the Ordinary Shares of the Company, par value NIS 0.01 per Ordinary Share.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(ff)</b>&#8220;&#160;&#160;&#160;&#160;<b><i>Other Stock Award</i></b>&#8221; means an award based in whole or in part by reference to the Ordinary Shares which is granted pursuant to the terms and conditions of Section 6(d).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(gg)&#160;</b>&#8220;<b><i>Other Stock Award Agreement</i></b>&#8221;<b><i> </i></b>means a written agreement between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(hh)&#160;</b>&#8220;<b><i>Outside Director</i></b>&#8221; means a Director who either (i) is not a current employee of the Company or an &#8220;affiliated corporation&#8221; (within the meaning of Treasury Regulations promulgated under Section 162(m) of the Code), is not a former employee of the Company or an &#8220;affiliated corporation&#8221; who receives compensation for prior services (other than benefits under a tax-qualified retirement plan) during the taxable year, has not been an officer of the Company or an &#8220;affiliated corporation,&#8221; and does not receive remuneration from the Company or an &#8220;affiliated corporation,&#8221; either directly or indirectly, in any capacity other than as a Director, or (ii) is otherwise considered an &#8220;outside director&#8221; for purposes of Section 162(m) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(ii)&#160;</b>&#8220;<b><i>Own,</i></b>&#8221;<b><i> </i></b>&#8220;<b><i>Owned,</i></b>&#8221;<b><i> </i></b>&#8220;<b><i>Owner,</i></b>&#8221;<b><i> </i></b>&#8220;<b><i>Ownership</i></b>&#8221;<b> </b>means a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(jj)&#160;</b>&#8220;<b><i>Participant</i></b>&#8221; means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(kk)&#160;</b>&#8220;<b><i>Performance Cash Award</i></b>&#8221; means an award of cash granted pursuant to the terms and conditions of Section 6(c)(ii).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(ll)<i> &#8220;Performance Criteria</i></b>&#8221; means the one or more criteria that the Board or the Committee will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Board or the Committee: (i) earnings (including earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii) earnings before interest, taxes, depreciation and amortization; (iv) earnings before interest, taxes, depreciation, amortization and legal settlements; (v) earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (vi) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (vii) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue; (viii) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation, other non-cash expenses and changes in deferred revenue; (ix) total stockholder return; (x) return on equity or average stockholder&#8217;s equity; (xi) return on assets, investment, or capital employed; (xii) stock price; (xiii) margin (including gross margin); (xiv) income (before or after taxes); (xv) operating income; (xvi) operating income after taxes; (xvii) pre-tax profit; (xviii) operating cash flow; (xix) sales or revenue targets; (xx) increases in revenue or product revenue; (xxi) expenses and cost reduction goals; (xxii) improvement in or attainment of working capital levels; (xxiii) economic value added (or an equivalent metric); (xxiv) market share; (xxv) cash flow; (xxvi) cash flow per share; (xxvii) cash balance; (xxviii) cash burn; (xxix) cash collections; (xxx) share price performance; (xxxi) debt reduction; (xxxii) implementation or completion of projects or processes (including, without limitation, clinical trial initiation, clinical trial enrollment and dates, clinical trial results, regulatory filing submissions, regulatory filing acceptances, regulatory or advisory committee interactions, regulatory approvals, and product supply); (xxxiii) stockholders&#8217; equity; (xxxiv) capital expenditures; (xxxv) debt levels; (xxxvi) operating profit or net operating profit; (xxxvii) workforce diversity; (xxxviii) growth of net income or operating income; (xxxix) billings; (xl) bookings; (xli) employee retention; (xlii) initiation of studies by specific dates; (xliii) budget management; (xliv) submission to, or approval by, a regulatory body (including, but not limited to the U.S. Food and Drug Administration) of an applicable filing or a product; (xlv) regulatory milestones; (xlvi) progress of internal research or development programs; (xlvii) acquisition of new customers; (xlviii) customer retention and/or repeat order rate; (xlix) improvements in sample and test processing times; (l) progress of partnered programs; (li) partner satisfaction; (lii) timely completion of clinical trials; (liii) submission of pre-market approvals and other regulatory achievements; (liv) milestones related to research development (including, but not limited to, preclinical and clinical studies), product development and manufacturing; (lv) expansion of sales in additional geographies or markets; (lvi) research progress, including the development of programs; (lvii) strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property); and (lviii) and to the extent that an Award is not intended to comply with Section 162(m) of the Code, other measures of performance selected by the Board or the Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(mm)<i> &#8220;Performance Goals</i></b>&#8221; means, for a Performance Period, the one or more goals established by the Board or the Committee for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board or the Committee (i) in the Award Agreement at the time the Award is granted or (ii) in such other document setting forth the Performance Goals at the time the Performance Goals are established, the Board or the Committee will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally accepted accounting principles; (4) to exclude the effects of any statutory adjustments to corporate tax rates; (5) to exclude the effects of any &#8220;unusual or infrequently occurring items&#8221; as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures; (7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8) to exclude the effect of any change in the outstanding Ordinary Shares of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to Ordinary Shareholders other than regular cash dividends; (9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles; and (12) to exclude the effect of any other unusual, non-recurring gain or loss or other extraordinary item. In addition, the Board or the Committee retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(nn)&#160;</b>&#8220;<b><i>Performance Period</i></b>&#8221; means the period of time selected by the Board or the Committee over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to and the payment of a Stock Award or a Performance Cash Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board or the Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(oo)&#160;</b>&#8220;<b><i>Performance Stock Award</i></b>&#8221; means a Stock Award granted under the terms and conditions of Section 6(c)(i).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(pp)<i> &#8220;Plan</i></b>&#8221; means this UroGen Pharma Ltd. 2017 Equity Incentive Plan, as it may be amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(qq)&#160;</b>&#8220;<b><i>Restricted Stock Award</i></b>&#8221; means an award of Ordinary Shares which is granted pursuant to the terms and conditions of Section 6(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(rr)&#160;</b>&#8220;<b><i>Restricted Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(ss)&#160;</b>&#8220;<b><i>Restricted Stock Unit Award</i></b>&#8221;<b><i> </i></b>means a right to receive Ordinary Shares which is granted pursuant to the terms and conditions of Section 6(b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(tt)&#160;</b>&#8220;<b><i>Restricted Stock Unit Award Agreement</i></b>&#8221;<b><i> </i></b>means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(uu)&#160;</b>&#8220;<b><i>Rule 16b-3</i></b>&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(vv)&#160;</b>&#8220;<b><i>Securities Act</i></b>&#8221; means the Securities Act of 1933, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(ww)&#160;</b>&#8220;<b><i>Stock Appreciation Right</i></b>&#8221; or &#8220;<b><i>SAR</i></b>&#8221;<b><i> </i></b>means a right to receive the appreciation on Ordinary Shares that is granted pursuant to the terms and conditions of Section 5.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(xx)&#160;</b>&#8220;<b><i>Stock Appreciation Right Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(yy)&#160;</b>&#8220;<b><i>Stock Award</i></b>&#8221; means any right to receive Ordinary Shares granted under the Plan, including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right, a Performance Stock Award or any Other Stock Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(zz)&#160;</b>&#8220;<b><i>Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(aaa)&#160;</b>&#8220;<b><i>Subsidiary</i></b>&#8221; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding ordinary shares having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(bbb)&#160;</b>&#8220;<b><i>Ten Percent Stockholder</i></b>&#8221; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b>(ccc)</b>&#160;&#8220;<b><i>Transaction</i></b>&#8221; means a Corporate Transaction or a Change in Control.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><img alt="proxycardfront.jpg" src="proxycardfront.jpg"/></div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<div><img alt="proxycardback.jpg" src="proxycardback.jpg"/></div>
</div>
</div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</div>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>urgn-20251231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 01:11PM UTC 2026-04-30--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2026" xmlns:currency="http://xbrl.sec.gov/currency/2026" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2026" xmlns:exch="http://xbrl.sec.gov/exch/2026" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2026" xmlns:sic="http://xbrl.sec.gov/sic/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:srt-types="http://fasb.org/srt-types/2026" xmlns:stpr="http://xbrl.sec.gov/stpr/2026" xmlns:urgn="http://www.urogen.com/20251231" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:us-types="http://fasb.org/us-types/2026" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.urogen.com/20251231">
  <xsd:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei-sub/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-sub-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd-sub/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-sub-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/exch/2026" schemaLocation="https://xbrl.sec.gov/exch/2026/exch-2026.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/currency/2026" schemaLocation="https://xbrl.sec.gov/currency/2026/currency-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/country/2026" schemaLocation="https://xbrl.sec.gov/country/2026/country-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/naics/2026" schemaLocation="https://xbrl.sec.gov/naics/2026/naics-2026.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2026" schemaLocation="https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/sic/2026" schemaLocation="https://xbrl.sec.gov/sic/2026/sic-2026.xsd"/>
  <xsd:import namespace="http://fasb.org/us-types/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:import namespace="http://fasb.org/srt-types/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd"/>
  <xsd:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="urgn-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="urgn-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="urgn-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="statement-document-and-entity-information" roleURI="http://www.urogen.com/20251231/role/statement-document-and-entity-information">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" name="DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" name="DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" name="IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>urgn-20251231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 01:11PM UTC 2026-04-30--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#PvpAdjustmentsOnly" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember" xlink:type="locator"/>
    <link:loc xlink:href="urgn-20251231.xsd#urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:label="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:type="locator"/>
    <link:loc xlink:href="urgn-20251231.xsd#urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:label="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:type="locator"/>
    <link:loc xlink:href="urgn-20251231.xsd#urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:label="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:type="locator"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:type="arc"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>urgn-20251231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 01:11PM UTC 2026-04-30--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="urgn-20251231.xsd#urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:label="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:type="locator"/>
    <link:label xlink:label="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deduction for Amounts Reported under the Stock Awards Column in the SCT [Member]</link:label>
    <link:label xlink:label="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deduction for amounts reported under the stock awards column in the SCT.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:to="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember-label" xlink:type="arc"/>
    <link:loc xlink:href="urgn-20251231.xsd#urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:label="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:type="locator"/>
    <link:label xlink:label="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Based Upon Incremental Fair Value of Awards Modified During Year [Member]</link:label>
    <link:label xlink:label="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the increase based upon incremental fair value of awards modified during year.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:to="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember-label" xlink:type="arc"/>
    <link:loc xlink:href="urgn-20251231.xsd#urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:label="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:type="locator"/>
    <link:label xlink:label="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deduction for Amounts Reported under the Option Awards Column in the SCT [Member]</link:label>
    <link:label xlink:label="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the deduction for amounts reported under the option awards column in the sct.</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:to="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember-label" xlink:type="arc"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>urgn-20251231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 01:11PM UTC 2026-04-30--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#PvpDisclosure" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember" xlink:type="locator"/>
    <link:loc xlink:href="urgn-20251231.xsd#urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:label="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:type="locator"/>
    <link:loc xlink:href="urgn-20251231.xsd#urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:label="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:type="locator"/>
    <link:loc xlink:href="urgn-20251231.xsd#urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:label="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:type="locator"/>
    <link:presentationArc order="310" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember" xlink:type="arc"/>
    <link:presentationArc order="311" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember" xlink:type="arc"/>
    <link:presentationArc order="312" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember" xlink:type="arc"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#AwardTimingDisclosure" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ceodirectcomp.jpg
<TEXT>
begin 644 ceodirectcomp.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )9!"<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1\^"YRD;A681 H<2H3@-T;K@9XGPM^U[KWBWP]XVU:Q^'430^$1YFH Z[]Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".X65K>40
M.D<Y4B-Y$+JK8X)4$$C/;(SZBO%O@%^SSJ?P.UKQ!='Q7;:W9ZW()[FW_LEK
M=UE!8J4?SW 7YVR"ISQR,<^VT4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[^_ATRU:XN&98@RK
M\B,[$LP50%4$DDD#@=ZH_P#"36?_ #QU#_P6W'_QNCQ-_P @Z'_K]M/_ $HC
MK6H R?\ A)K/_GCJ'_@MN/\ XW1_PDUG_P \=0_\%MQ_\;K6HH R?^$FL_\
MGCJ'_@MN/_C='_"36?\ SQU#_P %MQ_\;K6HH R?^$FL_P#GCJ'_ (+;C_XW
M1_PDUG_SQU#_ ,%MQ_\ &ZUJ* ,G_A)K/_GCJ'_@MN/_ (W1_P )-9_\\=0_
M\%MQ_P#&ZUJ* ,G_ (2:S_YXZA_X+;C_ .-T?\)-9_\ /'4/_!;<?_&ZUJ*
M,G_A)K/_ )XZA_X+;C_XW1_PDUG_ ,\=0_\ !;<?_&ZUJ* ,G_A)K/\ YXZA
M_P""VX_^-T?\)-9_\\=0_P#!;<?_ !NM:B@#)_X2:S_YXZA_X+;C_P"-T?\
M"36?_/'4/_!;<?\ QNM:B@#)_P"$FL_^>.H?^"VX_P#C='_"36?_ #QU#_P6
MW'_QNM:B@#)_X2:S_P">.H?^"VX_^-T?\)-9_P#/'4/_  6W'_QNM:B@#)_X
M2:S_ .>.H?\ @MN/_C='_"36?_/'4/\ P6W'_P ;K6HH QYO%=A;Q/+*E]'$
MBEF=].N % Y))V<"MBLGQ9_R*NL_]>4W_H!K6H **** "BBB@ HHHH ****
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MEV$J8APG337+^ISXC%5X4E*,G>_Z'M4'[?'BY?\ 7>'=$D_W/.7^;FMO3/\
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ML_?"CQCX'^(VOZGKT7DVT]I-#<WGVA'_ +8N6OIIHKC"L6_=PL$S*%8;]H!
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MUX'\;/\ DL7CC_L-WG_HYZ]\\)?\C7HO_7[#_P"C%KP/XV?\EB\<?]AN\_\
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MU";48I;^Y?\ LV?5$Q;RQFXM]TWDEU!CB6260D*[_NF48;@O"GPU\:Z/X?\
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M **** "BBB@ HHHH R?%G_(JZS_UY3?^@&M:LGQ9_P BKK/_ %Y3?^@&M:@
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M]>4W_H!K6K!U'2=8U/3[FSEU*Q6*XB:)BE@X8!@0<?ONO-;U !1110 4444
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M***\ ],**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?$9ACGB9<D/@7XGT.&PRHKFE\04445XYW!1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:LGQ-_R#H?\ K]M/_2B.@#6HJ"]O;?3;.>[NYXK6TMXVEFGF<(D:*,LS,>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %9/B;_D'0_]?MI_Z41UK5D^
M)O\ D'0_]?MI_P"E$= &M1110!6U&UEO;"XMX;R;3Y94*)=6P0R1$C[RAU9<
MC_:4CU!KB-6^#EGJ_P /M'\)OKVL00Z7/!<P:G!]F%Z7A??&Q<PE00V"650Q
MQR3N;=V>M:O;^']&O]4O&*VEE;R7,S*,D(BEFP/H#7SWXV^,^O\ C7X0^,KF
MVTG6O!LMKID.HV6K6J7,2S*S\Q>9/;1;7 VD^5N&'^60X- 'L_A[P!%X=\5:
MKKL6L:C=3ZI#"EY;W @\J:6*-(UG.V)6#[4P0&"<GY!QB!?AND7CK7/%4&OZ
MK;7VJV$>GM @MC# L8;RWC#0EMRL\C?.S ESD$!0.8O_ (Z7"?$&;P_I?A/4
MM=L+2_73+N^L8+EFBG,0?(_<?9]BEXU8O<(PRQV[0"V'H?[17B#7[;0Y8/ *
MQ-KMK>SZ>DVM(#FU=!+YQ$1V(0YVLN]BRX* '=0!T%C^SWIEGX<TGP_)XDU^
M]T'3_)']G7+VK13B*8S1[L0!E(8XW1E&("@D[1AWA_X V7AOQ/;Z_:>*?$']
MHQWEU=RNWV,"Y%Q(DDT,NVV&Z-G3( P5+$J5.",#5/VF7&E^'KC0_"&HZ]>:
MEHL&N3Z?;)<2RPPRL51$,%O*K.2DF/,,2G:/FYP+H^/]^WBF\L/^$0E@TJS\
M1VWAZ6_N;]4E9KA8S%*D(1CCYP65V0JK)U8ND8!VOBKX<P^)/$-AKUKK6J>'
M=:LX)+5;W2FA)E@<AC'(DT<B,-P##Y<@]#7G/Q:^#FH6^BWEQX1DU_4KC4-1
MTVXO=#BN;,VURUO+"6N)&N0'$AC@4%DE!=Q&6!&XUV'P6\8>)/&6G>(;CQ%:
MV%LUIK=[80?8;IIL+#.\90YBCX7: &Y+Y)(3I7HM 'E]S\!=)U37HM6EUCQ!
M;0#6!XA&CQ7444$=X4VLVY$\P@C.5\PC).."<ML?@9:Z!#:W=MXB\0W>I6&J
M7>M0W'^@^?)-<!O/BP8%CVR%F/(!!/#* ,>I44 <7\/O#C6>I^)/$=QI,VAW
MNOW,<KV$\J/)&D42QJ7\MWC#L0['8Q&&7/S9I?$'PR@UGQ-+KMEKNL>'KZYM
M$L;W^R9(E6\A1F9!)YD;E67?(!)&4<!S\W QV=% 'GO_  I325U^YU"+4]5A
MLKC4O[9;1UDB-F+['%P T9D#;@)-N_87&2IK+T;]GVVT%M":T\9>)%?1)+R6
MS9A8G8UR29L_Z+SDLQ&>F?3 'JU% 'SY:_!#5_#WCWPOI.CZCXIM?#6FZ#>:
M</$=O<:<)HFEECD6)E9,E,1,-PA+!FC(;@E?0(O@GI.E:E%=>']5U?PM#]A@
MTZXLM)FC$-S!""(U?S(W96"DKYD;(^#][.#7H=% 'ED'P!M;>[M)QXN\1,;;
M79/$2HPLMK7;JRL3BVSM*NXV@C[Y[@$1ZC^SKH^M07?]IZ]K>I7TXLT&H79M
M7F2.VD,D2,/(V3#<3DSK(QXR>*]7HH \OTOX"VFD3V5S;^*O$'V^TU*ZU2.\
M861D\RYS]H4C[-LV.221MR"?E*C INE_ #3]%L-(2Q\2Z_;ZGI5U=W%IK"FT
M^THMTQ>XA*FW\IXV=B^&C)#8VD  #U*B@#RBZ_9TT>1)H;37]=TRTFT1] >V
MMFMF4VSL6D^:2!W+NS,Q8MG+'&.*]&\.Z,/#VA6&EB[N+];.%8%N+H)YKJHP
M"VQ57.,=%%:-% !1110 4444 %%%% #)8DGC:.1%D1AAE89!'N*\P\;_  (T
MOQ 9+K2V&FWK<[>L3G^8_7\*]2HK6G5G1ES4W9D3A&:M)7/C;Q3X&UCPA<F/
M4;1XT_AE491A[$<5@5]PWME;ZC;/!=0QSP,/F2100:\'^)/PO\+V:37>F:S:
MZ?,O+6<DH<?08R1^/YU]-A<W4K0KK7NO\CR*V!M[U-GBU%/GB\F5DWJ^/XD.
M0?H:97TB::NCRFK:!7T+^S1;!?#NKW&.7NE3/^Z@/_LU?/5?2G[.483P'<G'
M+7\A_P#'(Q_2O(S9VPK7=H[L$KUD>J4445\.?0A1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+,%Q@ [N+X2K9ZW>:G8>*O$&FO?O#/?V]J]L(;NXC14%PRF E'8(F\1E$?8
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M=30 445E>)7==+41R/$9+FWB+QL5;:TR*V".1D$B@#1GGBMHS)-(D48ZL[
M?B:S3XGL')%L\E^W_3G$TH_[Z4;1^)I\'AO3()!)]CCEE'26?,KC_@39/ZUI
M 8&!P* ,K^T-4N?^/?2Q I_BO9U7_P =3=^I%>"^(/V@/$;W,UO:QVUCY;LF
MY$W$X./XLU](5\3>((_*U[4D/!6YE'_CYKW<JP]*O*7M5>UCS<;5G34>1VN7
MM7\=:_KFX7NJW,R$YV&0[1]!VK$DD>5BSLSL>[')IM%?70I4Z6D(I>AXDIRG
M\3N%%%%:D!7TQ^SL0? $GM>R9_[Y2OF>OI#]F^8/X)O8^Z7[_D8X_P#Z]>+F
MZ_V;YH[\#_&^1ZQ1117Q)]"%%%% !1110 4444 %%%% !117CW@SXV:EK_Q^
M\2^!]0TVUM=#&G?;O#NHQNWFWWV>X>UU%)%)X,4_E!0HY5PV3NP #V&BO.?A
M+\<-'^,.I>+[72M.UBR'AW5&TR234]*NK19RJKN96FB120^\%%9F ",P7S%%
M>&?%G]I+Q_X!^)OQ"\-6GBOP +W1=.M=4\/>%[O0KN35_$)G^T$64 CO]SRC
MR%7S(X'&903&H'(!]<T5Y[<?%;3K+Q+X0T;5M9T[PWK>JZ7/JUSX>O8VENEA
MCC5I&\Y75(5B9B&=U(?!"X()KCM>_:4@U.]\"GP2EO?V&J>*+?0=:76K2\L+
MVP66WDFC M9HHW5V54<&3:-CHP5Q(I !ZWX<\':!X/&HC0=#TW1!J-W)J%Z-
M.M([?[5<OC?/+L WR-@9=LDX&352_P#AQX2U7Q/'XDO?"^BWGB*.-84U>?3X
M7NU122JB8KO !9B!G W'UJGX(^+'AGXA^"G\7:)>74GAQ4:5=0O=.N;))8E0
M/YT8GC0R1%2")4!1N=K'!KRSP1\2?C!\3O =G\1O#FG^%!X>UF)+S1_"E[#.
MFHM9/M\N:2^$WE>:ZYD$'D*HWJAFX,A /H*H+^PMM4L;BRO;>*[L[F-H9K>=
M \<J,,,K*>"I!((/!!KAK_X]>!=,\;1>%+K7#!JLEV-.$KV=Q]A%X8_,%HUY
MY?V=;@I\P@,@D((^7D9Y;2OVR?@]K_DG2?%_]K1W!N([:73M,O+B.[F@D\N2
MW@=(2LT^=K+!&6D='2159'5B >MZ'H6F^&=(L])T?3[72=+LXEAMK&QA6&""
M,# 1$4!54=@!BLCQI\,_!_Q(BM8_%OA30_%,=HYDMTUK3H;P0L>K()%;:>!R
M/2N(U']K'X4Z;!X:<^*UO+CQ)I3:UI.GZ;875Y?7=FI7=(MK#$\P(W$E"@8"
M*<D8AE*:>I_M&?#W2K?0;J37GNK'6K>VN[:_T^PN;NUBM[A_+MYKF>&-H[6*
M1MP62=HU.R3!^1]H!Z):VL-C:PVUM#';V\*".*&)0J(H& J@<  #  J6O+-'
M_:@^&'B'Q?'X9TOQ7#J.JOJLNB'[+:SR6T=]'&TAMWN1'Y*2%4?8&<;RCA-Q
M4@3O^TA\/8[77KA]:N$716C%TC:7>"202S_9X'MXS%NNDEFS'$\ D65@1&6(
M. #TRBO%;O\ :S\%'5/ MIID.NZNOBK5;S2$>WT#4!)8S6R3><MQ$;?S(G62
M(*8W56"L93B-2U:NE?M">#G\+2Z^_BFW\1:?<:U=Z5IY\.Z1=W$US)"SAH(8
M(O.ENGC6.1FEA7851I %0$T >JT5X[J7[7OPATR+12WC."\N-9TN36K"QTVT
MN+V\N+2-]DCBWAC>4%&$FY"H=1!<$J!!*4]5T36K'Q'HUAJVF74=]IM_;QW5
MK=0G*31.H9'4]P5((^M %VBBB@ HHHH **** "BBB@ HHHH QO%?_((;_?6N
M*KL_%K;=* _O2 ?H:XRO2P_P')5^(****Z3(**** "O3J\SC7=(H]2!7IE<.
M)Z'12ZA1117$= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMT_O2;OR'_UZY*NB\93;KFWB_NH6_,__ %JYVO4HJT$<=3XF%%%%;F84444
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !113)I5@A>1N%12Q^@H
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MR[/OMOPEGQ?\)/%/B_Q#\0B_]D6&F>(K"RMK2Z2\EEGADM'EDB:2$P*I5VD
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MX("9+\#N?"WB_2O&=G<7.DSRS1VTYMIUGMI;>2*4*K%&21596 =<@CC..H-
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M.\=?EU._!U?9U.5[,^CZ***^(/H0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KZA=K8V
M<L[?P+P#W/85YV[M([,QRS'))[FM_P 6:EYUPMHA^2/E\=V_^M_6N>KTJ$.6
M-WU.2I*[L%%%%=)D%%%% !6SX5M/M&IB0C*PJ6_'H/\ /M6-7:^%;/[-IHD(
MP\QW?AV_S[UA6ERP9I35Y&S1117EG8%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %9/B;_ )!T/_7[:?\ I1'6
MM63XF_Y!T/\ U^VG_I1'0!K4444 %%%% !1110 4444 %%%% !1110 4444
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M"WA:XE2XMY?*0J&8),CM@L0,X4]36G10!D_VS>?] '4/^_EO_P#':/[9O/\
MH ZA_P!_+?\ ^.UK44 9/]LWG_0!U#_OY;__ !VC^V;S_H ZA_W\M_\ X[6M
M10!D_P!LWG_0!U#_ +^6_P#\=H_MF\_Z .H?]_+?_P".UK44 9/]LWG_ $ =
M0_[^6_\ \=H_MF\_Z .H?]_+?_X[6M10!D_VS>?] '4/^_EO_P#':/[9O/\
MH ZA_P!_+?\ ^.UK44 9/]LWG_0!U#_OY;__ !VC^V;S_H ZA_W\M_\ X[6M
M10!D_P!LWG_0!U#_ +^6_P#\=H_MF\_Z .H?]_+?_P".UK44 9/]LWG_ $ =
M0_[^6_\ \=H_MF\_Z .H?]_+?_X[6M10!D_VS>?] '4/^_EO_P#':/[9O/\
MH ZA_P!_+?\ ^.UK44 9/]LWG_0!U#_OY;__ !VC^V;S_H ZA_W\M_\ X[6M
M10!D_P!LWG_0!U#_ +^6_P#\=H_MF\_Z .H?]_+?_P".UK44 9/]LWG_ $ =
M0_[^6_\ \=H_MF\_Z .H?]_+?_X[6M10!D_VS>?] '4/^_EO_P#':/[9O/\
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M3P]1TYGTU*I&K'FB%%%%<YJ%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%87B'7A9HUM V;AAAF'\ _QJXQ<W9$M
MJ*NREXFUOS"UG WRCB1AW]JYNEZTE>K""@K(XY2<G=A1115DA1110 5/96CW
MUU' GWG.,^@[FH*Z[PII?D0&[D'SR#" ]E]?QK*I/DC<N$>9V-RW@2V@CBC&
M$0!14E%%>2=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK?4_TK'HHKOC%15D<S;>K"BBBJ$%%%% !1110 O6NR\.:+]@B\^9?W[C@'^
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MFOAYXYTWXA^&8M6TQ+F&$2RVLMO> ">"6)RCH^&8;@5ZAB#P<G-=+0 4444
M%9/BS_D5=9_Z\IO_ $ UK5D^+/\ D5=9_P"O*;_T T :U%%% !1110 4444
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MD8NVV%F!B#H<@;LY C\-_M%^'?$*V%Q+INM:+I=_'=O:ZGJMHL4$K6P9IHP
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MY557))/0 #@ 5TE%% !1110 5D^+/^15UG_KRF_] -:U9/BS_D5=9_Z\IO\
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M3T/_ * VG_\ @*G^%:U% &3_ ,(GH?\ T!M/_P# 5/\ "C_A$]#_ .@-I_\
MX"I_A6M10!D_\(GH?_0&T_\ \!4_PH_X1/0_^@-I_P#X"I_A6M10!D_\(GH?
M_0&T_P#\!4_PH_X1/0_^@-I__@*G^%:U% &3_P (GH?_ $!M/_\  5/\*/\
MA$]#_P"@-I__ ("I_A6M10!D_P#")Z'_ - ;3_\ P%3_  H_X1/0_P#H#:?_
M . J?X5K44 9/_")Z'_T!M/_ / 5/\*/^$3T/_H#:?\ ^ J?X5K44 9/_")Z
M'_T!M/\ _ 5/\*/^$3T/_H#:?_X"I_A6M10!D_\ ")Z'_P! ;3__  %3_"C_
M (1/0_\ H#:?_P" J?X5K44 9/\ PB>A_P#0&T__ ,!4_P */^$3T/\ Z VG
M_P#@*G^%:U% &3_PB>A_] ;3_P#P%3_"C_A$]#_Z VG_ /@*G^%:U% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5GWGA[2M1S]KTVSNL]?.@1\_F*T**:;
MCJF)I/<Y2Y^%7A*[)+Z#:+G_ )Y*8_\ T$BG:)\,?#?AR^DO--T[[+</$T+,
M)I&!5NHPS$=JZFBMO;UFN7G=O5D>SA>_*C(_X1;3_P#GDW_?9H_X1;3_ /GF
M_P#WV:UZ*CVD^Y7+'L9:^&M.7_EWS]7;_&IDT.P3I:Q_B,_SJ]12YY/J'*NQ
M%%:PP?ZN)(_]U0*EHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>lbsig.jpg
<TEXT>
begin 644 lbsig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  U *4# 2(  A$! Q$!_\0
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M-PB)A&DO9"C*[+^[=X$4[0OW\5K^(+?QAXDT*'PIXW\!>(/!?P]MK6.V73?
MUX-1FNE" ;9IXBLJ1KC&Q(R6_B;'%?5=+0!X;X4^-7PJ\ Z8-+TJSUO2$CP)
M(G\,ZEYK,!C+L8"7; QDDU#XT^-1\<>$M3LO#7PF\1^.UFB*BVUK2SI]C,#G
MEFN0I8=\*A/TKWBB@#P']D3X6:]\/_#_ (DU3Q1#/!J^MWZR10W;;I+:TCC"
MQ6ZYDD*1(3)L0N2 >>3@>_444 %%%% !1110 4444 %%%% !1110 4444 %%
9%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>netincomegraph.jpg
<TEXT>
begin 644 netincomegraph.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (K Y,# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:@#:HID4J3Q)+$ZR1NH970Y# ]"#W%/H **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)?F9:T]M4?8=%>;?!+X^^%OCMH'VW0KGRK^%5-YI5P0+BV8^H_B7/1QP?8Y
M])KG:<79FJ::N@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#B_B1\9/!_PC73SXLU?^R1J!D%M_HTTWF;-N_P#U:-C&]>N.M<3_ ,-F?!W_
M *'#_P IEY_\9KQC_@H__J/A]_O7_P#*WKXHK[;+LDP^,PL*]24DW?9KHVNQ
M\]BLPJT*TJ<4K+U[>I^GW_#9GP=_Z'#_ ,IEY_\ &:/^&S/@[_T.'_E,O/\
MXS7Y@T5Z7^K>$_FE]Z_R.7^UJ_9?C_F?I]_PV9\'?^AP_P#*9>?_ !FC_ALS
MX._]#A_Y3+S_ .,U^8-%'^K>$_FE]Z_R#^UJ_9?C_F?J5HO[6GPI\0ZQ8:5I
M_BK[1?WT\=K;Q?V==KOD=@JKEH@!DD#)(%>O5^1'P8_Y+#X%_P"P]8?^E"5^
MN]?+YOE]++YPC2;=UUM^B1[&!Q4\5&3FEIV"BBBOGSTPHHHH **** "BBB@
MHHHH *Q?%GA2T\8:?;6MW)-;M;7D%]!<6Q42130R*Z$;@1SMVD$$%68=ZVJ*
M "BBB@#/U_0;'Q1H]SI6IP?:;"Y79-#O9!(N0=I*D'!Q@CH1D'()%:%%% !3
M74NC*&*$C 9<9'OS3J* ,;P?X5L_!/AG3]#L&EDMK./8);A@TLK$EGD<@ %F
M8LQ( &6. .E;-%% !1110 4444 %%%% !1110 4444 %%%% !117/>._ NF_
M$;P^^B:Q)?IILLBO-'IU_-9/,%.=C20LK[#W4, PX.02" 2W_CGPWI=_]AO?
M$&EV=[D#[-/>QI)D\ ;2V:VD=9$5T8,K#(8'((]:^-/$WACX'Z!-<>&_"G[/
M/@;Q;XL;Q"_AS3](O+*QBFNGCM1<W-S+-)#(\44:%OG8,6;;@?.I/M?[-W@3
MP1I/A"Q\5^!]"N_"%CKUFDD_AY;V5K.UE!.X);[S#&ZL&4O$%# 9Y&* /8J*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ^:OC9^RQ=7'B!?B!\)[P>%/'=NQEDA@81V]^3]X$?=
M5F[Y&QOXAR6K4^ ?[5%KX_U ^#O&EI_PBGQ%M&,$VGW*F..Z<#DQ;NC'KL//
M=2PZ?0->0_'S]FSP[\<M,$TO_$G\4VJ@V.NVRXEC(Y57QC>F>V<CJ".<[QFI
M+EJ?>9.+B^:!Z]17R5\.?VC?$WP6\3Q?#WXY*8)3\NF^*Q\T-RF< RO_ !#I
M^\ZC^,#EJ^L8)X[F&.:&198I%#I(C!E92,@@CJ#43@X;E1DI;$E%%%9EA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=  ?8=%?/G[-GP[\*V_FZ]X8TCQ3\.+S3KJ;3-8\$W6MM=6,5PJ [3#YLT(
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MK\_XF_BT_1_F?3Y1\$_4****^,/>"BBB@ HHHH **** "BBB@ HHHH ****
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M/'%=Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP3]0HHHKXP]X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN=IQ=F:IIJZ"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8? O_8>L/_2A*_7>OS_B;^+3]'^9]/E'P3]0HHHKXP]X**** "BBB@ HHHH
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MO_#IM(L2L)1;_:YHH6DB7$:)'$LF J%CU>OHR@ HHHH **** "BBB@ HHHH
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M^K9'_P B^G\__2F?%YC_ +U/Y?D@HHHKW3S@HHHH ['X,?\ )8? O_8>L/\
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M9=Q(7;&6W-D@@8'.#5W6]=TWPUIDVI:OJ%KI6G0[?-N[V=88H\L%&YV( R2
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M>^%]&DUV^GT/P[J4BM<Z5I[N#%;NJNXBYWN(MQV*ZKQC ]NH **** "BBB@
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MT>Q\0:7=:;J=I#?Z?=1F*>VN$#QR(>H(/45<HH ^,O%'P_\ %G[%WB.Y\8^
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M&?4=%%%?F!]@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^K9'_P B^G\__2F?%YC_ +U/Y?D@HHHKW3S@HHHH ['X,?\ )8? O_8>L/\
MTH2OUWK\B/@Q_P EA\"_]AZP_P#2A*_7>OS_ (F_BT_1_F?3Y1\$_4****^,
M/>"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD[]I+Q1I
M_P .?C!_:OA?XC:GX4\?:KHMO!J>D:;X-N/%"7%C#-,;>XE@@VM 5>:=%<N
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ML HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN]?D1\&/^2P^!?\ L/6'_I0E?KO7Y_Q-_%I^C_,^GRCX)^H4445\8>\%%%%
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M_P!X7HSZCHHHK\P/L HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXDG)SGFMN?2[.ZOK6]FM();RU#BWN)(U:2$. '",1E=P !QUP,U:HH Y"_\
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M 3D@4FJ?!+P7J\%C!-HQAM[.R&FQP65W/:QO:@Y$$JQ.HECSD[) PY;CYCD
MW? NK7.O>"?#^IWH"WE[IUO<S@+MQ(\:LW';DGBMRF11)!$D42+'&BA51!@*
M!T '84^@ HHHH **** "BBB@#C?C/_R1[QU_V ;_ /\ 2=Z_(FOUV^,__)'O
M'7_8!O\ _P!)WK\B:_0.&?X-3U7Y'S&;_'#T"BBBOLSP0HHHH *_07_@GG_R
M1[7/^P]+_P"D]O7Y]5^@O_!//_DCVN?]AZ7_ -)[>OF^(/\ <7ZH]7+/]X7H
MSZCHHHK\P/L HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YOX@_#
MS0/BCX7N_#_B.P2_TZX'1N'B?L\;=58=B/IR"17244TVG=":ON?%FE>(_&W[
M$'B"#1?$AN?%?PANIO+LM312TNG;CD*1_">N4Z-R4P=RU]A>'O$.F^+-%L]7
MT>]AU'3+R,2P7-NVY'4^G\B#R""#S3M>T'3O%&C7>DZM90ZAIMW&8I[:X7<D
MBGL1_G!YKX\UKPAXT_8D\07'B+PF;GQ1\)[J;?J&C2.6EL,G[P/;'02=#P''
M1JZ-*WE+\_\ @F.M/T_(^TJ*YCX=?$GP]\5?"]MK_AO4$OK"888#B2%\<QR+
MU5AZ'ZC((-=/7.TT[,V3OJ@HHHI#"BBB@#XN_P""C_\ J/A]_O7_ /*WKXHK
M[7_X*/\ ^H^'W^]?_P K>OBBOU;(_P#D7T_G_P"E,^+S'_>I_+\D%%%%>Z><
M%%%% '8_!C_DL/@7_L/6'_I0E?KO7Y$?!C_DL/@7_L/6'_I0E?KO7Y_Q-_%I
M^C_,^GRCX)^H4445\8>\%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %?)7[3_B.\?XD-I^C?#[X;:W/8IHEO?:SX[M3-(/[2O9K6W6,*A(
MC1XR2S/U?:JDYKZUKYM^,\/BCXI?%O7/AQX;T/P+;VZ>%[:XU75O&FDRZA)J
M-O<7$ZK:PQ1R19B1K?<[,YVM*F%!PU '8_LPWM[)X+UW3=4T'POX;U?1M=NM
M-O+'P?:F#3]Z",JZ \L61T)) (SM(!4U[#7BO[)$]M!\*[G0K?PQH?A1O#>L
M7VB7%MX9##3)YH9<23V^[YMK,3N#$LKJZDDJ37M5 !1110 4444 %%%% !11
M10 4444 ?$WCGX4Z)\:OBS\0[G1O@)H_BYM,U)=)U36O$'CJ\TJ2[N1!'*RI
M;10S 1!)TP25W;B0N.3] ? 7X">%?A%I0U#2/!MMX-UW4+9(M0LK+6+G48(]
MI)"))+MW ?W@BGGI7S%XRT+P[_POGXI7_CCPI\;=4O[O4X!8:KX'T_6H=/EL
M4MHUCB!M BNT;B;+DN"'!#=57[)^$L>GQ?#?P\FDVNN66G"U7R+?Q*+@:BB\
M\7 N"9=_KO.: .MHHHH **** "BBB@ HHHH **** "BBB@ HHHH XWXS_P#)
M'O'7_8!O_P#TG>OR)K]=OC/_ ,D>\=?]@&__ /2=Z_(FOT#AG^#4]5^1\QF_
MQP] HHHK[,\$**** "OT%_X)Y_\ )'M<_P"P]+_Z3V]?GU7Z"_\ !//_ )(]
MKG_8>E_])[>OF^(/]Q?JCU<L_P!X7HSZCHHHK\P/L HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "HYX([J&2&:-989%*/&ZAE92,$$'J"*D
MHH ^0/B-\"O$_P"SEXGN?B3\&P\VED[]8\)<M&\6<L8U'51R<#YD_AR,J/>/
M@E\>?#'QV\-C4=#N/*OH547NESL//M7/J/XE)SAQP?8Y ]'KY@^-W[,VIZ/X
MD/Q,^#\O]A^,[9FFNM,APL&H@\N OW0S=U/RO[-R>E2572>_?_,Q:<-8[=CZ
M?HKQ3]GK]IO2/C7;RZ5>P'P_XVL05OM%N,JQ*\,\6[D@'JI^9>A[$^UUA*+@
M[,T34E=!1114E'Q=_P %'_\ 4?#[_>O_ .5O7Q17VO\ \%'_ /4?#[_>O_Y6
M]?%%?JV1_P#(OI_/_P!*9\7F/^]3^7Y(****]T\X**** .Q^#'_)8? O_8>L
M/_2A*_7>OR(^#'_)8? O_8>L/_2A*_7>OS_B;^+3]'^9]/E'P3]0HHHKXP]X
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^2OV@O!6B_%
M?X\R:#:?!VR^('B31]!M[V[U76O%USHD%O;W$TR110K#'*9"6MI"Y"*!M0$D
MX ^M:^+_ -I/1=+O?VF4U#QAX=^*FO:'#X7@MM)N?AWI^IA+*=KF5KI)IK,*
M9#*HMBHWD+Y+;E&49@#U']GG]F3PG\.98/$C?#/3/ 'BJW>:*&#2/$EYJL A
M=<%MTJQ+EMS94Q\8SG)X]_KRO]FV#0;?X=,OAW3O&NEV'VV4F#QZM\NH[\+D
MXO"9/+QC&#MX;'.:]4H **** "BBB@ HHHH **** "BBO.OVB]8\1^'_ ($^
M.]2\)?:!XCM=(N);)[.(2SHX0_/&A!#.HRRJ0<D 4 ?,GQ \3^!9/BW\24^,
MOQ<\3?#W6M,U!1X9T^RUZYTJ"/3OLL317-K%$0MV[2F;<2)#N385P,'Z<_9W
MUOQ)XD^!G@;5/%ZSKXEN])MY;XW4'D3.Y0?/)'@;'889EP,%B,#&*S9?C/\
M">^^&$/B>7Q_H<WAF*RWQZ[)J49D1=GWPY.X3<=,;]PQC/%7OV;]=\0>)_@+
MX"U;Q2T\FOWFCV\UU+=1"*:5B@(DD0 !79=K%<#!8C H ](HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH XWXS_P#)'O'7_8!O_P#TG>OR)K]=OC/_ ,D>
M\=?]@&__ /2=Z_(FOT#AG^#4]5^1\QF_QP] HHHK[,\$**** "OT%_X)Y_\
M)'M<_P"P]+_Z3V]?GU7Z"_\ !//_ )(]KG_8>E_])[>OF^(/]Q?JCU<L_P!X
M7HSZCHHHK\P/L HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH **** "BBB@#C?C/_R1[QU_V ;_ /\ 2=Z_(FOUV^,__)'O'7_8!O\
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MZ&U#^)$^G:***^"/?"BBB@ HHHH **** "BBB@ HHHH *\8_;&_Y-O\ &/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUO\ 9F_Y'Z\_[!TG_HR*N''?[M/T-J'\2)].T445\$>^%%%% !1110 4444
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M7(['#"M&@ HHHH **** "BBB@#C?C/\ \D>\=?\ 8!O_ /TG>OR)K]=OC/\
M\D>\=?\ 8!O_ /TG>OR)K] X9_@U/5?D?,9O\</0****^S/!"BBB@ K]!?\
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M(/V8O^1&U'_L(O\ ^BHZ]?KX+'?[S/U/>H?PXA1117";A1110 4444 %%%%
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M?V+IW_/A:_\ ?E?\*NT4 4O[%T[_ )\+7_ORO^%']BZ=_P ^%K_WY7_"KM%
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M*/[%T[_GPM?^_*_X5=HH I?V+IW_ #X6O_?E?\*/[%T[_GPM?^_*_P"%7:*
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M&=&6ZTN,16$ZV$0>T0$D+$VW,8!)("XZF@#PWX9:EJ_@KX8>&I(?$5W<"_\
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MM);L<M"Q(Y0DG*G@YZ5!J/A#0M7T*+1+_1-.O=%B5$CTZXM(Y+=%3&P",@J
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M(^&/S#)7W'2[I;W3+2X2Z@O4FA207-K_ *J8%0=Z?,WRGJ.3P1R>M<6_P/\
M"CVUY"R:T?MIS=S?\)#J/G7(V; DLOG[W0+D!&)49; &XY[>PL;?2[&WL[2%
M+>UMXUAAAC&%C11A5 [   4 3T444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
61110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>proxycardback.jpg
<TEXT>
begin 644 proxycardback.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0# V # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ'^*/BWPO:>"IH-'\-:G+IMYX@;44,198D>/;$5#%FW$$#(4!3N.[ POB/\
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M]Y6?I^?^;/GO5?V3/[3^&GCWPE_PE7E?\)3XL/BC[9_9V?LN;B&;R-GF_/\
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MC1?#$5E;HRSK*+CRHY068A<$,Q))SN  6O8)OC2FFPVUK::7J'Q!NH-.@O\
M4M3\)6\"V444BDI,HFNLLKA6=8XFF?;CKE27O\?=%GUJ:QTO2=8UNW@T>#7I
M]3L8X1:Q6<R3-$Y:25&);R&&U5+99>,;BMR=FY-[:?))K\KZOS>Z%'HEWO\
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M7=M0'CY16EX5\4>,=+\9Z;H/C*;1;TZS83WUG-HUE+;"V>%H@\$GF32^:<3
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !16'XO\ &-AX(TV*^U&WU6Y@DF$
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M_P A5:TSXY^'-7U*TL8--\8QSW4R01O=>"=:MXE9F !>62T5(UR>6=@H&22
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M8!(K>)/C%H/A76KC2[VP\53W,&W?)IOA'5KZ [E##;-!;/&_##.UC@Y!P00
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MMOLNSS/[9T"_TO=NW8V?:H8_,^Z<[,[>,XW#(!TM%%% !1110 4444 %%%%
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MT_\ Y_[;_O\ +_C1_;6G_P#/_;?]_E_QKY+_ .'5OP._YY>(?_!G_P#84?\
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M_ [_ )Y>(?\ P9__ &%'_#JWX'?\\O$/_@S_ /L* T/K3^VM/_Y_[;_O\O\
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MT_\ Y_[;_O\ +_C1_;6G_P#/_;?]_E_QKY+_ .'5OP._YY>(?_!G_P#84?\
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MO )E6/B-0^,@+D[1GCM7S3_PZM^!W_/+Q#_X,_\ ["C_ (=6_ [_ )Y>(?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?EO9KKW*Q%HN?+LK?CR6_-WZ6L?7^E>-O#NN^'SKVFZ]IFH:& 6.IVMY'+;
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M;X?_ $ U]N4#"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M44 %%%% %+6O^0/?_P#7"3_T$U\E_P#!*W_DU6+_ +#=Y_[3KZTUK_D#W_\
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MZ^T'X4ZAXR\.:;:+?7NL0ZO;6J^5M+/Y,39>5E49(PH/8D\5!XC_ &J-'M/
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MPGXV;[7K%]X&'B*X'A*XUUI7G?3\+@JTOSF+=G:6YZU%_P %'%'_  R?XG;
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MT+Q)\,M!^/\ \;#XZ^+GBKX>7W_"6.]M8:#K%S9PW2!1EY$B1@YSQSVXKO\
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M"BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** *6M?\@>_P#^N$G_ *":^2_^"5O_ ":K%_V&[S_V
MG7UIK7_('O\ _KA)_P"@FODO_@E;_P FJQ?]AN\_]IT#Z'V#1110(**** /B
M/_@J%_R+GPC_ .QOA_\ 0#7VY7Q'_P %0O\ D7/A'_V-\/\ Z :^W*!A1110
M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[$9).V(ESSDX]>>WJYMJ_P#V[_P==N:FN6.O]W[E&SM_V]8^7?&?Q6\=:O\
ML&>&O%?@Z/PW\/;*?6&MKZR\-VMQ9;2=1\N,6^R7"*Q#&4-NW;CC&:]Z^*'[
M2'BCX8:QX.\":CK/P_TGQOJ>GS:EJ.NZ_<RV.BVT*2;$$:/+YCR.> OF?P,>
MG2]IW[&=E%^RO'\&+[Q3<7"Q7+7D.NVUF(7CF^U&X0^27<$ D*1NY&>G;0\4
M?LR:YXL?POXBO/'D(^).B6L]B_B'_A'X'M+ZVD?<(I;)W(PORX*R Y!.>< F
MTVTMN:_RY;+[I+7RVN;2LYN7K;_P)N[]8[>>]C@H/VV]7\1?#?03X;T;0]2^
M(&K>+'\'QQQ7[3:0)T&XW2RI\TD!0HPQ@G=UXYI?"^Z\83_\%"=9B\;6FE0:
MQ;_#](EGT5Y#;74?VQ&$JK)\T?+,I0EL;>IS7I_BW]EV?QIX T33+[QE);>+
M]$U==<T[Q/INDV]J(+E>%'V9,(T>TX*DDD8RQJ3X<?LVZQX2^.U[\4O$'CZ?
MQ9K-]H0T:XMY-,2UC4B57#1;'(1 $QL(8Y9F+G.**;2J<S\_QIVT_P"WF_OZ
M](E=Q:7E_P"EWU_[=M]W<X7]L^\UBP^+O[/,V@6$&IZR/$-TMK;74QAA9S !
MEW"L0HR6. 3@''-1^(_VE?BMX43XJ^%K[0_#%QX_\(Z+%XDT^:Q2YDL-0L2_
M[T&(R"19%4,/OX)[8Z^H?'_]GJX^-VN^ ]5M/%UWX1O/"=_)J,$]E:)-+)(R
M +@N=J@%02"K!AD<9S61X;^$^F_!;4/'/Q0^)GC?_A)M3U6SCL]0U6YL%M+6
MTL4.%B2%"^%)8;CDY//'-<ZO&$E>VLG^"Y?Q6M^E_(U=G*#2OI%?^3-O_P E
M>GFR+2/VD-0\=_$+X1Z%X1M=/N+'Q/H4GB76YKE7>2RLPBB-8]K@!VF8IE@P
M^4\5SG_!0KQ%X[\+?!6+4/"&MVVB6?\ :%K#?RH9X[UB\\:QK%)&ZA4)+!PP
M.Y3@8KGO^">/P??PGI/B_P 72O=W&FZA?2:7X9>^C9'71H9I'A958!E5WD9@
M".=H/>OH#X^?!JR^/7PQU+P??:C<:2MS)#/#?6RAW@FBD61&VGAAE1D<9!/(
MZUT5+*4&EU4FNMF[V]5&RMW3,H7]Z-^CC?SM:_SE=^ECYO\ BU<?$&P_:G_9
M^#0>']6\<2:1K,4KPF:UTU,J,R88R285.=N<LPQD Y'5:=^V%K/A3X9?%K4_
M'>BZ9_PD_P /M233)8]&F>.ROY)=HMV4R9:,$N-V2<#GVKO;']G[7KSXF?#?
MQSXF\;Q:[K7A*RU"SG,.CBU74/M/"L )F$6Q<#&&W8SQFJ%Q^R-H^MP?&*SU
MW6)M0T[XB7\-^T=O;B"73GB4!"CEF#L&56!*@<8(-0](\OE+[W4NK?\ ;K;^
M>O04?C3:ZQ^Y1:?XV_3J8'P7_:HU#Q7\6--\"^(M8\!>(;C6-.FU"ROO >JF
M[CMI(L%[:X4NQ#;3D." VUOE%<S_ ,%$K'3]3A^#-IJVA77B;3)O&4*7&C6*
MAI[Q#"^8D!= 68<#YE^HKV3X4_!CQ)X$UU+W7?&UIXFMK>W:"VMX/#=KI\F3
MM DEECRSN "/EV*=QRN<5%^T7\!]3^-T7@V?1?%J>#]6\,:PFLVMZ^F"_5I%
M1E53&9$'5L\D].E.?+>#[--^BE?KY??ZA'FM/7=.WKRVZ>?W'S]^SKXPTGX(
M/\>==CM-6\*^#= M[>]M/AWJ\TC:AIX6)BTFUV9429L;=CNO3)&,5WT?[1OQ
M0\%:;X$\7>/O#?AF'P3XOO;6R6#1KB=K_2#<C,#3,_R3#INV!=N>,UT_A#]D
MVV23QUJ/Q!\57GQ"\0>,M.72-2OI;2.QBCM%! C@ACR(\$YSN)R >N<T-)_9
M(U*X;P?I?B[XDZEXM\&>$;J&[TG0I=.AMW:2$8@^U3J29Q&.@"IG'.:<7[T>
M;IR_<K\WG=JUNSZVW<MI<O\ >^^RY?*R=[]]W=W.=_:'_:QU_P""FO:W-#KO
MPUN;#271O^$7N=3E_MV\B(3<5"MLB?)8JA5L@ Y&<5K^-OVA_B!=?'/3?AY\
M/]#T*_?5_"L'B"UN];,T:6I:9E=YFC;+($"@(J[B[#Y@,U7\3?L6W^L:1\2-
M TWXDWND^%_&MW/J5Q8?V5#-/'=2G)W7&X/)"&"GR_E.!C?@D'O] _9].B?'
M#1OB(=?$YT_PC'X6.G"RV^9ME$GG^9YAQG&-FT_[U32^SS_U[LM'_P!O6^^^
MG2YV][E_KWHV_P#)>;\M>OBGQ&^.GQ)^*W@'XYR^%M \.-X&\,1:CX?N1>SS
MKJ-[+' 1<2Q,N8T5 Q(5E);@;EKVW]D,A?V7OA@3T&@6O_HL5Q7B#]C[49[K
MXA67AOXDZAX7\(^.99KO5M#BTV&=EN95VR/#.S QH_\ $NTDC@,O6O9/A#\/
MO^%5?"_PQX.-_P#VI_8FGQ6/VSR?)\_8N-VS<VW/IN/UI0TIONU#[TI<WRN]
M/4*C3DDMDY?<^6WSLM3Y^_X:?^)OB?P+XI^*7A/PUX:G^&^@7%TJV6H7$ZZI
MJ5O;,1-/&Z_NXONN51E8G'4=_.?C?JOBGXP_M)?L^:GHC>%;O0-=TV^U/0+/
M7M/GGC16LXWE-X@D =N?DV;=I SNKV&^_8YOH='\1>$?#_Q)U/P_\-?$-U-<
MWWAN+3H998Q,V9HK>Z8YBC?G*E6QG@CG/:ZI^SE83?$WX3^)]*U)=)TSX?65
MW86VCK:^8+B*:!85'F[QLV!0?NMGVJZ7*I0E+I^?+*]_65K?/9!-_&H]>;[K
MKE^=KW_49^V"I7]E;XG@@ CP_<C"CC[G:OF3QO\ !/1O@;^RGX<^+_PUO;SP
M1XOTC2]-U2Y^RW\WV35#((A)'/ SE&W&0] ,G Z=/L[XQ?#S_A;/PM\4>#?[
M0_LK^W+"6Q^V^3YWD[QC=LW+NQZ;A]:\0M/V,]9\2Z+X;\/?$KXJ:AXT\(:!
M]G^S>';'28=+M;@0@",7!5I'E  '!8=/7FHA=2DT[-N.OHY7_-:;/J+1<M]4
MN:Z[WY;?D]=UT+>B_%:2\_:8\162>&="MKF'X?6^N#5OL;#479GR+>27=S"#
MSLP#GO7&^%OVRO'?_#/3?%[Q/X;\/6>@W%K!::9;Q7,L$UYJ3S^2SN7++#:@
M[N2S-A"V0"!7MDOP"5_CAXC^(:ZV(UU?PPOAL:6+/B !RWG>9O\ FZXV;1_O
M5A:'^R9I%O\ LPZ9\&]9UF?4K>P0&+6K6 6TR3+.9HYD0LX!5B."2" <]:=U
MRW_#RYIW^?*XV\_-:9Q332?W^D86^7,G?K:_<X?P7^V@;#7O$>D^,-5\%>)A
MIWARX\20ZG\/M2^UP;(/];:R*SL5E ((;.&&3A>@W_"/COXX_$?X0WWC,0^"
M/#=KJ^C_ -HZ-9LEY<7-JC;74SN'17)B+$; NUMO49%=1X0_9]U.WL]:T_QM
MXKLO&&E:EITNF&TM?#EMI9\N0!6=WC+,SE<C(*KR3M'%/^#WP*\2_"W3!X9O
M?B+/XG\"6MB^GZ?H]WI445S!&<!0]TK9D"+E1\B]><X&)J+FA)+>VG:_O?C;
ME2]&:P:C)-]]?3W?UYF]M]-#P7X$?M ^.?AK^QQX;\7^*);3QIJ6MW<6F>&[
M=I9EO+FZFN)4Q>7$KN&Y&0R@85<<GFO6]'^-OC_P1\6?#G@3XG:9X<:;Q39W
M5QH^J>&6G$2S0)ODMYHYB3]T\2 @'^Z,\9OA[]C 6/P=N_ACK'CB[U;PQ9W,
M5WX:F@T^.UOM%E25Y0_G!F$S;G')5> 1CGCI_"_[.6J-\1--\;^/O'5QXZUW
M1K.>RT<?V9%86]DLHVR2^6C-OE9< L2!UPHXQI4DI3G)=;V].71>JEN]O-JY
MG"/+%1>Z_.^_I;IOOILSR[X=?M8_%3Q5\ ]8^+%UX)T:\T33M,N/*LM.:<7=
M]?)<!-Z)EPELB;MV2SDH2 !7KG[,OQ;U;XP^%KK6-2\1>"O$"'RC&/"#3@VK
M,"6BN$F8LK#Y<'Y<\_*.*=\'_@+JOP8^ =M\/=$\8E-5M7GD@\0#3$^1I+AI
M?^/=W92 &*D%N>O'9WP1_9\?X5>*_%_B[6/$C>*/%GBEH/M]Y#I\>GVRK"I5
M%C@0M@X/+%F)_/+?+SR2VMIZW_KM9+2Y4]M.[^[I^'K=O6Q[#11168!1110
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MFB1Y%<J51D5@Y!"DGBN3UGX>:Y??#?Q_I TX2W>JZ[+>6L#2QXF@::)@Q);
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M/IOC'6=>L]:2ZGTCQ1<:)'>W<2V4]N#;_8F2V# 3DCS'#$(02!BJG@'2-?\
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MFGW.DV4\$5P4N# PFB,\D<9*F *0SK\KDC)&##MHUL[_ (77YJWXA#726_\
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M]I_P7-#XE70]4T_6[WP]JUGI=[;1:C#D">:WB:<%&<^6AN"I+ ?/$Z<8S3O
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M"H=1^(OA;2O$<?ARY\1Z1#XEEA,\.BRZA"EY*@4MN6)F#$85CG&, GL:^?\
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M#$.F6=R% ^IKS?XE?M(>$/ _A+1]9L/$GA;4CK=RMMI;WOB"&TLKCY@))#<
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MGXCC5'5;-UG>+^W%/GD8W;?LXSNZ;.<XJJ:YW9][??R_E=_=]VDHV@K;Z?\
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M^1<^$?\ V-\/_H!K[<KXC_X*A?\ (N?"/_L;X?\ T U]N4#"BBN8^)_]L_\
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M +/@;X7TWQIXA^'J:_:V>MV^E:=XC-E$]DT-HHAUF%+=X[>1G**BJOEJS,4
M7!R :<8\S5NJ3^7*Y?\  _$52\(W??\ -V7_  ?N/KNBOD;PM\(?!^HV7PCN
M+O0;2ZN-<U748=7EFC#MJ4 @O)5@N2?]="KQQE8GRJ[%P!BJ>HW?AF/PSIG@
M_7K+P19:-!K&OQ:9?>.K(7EA:"'4'BAM+:W+QAY=C85%D5E2/"@CIGT\QVNN
M;IHOOO;\CZVU_7;'POH6HZQJ<_V;3=/MY+NYFV,_EQ(I9VVJ"3@ G !-1:IX
MGTS1K2PN;RY\F"^N(;6W;8S;Y96"QK@ D9)')P!WQ7B5E>7-[^PS=SWLLDUR
M?!-R'DF1D8XM7'*N2RG '#$D=R36/\6O$_PA^*W@/PS?W&K>"O&5AX?UC2VU
M&YDN+2_CTVWDE19#,V6$2,%PV[ (7GI6C24^7^]%?)NS82TI*?6TO/5)-?>W
M\SW_ ,9>*[3P/X7U'7K^.:6SL8O-D2W4-(1D#Y02!GGN16U7QE\8C\.6T?XB
M-X@;37^(#:A$VA,"IU V!6W^S_8\?/\ 9-N[?Y?[O_7;OXJ^O=,UW3=:FU""
MQO8+R73Y_LEW'"X8P3;%?RW Z-M=3@]F'K4I7BGW5_P7Y7L^S,[^\U_77\':
MZ[HP]5^)NB:9;2S*\UX(=9M]"F6WBP8KJ:2-%!W[05'G(25SP3C)&*Z6.QMH
MKN:Z2WB2YF54EF5 'D5<[0S=2!N;&>F3ZU\B7_@;P#81>./#.G:5H>CZI-\0
M-'^VV&EPQ6MT;)[FS,>Y8P'\IF:3!^Z2SXYS6SXWC\*_#/4O%WA1/#WA73O!
M-Y>:4'M];MXXM TUY8;AGN)XAM0*QMXU"G:&D9,D$YH6M*,^KM^,8/\ .3_)
M]QW_ 'KAVO\ @Y:_=%?FM['TA>:KHWAC4;"UE,5E=Z[>-# L<)S<W A:0[BH
MZ^7"QW-CA ,YP*L:MX@L-"ETZ.^N/(?4+I;.V&QF\R8JS!> <<(QR<#CK7QK
MX>T'P2]EX+U/Q1:^#[[P_HWCZ\LK?53I$=GIEO:O82O$D"S/((H&N&C9!YA4
MN49>JX]O_:8\.>"KY/ FM^-=+T&YTK3M?B6XU#7K>%X;6"2*4$/)*,(C2"+.
M2 6"=P*;5E#^\X_<[?C9_(K1\UNBD_FG)?=[IZGX:\4VGBD:H;2.:/\ LZ_E
MT^7SE W21XW%<$Y7D8)P?:MFOEG4/ WAZ+1?&OC6+3+67Q/:^-XVLM99 UQ:
MI]KM4*02=8T92P95(#;VR#DUA:7=7&I?&:6"[@\!:1\0$\6.R:EJGB-XO$4N
MFI<G;!#9_8\O ]H,*JS>622YPP8":?OJ">[2O\U'_/\ X<):1G/HFU]SE_EO
MYGV'6-X:\4VGBD:H;2.:/^SK^73Y?.4#=)'C<5P3E>1@G!]J\7_:>E\):5JF
M@:WK\_A76=0T^"9K/P?XH$<CZIED.;%')(NP5"HRH^=^W"[MPYF^\#Z"FB>-
M/&PTF#_A*[;QM&]IJTT8:[LU-W:HT<4A^:-&4L&12 VYL@Y-*'O2UVL_PE%?
MDPEHEYM?DW^B/J>BOCZ+7=&UGXY>'=8TN'P=HOB1_$]S8ZGIVFZ>9/$(A$=R
M@>^N1(#'&^Q&$<D14[H]K_*#7/0:!H?@WX6?""YNO#/@^[\+:KI#W>MS>,]1
M_L[3KJ_\N$6QNIS;3B1E1IQ&DJA1@;2"JBG'6/-Z?BK_ )?CH:<FK2_K?_+]
M3ZX\0W.B>*]6O/ FJV<UTMUIOVR=<E(GA\S9MW*P8-N&>.W>NJKY:^'7PST7
MQYXE\/6OC*T\/^,+&'PO<26<%O<_VKI?D/J#FWV/)&HF\N+8BR%!T)'7-9?A
M^Z\%7MGX0E^,<VD7'AG_ (16U319/%;(UFUVLLRW&&F^0W'EBVVG[Y7=M_BH
M6ROO=_@Y+_VTS2NY-=+?BH_YM^A].V_BZSN?&E_X86.<7]G80:C)(5'E&.:2
M:-0#G.X&!\C&,$<GG!9^+K.]\9ZIX92.<7^G65M?RR,H\IHYWF1 ISDL#;OG
M( Y7!/./DZU746TG4?[3-\--_L/0C>_:?,^T?V+_ &U>Y\[=\_\ QYX\S=SM
MWY[U3UBZ\)6>I_$U_A3;:-=>$S9^&EOHM*N?LVD&W-[=_:@LL$<BI#LR)6C1
M@,R$C.ZKLM?6WXVN^RU\]F7)6YK=HO[U%M+N]7IYH^V:R-+\3VFL:YJ^F6JR
MR/I31QW,^!Y0E=-_E YR65"C'C $B\DY ^3M!\-Z%XS/A>RCMO TW@6^\9PB
M+0?!.M?VKID+KI=X9HV(MX459,1EH@A!RQ;.\UT>N:%X6M/A;J.E^*-9\+^'
M$TGQE?2-9>*UB&D7I+RO;6T\;LJLGV66%D /RF.-@K;-IEKENW_7PZ_CZ[!R
MZ*W7_P"W_P#D?E<^CK'Q-:7WB/4]#"RPW]A'%.R2@ 2Q2 [9$()RNY'4YP04
M/&"";EOJ*7-]=VJQ7"/;;-SR0,D;[AD;'(P^.^TG!X->-?#K4(?$?CCX?W^D
MZ/%X?M(/!UP;K3+90(K6.6>V%K&H"K\G[F<I\H^53P,XKD_B]8>&[[Q-XW;Q
M1K_AO1+&WU+2YXX/&!C.DZA(+.4"WN$=E#@@EEY)5T1L-MP5/W$F_/\ "37Z
M7_(F/O.W];7_ *\M3Z(U+Q+IND:MI.F75QY=_JLDD=G"L;.9"B&1R=H(4!0?
MF; R0,Y(!U*^5?#/C&R\6>#_ !'\0(O"=K!X?\/:$GAS3M"8&.SB+['O2"$&
M+=08$+!!A('^7M7"Z7I>A:K<^)=!TF[\*7WA"ZU7PE,L7@2P^PZ47?4I5F"%
M)9$E<K&BO(A4$ *5!4U<8\TE#O;\967X:_@2VE!SZ*_X+7[GI^)]R45\9^)K
M"UTSXIZUH$6E?#OPWKMKJMG!X3O=;UXZ9J%G:+' 8X].M5LV#1,_FJRQ2@.S
M.K8Z5ZG^U-?BR'@_^UM-\.ZIX0:[G.IP^+M3:PT@R"+]P+F46\Z[<ERJR($+
MA.=VT'-M<BFNO_ _'77SZE)>\XOI_P '\.WET/>:S+CQ)IUKXAL]#EN-NJW=
MM->06^QCOBB:-9&W 8&#-&,$Y.[@'!Q\R_#WX?:+XZ\4>";#Q/:^&_%6@?V'
MK=U8V&GWG]KZ0L#:A;&"-'>)%F$2ML4F,!=HQT!JKX%T+P=:?$'X5:UX@T_1
M([]M-UO2]/U/5(8O/DN(+^".SACF<;FE6)91& 2VW?CO5M6LWUYOPYOQO';S
MM<A23E*/;_@/[K,^EK?QWI-Q);P;KF&]GTYM52RN;62&<6ZE0Q974;&!91M;
M#<].#3O 5_I.L^#])U?0[!=-TS5H%U.*W$*1,//'FLSJF1O8N2Q!.6).3UKY
M;^&/AWP3I>H_"S6=5TO0+37M1\ -'8ZA>6\"7-S=HL*A8Y&&YI1$6  )8)NQ
MQFN0N[I9]&T2QUJW\#VM[+X1TB+POK'C/Q(^ESV4AM!F;3U^QS!I5F.6*.K_
M "Q@C&TFE%6?>]O_ "::^^T45-6JN%]%_E#\/>>WI8^V/&7BNT\#^%]1UZ_C
MFEL[&+S9$MU#2$9 ^4$@9Y[D5/K_ (CT[PO8Q7FIW'V6WEN8+-'V,^99I5BB
M7"@GYG=1GH,Y) R:^1/C G@B/1?B(OC5]/D^*?V^+^S68C^T3:[;?ROLF?WG
MV7[_ )FSY,^=O_BKVC]JOPUX;USX:V5YXGTK2]0T[3-<TJYFGU:VCEBM8/MT
M N'8N"$3RBX<\#9NSQFH2OR-]6ON=NO=7U["@^:;C_77\';3N>S45\?^*G^'
MLNE^-GG;1W^*;3R'P:T1C-^8?*3^S?[+Q\WD8V9\GY,^;NXW5[7\=[C_ (1G
MPGH7CFZR)/".H0ZG=M$"<6S*8+O@=0(II'QZQBAV45)];?*]M_3KV*LV[+5Z
M_.WZ/[+ZGIM_8Q:G8W-G/O\ (N(VBD\J1HVVL,'#*0RG!Z@@CL:XKPKX4\(?
M#OQ6FF6,VHS>(M4LY9TDU?4[W4[A[:%XPX6>YDD*(K31_(& );(!P2/#;;1_
M"&F3>&KKXQQZ3%X>UC2[G653Q1Y9TY=4N;GSI4E\W]UYR1/$D>[YMJ2;>]9W
MA30/#NF^//A]X@UC2M)BU"YT_7[;PWJ.N6\:W4Q6^@.E1K+*-YE%N6\L9W["
MV/XJ$N5W?G?OHI:>K:T75/H.RE=)Z=/G9W]+;OH]-=S[ HKY(_9EG34O&GAZ
M:UB\":1X@BTV4^*(=+\2/=:]?RLJ9:_M&LX661)L$F1VV;F5>&J+]K77=&N]
M1\5Q31>#=)\4Z'I"SZ1>:W8&\UN\?8\@.FJ)(VB",/\ 6IOPP8LN%YIQM*,;
M[_UIW_ F'OW2T]?EOVW/JO3_ !!8:IJ>IZ?:W'FWFF2)%=Q[&'E,Z"11DC!R
MK \$]:Q?%'Q+T3PIIOB>ZN))KF3PY9K?7]K;19D6-E9DVEMJL2$;C=VYQ7F_
MPG\/^"?#/QX^(L5IIF@:3XMOA;7J)!;P07UQ:O!$9I0  [1M."68<%^O->>?
M%[POX(T/7_CPB:;H>D>*=5\*)<6\D,$,%_<QLDXN98V #ME@F]AGD+N[5*5[
M>:_'^ON)NM'TT^YGUJIW*".A&:6OE3XN^%8/AA=ZO8> M"M--@U#P_%<ZK:V
M9:T2[C34;=)YII(HW?=Y$LX:8([[23\Q %=G^S";&XN/%%UX>_X0.R\*R?94
MM](\ :Y_:EG;7*B3SG8K;0)$SJ8<H%))0L>6IQ7-'F7G^#M]W8+]_+\4G^IZ
MMK_Q!\/>%_$>@:#JFI)::MKTDD6G6S([&=D7<W(!"\$<L0"2 ,D@5T5?,'C+
M0_'?Q;U+QEKWA?0O#NH60DBT_0=4U+79[2>VDL9RYE2%+.56!NE;GS5WK&H.
M!S3;?2/"?QV\1>,?%&KZ);ZH#X0TNZM(=0C$AT^<_;B[(#_JYD9=N]<,"F 1
M6;=J3J/IJ_3=?/N:6O44%UT^=[/\]/1GU#17R1#X-T7Q[X4\?^)?$6GPZQKE
MIX3TV\L[Z[7?)9W TTR>? 3S%+NP?,3#?*O/ I/B!X\TCPSX"^-^F:]JMO:Z
M_P"(=+2\TW3Y9 +G4$;2((C)#']Z0"2.0,5!V[23@5MRVG*FWJOQUMI]S?R%
M1M6C">RE_P #_P"2/KBL+PKXQL?%VF7U_:1SPP6=]=V$GVA0#OMYGAD("D_*
M6C)'?&,@'BOECXQ:[HVH_$">XBA\':+XPT76-*@MC<Z>;GQ+>0>9;$S0.LB/
M;V^)'4MMD0A9-V-Q ]S^"O\ R(WB?_L9->_].%Q64G:G*?DW^5OSVZ%12E%/
MS2^]2O\ EN=?X!^(7A[XH>$K+Q-X7U./5=#O YANT1XPVUBK JX#*0RD$$ \
M4O@3Q_H'Q-\.1Z]X9U%-5TB2::!+J.-T5WBD:-\!@"0&5AG&#C()!!KY;^']
MQ?\ @_X;^#_!6E+<1+\2="TUM/N(%8BSG^S1QZB^[!"$6ZK,N>KA^YK/U@6?
MAO0=!T[4-$\*7WP^M_$'B:*>U\9ZH=.T=+A+\K:K+)]GG0D)YVQ'4*2,@[E4
M':<5"4ET6GS6_P#DN[[!RZ?/\&FU^6O8^U:PK[QII=C?ZM8;[BYU'2[.*_N;
M.TM99I1#(9%C*JJG>6,,@VKEOEZ<C/QUK-T;)- MO&T7PUUSPTVB,^@7_B+Q
M>]OI4#O=W)'V*Z:Q<331P?9%$F(W 7*9#,1=\8^%_#OA9_'4NO0>&_\ A/-1
M^'%C)'J<,42SZE<JEVM[-;R,JR2Y41%V R5\O< ,41AS-WZ:?G_EK^I$O=3]
M$_O<?_DC[4!R,TM?*GQ$\$Z%J-I^T'XJN],M[KQ#HA2XTK49T#S:?+'I%M(D
MENQYB?=@EDP3M .0!6!\9T\ MI7Q%E\8)ITOQ+?48VT<W"JVIBTVV_DFTS^\
M%OC?YFSY,F;=_%4*-VEW5_OMIZZ_@$[P@I[W_P KZ]ETOW/LJN>\=>,[?P'X
M?;5+BSN]29IX;6"RL1'Y]Q-+(L<<:>8Z("6<#+,H'4D5Q7[0?V/^Q/#7]O[/
M^$)_MF/_ (2/S_\ 4?9/)EV>?V\GS_(W[OEVYW?+FO$M<\&?#_Q?;7JZ!H7A
M_6_AQ%XH\/QZ4(;.&XTY+B2Y1+Y;3@QB)D,*N(OE+&0'G=2BN>2CW:7WM+Y;
M^83:A'F?9O[K_P"7W'U+XA\:Z;X1T"+5M;,^GQR%$6U6!KFY:5AQ"D4 =I9.
MHVQALX.,CFL_2_B?I&L7F@6]M;:K&VM&X6W%_ID]BZ&%0S^9%<+'*N0>/DYZ
M].:S?BY!X0T[PC8OXD\1VG@6TL;F-M,UI[J&S%C<A&6,QM*/+SL+KL8%64E2
M"#7D\+V?QQ\0_#^#Q3#IWBO1[>_U6&&]BA']GZY"ELFR?RB65XR7((RR%H]R
M\8PKWYK?TM/QUV_/6R?NJ-^OYZ_AIOZ^5_IBBOCW7+CPO;:1:^"];L/!%AH5
MOJ^MQZ7>>.;(7>GV?E702*TM;8O&'EVN=B+(I5$PH(X%/P7H5UXFT"77$T_^
MV_&6D?#&PGT5KJ F2&]$E^(I$CDW%)054*QRZY(SR<I-.'.MM_E9O[]+6^>Q
MLJ;<I1OJG;Y\RC]VM[_(^M?%_BFT\%>';K6;Z.:6UMM@=+=07.YU08!('5AW
MK9KX;LK72]>\&>*D\/CP'HVDOHL5MK%AX,\3R:A?SW+W=OY=Q=H;2!HIE G5
MG<F0LV#]WCTCX@^$;#X?ZQXPT?PAI2:#H=SI&E7NK6>AP&$R0_V@Z7DP6( F
M4VPD#./G8*.20*IJTE%O?_@[]E97O^!C'WDWVM^-E^;/H#QCXNL_!&BKJ=]'
M/+;F[M;/;;J&;?//' AP2!@-(I//0' )XJMX^UK1_#VDV-[K>G_VC;_VG96\
M""%)3'<37$<,,@#D ;7D4[AR "1D\5\R>(?^$'^VW'_"I_[%_P"$,\S1?[4_
MX1GR_P"S?MW]LVGD[?*_=>=Y?G;\?-CR]W\-4O%2^!5EM!JQL#\8/^%@6GGX
MV_VK]F_ME/)WX_>?9/L_E;=W[O[F/FQ5TXJ3IWZRMY[Q7ZWOVLRVDHR?;[OA
MO_P/4^S:*^//!%U+J?Q:MTN8/ FD>/X_$5Y)>7EUXD=?$EU8B68>1]B-FK-"
M8-A1?.,8"HX)(K)A\&?#KPA\#OAGX@U-/!;:G)I'VQ] \7)$R>(93'&?D+Y9
MKE,*D3[9-BR,@3##&<=8\SVT_'MY:>OD/EO)Q[?\'_+TUW/MFBJNEW N],M)
MQ ]J)84?R)!AH\J#M([$=/PJU3:L[&<7S),I:U_R![__ *X2?^@FODO_ ()6
M_P#)JL7_ &&[S_VG7UIK7_('O_\ KA)_Z":^2_\ @E;_ ,FJQ?\ 8;O/_:=(
MKH?8-%%% @HHHH ^(_\ @J%_R+GPC_[&^'_T U]N5\1_\%0O^1<^$?\ V-\/
M_H!K[<H&%(S!%+,0% R2>U+67XHTF'7?#NHZ?</<QP7$#H[6=U+:S 8_AEB9
M70^ZL#43ERQ<ET'%7:1<T[4;35["WOK&ZAO;*YC6:"YMY!)'*C#*LK#(8$$$
M$<&H]8U:TT#2;W4[^7R+&R@>XGEVEMD:*68X ). #P 37S+\(O#EO?>$/@[X
M/GUO7M/T#4/"9U9DMM?O89[R[5+4>6MPLPE2-%=V$,;JO/W<*17;6&K76J?L
MZ_$))]2FUBVL8M;L++4[B3S)+FWB\U$9G_C*X*;SDMLW$DG-77_=*;72[^YV
M_/[UJ.G'FG&+ZM+[U?\ +[GH>U6EU%?6L-S V^&9%D1L$94C(.#ST-35\G>(
M=;NOA+X'T#7?!_B?6?$-WJGA2\OKE+S5)+Z*016J.E[%%-(8X-LC*-L?EQGS
M,$<#'I'P2A\0V?B>]5]#\7Z7X8N-.CF$GB_7;;4Y)+O?R\+1WERRHZ-DKE(P
M4&U1DUI*-IN':_X7_P OOLK=N>,[TU/O;]/\_NOKW]7TGQ%I^NW.J6]C<>?-
MIEU]BNUV,OE3>6DFW) S\DB'(R.>N0:TJ^7];T2;2S\9O&EMK>M6VJ:/XB2>
MQM[74YX+12MG8EA) CB.</D@^:K8'W=O6I)M>\8^)/B%KU]I.A^,;O5-*\31
M:?%<V^MVD.BV]DDD0DCELVO59R\32/O:W9\R*4. M1%<W(NZ3^]1_67W=WO=
M_B\FU^,OT7WGT5X?\1:?XITW[?I=Q]JM/.FM_,V,G[R*1HI!A@#PZ,,]#C(R
M,&E\/^(=/\4Z5'J6EW'VJRD>2-9=C)ED=HW&& /#*PZ=N.*^<_AY9#Q9J&E>
M'=3UG5=)T5/^$@U*.+2M4GTY[F=-8D0LTL#H[+&K ["VT^;E@<#'3_"'Q18>
M%OV4X]=N;^[U;3[2UU"=KZT=5N+I/M,^)$8;5#-P0> "<\"C[/,OZU:_-/\
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MR*N /*R *;72.NMOGJU]ZUO]XMOBTTO\MG]SW^\^KZ*^2[?Q[XE\1Z&/$_\
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M7B.SM[-CH5TL>GK+&^V2)K6VF!E&[);,[#@KP!QU)S?$/Q7\>:?'\2]4LH-
M;2_#%^FFV%E/;S>?>2/%:N&DF$NV-09W7 C8GY3QM(8<6O=:Z7_+_-(SC.+U
M3ZV_/_)L],T3X6^#/#.E7.F:/X1T+2M-NHF@GL['3(8898VSN1T50&4Y.01@
MY-;>BZ)IWAO2K73-)L+72]-M4$5O9V4*PPPH.BHB@!1[ 5XWXD^*/COP%:>+
MK+5!X>US6M/TVUU33I;*TGLK=Q-<-"8)4::5LJ5!$BL,[ON#'.=XB^)7Q4\,
M7'C:&XN?"%TGA'28M>N+B/2[J/[?"ZS-]E2,W1\EU^SO^^+2 [U_=#!H6O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 65"JE@&8&L;6_VP_!^@7_BF*ZT;Q(;'PMJR:1K6J16"-:63/MV2LXDR8R7
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MX6U9-(UK5(K!&M+)GV[)6<29,9+@?*"PZLH&"2/O6MU_X'^:^]=RFK73Z?\
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MG9+*T8(CB+ #>[*IZ US7P__ &G-!G^#_@+Q/XXU*STG6_$FEKJ!L=.MIYN
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M6;RLJQB6W9!*FXNN-R#@YZ FG&\%RKHDOE:*_'EC_3%/]X^9[M_C>3_]N?\
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MK2=_GS)_?9W,[+EC"VB;7X6:. L/@3XJ\7_$;6O&WCK4=(M-1N/#$OA>RL-
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MTU/5O$OBB\O+;2-;TWQ;>+J6I6=UXCUBSCLYVC03(L-LZQW2;URI<1M@X).
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M;\'^C9Y?IW[+?BNT^$/@KPJ^H:.=0T3QXOBBXE6:7RGM1>RS[$/E9,FV0#!
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M2;,J_)N*X4G?VKT'P9^TEX=;X4>&?%7BSQ!I(N-;EG@M5T"VO)EO'CD=2MO
M\0N'("?-^[ZY[8)W_$G[0_P_\(7%G#K&NM8&Y@AN1)+87/E012Y\MYY!'M@#
M8('FE>1CK19IV[<J^<=5\_S6X3][FYNO-^.DOQ_$\8F_9*\7/X N/A4NO:./
MAM/KYU<WY2;^U5MS="Y-J$QY9._CSM^<?P9J_P"+/V7_ !1KGPT^.GAVVO\
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M[J&*2PD^U>:)G61E+Q[21\FYLCIWKRWP7^SYXXT;X-? +0I_#ZV^J^&/&/\
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MK;0%Y*JW7OTKV_1O'_A?Q%>Q6>D^)-(U.[FLUU&.WL[Z*:1[5CA9PJL28R>
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M]IOQH\+QZ]H^H>(M.TKX6)I<>KZOI1C4W'VEAY3 M(BS>4<%-['&>QKZMO\
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MW_!/@F3X8>+X]/U+QG8>"]8LO#H^*MEXJM/#J616_6PCC\N:=;4?.&=CO\K
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M"\[0%_9<TV/P-]O/BII-(/Q%%GY_]N"V\Q?MIGQ^]WY+9[[,X^6LGXL-I_\
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M#/@_5/A!^S=X<LK>"TU%?&D4/B:TLPUO<+>"VN-R7&,,'*JH(/)7'8BOTEI
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M6_%7P2N;*0>&OAX-=\6QR,#Y;VLMJSZ?&/79)=3<?],AZ5^CU%9N-XRCWO\
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MBMDOM/CMY$6T25-T(#%0C JO\).,<XKJZ**EN^X62VV"BBBD 4444 4M:_Y
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MH"0H+'&2>@IU !1110 4444 %%%% !1133(@D$>Y=Y&X+GDCUQ^(H =1110
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MBFY\)2Q>&[?6+R\TJRMG-[<2RR1;<7$<JK$OD,S*H#?O% <8YH^+]2UOQ_\
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MD'&0,:RE=-=[N_SDU^#7W&-.T$TU?1)?^ V^6NIY+\0=)\4>+OV8?%/BR_\
MB'K"_P!L>%9=1.DV%KIXLK</!YGE1LUJTQ7;\A+2,Q!)!4XQH^)?%.N?#[Q#
MK5G:ZF-3U)=!T&SAUG4[*V\]9;K4KFW\Z9H8XPRQAPP3 0;3@ LQ/IFG?!'P
MAI2:M#;V5]_9^J6TMG<:5+J]Y)IXBE_UBQVC2F&'/K&BD9.,9-6+7X0>%+:P
MN[.33Y]0AN]/32K@ZI?W%[)-;(\CHCO-([-AII"&)W<@9PJX;E'HM.WWZ7W^
M?^1:=H\LM7W^<'>W_;KT/+?'OB?QM\+DUW1+?QC<^(KN;1EU.PU36+&T\ZRF
M6[AA9'6WBBC>-Q,"H*!AL?YCQM[OP/<>(-!^).L^%M7\37?BJU_LNWU2"ZU"
MVMH9H'>6:-XQ]GBC4Q_NU*[E+#G+-D8T-+^"7A#2M/U*S6QO;U=26)+JXU35
MKN^N9$C;?''Y\\KR!%;)"!@H)/')KJ4\/Z?'XAEUQ;?&J2VJ63S[VYA5V=5V
MYV\,['.,\]:A:-?._P"-ONT];>9G_-\K>6U_OL_O/G6W?Q%X*\6_%2ZL?%^I
M75UJ7BK2]'A.I6]FT%G]I@LAYX$<",6C20HBLQ4X3<&8LQTO'OBKQQ\.UUOP
MW:>,KC6;YDT>YL=:U2QM#<VWVC4DM98Y4ABCB="IROR!OO\ )(!'LM_\.?#F
MJ6WB""[TQ+B'7Y4GU%7D<^=(D<<:./F^1E6*/!3;@J&'/-9>F?!7PCI>G7=F
MMC=WBW=Q;7-Q<ZEJEW>W4KV\@E@W7$TKRE4=00A;:.1C!()&RY5+96OYI)*W
MWIN^[V>AI)IRNO+\]?O6EMEON>5>/=6\?>'KGQ\EA\0=0$/@WPO;ZS T^G6#
MOJ%R1>.RW.( /*(@12L0C;N&'.>Y^'E_XETSQY)H>N>)9_$L5[HD.KJUS:V\
M'V28RE'CB\F-,Q'*[1)O<;>7;-=GJO@#0=<;Q U[8><=?L%TS4OWTB^?;J)
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M0ZI<:MXUN=*2\;2(+Z>R!N)/-GAM[2T#22LJMP4= VTA H(-_3O'/CCQ'?\
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M?)'M7Y1QP*@LO@AX.L=&_LI=.NI['^S;G1Q'=ZG=7#+9SE/-@5I)694/EH
M1L"X7:.*N.C=^J_2:_\ ;EKY$JW-!RV3U\]8-_A%JVSN>9>)O&_C7X7-(EQX
MHD\3W.J>&KK58CJ-E;Q0Z?=QRVL8,8ACC8P?Z46*R,[ 1CY^376^$/\ A*?#
M/QD'AK5?&][XMTJ?P^^HJFI6EG%/%.+A(R0UO#$-A5OE!!/WLEN,=AXL\":=
MK-I-=)HUEJFJPZ5<Z7:P:C<21VTD,P0O#*5#X1C#'EMC, .!R0>&^#WP<O\
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MB=7?T_&[_2W]7*9^,M__ &X9QX>@_P"$)&L#03KAU$BY-WYWD9%KY.WR1/\
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MR]TG5;?2-5T+4O[0MY;RR:[@?,$L#H\:RQ$Y29\$.,$ X(R#::=I2ZO\-O\
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M^#7+2;58-2TBXU&ZU&RACL6BN+?SYI)Y4D?S6$WSR':51,  $,>:\O\ AO\
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MDMA&Q:[FFE),8;'RF;'!&<=LX"JZTIJ'Q-/];6^5M^OD7%QC-)ZQ4E]ROO\
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M'44?Q1J&O/.AL9+:,K<WD:R%AO7Y,*H5>"3U<$G?F_K;\];]GTMO,W;X=?\
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MD9., <G !->#W/Q#U"S^,EKK_B/PG=>%=.\-^"M5N+H7-S;3S,//M&)402R
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M,0RE3AN*\\^&_P *O%ND^)-"TGQ%-XTNM/T"^N+VTN1+H7]BLQ6948;(UO\
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M\$^"-6\">*O!$UMHVM:EI7]AW.G7=Q?7%B;JPFDN([C=<"-T1APZ_P"CJX!
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M]OZTO_P/UOH>U6'Q#\$6^LVOA6R\3>'XM6"M%;Z+;W\ G"Q$HRI"&W80HRD
M<;2.,5B>&?VA_AUXKMO$UU9>,-$%GX=N/(U"ZDU.W\J(87$I82$+&22H9L99
M6':O/8_!5_:?#:]$&A7,6IR_$@:FP2T83-%_;JG[1C&=OD#._ILYSMJ74M=U
M[PF?'EE8Z7K%O<R^*8[Z;4(?#US?B*PDBA!N+95C*W$BM&5V)O9#\S(0,%K7
M63_X?W/_ ))_<WZ54CR.T=D[?)<WYV5O-VUZ^O)\3?!\GA$^*E\6:&WA<9SK
M8U&$V0P=I_?[MG7CKUKG],_:$^'>N>.M.\):9XOT74M6U"S-[:BSU.WE69<C
M"+MD+,[*2X !RJL<\5XKX*L-8T#Q+<>+=:T[Q;XA\.V_BFYO%EU'0R-099=,
MM8XKT64$".0KK-'A(=X\PEAN#FO5H]=CN_C#X6UZ'2];32=5T*ZLH9Y-$NX_
M*F-Q$X6X1H@UME58@S! <=<D TE[\4]GOY>XW;UOI_5C.;M%M;__ &R3?I;5
MG1>(_C/X-\)>/]#\&:MK^GV7B#6$9[6TGO(8W."JH"C.&S(Q(0!3N*L!TJKX
M!^-GAGQQ<#3#J^DV'B5KB\B70#J44EX8X+B6'S1%P^UA%N^[@9QDXS4'C^63
M2?BE\/\ 5I+'4+G3U6^L))K"PFN_)EF$/EF01(QC0^6V9& 1?XB*X+1?!%_I
M?PTT"*TT2YM-2'CV?495%JPE57U2<M.PQD*8F!W'C8>N#4+976[M][2_!.[_
M $W'-\J;79O[DW^-K?U8]HTOQWX:UOQ!J&@Z=XATJ_US3AF]TRUO8I+FV_ZZ
M1*Q9.H^\!3]>\;>'?"US:6^M:]IFD7%VP6WBO[R.!YB75 $#,"Q+.B\=V4=2
M*^=O@;H'BS^WO!&D>(]0^Q7WA87$ES:0^!=1M//D>)XY=VJR7#VTX=Y!*2@R
M[*#A<$#U/Q9X8N]3^-NB:I;V+LUKX7U2WM]1:(F.WN))K3:-^,*Q"MQU(5O0
MTWI;KH_P3>GK:W7<IZ-KT_%I?A>YUUC\1_">J7NL6=GXHT6[N]&4MJ<$&H0O
M)8@9R9U#9C P?O8Z&H-+^*G@K6SJPT[Q?H-^=(C,VHBUU."3[$@!):;:Q\L
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M&#S7,?&C7M:T1O#ZV#ZII^E33RB_U;1-#?5[VUQ'^[6.%(I2N\D@R&-U4#!
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M  +I^NQ]"1^(])FMK.XCU2R>WO9?(M95N$*3R?-\B'.&;Y6X&3\I]#7/6_Q
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M=M-*^QW]MHEW?*D:64$+6TSPQOY!CF69SYNQ?WI;/WL"7,Y+:S^_5JWKI?\
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MW_\ UPD_]!-?)?\ P2M_Y-5B_P"PW>?^TZ!]#[!HHHH$%%%% 'Q'_P %0O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@"EK7_ "![_P#ZX2?^@FODO_@E;_R:K%_V&[S_
M -IU]::U_P @>_\ ^N$G_H)KY+_X)6_\FJQ?]AN\_P#:= ^A]@T444""BBB@
M#XC_ ."H7_(N?"/_ +&^'_T U]N5\1_\%0O^1<^$?_8WP_\ H!K[<H&%%%%
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH I:U_R![_\ ZX2?^@FODO\ X)6_\FJQ?]AN\_\
M:=?6FM?\@>__ .N$G_H)KY+_ ."5O_)JL7_8;O/_ &G0/H?8-%%% @HHHH ^
M(_\ @J%_R+GPC_[&^'_T U]N5\1_\%0O^1<^$?\ V-\/_H!K[<H&%%%% @HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M .07WOU+YO>YO._XR?\ [>_N1Y;^T%X.U#QS^SIXT\/Z98_;M7O=!G@M+5@
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M_LHG)DC5"0)""5?8?O;?7%>ZT5"?+&*71I_-**7R]U?\ ;?-*4GU37WN3?\
MZ4[?(^!/C-\-/$OCS0OCIK_ASP1K6F^&?$5IHEI9Z,^F20W>I7,-RAFN1: >
M8@$9VDLH)"D]!FO>/!O@2X\,?M?ZO>Z;X?FTOPS+X&L[475O9M%9O<1W3XCW
M@!#(J8XSD+[5]!T547R62Z7_ !BU^MUVVV%+WTT^MOP<7_[:KGS;J'PLF\2?
MMA>*O$%YX?::"#P;:0Z1K%[9%[:"]$\QS&[+M\U 5/!W*#VS7D7P#^#/C&RU
M[X9:3XF%YI6H^$KJYDNXX/!4D<=P)4E682ZK]J,4Z2YW95"Q)3*"ON^BIC[M
ME_6[?ZZ]T$O>OY_Y)?I\CX8^&GP8\=2>/+WP)-I=_I7AWX;Q:U)X7UF[@=+6
M[FO@19F.0C#^1')*#M)VG%5O@C\(?&%I?_#^#6$O]'U/PAI5[:3V-MX(EM4F
M$MLZ/'+J7VIH[D-(%<,B,2V"57/'WA12:O'E;UM9OJ]]?7WG?Y%<WO<WG?[[
M:>FFG:[/B#PI^S_I%G^QU\.K?5/#WB/PSXKM+BWU62?1/#[7>HQWT1E,;75L
MT9:5 &*[74XW*!@52U+PY\8]4O?ACXW\4:%;Z8UKH>H6%[:VOA1M:%G/)< K
M*VGPSHR--"JY*%]IW @;N/NRBKD^>4I/J[VZ:IK\OR78B/NQ4>RM?KO?\_U[
MGBWP0^&[>#_V:8/"6K3ZKJEJ+.]B*/IYL+P6\CRD1)!YLAC(5MJ#?G&WH>!\
MO:MX"\>P?L^_$?P)HWAS7=;\&Z?#I,/AVZU'PX;'69BEXC2P-"B!YTC4%O-*
M#/)RPYK]"J*?,_:.IWM^#NOZ_P V4G9)=G?^OZ_0^ ?B[\/->TWPU^T9HNH_
M#C7?%OB#Q7>IJ&@ZKIVEM=));B*-8U$JY\MH2K?NSAF_A4Y-;/Q.^%OC9_B#
MK5U>VTQ\-^(O".GZ+!,O@^7Q!);[8V6:WV1SQ/;-O??O92IR,E=G/W+167*N
M7E?9+Y)./Y/?OY:#4FG=>?XM2_-?UN<K\*="N_"_PR\*:/?WESJ%Y8:7;6TM
MU>0^3-*R1JI:1 [[6XY&YN<\FNJHHK6<G.3D^IG&*C%170****@H**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"EK7_('O\ _KA)_P"@FODO_@E;_P FJQ?]AN\_]IU]::U_R![_ /ZX
M2?\ H)KY+_X)6_\ )JL7_8;O/_:= ^A]@T444""BBB@#Y'_X*6?#O7O%OP2T
MGQ%X=M3?WW@_6(M9EM0I8O JLKM@<G:2C$#^$,>U=A\/_P!OCX*>./"=AJ]Q
MXVT[P[=SQ@W&EZM+Y,]M)CYD.1A@#T920?TKZ'(!&#R*\<\1?L<_!3Q5JDVH
MZC\-M"DO)F,DLD%N8-[$Y+$1E023R3C- Q/^&RO@?_T5#PW_ .!JT?\ #97P
M/_Z*AX;_ / U:S?^&%O@-_T332/^^I?_ (NC_AA;X#?]$TTC_OJ7_P"+H#0T
MO^&RO@?_ -%0\-_^!JT?\-E? _\ Z*AX;_\  U:S?^&%O@-_T332/^^I?_BZ
M/^&%O@-_T332/^^I?_BZ T-+_ALKX'_]%0\-_P#@:M'_  V5\#_^BH>&_P#P
M-6LW_AA;X#?]$TTC_OJ7_P"+H_X86^ W_1--(_[ZE_\ BZ T-+_ALKX'_P#1
M4/#?_@:M'_#97P/_ .BH>&__  -6LW_AA;X#?]$TTC_OJ7_XNC_AA;X#?]$T
MTC_OJ7_XN@-#2_X;*^!__14/#?\ X&K1_P -E? __HJ'AO\ \#5K-_X86^ W
M_1--(_[ZE_\ BZ/^&%O@-_T332/^^I?_ (N@-#2_X;*^!_\ T5#PW_X&K1_P
MV5\#_P#HJ'AO_P #5K-_X86^ W_1--(_[ZE_^+H_X86^ W_1--(_[ZE_^+H#
M0TO^&RO@?_T5#PW_ .!JT?\ #97P/_Z*AX;_ / U:S?^&%O@-_T332/^^I?_
M (NC_AA;X#?]$TTC_OJ7_P"+H#0TO^&RO@?_ -%0\-_^!JT?\-E? _\ Z*AX
M;_\  U:S?^&%O@-_T332/^^I?_BZ/^&%O@-_T332/^^I?_BZ T-+_ALKX'_]
M%0\-_P#@:M'_  V5\#_^BH>&_P#P-6LW_AA;X#?]$TTC_OJ7_P"+H_X86^ W
M_1--(_[ZE_\ BZ T-+_ALKX'_P#14/#?_@:M'_#97P/_ .BH>&__  -6LW_A
MA;X#?]$TTC_OJ7_XNC_AA;X#?]$TTC_OJ7_XN@-#2_X;*^!__14/#?\ X&K1
M_P -E? __HJ'AO\ \#5K-_X86^ W_1--(_[ZE_\ BZ/^&%O@-_T332/^^I?_
M (N@-#2_X;*^!_\ T5#PW_X&K1_PV5\#_P#HJ'AO_P #5K-_X86^ W_1--(_
M[ZE_^+H_X86^ W_1--(_[ZE_^+H#0TO^&RO@?_T5#PW_ .!JT?\ #97P/_Z*
MAX;_ / U:S?^&%O@-_T332/^^I?_ (NC_AA;X#?]$TTC_OJ7_P"+H#0TO^&R
MO@?_ -%0\-_^!JT?\-E? _\ Z*AX;_\  U:S?^&%O@-_T332/^^I?_BZ/^&%
MO@-_T332/^^I?_BZ T-+_ALKX'_]%0\-_P#@:M'_  V5\#_^BH>&_P#P-6LW
M_AA;X#?]$TTC_OJ7_P"+H_X86^ W_1--(_[ZE_\ BZ T-+_ALKX'_P#14/#?
M_@:M'_#97P/_ .BH>&__  -6LW_AA;X#?]$TTC_OJ7_XNC_AA;X#?]$TTC_O
MJ7_XN@-#2_X;*^!__14/#?\ X&K1_P -E? __HJ'AO\ \#5K-_X86^ W_1--
M(_[ZE_\ BZ/^&%O@-_T332/^^I?_ (N@-#2_X;*^!_\ T5#PW_X&K1_PV5\#
M_P#HJ'AO_P #5K-_X86^ W_1--(_[ZE_^+H_X86^ W_1--(_[ZE_^+H#0TO^
M&RO@?_T5#PW_ .!JT?\ #97P/_Z*AX;_ / U:S?^&%O@-_T332/^^I?_ (NC
M_AA;X#?]$TTC_OJ7_P"+H#0TO^&RO@?_ -%0\-_^!JT?\-E? _\ Z*AX;_\
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M2_X;*^!__14/#?\ X&K1_P -E? __HJ'AO\ \#5K-_X86^ W_1--(_[ZE_\
MBZ/^&%O@-_T332/^^I?_ (N@-#2_X;*^!_\ T5#PW_X&K1_PV5\#_P#HJ'AO
M_P #5K-_X86^ W_1--(_[ZE_^+H_X86^ W_1--(_[ZE_^+H#0TO^&RO@?_T5
M#PW_ .!JT?\ #97P/_Z*AX;_ / U:S?^&%O@-_T332/^^I?_ (NC_AA;X#?]
M$TTC_OJ7_P"+H#0TO^&RO@?_ -%0\-_^!JT?\-E? _\ Z*AX;_\  U:S?^&%
MO@-_T332/^^I?_BZ/^&%O@-_T332/^^I?_BZ T-+_ALKX'_]%0\-_P#@:M'_
M  V5\#_^BH>&_P#P-6LW_AA;X#?]$TTC_OJ7_P"+H_X86^ W_1--(_[ZE_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
H% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>proxycardfront.jpg
<TEXT>
begin 644 proxycardfront.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 00 UT# 2(  A$! Q$!_\0
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ML'I75?"CXY> _CCIES?^!O$UGXA@M2@N$@W)+!OSL\R)PKINVMC<HSM;'0T
M=W17DOQ=_:M^%7P(\06FA^.?%B:)JMW;"[BMOL5S<,8BS(')AC<*"R,.2.AK
MU6UNH;ZUAN;>5)[>9!)'+&VY74C((/<$'- $M%>:?"+]I#X<?'>ZU6V\#>)X
M=;NM+V_:X#;36\D88D!@LR(67((W*" <9/(JQXI_:!\ ^"OB?H7P\UK7OL?C
M'7(HYM/TW['<2><CNZ(?,6,QKEHG'S,.GN,@'H=%8_C#Q;I/@+POJOB/7;O[
M#HVEV[W5W<^6\GE1*,LVU 6.!V )KP+_ (>/?L[?]%#_ /*)J/\ \CT ?2M%
M>3_"#]JGX7?'K6[W2/ GBC^W=0L[?[5/#_9]U;[(MP7=F:) >6 P#GFL#QK^
MW-\"OA]KL^CZS\0[%=0@8I+'86UQ?+&P."K/!&ZA@>""<@@T >[T5S_@?X@>
M&_B7H$>M^%=;LM?TF1S&+NPF$B!QU4XZ,,C(.#R/6N@H **** "BN;^(OC[2
MOA=X)U?Q7KAF72-*A\^Z:WCWNL>0"P7/.,YP.<#C)XH\ ?$CPQ\5/#D&O>$M
M<L]>TF;A;BSDW!3W5UZHP[JP!'<4 =)1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/C3HOP]^)=SK'Q0MO%WQ)\7Z7'I<$U\\L%AI<?S"0Q,J,1Q(Y 2)!N . 22
M&?%WB:X\(?M=_%OX]>,_$GC#1?#T5GIS6WA&+5]5ALS<2QL!;E [C<&2!MP
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MXQ^"_P 4;2#5O%]_='1"-%U76]$31=6-^UHYF@BA^SPCRU<1!) F=TL@$C;
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MYV,4&WWG_AF3X/?]$H\#_P#A.6?_ ,;H_P"&9/@]_P!$H\#_ /A.6?\ \;H
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MS<_V5J/B#QOX8/PR\/W;^%=+TR\TF.8P^5?1_P"DM;1X,)%N(I89=N-^W?N
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M;;RQ0K;ON'VJWF#@NN(U5D\UFV#(\'_M.>"/!WA6UO\ 1_A/JFB::;*%9)=
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MT91110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZSH&I:+KGQD77K+'_"5KI4UQHM\\4GEFXEU"*U%HQE$J/+(5*/$1.[(BY4J
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MM4+9!V+7/[*NC/JO]J2>+O$\NI7=Y:WVLW3/9!M;DMKI+FV%R!;!5$;1JBB
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MW/13C&L/C-\/]5U;3M*LO'7AJ\U/48UFLK*WU>W>:Z1LE6B0/N<'!P5!!P:
M.QHKC)?C5\/8)=6BD\>>&8Y=(V_VBCZQ;AK+=(L:^<-_[O+NJ#=C+,!U(JYJ
M?Q1\&:)<BWU'Q=H5A<&\.G"*ZU*&-OM05&,&&8'S-LD;;/O8=3CYA0!T]%<E
MJ/Q>\":1_:_V[QKX=LO['E2#4OM&JP1_89'SL2;+CRV;!P&P3CBK<?Q&\)RZ
MSI6D)XGT9]6U:#[5IU@NH1&>\AVEO,ACW;I$VJ3N4$8!/:@#HJ*** "BBB@
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MX?:II=A=>(?LA?5+V[$-QI_V>,HL0B>SN4N(26:39F%@S/AQOR*GP2^ FJ>
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MOC/XO?$S0/B[X^73O%>AWA\*P:]J*Z'=:?-L%E%8Z5<V\<D<=RIWL975)F&
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M2&9,W]3^.7BW2GT?P6-?TN>[MM;TW2;O3+$W0URR@BO;)3J%S-+=2LUO=!B
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M[3M,\;^*K/PQ\5I="T3P_P"?I5UH8GNH]0NKR\@D6S8S,EI<H\<"S?NR9&A
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ML<L20,*5./E9NVC\5_C(_P +/$_@73I] EN]+\2ZI_9DVM/>1P6^GMY,DH+
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUWQ%XJNK_5&N-06UNK[48%N]2$5N$4/+<00JWEPSNMMYJ2P*LLJKYD;.'W,
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M/P_XU\,Z^EEKU^=&\82V]]>SZ=-;R1WMN+6&W$2.8V'DRQ0IEE.X[B5=<C'
M1?L@0:=X-T[0;'7[:8:??17D,FIZ8\J,J:/%IBJXAGA;(\E)@Z.A#!<8V@U[
M5X$T+6?#7AJRTO6]<7Q%<VD$%NNH&V:&:8)!&CO+F1][O(LK[AMP'5<$J7<
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M#P3XUL9/AC;>&HG\$3:?#I%SJ=O=_P!L>(PC>1J2E9"J.I+*)I2DA\WY@ M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIH^D036\MHXO+9"\"73>3Y$S"5(C*=OD2D%?]5)C8V)XX?XL6?Q/^(EGH?\
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M:Z?!^D*+-0=1N[=;JY>['E)\OFVOE%@<(C6T@&,G< >[4444""BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB*QAVQLP<KE"M 'T?1110(**** "BBB@ HHHH **** "BBO%/CI\=M3^%?Q
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MU+3;G24@FRH)VB>^BD&"2IW(.5.,C!/<44 >:?\ "V/%'_1&/''_ (&:%_\
M+.NOT_Q#?WOA-]7F\,:K8:@L,L@T"XEM#>LR%ML89)V@W/M!7,NT;QN*\XW*
M* /-/^%L>*/^B,>./_ S0O\ Y9UI^&_B%KVN:U;V-[\,O%7AZVEW;]2U*YTE
MX(<*2-P@OI9#D@*-J'EAG R1W%% '(>+_&^L^&M2BM=.^'_B/Q7 \(D-[I%Q
MIL<2,68>61<WD+[@ #PI7##DG(&'_P +8\4?]$8\<?\ @9H7_P LZ]+HH P]
M/\0W][X3?5YO#&JV&H+#+(- N);0WK,A;;&&2=H-S[05S+M&\;BO..0_X6QX
MH_Z(QXX_\#-"_P#EG7I=% '#^&_B%KVN:U;V-[\,O%7AZVEW;]2U*YTEX(<*
M2-P@OI9#D@*-J'EAG R19\7^-]9\-:E%:Z=\/_$?BN!X1(;W2+C38XD8LP\L
MBYO(7W  'A2N&').0.OHH \T_P"%L>*/^B,>./\ P,T+_P"6==-HGBS5-6\-
MW^IW7@O7-&O;;S/*T:^FL&NKO:@9?+:&YDA&\DH/,E3D'=M7#'I:* /-/^%L
M>*/^B,>./_ S0O\ Y9U:TSXF^([_ %*TM9_A+XQTV":9(Y+VZN]%:*W4L 9'
M$>H.Y50<G8K-@' )P*]!HH YKQGXLU3PO]C_ +-\%ZYXO\_?YG]C36$?V?;M
MQO\ M5S!G=DXV;ONG..,\S_PMCQ1_P!$8\<?^!FA?_+.O2Z* ,/PAXAO_$NF
MRW6H^&-5\*3I,8Q9:O+:22NH53Y@-M/,FTDD<L&RIX P3R'_  MCQ1_T1CQQ
M_P"!FA?_ "SKTNB@#S[3/B;XCO\ 4K2UG^$OC'38)IDCDO;J[T5HK=2P!D<1
MZ@[E5!R=BLV < G K<\9^+-4\+_8_P"S?!>N>+_/W^9_8TUA']GV[<;_ +5<
MP9W9.-F[[ISCC/2T4 >:?\+8\4?]$8\<?^!FA?\ RSKK_"'B&_\ $NFRW6H^
M&-5\*3I,8Q9:O+:22NH53Y@-M/,FTDD<L&RIX P3N44 >:?\+8\4?]$8\<?^
M!FA?_+.K6F?$WQ'?ZE:6L_PE\8Z;!-,D<E[=7>BM%;J6 ,CB/4'<JH.3L5FP
M#@$X%>@T4 <UXS\6:IX7^Q_V;X+USQ?Y^_S/[&FL(_L^W;C?]JN8,[LG&S=]
MTYQQGF?^%L>*/^B,>./_  ,T+_Y9UZ710!S7@SQ9JGBC[9_:7@O7/"'D;/+_
M +9FL)/M&[=G9]EN9\;<#._;]X8SSCF?^%L>*/\ HC'CC_P,T+_Y9UZ77,>,
MOBAX-^'36B^+/%NA>&&NPQMAK.I0VAF"XW;/,9=V-RYQTR/6@#F_^%L>*/\
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MMT/5=>U+0[+6M/O-:TP1M?:;!=1O<V@<;D,L8.Y-PY&X#(Y% '%?\+8\4?\
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M\-_$+7M<UJWL;WX9>*O#UM+NWZEJ5SI+P0X4D;A!?2R') 4;4/+#.!DC9O\
MX@>%]*.N"]\2:19G0DCDU83W\2?V>L@W1M<9;]T&'*E\9'2J6I?%KP-HUA;7
MVH>,_#UC975D-2@N;G5((XYK4LJB=&9P&B+2( X^7+J,\B@"GXD^(6O:'K5Q
M8V7PR\5>(;:+;LU+3;G24@FRH)VB>^BD&"2IW(.5.,C!.9_PMCQ1_P!$8\<?
M^!FA?_+.NH\1?$CPEX0N;BVU[Q3HNB7%O:"_FBU'4(;=XK8R"(3L'8$1^8RI
MO/&Y@N<G%9UG\:_AYJ.D0ZK:>//#%UI<U\NF1WT.L6[P/=LNY;=7#[3*5Y"
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MG@WPC)IGB[5]8T@Z8=5F:SBBCMU5PLD^R9&DWE<>^37T+_PUY\%/^BI>%?\
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MG@WPC)IGB[5]8T@Z8=5F:SBBCMU5PLD^R9&DWE<>^37T+_PUY\%/^BI>%?\
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MVO\ :=UJ7A!="NK6T:RG1I_)AAC41(77]\RXW':3P!7TE_PUY\%/^BI>%?\
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MC_X&77_QVOH.B@+GSY_PP%\ /^B;V/\ X&77_P =H_X8"^ '_1-['_P,NO\
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M?/\ A@+X ?\ 1-['_P #+K_X[1_PP%\ /^B;V/\ X&77_P =KZ#HH"Y\^?\
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M\#+K_P".T?\ # 7P _Z)O8_^!EU_\=KZ#HH"Y\^?\,!? #_HF]C_ .!EU_\
M':/^& O@!_T3>Q_\#+K_ ..U]!T4!<^?/^& O@!_T3>Q_P# RZ_^.T?\,!?
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M?M<_%7P9X\\7^&K_ ,':+JUYX?TVYN#!8,(9+AH[+[0EU$DET9Y("Y\LJD!
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M44""BBB@#P_]MS_DT_XF_P#8)?\ ]"6LS]@+_DT#X;_]>D__ *535I_MN?\
M)I_Q-_[!+_\ H2UF?L!?\F@?#?\ Z])__2J:@?0^@Z***!'R1J7[>%[I5DMU
M)\/H9TOKBZM=*BMO$"O+.]OJT&G2>>OD#[.";A9%)W;L%>/O5+XC_;LNO"6F
MZI>:I\/A"+0ZG8I;QZXLDQU"P@$MU#(HA_=PY#JDX+;L*2BAUKVCP)^SKX \
M :5=V=IX;T[4)KRZEN[K4-1L;>6ZN6>\:[022",%Q%*RF/.2OEISE<U9^(7P
M'\%_$C1_%%I?:+:6%_XDL&T[4-<TVUABU&2$@#'GE"3C:N V1P.*!Z'BE[^W
M+-90ZW;OX(@;5_#PU2XUB$:\@MEMK$6[2M:SF'_2)66ZCVQ;4Y# L,#*:Q^W
M=;Z+X7\6:K<^%8;:^T/4/(30[K49X[ZYM?*N)A<[/LA WQ6S.FPO'M)+RQA6
M(]_/PA\"-I6GZ8?!7ATZ;ITYNK*S.E0>3:S$Y,D:;,(Y/)90#FF2_!GX?SV5
MS9R>!O#4EI<WG]HSV[Z1;F.6ZY_?LNS#2<GYS\W)YYH#0\%\._M9:KIOQ0U3
M0=:L!=>'[_QD^C66NWLGV:WTZ(VE@\-L?*@??*[W$K+YS(#@CS. H^IK:YAO
M;:*XMY4G@E021RQ,&5U(R&!'!!'.:YB?X2>!KG5%U*;P7X>EU%7>5;Q]*@:8
M.Z+&[!RF<LD:(3GE44'@"NBTS3+/1--M-.TZT@L-/M(4M[:TM8UCBAB10J(B
M* %50   ,  "@1:HHHH **** "BBB@ HHHH **** "BBB@ J*ZMDO+6:WDWB
M.5#&WENR-@C!PRD%3[@@CM4M% &'X,\%Z-\/O#MMH6@6?V'3+=G=(S*\KL[N
M7=WD<L[NSLS,S$L22236Y110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5YI^TW_ ,FV_%?_ +%+5O\
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M^\/^!YO#_B30I+^3QS-I,?B/3;29]&U:U33[N0RK MSN>,,-A7SRIEMRP;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5YI^TW_R;;\5_P#L4M6_](Y:]+KS3]IO_DVWXK_]BEJW_I'+0!\U_P#!(K_D
MVWQ)_P!C;<_^D=G7V_7Q!_P2*_Y-M\2?]C;<_P#I'9U]OT#>X5\/_L__ /*2
MWX]_]@F'^5G7W!7P_P#L_P#_ "DM^/?_ &"8?Y6= 'W!1110(**** /#_P!M
MS_DT_P")O_8)?_T):S/V O\ DT#X;_\ 7I/_ .E4U:?[;G_)I_Q-_P"P2_\
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MSEMN6]+TSX:>$-%UR#6M.\*Z)8:Q!:K91:A:Z=#'<1VZ@!85D50P0  !0<8
MXJ&]^%/@G4M:U'6+OP=H%UJ^I6SV=[?SZ7 ]Q=0,H1HI9"NYT*@*58D$#&,4
M#/%)OVJ_%B^*M2\.0_#W29=3T>[L=-U20^)I!;1W5Y=M;VPA<61,L>?+:1RJ
M,F778S)AH+?]L"[U/0KO7)?".EVGA2"/3HKN]O/$1CGBEO;&.Y3,(MC^Y0S*
MKR[@0JO($.QE'N^C_#/P?X=LH;/2O"FB:99P>68K>STZ&*./RYFGCVJJ@#;*
M[R+CH[,PY)-<Y8_LZ?#BSU_6-8D\':)?7FI*L1-YIEM(+: 6D=H;:',>4A:*
M/!CR0=[]FQ0!XS\,?VJ;CS%\*:7\/+;2]#\)2:5HNHO)K%TC6:W-TMG;"WBN
M+*.68!2CDRB(XSC=P6Z_PQ^T/XL\=Z%KFO>'_!%O=6?AZV:SU32FOI&O#K(6
M!Y;2,I$<QP"20.X1G=@ D>Y2I]5T+X4^"?"]G)::-X.T#2+61HG>"QTN"%',
M4GF1$JJ@$H_SK_=;D8-5O#_PE\/:/X*O?"]]:1^)=-U"ZN+W4?[;MX)OM\\\
MS32/,BQK&Q+MP @ "J !@4 <)\0?VB-1\*^&?#.L:)X<TWQ)#J?AN^\474@U
MF2VA@M+6&"23R6-JS3,WV@! R19Q\VS)QQOB7]M:?P[9^*-6_P"%?WT_AW1;
MZ:S74Y)YK:.X\JZDM'*RS6R6[-YRHVV.:0"$RR.R-$T1^B'\&^'Y;"WL7T/3
M7LK:R?38+9K2,QQ6CJJO;JN,+$RH@*#Y2$4$<"LM?A+X&36;G5U\&>'EU6YD
M\V>^&EP">5_+>/<TFS<QV22)DG[KL.C&@#@?"_QG\3_\*C\1^*O$FD^'[35=
M/UV]TJUL[75+E[:<1WQM8U,@M6E+EP44)"YD(0A5,FQ/)M&_:T37KJ^^)$OP
M[$<.DP7WAX74OB"Y$RW,5A+J4\*6<ELJHC-:!#,P24XCW)A=J_3+?"GP2^@Z
MAH;>#M ;1=1>.2]TTZ7!]FNFC""-I(]NUROEQX+ XV+CH*=9_"WP7I^D'2K7
MPAH-MI9=I#8PZ9"D!9HC"S; NW)B9HR<?<8KT.* /(I/VJ-1T2#Q5#XB\'VF
MG:MX>TF^U2XM[/6S<0R&"#3YDB65K>,Y==212=F%:,@;P0:9X?\ VCM4\:_&
M#0_#%I96UCIHU;RI+ZQFFN;?4K5[+5'CV236L(RLM@I+0&6//RB5L,*]=\1?
M";P/XOE637?!OA_6I%F^T*^HZ7!<$2[$3>"Z'YMD<:YZX11T I^A_"WP7X8U
M.74M&\(:#I.H2SFYDN['3(897E*R*9"ZJ"6Q+*-Q.<2./XCD \@G_:CUVU\8
M_P!G3>"+%-$?5[C3HM1&NL9WB@U:#2Y9?(^RX#>=<Q,L?F8*;R7! #<HW[=6
MI7+(NF_"GQ!J1O&EN-+\FTU,C4+2/S=_ED:><W(V0_NUW0C[0N;A=K8^F)/!
M/AV617?0-+=UD>4,UG&2'>=;AVSMZM-&DI/=T5CR :PKSX'?#C4/MWVKX?\
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M#<1''&@)YVHHZ "@1=HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#Y(<CFSHG[$\.B:Q87T?BW/V6_L;XQKI87S#;ZY=ZJ 3YO5A="#/;R]V#G8
M-#VBV^-WPZO='O\ 5K?Q]X8GTK3_ "S>7T6LVS06WF?ZOS'#[4W?PY(SVJ_+
M\3_!T%]-92>+-#CO8;(:E+;MJ4(DCM"-PN&7=D18YWGY<=Z^;;K]@"VD\/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5\/_L__P#*2WX]_P#8)A_E9U]P5\/_ +/_ /RD
MM^/?_8)A_E9T#/N"BBB@04444 >'_MN?\FG_ !-_[!+_ /H2UF?L!?\ )H'P
MW_Z])_\ TJFK3_;<_P"33_B;_P!@E_\ T):S/V O^30/AO\ ]>D__I5-0/H?
M0=%%% @HHHH ***Y+7?B3I_AWQI:>'+RQU(S7.DW>L)>06WFP>5;/$LL8"DR
M-+^^0A%0Y!]< @'6T5@>"_'6C_$#2I=0T6:X>&&=[6:*]LI[.X@E7!9)(9T2
M1&PRG#*,A@1P0:WZ "BN)^+WQ;T3X*>#)?$NO1WMQ9I*D0M].@\ZXD)RSE4R
M,A(UDE;G(2)R 2 #C:_^TAX%\.:G<V5S?WDGV2[^PW5S!I\[6\4ILI+U5639
MMG8PH,) 9'W2Q#:-XH ]/HKR?Q]^TOX0\ _#O2_&DHO-1T?4=0?2X@ODV,D<
MZ"?S$E%]);K"R-;2HRR%6#C;MW'%1:]^TUX1TV*RBL)9]0U.[FTV)+22VG@0
M?;);50IG,9C\Y(KN*8P;O,V$$@ [J /7:*\&T_\ :_\ "MUI?@^ZN;>XLWUA
M$EU21X;@V>C(=,DU%A)>>3Y+2+$B'RMROMD#[<#GIT_:9^'LEW;6HU/4UN9I
MX+:2%] U!7LY)IS;P+=@P9M3)*"J>?LW8R,CF@#U*BO/-#^/W@7Q%HT&JV6K
MSBRG2PEC:ZTVZMW9+V=X+1PDD2MMEDC8*V,8PWW65CI?#?XN>%OBU837GAB]
MN;J&)(9F%YIUS9.8I4WPRJEQ&C-&ZY*R*"K8."<&@#L:*\7UC]K/P/H7A#QS
MXANEU-8/"&M/H5]9B!/M,\ZR"/? F_#QD[R&)'$4A(&PUN?$/XZV'PYUW4;"
MZ\.:[JEII6E1ZWJVJ:<MJ;?3;-WF7S9%DG25PHMYF(BCD;:O )(% 'IE%("&
M (.0>012T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445X[\?
M?&VOZ+XB^&?A70-5DT!_%NN/876K6T,,UQ;P1VTLS"%9D>,,QC5=SHP )XS@
M@ ]BHKP3Q%J_BSX1?%CX8:9/XYUCQCH_BO4+K2[RTURTT]#"5M9)HY8GM;6
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M5I_MN?\ )I_Q-_[!+_\ H2UF?L!?\F@?#?\ Z])__2J:@?0^@Z***!!1110
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M*** "BOG3QCX5T7XD_MC6_A_Q;I%CXGT'3_ ?]H6NEZO;)=6L-S)J!C>98I
M5WE$5=V,X&/6G>!O#.C_  V_; U?PUX3TFR\->'K[P-!J=QI6DVZVUJ]TM_)
M$)O*0!0^P[2P&2 ,YP* /HFBBB@ HHKYB^%OP[\*?%OXN?&^^\<>&-&\87>G
M>)8].LI=>T^*]-K;)90,L47FJWEIN=VPN,EB3DG- 'T[17@/[+$4>B^(OC-X
M:L(DL] T7Q>\6FZ= H6&SC>TMY&CB0<(F]F8(N%!8X S7OU !1110 45X/IG
M@;4=*_:6U3QSI_@G4K2QFTZ73;RX,>D0B]EDN+)8YXFAD$\J*D4TC_:VW*%
MA7+%#[Q0 445\\?M&? JX\<^,])\4:#X6L+[6++2+R.34HUMX;\RBXL7A2"=
MR&CG\J.\6&8,/)=]VY,YH ^AZ*\M^%FE>*=%^'&OQWNGZK%</=7<NBZ/K^L?
M:]0@@*CRX9[P2S99I!(P;S'*)(BYRF!\V:5H/QE36="\/ZG!XKMM:G@U:]TB
MW@\2N(]/ FTH0W%\6U&8W4,;R78\MI9V97P(U! 0&?<M%?'_ (0\*?$/Q\FM
M2V=QXOM='N?$D]OJ%W<>*)5^V0Q>(R&-CLNC):1Q644T3JHA+Y4*K8W&/4O
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MEM&6,<#(5P8U+,0A& 6.!R:I2?"'P)+:):OX*\.O;)9Q:>L+:5 4%M'+YT4
M79CRTE D5.@;Y@ >:ZVB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\[^+OPHN/B-<^$M5TO68M"\0^%]3_M/3[JYLS>6[$Q/$
M\<L(DC+*R2'[KJ00"#U!]$HH \C_ .%0>*/$_C[PCXD\;^*]'U>+PM//>:?8
MZ'H,NG![B6%H=\KR7EP6"J[850O)R2<8KURBB@ HHHH \N\9_"76[[XIV?Q
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M_%WB/3]=UT:/_8=G'I&D/IUM;VS3":0E7N)V=V=(^=X "X Y)KT^B@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5\/_L__P#*2WX]_P#8)A_E
M9U]P5\/_ +/_ /RDM^/?_8)A_E9T#/N"BBB@04444 >'_MN?\FG_ !-_[!+_
M /H2UF?L!?\ )H'PW_Z])_\ TJFK3_;<_P"33_B;_P!@E_\ T):S/V O^30/
MAO\ ]>D__I5-0/H?0=%%% @HHHH **** "BBB@ JAIN@Z9HLU]-I^G6EC+?S
MFZNY+:!8VN)BH4R2%0-[X51N.3@ =JOT4 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !63XG\):'XVTE]*\1
M:-I^OZ9(P=[+5+6.YA9AR"4<%21VXK6HH Y#PE\'O 7@#4'O_#'@CPYX<OI$
M,3W.D:3;VLK)UVEHT!(XZ5U]%% !1110!S?C'X;>$?B)';)XK\*Z+XG2U+-
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M+ #U(IVJ_M#?#S1?%][X=O?%VC6UWI]G+>:E/+J5ND&FA)H(1'<L9 87=[A
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M%%% !117'>+/C+X \!:FNF^)O'/AOPYJ+1B46FK:O;VLI0Y ;9(X.#@\X[4
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M]6.\MK2:.33YG,2VL5K#---MMXD$QVR22')15V(H6@"77];^'WQA?PE;Z?\
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M"!;,",2GS23^[_=LK_-CY2#T.:O(ZR*&4AE89!!R"* '4444 %%%% !1110
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MSQ#XI\/+>WFI^.+N#4;234';3C!':R7DMB(GA665$4Q23-LB#>6"KBOMNB@
MHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?#_P"S_P#\I+?CW_V"8?Y6=?<%?#_[/_\ RDM^/?\ V"8?Y6=
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M&1=+M1J>65O]*\I?.Y4E3\^[D''I70T4""BBB@ HHHH **** "BBB@ HHHH
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MQ-^%CZMK6DQ?!R:74?%&IW$:6JZ/I0/BJYL[V1)I03. YAF1Y=UR8SSO7)-
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MX?'.K^#M'\)WEEI]G:Z%:6#M.9+1)Y)9GNK:<D[I H";0 O.2<T >\T5X_\
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MD6;A/'WBNXU5=8;7K?6ITTUKRWNWAE@E<$6820/#,T9$R2!52,)LV+BQX?\
MV<-,\*7&HG2/%?B2QL[GP]#X:M[-)+1ET^VAA\J)[>1K<RK(I+R99V5G<LRM
MA0 #A;'3?A)_PJ1_'>K:9XTT#0+Z=IIQ<:OJMW<6LMM(P-[FSN9Q$2+=G:\C
M8;T8L\A$C;LK4[?]FZWOKRRN+;62VE>;I,EK;PZZ\%W,#_9DNQ$!CO;G-Z(6
ME02R_O@2W(->M?%+]GCPU\4OAII/@2:XOM \.Z8$CM[?21 P\E+=[=(2MQ%*
MA54DRIV[E9$96!4&A_V=O#+W&DS?:M3#:9J-SJ< $T>#+/J=OJ3AODY436L:
M@<'86!))#  X[7G^!GC&PU+7K[[3<)<10F]:V&I132I?*-.2%X8\.WF&R6(P
ME<J\"EE5P&KE]?F^'GQ&@\2VWAY%\.?\(=IDFMRZ_JUMJT5QIQN;VXN;U#:I
M-:74,FZT$NX.&VRX5=APW9>+?V/_  [XJM+ZTC\6^+-"M;^3SKR+2;FUC,\@
MO;J]B<N]NSJ8YKR4KL9> F[<5S5CP'^R)X.^'VB>.]-L+[59H_&=@VGZG(ZV
MD&$*2H6BC@MXXXVQ,W1,$@$C.<@'*^&O%OP2O_A=X>\%:C?:IK%EX7T@:?']
MOT74[.>?=;II\BJAB1I)Y$OHU$*;I/\ 2HRJ_,C5+XH\>? C2/#6JR-:WNIP
MSZ'JD\EK:6>H$SP7?F7MY;%R D=Q(;620PNR2(L3'"(&-=AXT_95\'^.WU1]
M2N-28ZA*\\BYMY8P[?V=@^7+"Z. =*MCLD5U.9 RL& &/9?L5?#VQU.6]BAV
M-<:7+I5TD.DZ5!YRR6\ENTJO'9J]NYCD((MVB0D E#EMP!G^#_BC\);_ %:^
MM8;OQ':0^*EELY?#VH:??_9(GFU2\@EGE41LMJ]S<RR1GSF0X2)0J$%3%X*?
MX$0Z=<:EI%QKQL?#(M_$A?4Y]<:.=9$6&TN46X.+Y"+15@VB4 H/* +<]IH7
M[,OAS1+.[A;5]:U&>\EM)[F[NI8!)+);ZG+J2N1'"J M/.^X*H&W  4C-<C\
M,_V:M:M-/\2V/B_5)(;"ZTG2]%T:VL-42^FTJ&QEGFMWCN#8VV6C>6,H)8Y6
MS#EY)-VU0#/NO%/PI\4?%6[C@T#4+I/$>@ZS<>)-3U(:K8QV5O%';6UQ$;:2
M()%+(D,(?/DN%CB;+&6/?K^#/BI\-O!?Q$.GZ9;^(-(M/$=G9ZE:SWB:N;-I
MKV^N(0#:3)Y=B9)U4^8RQ"5K@8SG)[SPQ\#--\,:I-K"Z[K.H^(;BVOH+G6+
MTVQFN&NFMRTKHL"Q;T6TMT0! @5,%6ZUD^'_ -F+PSX>T9M/34M7N5860:61
MK>(_Z+J<VHQ;4BA2-!YT[J51541A54+C- ' OJWP$B$VG_;?%=@UI+<7,=C'
M-XBMFTEK:!&<V\0*FQ!BOHD01",2K=)$@?S AAL/%7P+OM4N?!\FB2:;X;^S
M17,-Y);ZA;VJ2S6]WH\MO.2BK9.D-FUN$F9"6R%4.A-=!HG[$O@;2?#>K:+<
MZEK6LP:E!/#/+J LRQ,OV$^:5CMD220-IUNVZ17WMO,GF;C6U;_LF^"E\)7G
MANY:[NM*O(K"&Y@C@L[..5+2\GNT7RK6WBB0.]Q('V(NX8Z-EB >.:-)\%(=
M4OX+TZ]JL>N3:CJ]Q?3?VUIUY8F34["YM8;2R.V93++<6866V53,ULOWSD+?
M3Q3\&;SX6ZCID4+>"VCDO?(?5M.U.^2S2UANM)BN+M&V-&TEK:SHL,[(SLCC
M#R*2?36_9/T6ZU!=6U'QAXJU;Q''!%;0:[=S6?VF&.&>VN+< );+$?*FM%<;
MT;<9)=^\, ,C4OV(?!.N32W&JZKJVKW]Q;7EO=W^H6FF3W$_VB>ZG9U=K,FW
M=9+R9E-MY7\&X-M% &Y\,K3X:>/],\+:-H,>NWEMX"@M8[.*\M-3TZUC988F
MA,L<BQ0SRA/*D4.'9-ZN N[)]KK@M.^$5MI?Q+N?&EOK^JI>7$$-I+8K':+;
M201QLJQN5MQ*XW,) SR,ZL-J,L;.C=[0(*\A_:&\%:]XDD^'FM^'],;7+CPK
MXG@UBXTN&:*&>YMQ!-"XB:5DCWCS@P#LH.TC<.*]>HH \#\8Z?XN^,?CWX9,
MW@+6O!^E^&M>.N7NH:[=Z<X=4MIXDBB2UNIF9F:8<L%  )R3@5[Y110 4444
M >)>/?#GB?P[^T1H7Q&TCPQ>^+]*'ABZ\/75EI5S:Q74$CW4-PDN+F:%&0B)
ME.'W D'!%'A'P]XF\6_M%M\0]4\*ZAX/TFQ\*R:!#:ZO<V<MS=2RW<<[.!:S
MS*J*(0/F8$E^F!FO;:*!A1110(*\%T32_%OPI^,/Q0UB+P+J_C#1_%EY9:A9
MW6A7>GH83':)!)%,EU<P$$-&""NX$-S@C%>]44 >/_ GP=K^F^+/B=XOU_2)
M?#S>+-8@NK32;J>&:X@@AM(H TK0N\89RC':KM@8YR<#V"BB@ KX?_9__P"4
MEOQ[_P"P3#_*SK[@KX?_ &?_ /E);\>_^P3#_*SH&?<%%%% @HHHH \/_;<_
MY-/^)O\ V"7_ /0EK,_8"_Y- ^&__7I/_P"E4U:?[;G_ ":?\3?^P2__ *$M
M9G[ 7_)H'PW_ .O2?_TJFH'T/H.BBB@045Y[X#\8Z[K_ ,1/'6D7<VFZEH.C
MR6\=IJ%A:26YCN'\UI;.0M-()7BC^S,TBB,9FV[ 5./0J "BBO"?B]\5O'/P
MZ^)^D:?I\OA[4="U2!'M].N=/GBN3,U]86*1O>"X9$1I;]7,@MV*K&5"2,10
M![M17EX^,L__  J*^\72:78VFJ6=_<:3)IUQ?RFV:[AOFLF2.>.W>20-*A\O
M; 7?<J[ Q('C=C^W5?WO@OQ'XO'@&V7P_H$XL+T-KDB7QO#"6");/:*WE^8-
MA=RC!=SF/Y&4 'UI17S9-^UCK]E?7&G7?@73%U&S24W@M_$;2VZ,8M,:V"2_
M9!N5WU>V$CLJ")4E<>8 H>GXH_;5D\!W6KZ9XA\%K'KVG>>!:Z=JQN(+QK:*
M>YO1!*T$>X0VL<#Y95S)<>40A7<P.Q]/T5XR_P :O$>H?L^^-?&T?A5] \0Z
M'97\L6GZO'=PP2M!$9%E3[1;03/&1C[T298,N1C=7GNJ?M4^*_AM)XIN_%GA
MJSU'3UU=-*TY=+OY998KYM*M;H6OEI:;G@+O+_I'S2<X\G  H$?5%%>::5\7
M;NZ^#$_C?4]!/AN^A6<-I>M-=6J;TG:&/YGMA.$E*JR$V_F%9$_=[CMKR[2_
MVO=?\3SZ-#H'@"QNI;](HG34=<FLFBNV;4@T>UK(MY:C2K@[W"/\R Q [MH!
M].45\N^'_P!M._\ &R/<^&OAW=W>FW$MG:Z=J.I3W5G;27$]U9VWESS&S:)#
MNNV91"\[,MO(65,J#-X@_:@\2:D=%M]'\/V>E/%JFD6^NSS:H'> SZQ<V,L%
MO&UOBX4FPN%,A,1"NK*I(8*#L?3E%?**_MN:KIWA:/7M:^']O;65RMO;VBZ;
MK4U[+)>7&GQW]M"R+9JP0Q2J'=0Y5LA4D'-=/HW[3_B75-1LXI_AVNE6VZP@
MO3J6I7%K<PS7M_=65L8[>6R21H6>V1]\@B<1SJWED@K0%CZ'HKQ_PK\8M<E_
M9MT#X@:Y8:-%KU_86MP;*.]G2TEDG=%C576WDE#/O7$:12-O8(N_ACYGH?[<
M5WJOAW5/$L_@..U\-Z;-=V$\W]KN+LWUOIL]])&MO):QXCQ;M'OD9&RRDQCY
M@H(^K**\3\/_ !:\4Z3X?^-&M>+=-L!=>#IWF@TC2[\SP+%'I5M=>6MPUO$S
M%VD<DM'E2^!D*,\]'^U'XN?7=:T2/X4WFH:II4&VX&E7%Y=6R7?V:&Z$9N!8
M"/9Y4ZC*LTQ=2JP,&C=P=CZ-HKY9U#]KS7M"T;Q3KD^@>'=6TRREMY=.M]-U
M6^DN+JV;2X+V9HU2P=G"B92)'6) '_>&+8&>QH'[6?B:3Q/;:!>^!?[6NIM8
MO8))]$>\G6VL$U-K*&9RMHT:E3',TGFR1*(X0ZDL_E*!8^GJ*^6X_P!LS6=*
MT>VUCQ'X!LK#3)M$AUW.F^('NY_*GT^]O8$"-:1*7*Z?.C@L I,94N"=NGH?
M[5WB34]:%I>?#=])M+.33H]4N=0O;NTD07NH&S@>U@N+&*2=,C>3(L/1P,E1
MN L?2-%>,^&?C/XAA^!^J>,_$FBZ<=:MM5O=-@T_3;YS;R.FHO9P!YGB4QIO
M"AI-APH,FT9*+D>$/BWXT\:_'?1_#MU8V.@:9IEEJPUFTL-2%Y'<W<$EHJ;)
M'M%9XU2[B8;3$=[RJX_<@2 CWVBOE?QY^T=\1O!_Q@\6V4'AW1=4\+>&K/4[
MQ[5=4:WGN(+>RTVZ9V8VS_O%%TP15(5C,0Q41!W]/^%'QVG^*7C7Q)I$?A74
M=.TC39KJ&UUJ2&Y^SW36]T]M*ID>W2'<60LHBEFRN=VQE*  ]9HKY=\<_MI6
MO@_XM>,?#MO'HNKZ=H>DWWD64=^(]1GU2TMEO)8V7YMENT+L@DV'$EO*"3D
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M5]-4 %%%% !17SIXQ\*Z+\2?VQK?P_XMTBQ\3Z#I_@/^T+72]7MDNK6&YDU
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MPR=NKJ%G\!H/$&LF]M]7L]7U>_&EW,4\>LP.DS,+OSH4('V>,FQ\\W<02/\
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M^ZN+:/S!/JU[KIC5#<RXM]1GF;:0)[.=1;7C?*T4BA!E@:>JV_P2^*W@RY\
MZ.FJV=WJVA1Z19Q2:'JPGM+6S436L[Q21JPBC>[1UDDVI*6V;VQ@ $_B+X[?
M##POHAM_%'POF\/6BF 7.G:O:Z/%Y%O-;_9X9C&;HB5&@$D(CB\R4)#(AC
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MQ&N?"6JZ7K,6A>(?"^I_VGI]U<V9O+=B8GB>.6$21EE9)#]UU((!!Z@^B44
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MDOHYBSFY9C @\Q?+C8 'U=I?C30]9TOP]J%IJ4+VGB"-)=*9\QM=JT)G78K
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MMK^XFOEAE^RPE?M$$^TA4 8E@QP Q^E*!!1110 4444 %%%% !1110 4444
M%%%% !1110 5\/\ [/\ _P I+?CW_P!@F'^5G7W!7P_^S_\ \I+?CW_V"8?Y
M6= S[@HHHH$%%%% 'A_[;G_)I_Q-_P"P2_\ Z$M9G[ 7_)H'PW_Z])__ $JF
MK3_;<_Y-/^)O_8)?_P!"6LS]@+_DT#X;_P#7I/\ ^E4U ^A]!T444""BBB@
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M!;2-,G\(67CBV$FK6E_X>@BC.F:=)>"[@L)I?(6WMH4N9!$EHPE59#B3#,W
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M(;N7Q!K][KVN/8W%WKL\EL+K[39W+7%M<*JP+$'1BB[?+,92)%*$;MUKX'_
M=/@:FI66F:M'>:+=7EW-#:36962RMFF\RTLX9/,.(8/,N>&5F<SY!0+M;UB@
M#Y]B_9'TZ]\4:O\ VUKNIZMX1O[2V%UI4\D.=5NQ=W]U--=[8%*CS;WS$6!H
MU!R"FU4%:C?LJ:5>:C8ZCJ?C3Q9J^JVK+C4KB2RCNV1(C%#&)HK5'C6,/,P,
M11G,\GF&0$ >W44!<^=;/]A_P?8:#>:5;^(=>A2]6X2YFCM]+1I%F6S$AVBR
M$:O_ *! PE51('W/OW'</6/B=\+-)^*^B66EZO/=V]O:W)N%:T9-SAH98)(V
M\Q'!1X9Y8VXSA\J58!AV5% CB?AQ\+H?AZ^HW,NOZQXIU6^2""74]<: S^1
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MU+7O!%MJ5C>W>DZ;;V.O#55CTNW:"2^:XCO+/SE:<LL\00^3(%9LADPV<O\
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M** "BBB@ HHHH **** "BBB@ KX?_9__ .4EOQ[_ .P3#_*SK[@KX?\ V?\
M_E);\>_^P3#_ "LZ!GW!1110(**** /#_P!MS_DT_P")O_8)?_T):S/V O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P_\ L_\
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MK6X",GF1.H96VL 1D$<$ U-K&KV7A_2+[5-1N$L]/L8'N;FXE.%BB12SN?8
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ME3>5'+LY S\DT;9&1\V,Y! M2:C:17\%B]S"E[/&\T5LT@$DB(5#LJ]2%,B
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M'[(7A0Z,_C34OB''']CGGDT=KB\CND@G8K<1_8I6>#S(UB$BQCS,QYG4.9:
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MQCXCL+-(?&'AB"^M=-74#-H,>+"=[O34N'MC)IWEJODS7I_>3W!&QBR1;,$
MU/@EX5^)<6B>#?'=_+XLUNX9-.FETRX\0.PN=/\ ^$>'F*;::X6'SWORN6D
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M2RJ8+%SF6)'#IMA<2DJG@;XE?'7Q/\2?"EYJ^EW_ (:\.:RZWC:-J&ERA;:
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M[;XB77PSUW6=5T_5[/Q;JNN>%;NY,=G+;2RC[-HZ7K",*I5!MN1(N %"R*P
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M/ __ (3EG_\ &Z/^&9/@]_T2CP/_ .$Y9_\ QNO2Z* /-/\ AF3X/?\ 1*/
M_P#X3EG_ /&Z/^&9/@]_T2CP/_X3EG_\;KTNB@#S3_AF3X/?]$H\#_\ A.6?
M_P ;H_X9D^#W_1*/ _\ X3EG_P#&Z]+HH \T_P"&9/@]_P!$H\#_ /A.6?\
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M[65XCH>J,4+QH"5)53C.,J#V%>\UYI\6/^1\^#'_ &-MQ_Z8M6KTN@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /GWX0? OX;>,O#FNZQK_P /
M?"NN:M<^+?$OGW^I:+;7$\NW6[U5W2.A9L*JJ,G@ #M7;_\ #,GP>_Z)1X'_
M /"<L_\ XW1^SY_R(>J_]C;XG_\ 3[?UZ70,\T_X9D^#W_1*/ __ (3EG_\
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M  G+/_XW1\)_^1\^,_\ V-MO_P"F+2:]+H&>:?\ #,GP>_Z)1X'_ /"<L_\
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M -NH_P"&V_\ J@?QP_\ "-_^W4!8^E:*^:O^&V_^J!_'#_PC?_MU'_#;?_5
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MGM?$^O7"ZCH?A5KBRN(I]5NKB)XI#(I=2DJ<XP>V1@G<_P"&V_\ J@?QP_\
M"-_^W4#L?2M%?-7_  VW_P!4#^.'_A&__;J/^&V_^J!_'#_PC?\ [=0%CZ5H
MKYJ_X;;_ .J!_'#_ ,(W_P"W4?\ #;?_ %0/XX?^$;_]NH"Q]*T5\U?\-M_]
M4#^.'_A&_P#VZC_AMO\ ZH'\</\ PC?_ +=0%CZ5HKYJ_P"&V_\ J@?QP_\
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M!=;E2)58W'!()7((->%:Q^WM^RKXBUVWUO5?#ZZGK-O,MQ#J-YX7CEN(Y0$
M=9&!8,!'& 0<_(OH*E\/_P#!0']ESPGK>HZSHFC-HVKZDS->ZAI_AI(+BZ+-
MO8RR( SDM\QW$Y//6@+'<WOQ*\=^ [U-'\3>(-7/C*ZUO1@MH]MI[Z5/I\^L
M6UM.]BT<*RJI2<1E;EO,4L""<>8<?6OCCXJT+X/6WCJZ\2^(9=4\4^$=2U33
M(+6STHZ'I>HQZ;<WHM2"AO#)"MM("9"Z,R$-@G8O*:'^W;^R?X9%R-'\-0Z2
M+F>&ZG%CX5BA\V:)_,BD;:!N=' 96/*MR,&F2_MR_LES:YJ&LR>%K>36-1CE
MBO=0;PI$;BY252DJR2;=SAU)5@Q.X$@Y% 'L?PF^,OBC7?C#HGP_\37,<>OZ
M7X:U&XUVWBMU2*\F2XT];._B.,B.6*>8[5.U7,B$$Q9'G4?[5GBSPLUMJOB"
M]BG\.^ H+C2/';K:HLEWJ)>\A@E4A?W9+V5NP5 JD:FG!PJA5_X*3_LZ)KB:
MTL=^-82U^PKJ T+_ $A;?<'\D2?>$>X!MN<9 .,U3O?^"AO[,FHV6J6=WIDU
MU::K<+=ZA;S>'5>.\F79MEF4C$CCRX\,V2-B_P!T4!8VSXM^*<GAN^CU7X@Z
MKI.O:1XL\->'KO\ L_3]-V.+^WT?[7D2VKX*27=RT9&,;@&WA0!=/QX\?Z;X
M',+:7KUY-;_$'_A'CXRG32A:2V:^(/L>QHDE67<81Y19;<?,=PP/FK F_P""
MD'[.%Q)<O+;WLKW-U#?3L^@@F6YBV>3,Q/WI$\J+:YY7RTP1M&$?_@H]^S=)
M8&R:VO&LFN_MYMCH ,9N?.\[S]O3S/-_>;^N_P";.>: .9LOVKOB3H/PG\9^
M*]>UB*;39/#6GQ:3JB6,(;3=;D\/V5\#*H3:T=Q+<R[=P(6140#$B@>P?M6_
M%#QQX!\3Z.OA*^O[>SM?#FJZ]?QVD-D\"K:3V(,UU]H4R&W2*:;<EL?.8E0O
M<CS@_P#!0/\ 9=;0;O0SH['1;Q8DN=-/AI/LTZQ(D<0>/&U@B11*N1PL: 8"
MC"^*/^"@G[+WC>\TZ[\1Z.^OW>G,7LI]4\-I<O:L2I)B9P2A)53E<?='H* /
M3T^(?BM[,>-E\63%#XY_X1<>#/LMI]F^S_VM_9^=VS[1Y_D_Z7GS=F/X-G->
M=^-_BWXPUW0OC#X=G\63VNG^%/#VN7VB^(--)L[KQ'- CG*2QH@0V$@6*7R"
M/-D*YP@>-JG_  \$_9>_X2[_ (2O^QW_ .$HV[/[;_X1M/MNW;MQY^-^-O&,
M].*Q?''[<'[,/CCX>R^#6_M71=*%G-86CZ5X?BCDT^&6)H95MMZ,L.Z&22,E
M5SMD8#'6@+'W9IKM)IUJS$LS1(22<DG JS7R%!_P5$^!%O#'$E_KFQ%"C.EO
MT QZT_\ X>D_ K_H(:Y_X*G_ ,:!69]=45\B_P##TGX%?]!#7/\ P5/_ (T?
M\/2?@5_T$-<_\%3_ .- 69]=45\B_P##TGX%?]!#7/\ P5/_ (T?\/2?@5_T
M$-<_\%3_ .- 69UOQE\?>+?#GBSXH:EI?BZXTFQ\%>$M/URST0VEI)::C=2R
M:ANAG9XC,?,^RPQJ(I4(+<9)P>7^,7[1/BZVMOB)I/AC6['?;>&]<U&PU"#P
MU>Q&QGT^:")X5N99?(O)#YLJEH1B&6,!E?[IY?4_^"@/[+FM^*;+Q+J.C-?^
M([)56UUBZ\-))>0!22H29@74 LQ&",%CZU6C_;N_90AU+6=03PW$FH:U#-;Z
MI=+X6B$M_%+_ *U)WQF57P-P8D-CG- ['LGPT^//BKQA\6)_#L^G"^T>UU"^
MT2\N+3PWJ%LEM/:)AKIKR1GMS'+(DBK I+H)(LN_S5]!5\.:)^WI^RIX:UN+
M6=(\/II6KQ6R6<>H67A>.&X2!45%B$B@,$"HJA<X 4#& *ZG_AZ3\"O^@AKG
M_@J?_&@5CZZHKY%_X>D_ K_H(:Y_X*G_ ,:/^'I/P*_Z"&N?^"I_\: LSZZH
MKY%_X>D_ K_H(:Y_X*G_ ,:/^'I/P*_Z"&N?^"I_\: LSZZHKY%_X>D_ K_H
M(:Y_X*G_ ,:/^'I/P*_Z"&N?^"I_\: LSZZHKY%_X>D_ K_H(:Y_X*G_ ,:/
M^'I/P*_Z"&N?^"I_\: LSZZHKY%_X>D_ K_H(:Y_X*G_ ,:/^'I/P*_Z"&N?
M^"I_\: LSZZHKY%_X>D_ K_H(:Y_X*G_ ,:/^'I/P*_Z"&N?^"I_\: LSZZH
MKY%_X>D_ K_H(:Y_X*G_ ,:/^'I/P*_Z"&N?^"I_\: LSZZHKY%_X>D_ K_H
M(:Y_X*G_ ,:/^'I/P*_Z"&N?^"I_\: LSZZHKY%_X>D_ K_H(:Y_X*G_ ,:/
M^'I/P*_Z"&N?^"I_\: LSZZHKY%_X>D_ K_H(:Y_X*G_ ,:/^'I/P*_Z"&N?
M^"I_\: LS7^,?Q'\<_"N'XB7FL>(M7L;N72=6N_":6EOI\ND2>1;-,BG,!ND
MN8T0NPE8Q,<[2?N+1\9?M+?$31]25]+'A26TU/4K_3-.L+BRN#<6KVOB"RTG
M?/(+D"02+<R285$V$(,N <\2O[=O[)ZZGK&I+X:A&HZS')#J=V/"L7FWT<G,
MB3OC,BMW#$@]ZYO2OVOOV7;+XFZQXZOKG6=;UO405_TWPU9HD*^=#,HS#!&\
MI1[> H\[2NGEC:P)8D'8]C\??M0>)OAOX:\3MJE]H=QX@\)ZE=0WD%EX=OYT
MU:VAMK*Y+1)%,_V$!+Z.-IIWDC5]N>'XUO!_Q@\9:5\>/''AWQ'JFEWOAI+O
M5IK*0V#V\EFEI9:1,D8<S,KH5OI2WRY+12."%;8GENO_ +>7[*?BR8S:WX=C
MUF8SO<F34/"T<[&5HTC:3+@_,4BC0MU*QJ.BC$>M_MU?LG>)M0N[_6/#,&K7
MUY-#<7-S?>%8II9Y84*0R.S*2S(C,JD\J"0, T!8Z;PY^U5\0M=\):5K4Z:%
M9?VQJ.G:/!%9^&=2U.6SGET&'59Y7A@G,DZDNT2QHJE 0[.P1@?7(_'&O>+-
M9^"EOJ=I>>$Y-=L)]=U73MSQ2+<0VL1&GN?E; DN6D*D#=]D(;@LI\"N/V\_
MV4[SPY+X?G\/)/H,KQ22:5)X7C:U=HXTCC8Q$;242*-%..%C4# 48FUS_@H+
M^S-XBTC2M+O;?4GTW2G5[*S31F2&$"%X#&$!V^6899(BA&TI(RD8- 6.K\)?
MM'^.]1\->/-?:YT.?3?!6MWEK=V5[9N;W58/[0G6 6\L<J)"/($4<9:*4R.C
M9(SFF^ /VCO'M]IW@:YO)M'OM-FT3PA-JIN+%_MMU<:S<S6IDCE25(HQ&\:/
MM\IMP+ %>,<</V\?V4A>Z)>#PY&+O0XUATJ?_A%H_,T]%.56!L9B /("8 J[
M;?\ !0S]F.SABA@TR6"*%+6.../PXJJBVSE[50 .!"Y+1@?<))7!- 'I>A_$
MWQQX>_9D\2^*M;UG3M0\0VVNZG91:HVGM!;64"ZO):?:)8S*VZ*% TV-PQ$B
MJ2Q4R/E?$3XV>(OV;O&]G:ZSXFF\=>#5LXM2UR_U6UMH[W287D:VCVM:QPQ[
M9IY(=F^,G$-P-WS*4Y#3?^"C7[-FC6VJV^GVEW8P:K<RWFH16WA\1K>3R@"6
M68+@2.X #,V2V.2:R-*_;I_9-T+0;_0]-\,0:=HM^ZR7FFVGA2**VN64@JTD
M:J%<@@8)!Q@4!8Z;PU^U'\5/%^O^$_"D6E>&="\4/J"Z-XD-W8W-Q#97DBZE
M+&(D%Q&3B#3DF*LQ)%S&,KFMK0/VI?&FM>+]&T2/P_!=O;$6^M'3]&OITF?^
MTM0T]YXYD)CLXHVT\S8G9BZR%%;,98\O_P /&_V;?[4?4OLEW_:+W2WK7G]@
M#SFN%A,"S%^I<0DQALY"$KG'%4)?V_/V69M2T_49-#\S4-.DFEL[MO#*&6V>
M9V>9HWQE"[N[,5(W%B3DDT >B^#_ (D_$+Q]I7@FT\7:GI6AZ%X_\-+<V>L>
M'=+N8)!>SVD]P;>.<WC&VDAB195D>-EEVN 8V7!]H^#'BV]\??"#P/XFU*-8
MM1UC1++4+E$7:HEE@1WVCL,L<>V*^1-7_;E_93UF K+HTUO<+I+:'#?6?AX0
M75K8LC1FWAF3#Q(%=@%0@#)QBNOMO^"H'P$LK:*WM[O68((D$<<46D,JHH&
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M75%?(O\ P])^!7_00US_ ,%3_P"-'_#TGX%?]!#7/_!4_P#C0%F?75%?(O\
MP])^!7_00US_ ,%3_P"-'_#TGX%?]!#7/_!4_P#C0%F?75%?(O\ P])^!7_0
M0US_ ,%3_P"-'_#TGX%?]!#7/_!4_P#C0%F?75?#_P"S_P#\I+?CW_V"8?Y6
M=;FJ?\%4_@C9:?//:OX@U"X128[6+3=C2'L SL%'U)K'_8%\'>+O&_Q'^(_Q
H^\6Z8^@CQD1!I6GR AFMMP;?R 2@6.%%8CY]K-@#&0#[<HHHH$?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tsrgraph.jpg
<TEXT>
begin 644 tsrgraph.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (X Y(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M K \3^!M)\736D]_]NBN;19$AN-.U*YL955RI==\$B,5)C0E22,JIQP*WZ*
M.'U+X*^#=3LM/LWTAK6VL;)M.BCT^[GM UJV"T$GDNOFQDC)23<"23CYCF;5
M/A!X2UC55U"YTG$H6W1X(+F:&UG6 YA$UNCB*78<;?,5L  = ,=E10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%)UH 6BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "N=USXA>'O#GB'2M"U#4XX-7U1Q':6:HSNY.[:6V@[ =C@,V 2K '(-=%
M7D?QRUD0:YX"@CTW6KYK#7H-4N7T[1KN\CBMQ#<1EB\43+D,R_(#NP0<8.:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***BNKJ&
MQM9KFYFCM[>%#))-*P5$4#)9B>  .<F@"6OE7XQ_M):_XY\5R?#'X+1?VIK\
MF8K_ ,01']Q8KG#['Z CO)T'1<MC&'X\^+WC#]J?Q/>> /A*\FG>$H3Y6L^*
MW#(KH>"J'@A2,X4?,_\ LKDGZ*^#GP7\-_!'PI'HOA^VP[8:[OY0#/=R8^\[
M?GA1P.W?/2HJEK/5]O\ ,QNZFD=NY\*?M-_L_P"E? ?PKX'ABN9-4\0:D][-
MJNJS$YN) (" H)X4%FQW.XDGT^?J^U_^"C_^H^'W^]?_ ,K>OBBOT[)6Y8"F
MWY_FSY#,$EB9)>7Y(****]P\\**** .Q^#'_ "6'P+_V'K#_ -*$K]=Z_(CX
M,?\ )8? O_8>L/\ TH2OUWK\_P")OXM/T?YGT^4?!/U"BBBOC#W@HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^?OVRO'EQ\/O"7@
MR\N/&5YX%\+W?B6WL==U72/+.I?9WAF\M+971]Q,RPEPB,XC$C 85J9^S?XV
M\">*?$^J0^$_BSXM^(-W%9[YK+Q!O\F!-ZCS%W6T0W9P.IX)X[UL?M*>%]8\
M47_PV7PKK6B:%XSL-?>^T>?7;.>ZAD=;.X$T>R(CAH'FR6*XZJ0P6K?PO\1_
M$BV^(=UX8^(WB'P-?WC:5_:5K8>&-*OK6X""81F5WGGE1DR=NT88$@]* /8:
M*** "BBB@ HHHH **** "N ^/U_XJTOX*>-;SP0DS^*X-*GDTX6T(FF$H4\Q
MQGAW R54_>8 <YKOZ* /@DZS^S/;:6;UOVA?'$?B95P;AO&FIC6!/CO8$_ZS
M/'E>1C^'9CBOK;]G_6/$_B#X)>"=2\9PSP>*+K2H)=06Z@$$QD*CYI(Q_JW(
MP63^$DC QBN3\7?M1>#O"WC75='M/#?C#Q=K&DLMGJ%SX4\*7FIQVCE5D$$D
M\494-AU8H"<9YP:]5\)^(X_%WAO3]9BL=1TR*]B$RVFK6CVEU$#_  R0N R-
M_LD9H UZX#XA^,O$'A3Q1X-@LK;36T35]4CTVYEG:1KG<\<K_(HPJ@"(?,6;
M.XC:,9/?UP'Q*\ ^(?&VJ^'[C3/$&F:3:Z->QZE%#=Z1)=/)<(LJ?,ZW,8\L
MK+]T+G(SNP<4 <OK?Q=\264OB#7[:+2?^$1T'78=&NK.2"5KZ=2\4<TR2B0(
MI5IAA"C;@A^89&.P^(7BW5]*UOPOX>T V,.JZ[<3*+O487FAMX88C)(WEHZ%
MV/RJ!O7[V<\8//WOP3OKR_U*U/B*%?"NK:K#K.HZ2-.S-+.AC=T2?S?DBDDB
M1F4HS8W ,,Y$H\">*_%%IHVNW^KQ:-XLTW4[N\LEN;-+J*VM9MZ"TE6)T$F(
MRGSJX.Y>IQR <_X>^+?C+QMK7_"*Z4NA:=XETU+XZK>7EK-/:.\%QY$8AC65
M& D)#$LY* $8;@U;T7XN^)/B,GABT\+1:3I&I:AH3ZS>R:O!+<Q1,L@A$*+'
M)&2#+O\ G+<*H^4DX%G3_@;JOAN[M]8T#Q5!9^*)8KR/4]1O=*^T0WK7$WG,
MXA65/+*/]SYF 7AMW6K47P4NO#*>'I?!OB"/1;_2M(;17GU&P^VK<PEE?>R"
M2/$@D!?(.W+L"I&, '7?#3QC_P + \!:'XA-O]DDO[99)8,Y$<@X=0>X#!L'
MN,'BNFK$\%>$[3P+X2TGP_8L\EKIUND"R2D%Y"!R[8XW,<L<8&2:VZ "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ***Y7XD_$WP[\)O"]QKWB6_2RLHN$3
MK+.^.(XUZLQ]/Q) !--)MV0F[:LU_$GB72O!^AWFL:U?PZ;IEHADFN;AMJH/
MZD] !R20!DU\?:CJOC7]N7Q!-IVBO=>$_@]93[+B]9=LVI,IS@#^(^B_=3@M
MDX%/T#P3XP_;9\0V_BCQE]I\-?"RUEWZ9H<3E9+X _?)[YZ&3W(3'+#[#T30
M]/\ #6D6FEZ59PZ?IUI&(H+:W0*D:CH !71I1\Y?E_P3+6IZ?F9G@+P#H7PS
M\,6GA_P[81Z?IML/E1.6=N[NW5F/<FNAHHKG;OJS;8^+O^"C_P#J/A]_O7_\
MK>OBBOM?_@H__J/A]_O7_P#*WKXHK]5R/_D7T_G_ .E,^+S'_>I_+\D%%%%>
MZ><%%%% '8_!C_DL/@7_ +#UA_Z4)7Z[U^1'P8_Y+#X%_P"P]8?^E"5^N]?G
M_$W\6GZ/\SZ?*/@GZA1117QA[P4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?-'[47PB^$7B#Q]\/_$?Q!TCSKR[OWTP7\^KO86B1
M+9W4Q\XA@#@*Y4)M9FVY;:"*Q_V/H_"MAXGNI=$^$]IX#A\1Z/\ VQHFK+J<
ME]=ZAI2SA4^T"5=UN6\R*58PS*1)URAKO/VM=6F3PAX?\/(OA^"'Q#JALY-2
M\3Z<E_9VGEVT]RN()"$>5V@6--Y R^>2 II? SXF6_C/QSH*J-"O]5U/X?Z9
MJFJ7>FVJ+=VDN[Y89I%)_=OYTK1QD#:8I2,AN #Z HHHH **** "BBB@ HHH
MH *S_$6OZ?X3\/ZGK>K7*V>E:;:RWMW<LI(BAC0N[D $G"J3P">*T*RO%7BG
M2?!'AK5/$&NWT6F:-IEM)=WEY.3LAB12S,<<G '0<GH.: /B;Q;\4;/X>_%7
MQS/X=_:.T?P=:ZYJ$>I3Z#<?#R\U);>8P1H7$PG +.B1EMH521G:&+$_8/PG
MUQ_$OPW\/:I+X@@\5275JLC:U;:>UA'>$Y_>+;LS&+/]TDXK ^)?[1'@WX51
MZ(-8DU6[O-8@>[M-.TC2+J^O#;1JK2SO!%&SI&@==S,!C..O%=WX<\1:;XN\
M/Z;KFC7L6HZ1J5O'=VEY V8YH74,CJ?0@@T :-%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 445XI^T+^TWI'P4MXM*L8#X@\;7P"V.B
MV^68%N%>7;R 3T4?,W0=R*C%S=D2VHJ[.B^-_P >_#/P(\.'4-;G\^_F5OL6
ME0,//NF'I_=4'&7/ ]S@'POX;? CQ+^T/XHM_B5\959-/'SZ/X2(*Q1Q9RID
M4]%/!VGYGZMQA3T'P/\ V9]3U7Q'_P +,^+\O]N>-;IEFMM-FPT&G <H"OW=
MR]E'RI[MR/IVMG)4M(;]_P#(S2<]9;=AD,,=O"D42+%%&H5$0850.  !T%/H
MHKG-@HHHH ^+O^"C_P#J/A]_O7_\K>OBBOM?_@H__J/A]_O7_P#*WKXHK]6R
M/_D7T_G_ .E,^+S'_>I_+\D%%%%>Z><%%%% '8_!C_DL/@7_ +#UA_Z4)7Z[
MU^1'P8_Y+#X%_P"P]8?^E"5^N]?G_$W\6GZ/\SZ?*/@GZA1117QA[P4444 %
M%%% !1110 4444 %%%% !1110 445Q/Q831X/#G]H:[J^L:=I]FQ86^BWTMK
M-=S,-D<:F$K([DG"QAL,S#(; P =M17SE86GBK6Y9_#WB_7M6L-4T#P5;WK/
MIFIR6S->RM.&G=X2OG%/(1<-N0G><'-<W#XW\1^+/AEXQ\=W>KZK8^(?#]AI
M<]C:6MY+!;K(;*VNI/,MT(27S7F=2)%;Y<!<8H ^L:*** "BBB@#R?\ :5TB
M'6?AS+%?>+?"OA724D\R]_X3;3(+_2+V,*?W-PDLD>%W;6W*ZL"HZC(/GO['
MGBS0YSJWA[PO\/?#FA:+#$+L^*/ ]E/#HNJ/N 4*\UM%ODVMG"/.H4?ZSD"M
M3]LC4X].T?X?I-<^&M"@N_$D=K)XK\3Z?#?PZ$&MIRL\<4K*@D=PD D8X3SL
MD'-;7P'O]3N]=U!+WX[Z)\5XDM1MTW2K"QMVM3N'[TFWD9B/X<' YH ]LHHH
MH **** "BBB@ HHHH *\=_:I\"_#CQW\*+VT^)-YI6AV&?*L/$>II'_Q*+R3
MY(KB.23B-@VWDD XP3@U[%63XIU_0O#FBSW?B34=.TO2&_<RSZI/'# =W&UF
M<A>>F#UH \>^#'P^U33_ !!X@^)GBOX@Z)\0/$U_IL.DV=_I=JMGIMA9QLTG
MEH!+*<RROOD8MSM0  **/V4M(\(?#OPG'\/M#^(5OXWU[2+."358+74OM4-E
M(05811[F^SQLP8K%G@=JY;5?AQ^QYK6J'4;S3?A%+=LQ9G673T#D]2RJP5C]
M0?6O?_ 6C^%-&\+V4?@JRT:Q\.N@>U308HH[1D[&,1 (1[B@#H:*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBOE+XP?M&>(OB)XLE^&7P43
M^T-8;*:CXCB;]Q9+G#;).0,=Y.QX3+$$7"#F[(B4E%:G0_'_ /:AG\+ZXG@#
MX<V7_"3?$2\/D[(%$D5@3W?L7 YVGY5 RY &#H_L]?LQP?#>XE\6^+KD>)?B
M+J!,USJ5PQD%LS=5B)ZGL7ZGH,#KT/P _9UT+X%:(_DG^U?$UX-VHZU.N99F
M/)5,Y*IGG&<D\DDXQZU6DIJ*Y(;=^Y*BV^:04445@:A1110 4444 ?%W_!1_
M_4?#[_>O_P"5O7Q17VO_ ,%'_P#4?#[_ 'K_ /E;U\45^K9'_P B^G\__2F?
M%YC_ +U/Y?D@HHHKW3S@HHHH ['X,?\ )8? O_8>L/\ TH2OUWK\B/@Q_P E
MA\"_]AZP_P#2A*_7>OS_ (F_BT_1_F?3Y1\$_4****^,/>"BBB@ HHHH ***
M* "BBB@ HHHH **** "N:\8_#K0O'DVES:Q#=O/IDCS6<UEJ-S9O"[+M9@T,
MB'.W(R3P"?4UTM% '$ZM\&_"NNP6D5_;:A<FWMI++SVU>\$\UO(VYX9Y1+OG
MC)_@E++U &#4FJ?"#PEK&JKJ%SI.)0MNCP07,T-K.L!S")K='$4NPXV^8K8
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M&O$4T$^N:7I4%K=M;,6C$BJ 5#$ OCIO/+8W'DU\C_%?P+X)\1?%Z\T[P_\
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MGQ>8_P"]3^7Y(****]T\X**** .Q^#'_ "6'P+_V'K#_ -*$K]=Z_(CX,?\
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M:DI;,FHHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?\%'_P#4?#[_ 'K_ /E;U\45]K_\%'_]1\/O]Z__ )6]?%%?JV1_\B^G\_\
MTIGQ>8_[U/Y?D@HHHKW3S@HHHH ['X,?\EA\"_\ 8>L/_2A*_7>OR(^#'_)8
M? O_ &'K#_TH2OUWK\_XF_BT_1_F?3Y1\$_4****^,/>"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "F32I;PO+(=J(I9CC. .M/HH \!T
MG]HGX;2V?Q;^)VFV5R^F>$X8=-U37H5VC4W@@-PMO%&6!9XS=A 7526FV@D"
MK'PL^)9\7?%B2#QS\/'^'?Q#70DET\3ZK'>K=Z;+/\Z*Z;0)$E1-\97(+)AF
M!S4OB+]F[X<?$+X@KXOGU?4IEO\ 4H+RZT.RUIETG5-0LB%CEFMU.V66(VZ
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M!I2P6BH++PM*TNF1<GY;=F524],J/I0!V-%%% !1110 4444 %%%% !1110
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M%%%04%%%% !1110 4444 %%%% !1110!\7?\%'_]1\/O]Z__ )6]?%%?:_\
MP4?_ -1\/O\ >O\ ^5O7Q17ZMD?_ "+Z?S_]*9\7F/\ O4_E^2"BBBO=/."B
MBB@#L?@Q_P EA\"_]AZP_P#2A*_7>OR(^#'_ "6'P+_V'K#_ -*$K]=Z_/\
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M[\1_$FC:SXBDTQ=&L['PYILMG8V=MYOFN?WLLDDCNP0DL0%V8 Y- 'L%%%%
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M.%:4E>Y^N%%?D?\ \+T^(_\ T/OB7_P;3_\ Q='_  O3XC_]#[XE_P#!M/\
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M./WUC<),HSZE2<'VK6KY?\2?L#^$UOCJ7@;Q#K?@/5%SY<EG<--&GTRPD_\
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MY#PZ:/X0 /E+KT 'RI_#D\U]+53DJ:Y8;]_\A).>LMNPV.-8HU1%"(H"JJC
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MVP"Q!&!7O?P \76'CWX+>#?$.F:);^&[/4=.BG72+,*(;1B/GCCV@*5#!@"
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M@ HHHH **** "BBB@#C?C/\ \D>\=?\ 8!O_ /TG>OR)K]=OC/\ \D>\=?\
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M&3_!*67J ,&I-4^$'A+6-574+G2<2A;='@@N9H;6=8#F$36Z.(I=AQM\Q6P
M!T QV5% !1110 4444 ?/?[8VEV_B70? WAI_#&F^*+S7O$*V%I%X@O[BUT>
M"7[-/+ONU@.9E(B9$A8%6D=.A KJ/@EX5^(GA:&;1O%>D?#K1_"T5OLLM/\
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M "1[7/\ L/2_^D]O7Y]5^@O_  3S_P"2/:Y_V'I?_2>WKYOB#_<7ZH]7+/\
M>%Z,^HZ***_,#[ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ^+O\ @H__ *CX??[U_P#RMZ^**^U_^"C_ /J/
MA]_O7_\ *WKXHK]6R/\ Y%]/Y_\ I3/B\Q_WJ?R_)!1117NGG!1110!V/P8_
MY+#X%_[#UA_Z4)7Z[U^1'P8_Y+#X%_[#UA_Z4)7Z[U^?\3?Q:?H_S/I\H^"?
MJ%%%%?&'O!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!X_P#M%>*[;PR/ 45OX/?QMXNOO$ A\.:>-0_L]([M;2Y>2:2XP=D:VZW
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MQ!&!7T5^SQXFTKQC\#_!6MZ+X?L_"NFWNFQ2Q:)IZ(EO9$CYHHP@5=@;< 0
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M!T '84^BB@ HHHH **** "BBB@#C?C/_ ,D>\=?]@&__ /2=Z_(FOUV^,_\
MR1[QU_V ;_\ ])WK\B:_0.&?X-3U7Y'S&;_'#T"BBBOLSP0HHHH *_07_@GG
M_P D>US_ +#TO_I/;U^?5?H+_P $\_\ DCVN?]AZ7_TGMZ^;X@_W%^J/5RS_
M 'A>C/J.OBCXB?\ (_>)/^PC<?\ HQJ^UZ^*/B)_R/WB3_L(W'_HQJ^0R?\
MB3]#Z#&?"CGJ***^K/*"BBB@ KUO]F;_ )'Z\_[!TG_HR*O)*];_ &9O^1^O
M/^P=)_Z,BKAQW^[3]#:A_$B?3M%%%?!'OA1110 4444 %%%% !1110 4444
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MP4444 =C\&/^2P^!?^P]8?\ I0E?KO7Y$?!C_DL/@7_L/6'_ *4)7Z[U^?\
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MW_(_7G_8.D_]&15PX[_=I^AM0_B1/IVBBBO@CWPHHHH **** "BBB@ HHHH
M**** "O&/VQO^3;_ !C_ +MK_P"E<->SUXQ^V-_R;?XQ_P!VU_\ 2N&N[ ?[
MW1_Q1_-'/B?X$_1_D?E]1117[*?!!1110 4444 ?K?\  O\ Y(IX"_[ -C_Z
M(2NYKAO@7_R13P%_V ;'_P!$)797]]!IEC<7ER_E6UO&TLKX)VJHR3@<G@=J
M_%*ZO6FEW?YGZ!2_AQ]$3T5P?_"]/ __ $'%_P# 6;_XBC_A>G@?_H.+_P"
MLW_Q%/ZK7_Y]O[F'M:?\R^\[RBN#_P"%Z>!_^@XO_@+-_P#$4?\ "]/ _P#T
M'%_\!9O_ (BCZK7_ .?;^YA[6G_,OO.\HK@_^%Z>!_\ H.+_ . LW_Q%'_"]
M/ __ $'%_P# 6;_XBCZK7_Y]O[F'M:?\R^\[RBLCPSXLTGQC8R7FCW8O+:.0
MQ,XC9,, #C# 'HP_.M>L)1<7RR5F:)IJZ"BBBI&%%%% !1110 4444 %%%%
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M)OXM/T?YGT^4?!/U/)/VF?\ D0;/_L(Q_P#HN6OF*OIW]IG_ )$&S_[",?\
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M3:6<^"#^\CA1&Y!.>0:Z*5#)&RJ[1D]'7&1^8(H ?15+[!/_ -!*Z_[YB_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI5JBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^K8.R$==K'YL\UW= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJNBZ;:ZH]_>ZQ;17EE'8V<]QYD$C%5E)C1@B!AAF8@)QN(R*X?6?@5>VVE^
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M#@9P #MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>urgn20240606_def14aimg001.jpg
<TEXT>
begin 644 urgn20240606_def14aimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "/ 9,# 2(  A$! Q$!_\0
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MNS-Z=6-17BQU><>)+AI=9N QR$.U?88KT8\"O*M4E-WJ]P8@6,DI"@=^U=>
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M?Y&O-PW\6/J>SC?]WEZ'G5K_ ,?D'^^O\Z]K+*B;F. !DDUXI:_\?D'^^O\
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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L@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>urgn20240606_def14aimg004.jpg
<TEXT>
begin 644 urgn20240606_def14aimg004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #L FX# 2(  A$! Q$!_\0
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M_GM'_P!]"OE;%&*/[&_O_A_P0_M?^Y^)]4_:(/\ GM'_ -]"C[1!_P ]H_\
MOH5\K8HQ1_8W]_\ #_@A_:_]S\3ZI^T0?\]H_P#OH4?:(/\ GM'_ -]"OE;%
M&*/['_O_ (?\$/[7_N?B?5/VB#_GM'_WT*/M$'_/:/\ [Z%?*V*,4?V-_?\
MP_X(?VO_ '/Q/JG[1!_SVC_[Z%'VB#_GM'_WT*^5L48H_L;^_P#A_P $/[7_
M +GXGU3]H@_Y[1_]]"C[1!_SVC_[Z%?*V*,4?V-_?_#_ ((?VO\ W/Q/JG[1
M!_SVC_[Z%'VB#_GM'_WT*^5L48H_L;^_^'_!#^U_[GXGU3]H@_Y[1_\ ?0H^
MT0?\]H_^^A7RMBC%']C?W_P_X(?VO_<_$^J?M$'_ #VC_P"^A1]H@_Y[1_\
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M=#H<<=U'=2W,\]S&X?S'P"0%V@8'8"B],7[PDM]:L;J]^QQR-YA+!>.&*_>
M/M4E]?\ V.6SWH##/+Y4DA.-GRD@_F,?C5:#0H[22=[>Y>-9"[*!&N8V8Y)#
M=:LZIIT6J:=+9SR.JO@[U^\I!R#^GZU+Y+Z%>_8RK+Q2MS;PRR6ZP%I9!*&;
M_5QHN[?^((_.M2RU6UU"*9[<N3#C>A'S $9''O59O#EB;JYF;S"+BV%LR9P
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MT%>;]J[,"I2BZL]Y:G+C7&,E3ALA****[3A"BBB@ HHHH&%:OAC_ )&C3?\
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M/^%4^&?^>=S_ -_J[:BCZW7_ )V'U2A_*CB?^%4^&?\ GG<_]_J/^%4^&?\
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M/,3^^OYU\M?:KG_GYF_[^&C[7<X_X^)?^^S1_8[_ )OP#^UE_*?4^01D$$4
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MN74U4KJ^VYQ9A4<*#L</1117U)\R%%/BBDFE6*)&>1SM55&236G_ ,(QK_\
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M!., GM39-!4VEG!%=RPO:HT:R*H)*L,$8JI;^''CNI%ENG^Q+Y.V( ?O/+7
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MXI/Q%&X78M)1^-'XB@044?C10 4^*)IY$AC4M)(P50/4\4T*20!R3V'6O3?
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M#AVS-& LN%(&[')'M4]%%9,U04444AA1110 4444 %6+/_CX_P" FJ]6+/\
MX^/^ F@#1HHHH$':N4USP!H^OZFU_>-<"9E"G8^!@?A75T54)R@[Q=B)PC-6
MDC@_^%2^'?[]Y_W]'^%'_"I?#O\ ?O/^_H_PKNZ*W^N5_P"9F/U.A_*CA/\
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M#^UE_+^)]1YHS7RY_:5__P _US_W];_&C^TK_P#Y_KG_ +^M_C1_8\OY_P
M_M9?R_B?4>:,U\N?VE?_ //]<_\ ?UO\:/[2O_\ G^N?^_K?XT?V/+^?\ _M
M9?R_B?4>:,U\N?VE?_\ /]<_]_6_QH_M*_\ ^?ZY_P"_K?XT?V/+^?\  /[6
M7\OXGU'FC-?+G]I7_P#S_7/_ '];_&C^TK__ )_KG_OZW^-']CR_G_ /[67\
MOXGU'FC-?+G]I7__ #_7/_?UO\:/[2O_ /G^N?\ OZW^-']CR_G_  #^UE_+
M^)]1YHS7RY_:5_\ \_US_P!_6_QH_M*__P"?ZY_[^M_C1_8\OY_P#^UE_+^)
M]1YHS7RY_:5__P _US_W];_&C^TK_P#Y_KG_ +^M_C1_8\OY_P  _M9?R_B?
M4>:,BOES^TK_ /Y_KG_OZW^-']I7V#_IMSG_ *ZM_C1_8\OY_P  _M:/\I]1
MYHKD/"4LC^$M,=Y'9FA!+,<D\FMG>W]X_G7D3CRR<>QZT)<T5)=37HK(WM_>
M/YT;V_O'\ZDHUZ*R-[?WC^=&]O[Q_.@#7HK(WM_>/YT;V_O'\Z ->BLC>W]X
M_G1O;^\?SH UZ*R-[?WC^=&]O[Q_.@#7HK(WO_>;\Z-[?WC^= &O161O;^\?
MSHWM_>/YT :]%9&]O[Q_.C>W]X_G0!KT5D;VQ]YOSHWM_>/YT :]%9&]O[Q_
M.C>W]X_G0!KT5D;V_O'\Z-[?WC^= &O161O;^\?SHWM_>/YT :]%8_F-_>;\
MZ7>W]YOSH UZ*R-[?WC^=&]O[Q_.@#7HK(WM_>/YT;V_O'\Z ->BLC>W]X_G
M1O;^\?SH UZ*R-[?WC^=&]O[Q_.@#7HK(WM_>/YT;V_O'\Z ->BLC>W]X_G1
MO;^\?SH UZ*R-[?WC^=&]O[Q_.@#7HK(WM_>/YT;V_O'\Z ->BLC>W]X_G4]
MFQ,^"2>/6@#0HHHH 2O._BIXADT[2HM,MI-DUYGS"#R(QU_.O1*\+^*TC/XR
M*$\1VZ ?K7;EU)5,0K]#BQ]1PH.W4X?I].E)117U)\R%%6;&PN=2O([2SB,L
M\APJC_/2MS_A"KQG,4>HZ7)<#_E@MT-Y/IZ9K.=:$':3+C2G+5(YJBK4&G75
MS<300PM)) &:0+_"%ZFJO!Z$'Z5::9/*PHI<=?:DIBL%%+]3BDH"P45UVC?#
MG7-7M5NB(K2!QE6G;!8>N!_6J^O^!-9\/VYNIECGM0<&6%L@?45@L51<^12U
M-OJU7EYK:',T4<9HP3G'-;W,;!11QZTH&>E'D%A**,C&>GM1UH"S"BCC/-*<
M=CG% 6$HHX[FI[.TFO[V&TMU#33.$0$@9)I70U%MV(**OZOHU[H5]]CU"-8I
M]H? 8$8-4.,9/%*,XR5XL'&2=F@HI0,G&::2!WYJKBLQ:*ZGQ+X./A[1[#4#
M>B?[7CY=F-O&?7FN6[?A44ZD:D>:.Q<Z<J;M(][\(?\ (GZ5_P!<!_,U+J6M
MQZ:UTLD#L8+;SUP?]9SC:/?./SJ+PA_R)^E?]<!_,U8U'2(]1O;&Y>5D^RN6
M90.)5_NG\<'\*^3J6]K+F/JJ=_91L1QZ_:.P+!EC\B.7=C/S/T3 Y)Z_E5S^
MT+7[$MXLA>!ONLB%B>W0#-9*^%8DM'A%RQD-U]H1W7(7KA,=P,G\ZN2Z07TB
M*QBG6$HX<M''A']05ST/UJ&H=&6G.VI*-:TYGB07()EC,JX4_<Y^8\<#@]:?
M#J5K=0SR6\H;R5RX8%<<9!.1T/K5"T\-PVULT#3M(K6IM6^4#@DG/UYJ>PT<
M6=G- SQL94$>](]IQC SS0U $YCDUW3V>.)K@"=PIV $@;AD#.,<CIZU'#XC
MTV:SCNC*\:2%@ T;9^4X)QCI[]*9#X>CCB""X)Q)!)]W&?*  'XXJ!O#(98-
MUTDA@#H@EBW QNVX@C/7/>G:G85ZES0.MZ:#,/M0/DD!V"L0">@&!R>>@JO:
M^(["2U%Q-*(U:5U3*D_*IQN/' ]S3FT)1:M'#<>7)]K%W&X0$(P  &.XXJI_
MPBR[TD:X223,GF&6'*N&;<>,\<T)4PO4-)=:TYIW@%TN]"P.00N5&2,XQFF?
MV_I@C\PW/&[;C8V[.,CY<9Y'-9L?AN2X\^.]GVVQN9I(X409&X$ [OH>E6[3
M0%MVMW::,O!)O#)%M+_*5 ;D^M#5,.:H+?\ B.RM+9)(I%FDD"&-0#R&..3C
MC\:L/K>F1/,KW:KY()<E3C X.#CG'MFL[_A%RL1ABOBD;J@E!C!W;&+#'IUQ
M2GPM%Y=Q$)D\N4N5;ROG3<VXC.>>?:G:F*]0N'Q!I_G6L2/([7$K1#;$WRL!
MG#<9%:4KB&*21\[44L<#)P!FLR71V^WM>PW&V7[2;@*4RI^3:5_'UJ[;)/\
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MB\$$TDT46P AWSG)[CDTERVW'>5]C6HH_&BH- JQ9_\ 'Q_P$U7JQ9_\?'_
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MCC;CJ.HSGBH+_6K@7T<%K PA2[6"6?<.NTL5 Z^G-2:?X?-AJ;7:W)*LSL4
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M'8$I]RI!XA$TUM$;1XO.=HR\C80$'H#_ !$]1BM*_NOL%G)<M&TBQX+*.PR
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M?_FG_P 31_PIO1_^@E?_ )I_\37HU%'U[$?SL/J6'_E/.?\ A3>C_P#02O\
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*4]% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>urgn20240606_def14aimg005.jpg
<TEXT>
begin 644 urgn20240606_def14aimg005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ". )(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#VBBBBMS$*
M*** "BBF2PI,H5]Q7NH8@'ZXI@5KG5;&T?9+<+YG_/- 6?\ [Y7)JA)XAE/_
M !ZZ+J4_HS1"-3_WT0?TK8BAB@7;%&D:^BJ /TI]4G%=+F;C-];?(Y>7Q)KJ
M<KX4N&7WN%S^04UG3>/KZS/^F^&KJ!1_$SG'ZJ!7<TA (P1D>E:1J4_M07WL
MRE2J_9F_N.-M?B7HTQ GBN;<^I0,!^1S^E=%I^NZ7J@'V.^AE;^Z&PW_ 'R>
M:@U+PKHNJAOM%C&LA_Y:1#:_YCK^-<)K/PYO;'=<:3,;F->?+;Y9!].Q_2MH
MPPU31-Q?GL8RGBJ6K2DO+<]3HKQO2O&^M:-+Y%T6N(T.UHI\[U]@W4'ZYKTO
M0O$^G:_%_HTFV=1EX'X9?\1[BHK86I3U>J[HTH8RG5?+L^S-FBBBN4ZPHHHH
M **** "BBB@ HHHH ***AN[J&RM9+B=ML:#)/]/K32;=D3*2BG*3LD2DA5))
M  Y)/:L>[\4:5:,4-P9F'58EW?KT_6LCRM1\41R3R.UIIX!\M!U?'<^OUZ>E
M7/"$%N^D"7[/&)5=E,FT;CWZ_C75[&%.#E-W:W2Z?,\WZY5K5%"DK)IM-K>W
M9"_\)C:!O^/2["?WM@_QJ[:>)=+O&"I<"-ST64;<_CT_6EUW56TNVC$$0DN)
MFV1J>F?4_P">]8Q\-WNHW"W.L36\4:@DK"H4_BV/\:J,*,H\S5ETUN_NL9U*
M^*IU.2$N=JU]+)7[LZ[KTHKC8[R?P[,NVZ6^TLMM)#!FB_S^1]JZ^">.XA6:
M%PT;C<K#N*YZM%PL]T^IVX;%QK7BU:2W7^1A>(_"=EX@A9F40W:CY)U7GZ-Z
MBO(KZPU#P]JGE3;X+B([D=6QD=F4^E>^UB^)/#]OX@TYH'PLZ@M#+CE6_P #
MWKHPN+=-\D]8_D98S!1J+GAH_P S"\(>-QJ92PU)E2\Z)+T67V/HW\Z[>OGF
MZMKC3[R2VG5HYH7VL/0BO5/ WBLZO;_8+U\WL*_*Q_Y:J._U'?\ /UK3&811
M7M*>QE@L:Y/V57?H=E1117G'JA1110 4444 %%%% !7+ZB#KOB*/30Q^R6HW
MSX_B;T_4#\ZZ<G )->?Z=?WFGSR:O\KVMQ<&.92><_>R/S-=>%@W>2W2T]6>
M7F-51Y(2V;N_1&YJ>IW%Q<2:+I$&65=LDN<+&.F!Z>F:V=*T]=,TZ*U4Y*C+
M-_>8\DUB:C;7.DZL-7L$>:*8XGA49/U'^>OUJ>U\3^;>PVUU8S6HF.$:0\$^
MG(%5.#E32IK3=][D4:L:=9NLVI7LM-+/:Q>UG25U:U5!(8I8WW1R#^%JRO\
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MTUKINF(?FO+I5Q[#C^;"LO3(=,D^(\+:#&IM886\]D'R!MK#Y?S4<>]:5_\
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=N&<I2=Y.[/0A"$%RP5D%%%%26%%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>urgn20240606_def14aimg006.jpg
<TEXT>
begin 644 urgn20240606_def14aimg006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "5 )D# 2(  A$! Q$!_\0
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M3,6CP(_#O*TB#N%P!G\2#^5!U!#\QL;8R?WMK8_[YSM_3%2?VDMTX6_B212
MOF(H5U';&.#CT/Z4Y.;:=MA14$FKZLSLUT'A>ZN+'6X8&W+'<@;E/0@C*M_*
ML]M%OO.:.&WEE7^%T0E6'8@_2NGL/#][_:ME>2A8HX8HPP8_,2J@$8^M8XFM
M3Y'%M:I_\ [,#AZZJQE%.Z:^XZ^BBBOG#[8\/\86(T_Q1>PJN(W?S$^C#/\
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MQ$CW#P6YD\(:<QZA&7\F(_I6]7/^"5*^#M/!Z[6/YLQKH*\#$?Q'ZL^CPO\
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M;_\ /8?B:26?4?']\8+;S+30XG^=R,&4C^9]N@ZFNZT_3[;2[*.TM(EBA0<
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FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>urgn20240606_def14aimg007.jpg
<TEXT>
begin 644 urgn20240606_def14aimg007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "G )8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#VJ3_7/_O'
M^=-ITG^N?_>/\Z;6ZV,0HHHH ***0YQQUH 6LZ[UW2[%MEQ?0*_]P/N;_OD9
M-32:?'<?\?+R3#^Z6*I_WR.#^.:EAM+:V7;!;Q1+Z(@7^54N5;D/F>VAAR^-
M--49CM[^<>L5JW]<51E^(NF0_P"LT[4T'JT"C^;5V%(54C! (]"*T4J:WB_O
M_P" 92A5>TE]QR4/Q(T&0_.;F+W>+_XDFMBS\3:)?L%M]2@+GHK-M8_@V*=>
M>'-&U '[3IUN2>K*FUOS&#7):K\,;=U9]*NFB;M%/\RG_@0Y'ZUK%8>>C;3^
M]&,I8J&J2:^YGH ((R#D'H:6O%3<>)?!]R(W>>!,_*K'=&WTZC\N:Z[1/B1:
MW)6'58Q;2'CSDR4/U'5?UISP<XKFB^9>04\?!OEFK/S.\HID<L<T2R1.KQL,
MJR'(8>QI]<9VA1110,**** '2?ZY_P#>/\Z;3I/]<_\ O'^=-H6P!1110 44
M44 %%%% !1110 4444 0W5I;WMNUO=0I+$PPRLN0:\O\5^!)-,$E]I@>:T'S
M/&>6C'K[K^H_6O5J.O6MZ&(G2E=;=CFQ&%A75GOW/#_#WBJ^\/S@1.9;5C\\
M#'Y3[CT->P:/K-GK=BMU9ON7HZG[R-Z$5Y_X[\(+9%]6TZ/%NQS/$HX0G^(>
MW\OY<IHFMW>@Z@EU:MQTDC)^5U]#_CVKTJE&GBH>TIZ/^MSRZ5>IA*GLZFJ/
M>Z*I:3JEOK.G1WEJV4<<J>JMW4^XJ[7CRBT[,]N,E)*4=@HHHI%#I/\ 7/\
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MT_[\K_A4_P!I1_E'_94_YC,\%R7$OA.Q>Z9VD*M@OU*[CM_3%;]( %  & .
M!VI:\N<N:3?<]>G'DBHWO9"$@ DG '4FO&/&FOC7-9(A;-I;Y2+'1CW;\?Y
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M*O22;YF^O/ _ "MRN*KF/2FOFSNHY79WJOY(Q=!\,:?H$.+9-\[##S.,LW^
M]A6U117FSG*4N:3NSUH0C"/+%604445)84444 .D_P!<_P#O'^=-ITG^N?\
MWC_.FT+8 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!TG^
MN?\ WC_.FT44+8 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UROGEN PHARMA LTD.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001668243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Required Tabular Disclosure of Pay Versus Performance</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The amounts set forth below under the headings &#8220;Compensation Actually Paid to PEO&#8221; and &#8220;Average Compensation Actually Paid for Non-PEO Named Executive Officers"&#160;have been calculated in a manner consistent with Item 402(v) of Regulation S-K. Use of the term &#8220;compensation actually paid&#8221; (&#8220;CAP&#8221;) is required by the SEC&#8217;s rules and as a result of the calculation methodology required by the SEC, such amounts differ from compensation actually received by the individuals and the compensation decisions described in the &#8220;Executive Compensation&#8221; section above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Year</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary Compensation Table Total for PEO<sup style="vertical-align:top;line-height:120%;">(1)</sup></b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation Actually Paid to PEO<sup style="vertical-align:top;line-height:120%;">(2)</sup></b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average Summary Compensation Table Total for Non-PEO Named Executive Officers</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average</b>&#160;<b>Compensation Actually Paid for Non-PEO Named Executive Officers<sup style="vertical-align:top;line-height:120%;">(3)</sup></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.6%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-variant: normal; text-align: center; margin: 0pt; font-size: 10pt;">&#160;</p>

			<div style="font-size: 10pt; text-align: center;"><b>Value of Initial Fixed $100 Investment Based on Total Shareholder Return</b></div>

			<div style="font-size: 11.1111px; text-align: center;"><sup style="vertical-align:top;line-height:120%;"><b>(4)</b></sup></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Net Income (Loss)</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 4.5%; text-align: center;">2025</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;">4,310,624</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;">11,841,327</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;">1,184,629</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;">2,083,905</td>
			<td style="vertical-align: bottom; width: 7.6%; text-align: center;">$264.04</td>
			<td style="vertical-align: bottom; width: 8.5%; text-align: center;">$(153,494,000)</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2024</p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4,149,858</p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,943,517</p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,231,158</p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">913,979</p>
			</td>
			<td style="vertical-align: bottom; width: 7.6%; text-align: center;">$120.07</td>
			<td style="vertical-align: bottom; width: 8.5%; text-align: center;">$(126,874,000)</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:4.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;">4,639,590</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;">6,316,189</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;">1,434,365</td>
			<td style="vertical-align: bottom; width: 8.1%; text-align: center;">1,958,801</td>
			<td style="vertical-align: bottom; width: 7.6%; text-align: center;">$169.11</td>
			<td style="vertical-align: bottom; width: 8.5%; text-align: center;">$(102,244,000)</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 4,310,624<span></span>
</td>
<td class="nump">$ 4,149,858<span></span>
</td>
<td class="nump">$ 4,639,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 11,841,327<span></span>
</td>
<td class="nump">1,943,517<span></span>
</td>
<td class="nump">6,316,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text">

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 6.9%;">(1)</td>
			<td style="vertical-align:top;width:auto;">Elizabeth Barrett, our President and Chief Executive Officer, was our PEO for each year reported</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">(2)</td>
			<td style="vertical-align:top;width:auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">The non-PEO named executive officers, for each year reported were as follows:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2025:&#160;Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith,&#160;our General Counsel and Chief Compliance Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2024: Chris Degnan, our Chief Financial Officer; Jason Smith, our General Counsel and Chief Compliance Officer; and Don Kim, our former Chief Financial Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2023: Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith, our General Counsel and Chief Compliance Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">(3)</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For fiscal year 2025, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2025, computed in accordance with Item 402(v) of Regulation S-K:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">(2,122,211)</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">(660,600)</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">-</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">4,514,275</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,405,200</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">5,144,729</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">809,218</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">23,910</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">244,734</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">7,530,704</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,798,552</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;">For fiscal year 2024, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:</p>
&#160;

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(2,751,111)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(1,071,230)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">-</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(695,294)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,866,200</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,267,052</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(1,401,192)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(459,291)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">79,762</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">7,227</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(2,206,341)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(951,536)</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;">For fiscal year 2023, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(2,464,250)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(896,250)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(836,533)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(468,459)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">3,982,234</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,885,051</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">859,009</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">286,886</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">136,140</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">241,644</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,676,600</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,048,873</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">(4)</p>
			</td>
			<td style="vertical-align:top;width:43.8%;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">Total shareholder return (&#8220;TSR&#8221;) is calculated as the difference between the Company&#8217;s share price at the beginning and the end of the measurement period, divided by the Company&#8217;s share price at the beginning of the measurement period.</p>
			</td>
		</tr>

</tbody></table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 1,184,629<span></span>
</td>
<td class="nump">1,231,158<span></span>
</td>
<td class="nump">1,434,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 2,083,905<span></span>
</td>
<td class="nump">913,979<span></span>
</td>
<td class="nump">1,958,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text">
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 6.9%;">(1)</td>
			<td style="vertical-align:top;width:auto;">Elizabeth Barrett, our President and Chief Executive Officer, was our PEO for each year reported</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">(2)</td>
			<td style="vertical-align:top;width:auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">The non-PEO named executive officers, for each year reported were as follows:</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2025:&#160;Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith,&#160;our General Counsel and Chief Compliance Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2024: Chris Degnan, our Chief Financial Officer; Jason Smith, our General Counsel and Chief Compliance Officer; and Don Kim, our former Chief Financial Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">&#160;</td>
			<td style="vertical-align: top; width: auto; padding-left: 9pt;">2023: Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith, our General Counsel and Chief Compliance Officer</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 6.9%;">(3)</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">For fiscal year 2025, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2025, computed in accordance with Item 402(v) of Regulation S-K:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">(2,122,211)</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">(660,600)</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">-</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">4,514,275</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,405,200</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">5,144,729</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">809,218</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">23,910</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">244,734</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">7,530,704</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,798,552</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;">For fiscal year 2024, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:</p>
&#160;

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(2,751,111)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(1,071,230)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align: bottom; width: 11.5%; text-align: center;">-</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(695,294)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,866,200</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,267,052</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(1,401,192)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(459,291)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">79,762</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">7,227</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(2,206,341)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(951,536)</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;">For fiscal year 2023, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for PEO</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Stock Awards" Column in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(2,464,250)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(896,250)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction for Amounts Reported under the "Option Awards" Columns in the SCT</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(836,533)</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(468,459)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">3,982,234</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,885,051</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase for Fair Value of Awards Granted during year that Vest during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">859,009</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">286,886</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">136,140</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">241,644</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based upon Incremental Fair Value of Awards Modified during year</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">-&#160;&#160;&#160;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:29.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Total Adjustments</b></p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,676,600</p>
			</td>
			<td style="vertical-align:bottom;width:11.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1,048,873</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.5%;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">(4)</p>
			</td>
			<td style="vertical-align:top;width:43.8%;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &quot;Times New Roman&quot;;">Total shareholder return (&#8220;TSR&#8221;) is calculated as the difference between the Company&#8217;s share price at the beginning and the end of the measurement period, divided by the Company&#8217;s share price at the beginning of the measurement period.</p>
			</td>
		</tr>

</tbody></table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Relationship Between Compensation Actually Paid and Company Total Shareholder Return</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our non-PEO named executive officers, and the Company&#8217;s TSR over the three most recently completed fiscal years.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;">
<div><img alt="tsrgraph.jpg" src="tsrgraph.jpg"/></div>
</div>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Relationship Between Compensation Actually Paid and Net Loss </i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our non-PEO named executive officers, and our net loss during the three most recently completed fiscal years.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;">
<div><img alt="netincomegraph.jpg" src="netincomegraph.jpg"/></div>
</div>

<div style="text-align: center;">&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><i>The information provided above under the </i>&#8220;<i>Item 402(v) Pay Versus Performance</i>&#8221;<i> heading will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 264.04<span></span>
</td>
<td class="nump">120.07<span></span>
</td>
<td class="nump">169.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(153,494,000)<span></span>
</td>
<td class="num">(126,874,000)<span></span>
</td>
<td class="num">(102,244,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Elizabeth Barrett<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">7,530,704<span></span>
</td>
<td class="num">(2,206,341)<span></span>
</td>
<td class="nump">1,676,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">4,514,275<span></span>
</td>
<td class="nump">1,866,200<span></span>
</td>
<td class="nump">3,982,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">5,144,729<span></span>
</td>
<td class="num">(1,401,192)<span></span>
</td>
<td class="nump">859,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">23,910<span></span>
</td>
<td class="nump">79,762<span></span>
</td>
<td class="nump">136,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Deduction for Amounts Reported under the Stock Awards Column in the SCT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,122,211)<span></span>
</td>
<td class="num">(2,751,111)<span></span>
</td>
<td class="num">(2,464,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Deduction for Amounts Reported under the Option Awards Column in the SCT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(836,533)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Increase Based Upon Incremental Fair Value of Awards Modified During Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,798,552<span></span>
</td>
<td class="num">(951,536)<span></span>
</td>
<td class="nump">1,048,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,405,200<span></span>
</td>
<td class="nump">1,267,052<span></span>
</td>
<td class="nump">1,885,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">809,218<span></span>
</td>
<td class="num">(459,291)<span></span>
</td>
<td class="nump">286,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">244,734<span></span>
</td>
<td class="nump">7,227<span></span>
</td>
<td class="nump">241,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Deduction for Amounts Reported under the Stock Awards Column in the SCT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(660,600)<span></span>
</td>
<td class="num">(1,071,230)<span></span>
</td>
<td class="num">(896,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Deduction for Amounts Reported under the Option Awards Column in the SCT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(695,294)<span></span>
</td>
<td class="num">(468,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Increase Based Upon Incremental Fair Value of Awards Modified During Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recovery of Erroneously Awarded Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_RestatementDateAxis=2023-12-31', window );">Restatement Determination Date:: 2023-12-31</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ErrCompRecoveryTable', window );"><strong>Erroneously Awarded Compensation Recovery</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ErrCompAnalysisTextBlock', window );">Erroneous Compensation Analysis</a></td>
<td class="text">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Clawbacks</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">As a public company, if we are required to restate our financial results due to our material noncompliance with any financial reporting requirements under the federal securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, certain covered officers, including the Chief Executive Officer and Chief Financial Officer, may be legally required to reimburse our Company for any cash bonus or other incentive-based or equity-based compensation they receive in accordance with the provisions of section 304 of the Sarbanes-Oxley Act of 2002.&#160;Additionally, we have adopted an incentive compensation recoupment policy (&#8220;Clawback Policy&#8221;) to comply with Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder and Nasdaq Listing Rule 5608. For more information, see the full text of our Clawback Policy, which is filed as an exhibit to our 2023 Annual Report on Form 10-K.</p>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ErrCompAnalysisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br> -Paragraph 1<br> -Subparagraph i<br> -Sentence B<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 6<br> -Subsection F<br> -Paragraph 1<br> -Subparagraph i<br> -Sentence B<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Section 19<br> -Paragraph a<br> -Subparagraph 1<br> -Sentence ii<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-CSR<br> -Section 18<br> -Paragraph a<br> -Subparagraph 1<br> -Sentence ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ErrCompAnalysisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ErrCompRecoveryTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 6<br> -Subsection F<br> -Paragraph 1<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Section 19<br> -Paragraph a<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-CSR<br> -Section 18<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ErrCompRecoveryTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_RestatementDateAxis=2023-12-31">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_RestatementDateAxis=2023-12-31</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"><b>Policies&#160;and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">From time to time, the Company grants stock options to its employees, including the named executive officers. In 2025, we did not grant any stock options, stock appreciation rights or similar instruments with option-like features to our named executive officers. Historically, the Company has generally granted new-hire option awards to our executive officers on or shortly following the executive&#8217;s employment start date. For other new hires, new-hire option awards are generally granted in the first week of the month following the new hire&#8217;s employment start date. Promotion option grants are generally granted in the month following the promotion date. Our non-employee directors receive automatic grants of initial and annual stock compensation awards which may be in the form of stock options or a combination of stock options and RSU's, at the time of a director&#8217;s initial appointment or election to the Board and at the time of each annual meeting of the Company&#8217;s shareholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under the heading, &#8220;Director Compensation-Non-Employee Director Compensation Policy,&#8221; below. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. Because we have a practice of generally granting new-hire and&#160;promotion options as described above, the Board and the Compensation Committee generally do not take material non-public information (&#8220;MNPI&#8221;) into account when determining the timing or terms of awards, and they do not seek to time the award of stock options in relation to the Company&#8217;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</p>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">From time to time, the Company grants stock options to its employees, including the named executive officers. In 2025, we did not grant any stock options, stock appreciation rights or similar instruments with option-like features to our named executive officers. Historically, the Company has generally granted new-hire option awards to our executive officers on or shortly following the executive&#8217;s employment start date. For other new hires, new-hire option awards are generally granted in the first week of the month following the new hire&#8217;s employment start date. Promotion option grants are generally granted in the month following the promotion date. Our non-employee directors receive automatic grants of initial and annual stock compensation awards which may be in the form of stock options or a combination of stock options and RSU's, at the time of a director&#8217;s initial appointment or election to the Board and at the time of each annual meeting of the Company&#8217;s shareholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under the heading, &#8220;Director Compensation-Non-Employee Director Compensation Policy,&#8221; below. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. Because we have a practice of generally granting new-hire and&#160;promotion options as described above, the Board and the Compensation Committee generally do not take material non-public information (&#8220;MNPI&#8221;) into account when determining the timing or terms of awards, and they do not seek to time the award of stock options in relation to the Company&#8217;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>65</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>12</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="urgn20260312_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="urgn20260312_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="urgn20260312_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995440 - Disclosure - Recovery of Erroneously Awarded Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/ErrCompDisclosure</Role>
      <ShortName>Recovery of Erroneously Awarded Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="urgn20260312_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="urgn20260312_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>urgn-20251231.xsd</File>
    <File>urgn-20251231_def.xml</File>
    <File>urgn-20251231_lab.xml</File>
    <File>urgn-20251231_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="urgn20260312_def14a.htm">urgn20260312_def14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ceodirectcomp.jpg</File>
    <File>lbsig.jpg</File>
    <File>netincomegraph.jpg</File>
    <File>proxycardback.jpg</File>
    <File>proxycardfront.jpg</File>
    <File>tsrgraph.jpg</File>
    <File>urgn20240606_def14aimg001.jpg</File>
    <File>urgn20240606_def14aimg004.jpg</File>
    <File>urgn20240606_def14aimg005.jpg</File>
    <File>urgn20240606_def14aimg006.jpg</File>
    <File>urgn20240606_def14aimg007.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2026</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
    <BaseTaxonomy items="88">http://xbrl.sec.gov/ecd/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>28
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "urgn20260312_def14a.htm": {
   "nsprefix": "urgn",
   "nsuri": "http://www.urogen.com/20251231",
   "dts": {
    "schema": {
     "local": [
      "urgn-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/currency/2026/currency-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026_def.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026_lab.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026_pre.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-sub-2026.xsd",
      "https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd",
      "https://xbrl.sec.gov/ecd/2026/ecd-sub-2026.xsd",
      "https://xbrl.sec.gov/exch/2026/exch-2026.xsd",
      "https://xbrl.sec.gov/naics/2026/naics-2026.xsd",
      "https://xbrl.sec.gov/sic/2026/sic-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "urgn-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "urgn-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "urgn-20251231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "urgn20260312_def14a.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 9,
   "memberCustom": 3,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2026": 3
   },
   "contextCount": 65,
   "entityCount": 1,
   "segmentCount": 12,
   "elementCount": 269,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2026": 88,
    "http://xbrl.sec.gov/dei/2026": 4,
    "http://fasb.org/us-gaap/2026": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
     "longName": "995440 - Disclosure - Recovery of Erroneously Awarded Compensation",
     "shortName": "Recovery of Erroneously Awarded Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31_RestatementDateAxis-RestatementDateAxis.domain-2023-12-31",
      "name": "ecd:ErrCompAnalysisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31_RestatementDateAxis-RestatementDateAxis.domain-2023-12-31",
      "name": "ecd:ErrCompAnalysisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "5",
     "firstAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2025-01-01_2025-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "urgn20260312_def14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r112",
      "r128",
      "r163"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r129",
      "r155",
      "r164",
      "r168",
      "r176"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r93",
      "r105"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r93",
      "r105"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r93",
      "r105"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r105"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "urgn_DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.urogen.com/20251231",
     "localname": "DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deduction for Amounts Reported under the Option Awards Column in the SCT [Member]",
        "documentation": "Represents the deduction for amounts reported under the option awards column in the sct."
       }
      }
     },
     "auth_ref": []
    },
    "urgn_DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.urogen.com/20251231",
     "localname": "DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deduction for Amounts Reported under the Stock Awards Column in the SCT [Member]",
        "documentation": "Represents the deduction for amounts reported under the stock awards column in the SCT."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r132"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r132"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r93",
      "r105"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r93",
      "r105",
      "r156"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r93",
      "r105",
      "r156"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225"
     ]
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r106",
      "r122",
      "r157"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r129",
      "r164"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r129",
      "r164"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r129",
      "r164"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r129",
      "r164"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r129",
      "r164"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r116"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r93",
      "r105"
     ]
    },
    "urgn_IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.urogen.com/20251231",
     "localname": "IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Based Upon Incremental Fair Value of Awards Modified During Year [Member]",
        "documentation": "Represents the increase based upon incremental fair value of awards modified during year."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r129",
      "r155",
      "r164",
      "r168",
      "r176"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r180"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r180"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r180"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r121"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r199"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r121"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r113",
      "r129",
      "r155",
      "r164"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r111",
      "r127",
      "r162"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r103",
      "r114",
      "r130",
      "r165"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r103",
      "r114",
      "r130",
      "r165"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r106",
      "r122",
      "r157"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r108",
      "r124",
      "r159"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r115",
      "r131",
      "r166"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r110",
      "r126",
      "r161"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-6"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>29
<FILENAME>0001437749-26-014237-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-26-014237-xbrl.zip
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MCFZ84<F0*%F3,'2Y$ =T:MOC 'EO&@S3(A35**^- WBVH+NG4SC@"6^I$S"
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M7%G.YEI!1C#',DGI4-_!A<GG-XJ('VU8K']9RW.$6)\6(_NB]YL)-N:=;N&
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MN[VNMSD:7LZ]\*<.^X&11Q)GAWC9N%#?:4ZE\O10%Y/^>JSW"VI@:1BH9I,
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MP5;\DQY!(Y_,QV]YR6[1%%MM"MM5'OV:CK=5C5<5%O2Y4XQ-?+]J(\_7^:;
MJY7G(A-CV![),IJB<4^ Q QL!(8+P4$0R5SC"J[JY2S/6>7'5IM8#\* I-7
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MVT5U,9X.EY:O\8Y'[7 "JACZ*/HQ2A5\]A<T*;1@,?4)H-<X']PHI'*I(+S
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M*P4!;B1NW=ROXHF!(>?WOMHRDH?_SL/\>"1?Y E0;C:*K;0O?+?EN?WS)FT
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MNQAP%&JB?)6F0)&5.'28*H:>YLB"^O,GFD=\+. 7,G-+TK:_[44H3Q88M^+
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M#<\!4-[6?:*_KZCZSQ!O8)=@L#/V0\&XJ$(,7 <H&L>6(AFRCN_WW9?&@59
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M8^;2-@[F(R<0P(B"D<U]4TOCE,EI_Q8'OMD[:E222=$%VBA%9A$JZ@9=IC2
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MKSXC-0(R< W8I:0?[,W&'N3,L8UT'<OZDN+0/AFCM1?81P0H>D4]NMP<A)B
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M![]. :;(&D>VW,=ENSLP?^U^QWU8\VFE[Z$AS%_B 7*XQM^,233?>#:[\1Q
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MCHIYZ'J7?][K>M_G_9[S_>N<^[[.YSXW?Y _!D@ZVCK8 B ( B<V N / P<
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MVOK&YM8VXO#H^.3T#'E^\=NXL !LK']M?S@NBNMQW<#!P<;!_VU<6#>\?[N
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M6B)W\/)NP-X=7^Q-L8'CC<V4??9,IAD-XR..P&=+-$&.=R_2(T$Y6J[0-L+
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M,]N--^'Q!5-5_D&?D6;SG!C@UY1(Z^9>G>I#4N_6;BZ]P5E2VI:T/[ -I1B
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MZ]?+P-QOL2G789%G%%(=;]&[]'0,DNOO7\)7_^;;"!6QB/3=6V]#%?&:73&
MC261D90EJ4]A7RM))2=H=X^HIZYBEA?4F=2_7Q&*)TQO1OHAAR1QYJPSBQN>
ME@G;@3 8.V3(5\%T*!><*+8N7N5,5_0P=1&^H:S6I>/X\3Q0T:+*P@I^=.H"
M5^AR=A6_E#%7,T6(<*@V7NMH3]-,@W.:8%)*TTAW^F=W'SCC9YL<7_R1;QF]
MW)0(NF9+]KD>QHTW7+Z4.GL*I /$AH[4&R\<GB>_]@.]EX<U.O)B0Q58MQM!
MP<VVGM (Y/2E*C)2OR8Y-QM-L2#"A'RB'VWKTUVQU<3PCH4A-+4:])'FI*W#
MV63$ JD+-=?4GCR)#^S<[Y3:.Y$#L[4VQD<8:-2R"\((-G,\(.EH461,5Z?%
MG>DEI4187V3-D*39>Y-(\S$PMGS)E[ET 5JFSP;"ONZ*;)9W4V:,\90 B>G1
M[*J3VE0GN%Y';.Z\(UV&YE:%IHMW<2]'0X,A4_,6-4#=\!SY&(_^F34UUJ;8
M?S.5^7=3)3I&H[M@Q8(%A\;,SY(7 1-VM_?*R67=;FT3R*F8Y07+BR#4NC
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MG/18$_?).X2T.2?"E+<R7%U*4O&PXSWE0)[ MT?= &VBONS_Y!L%?@G+Z"O
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MKLUM0I9?@8NQH1JF5P#\UU< 1/%VV36S?N^ES&L(A&&6]QL.;^Z$J/L5,6K
MK/QT=&++)-KK"L!)$8HSTUAQ=FON1!/+ E6,Y$&Q@]<RLYN7K:(2C6%OUO]J
M"9'_:8F1_Z*@8#\=%#569?\69$H99Y@JB_N76=+X/;D")%S LT^HZJX PS&6
MMW%BXU9 V)"5',W;,1TE?^.U/\6.^2SN]..DT?'&97 ^[KD$PT1#*+9O\4#>
M C(EI77)2.NR ILOW'121"?(9>),_:4XOS_T"W7(OP&=25P!&*X C8XX&\UE
MLG+RKX3)#M'%/#M*Y5!%CA=-?01).//'+7VG\.=_)(_@2.%WG%G*O&2)2=#"
MPYD>G5> )]Q>XN@O7.C18TC:^77AY<YAW#"S]9R_BU<7?^=&\R_[:V?;UC0[
M)NH7Y@IP],7/P@I[+)^Z&I1G1 6TOQ:X.S;VP; &46 ST9F588J;5Y_K?R\0
M6 MX^06R^J@2=YK1D',AD[/(ELS?]T077T[[5#XS1.%,LK(7JW]2AA>6RXN8
M<#F<UBSW@&&C3'ZKR?![,F_QE<2RR&HI$J'NY^!.:TU+_^_QZOVOM/\R)]%?
M*^S)LD@Y3DC7)4+K@G@.LME1%M_]6S$SQ4V1[)L/MW 6:<G!G[)YFD$G-CAF
M.#_$_AR!;'85=_-/7 %L0&?L9?([K+S8Z,@ZU\6]T2.)'(QJMN:P$BU2I>4/
M[SU6V&L>8#(@T9#Y:MS)UCE.;_\UU7OB7^[%H?/.\K*I,3?.Y;LP+;BEG^@M
M_7M:$05NZG>0 R69Z[\!(/9+RN1QQYG"$YZPHBTYR\P3:7LAF>99KQW=J4$<
M3)GD1PIC50L#83OX5KC3O54K@\-"G _"83NL;W'?TV'T11\J1+7.8'K[RP5
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MU\J/DV0Q>>MSB^+^=SQP.+WU=.&V1L!&FX]21T-T:7I^#97XR/= FHBG>P0
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M*ZA2:DM8"E5$%' 3T!XC&!TB&24("FD<EO5W'LG<(ZNA9&/Z)M7^P$H0.@>
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MX:BQ0C?MY[75W*39B61_CDV,V521=T5G^K>?+&_%U;\W^Z)D]6ZIZ[I 6G)
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M ;@B6-@2Y\$]_-3V#]^3\ *O9(ME[FAE/H:/%>VY?3-4M>K^)O?M!%-L>$G
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MYWT%PV:T^8=0X)W0$/KY;HKQ>MM,NKPA*VF7R<$+R7EO=7]N4PW5]XB9*^Q
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M29W:(>2U&0')P\>33Y#$]=>$H>%4UL*1&6USG+6(VLH1YA-(C1VL>-:=]4,
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M7)*X4'2HUY^.;M O-!C=^=>2?<WW'X<;,R>([_B&-[>L'=KQ4'FBVL?CWUV
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M1I/Q<7JR9L1JP2^9-P9"@B[W7.KGA'=&.XQ=*>"]457J53DS8!ZA'"R(T([
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MIH0N1W9^//84D*-J&HP;FEYD 89]F6Z64Y;Y%2R S,#^<J2H49CF^BG*.Q:
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MQG&A<;11_F&8$ O P?[0J2!-5QZ*-<E=E]F;&=Z9,%9Z.&H_2;_NA^'$_)5
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M.?LR@L&V&ZDEU\\E2CP_T;-D24Z)$M#RK\,M0EZ9+NT7/>H+2,VWI(VIH8=
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MI%N#'R,: *J= \G_%:V=<"\,59Z?GR,H*='$LTJ.R-V3E:4 M.W =F-R&-2
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M*W+ &:C#*V6D-#"^]$SSO4+P!.=/CI> YR+7TO@;>-(]NW?)3\]?X5O90SJ
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M@1*@DO6Z5T._GGI?@R[9&N3BI'[($?H-I)]IF#Z?^>J6-%7=3T/YR0;3>0G
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MH!0$#Z2$<EJ[^@MSZ",?MLSP:JRH5[;Z3'RU>M?VZ-_*PZ28&'!Z!40A<2Y
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MI8)N7Y%M?OZ248\KR3OA4@C__QX.]WR+'R'L7H8(B4X >T(7GWF+#Q<"KTQ
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M1WF.X6T*5]C=[_B&R).!V:C&JSV#WL6- 10H%?'V8"0>;E<,$^B:#L95*_^
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M3;EJI^;B33-'9;@ ]"?B$6=\*KOG=QVM+0)*I$[43ASV9_/,'YF;#LNW/;H
MI*^!%X1CG87(>8O2\APPL&6RU9]=FL^>HT(*L[9EERIII!@+61]H6) Y^D[I
MNN>9]:M@;N;&-@:ID*]&I4M^-K#"5_/_A8O16O/U,BO27^;_)_OG/?^[#R1
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ME<>;LF%@W&.]JZKC*B4MT;]LYR)=$WK'DN75KU7V7K$SM+BJLDQLR^T39J6
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MO6TL8P2A-MXF'&,*%%VG^@5"!WZ99L>,-GL%LJ>RS89T$5D#W_Y3K KT7AZ
M<8\7C+?HKSGYOW-$NC0T0Q5&=*K+;%T^E)5MD-QX;G,CQ51<D51[Z<%^1!KK
M#BCFZ?&@H6%C+"?^)$J_,7;9.U8AS-DO12#YME;8IXRQU'SXA/J^DZS?_IDO
MWS=GPN)<ING![.'NR+9%47?.S<U@CJJI8V$6?(C>/_@58&7,J&GB8>SD"K&Q
M?XCA"G #HF* 0T9YN5$D4B_NG%LE?-"W8ZT87'5'?7%K6G!ZTR"?X ?G^1<(
MM5M*Q^V>U$%*AWV72S!RL@4H#*VUI41%8Q877P183G=4416UUL2ZSH0>CB'P
M+"]&!#./[1\)!C0'*9I/Z"R4O>69_R(3GM+.=<:X(_0R%10SJ;CP=/SI>W\#
M[8S)'8?3WF]PR?2MN8I,O6M"N>.63E"TW813XM,U<)&);F6.,A5I]066[SJ#
MBBQYNFB74F6M[AF&WI665ZX06%%@Q ^M=!.9F"P^UR2^CB7NZR9K/W[))'QK
MF"7M8=?GBE]UHV9P+N"G'.G+'[7FWH(8/=U1FW'%6G%V^AVZ!2HFJTU&GZ3G
MG[D:Z\D=7'YO0'K^W%A*:OY6PD,54'@%$ 2?MT;=;93UGMT("'9H-?&-)J@4
MX?64QKTK3%9VF^QS7$]-Q78=#I95A09KE:^M*H"WS>6.*6XX*A"R'+!/#PL=
MO=#"_J=5L5L9Y2=I)Z?0-_9^K_1_F:M(6_;R>ZWL'7BFX_R&/Q$9"'93UXJ/
M=KO)>"_1!E@.A7H_K\#0LHCCN4DPJ5V&?J,Z GM)9B<&]V/'DL>^<. 6]^LW
MQJK$,XI_/DV>Q5[4+S8>5TLG,7Q9,WO'ZJWB< 7@^!S2@.PO+'$>ZE(^5)4T
MF$2N4H5< 2RYKP#_= +3KP"W*JX *<9QQ$[?G O=-L3_OIY4I+++RI_[D91>
M7XGS_^6-!<%E1;P $R$NY^X58-<MZ@J@)'&R=O,^?RDJ:]D)!9T?K^F$LM'(
M54@,0&.?D?!\/]'_E+*EB4B=YO%]YRFE>(=P)^#'8*XEC*\S9;/&2F*WR:M)
MIQG4VGXQ)FXGF2X__>EB2H4QJK ]C^*QO,*D/+_*R5N;S\4?5./;P.GQS>X]
M<[8,AQW$D6#>ZCJ<N(A>/K[P9$H[T7#,%8W=^YEG/I 9'M[;MFQ^:SNP^[$9
MZ.9W^*NCC.%NQ0?XFZ:M5;A[_[QANU> FEJRN$'1'H@^>T3WP.S?^W('@;BW
M[PZEWJ:_G\Z_:92*X5R_ D02A CE,<BN*T#Z<0W!M<UM_&B?BB"-30^'2Y"U
M4G6</XWW+;X"]*Z>!^>0TUI> :;45$G/<UJS$3!M]+4_)>%9S6;&UL6A>UL?
M569JC*%KQ9*^,XD4SW_*;MP.<D[OA#-;PR;D5$*$WJL7*)?-F3G!:7_YV831
M:.QI/DR1>44"H/CI?ZR@IXCA]$,OTEM=UAB.M>BA#QV*Y[O.%:/@%;14U1V'
M+A>!R9IN7EH]_2_?FK&Q-PPQ8$[!:Y!9Y)\"QD6!?;<LS-D5X+<\RHUBBXD1
M%='29/4E[3SLK#Y)OHFA,:BT.9^Y,ZLX#YA-3]E1(R$<&4PU&:@/609= >X[
MIB]P(69/@FPV=".U&WPNYU,8GC;T]5"QP'.(/#O!LJ/"N]Z)='41@7GMY\2?
M;API%(,Y,_G42HL.2<1_PWR7/O&Y<FP"WUGWW-H>X]>)PUWGPU%,RG$J6/A>
MX:]QJ$/:AB$,DY>MS[9L!WI_*Y,>X;%:PG<CI[-L=#%4=S$J?96QQ69JMLDZ
M0+'GOZE*$'11N)QFH7+A-I%A1,)*ABRR.7+T5#?2,>_;UQJMXGXEC[]=OUAX
M8O8MTMHX1W<1806@K;JT<Y#@SZI84K/[C3P]OR71<;1JS_N.X<#T%=T\Q<[]
M:&NNFOH:VY]60O[^ P\PR;RU=5]9U';3_NY*"_YF\^:3ZE)D(/@5]>*$C:K#
ME*#"G4Q;A=/F>FY2.7Y<W<[H_*_:=1*W?2WO3N=\P2$BV2Q.+;9"!@BC8I^6
MC_4JD(H'+D>#=&BW,#FQ LNM#,5P+Z"@3E/,C^RAWE>1S';Q-8WL#$IVSY_?
M>K,ZN1"7Z[3P8+3":Y"W8TI[#/I:U<W![GXG.;^,P.,/] $DUE++>K$*LEB&
MHKCR6F4TQM-B[&C6RE WK7\T0-"7SE*<]YY^86IU@3*M(/G>11C;!BQNV;1;
MC]P2AGIPG:M6?.%>7VMWXJ*/FHN)BV3E@R=&G^8Y>:9V]R^61V^VAG@]<[2X
M H G4<3(6.! JAO1IWZQ:*>FOK'WA]/[K7I6+W]HKM,IA:".XR_^6$,NQB_5
MMK>:Q1C_K%;Q/2^/YT.GAR'8[UQ0O<)F1Q4YMOG/A]BCG'YU0S<$[YC+U;YN
M[A3XY?*.X4XQG!GG@-&#Y.*1QA%RQDN#DF-J+74U.9W^6?U7 )=M!9NN?6[F
M+!\HW5NCSD>?>SH%/T-,%I>1B>2&L,@EO+\BA>IRHYRX.'ZW"-)'O7V[7S91
M<7@Z7^R)(Z&F09!ZIX'47:<6.H^4<.LN"T[S,6U:QYPA%C>'S<>#.6$@,QPP
M/1I.D,BWQH?^@=9.5+H\3MZ;\^SR2'W:JO=")D,[)VJ!L15GQ,'7@)U,4HR!
MC@U$F:=U\+;$OU>;^%J)?2YW<VZ*YD)Q>(4L2[%;>!E);08IE/<_69B;V3H$
M,8?J;G>*6@Y^N6BFMGW#/.#-PEK4[<:BG@\A2M<0.SGNC4B0Q6DB&C&\,A%_
M)<>^/N4#)3W3^//N<[D]XQ_E] =MQ@S!(&_-<^O%C4O!! M/<%Y]!9RH=UZU
MG2V(U8L*]"WBS5FVNO,*QQ"JP0NR,AF2+4[M52-[_/ENWP9<O"Z;#'L9GC8*
M<K2P:TDK$7\O;N)>$L'[9DR 6N'U+LD;!1S@^Q0/-KT[6P!7.QSMS6YU%"VN
M;65R!="NJJVI_6+YK+XI^9%0,J+ SZCG=Y8:9EI6G=T=I[=,6IL8TV+X&.\=
M*/@#DLX:F.&(^+XP;]$M'5]H3KA,:@KM?1O3Z;+=W*!I57QJ2DA#^E_ZO!7V
MP!SYG.T07YT$@"FW3(!O)E%V6<U.V <@,8:F)W7AF+_N2X'1@8@SM3M_VD*K
M:A<CFV[7YEH[X<Q4\EM[LMP+"HB9M_0M9Y6E1(6$?^T. *9[R/BY:06':O5B
M%T03U:=:W!TN(^7H<IV9&).W/%&OO,F^0HN>6>K6/WZ3]+F/2^C_":FUX3)G
M5P[[-I)*02!?@7ND1;C"R0*ZBW7<4&U.U*_[*!6>]31X,NZ9%Z!\Y*&1/6!/
M0%EH#0G>.? G[!G1&>I;B&,.D9M7@"7.%T411TGH+]C=C*#:GNBZT*YIRY?5
M+["W9M:JJ56>+MSENF4J6Q1(A??,VSQ/2WF[1$4VXV21W1YDZY8'4B==Z-#R
M*Z86Q' G-; YQ"ZG=RW2[Q.@OFAY*4-LQF#!IJ1,UE");]Y<]=RP>/V3->['
M6.;Q:/K]IVL:<I+H.BHR@@ENN#N3*P!]]XB=4I!"87+YA,)Y$M+3T)0F+%&1
M!UN/?EDJF2@>(PK>"VQI;/;4TIL:LPHX(E;"J2VX6]I,->'M\"TQ9 M>$'OX
M>JQ"_ ).@K=?[QA5EF@M1\DW=Y.%&Y''&M[WR7VJ+FW,#JC(3"2%^>];))KE
M*(_Q3JS40KB1R4.26=#9_1?<@@V/]AK;C^!LU?B^E9#HVWNG'=H_G&2,X9&(
M*P!UZB20KRG#OL%\IJ*&;20:M_IQ'8U+.9!RH:(C3J7Y!W5C=JWYL*X1D/P9
ME)4ES->R\:;)^-])W)RH!?%2$II@;,S[W+?!KF.%]_N[U:53$&$/^>#:10*L
M*F8/ZG)BKSWEJU-AJD ^K'HXU+[N7PL[^I(1Y;32E,PNJQUZRR]/-B\IE)]T
M_(-QXL,#00\K,IV<"Y7!,0PW\9\R^SJ>_K+@1BH9'Z<T2J-]^ X#&K78G1B-
M4R@JV4J"V2$"0NAZT64!@F601(063YIT\EHA':E5/#^OL-#^W?=;#3:<U($A
M$P0&MX"?L'0P-B$.W@FO_"2G6?)RTE_K497V\/,?R1L^&/A:]+4S^O;+E^1W
MQ'YG9M%9,3$Y<7%U=ZH+,W;D=JQW[O"/#'H?1.8=0]J@)_22WH7L$[3WE>TG
M8W'L7G(:"MJTE09Q*V20%"'SNN=H3.YLP]SQEN4+M(<A>A/209# #72#:> $
M^3R8GC$V?KY[9,*F!4?^3#O@S?H()E3;C<V7K/$=Z..7PX31X N71YE,\8%!
M*\)TA&>-B"GQ>-9[$CJ&.A,NZ3H-J4\+$%(T6MNJHV^95;Z8F/!WB0A_8EUS
M'<Z[ H3!CRMS@W?=#BZ!>$4@E0\"NYY2U%O$4YENYY+A8B_($SE/;?'S@587
MX(P$0/Y4FN%;)4$<&Q4K;C1RG'/?,:,M.:6V?QKL]&_P1O_?OZ-W9[3VA/YJ
MVW)7R>]$X8?=5YCE_+!-G)2PR%[UJI;)@M"]A1V]C)7A[OCQKS;I(C>^JH0_
M1)\H!.M4=.'INH.%L=99)<X].BPMW$2YMC&.WRBMJ=&X+',T';#W.XUDG_!Y
M#9W=:\)2-BF'3\H.T4FXM4:3C_F_?D,P(?%X:E/;BDJG:B1O%(BX  7Q2JM6
MFZG>+[]'_>"ES3/)B-X'[I],%,*PO>T+C"-[7EE,'?X<2056&CS9/9TZD7=Y
MW$-91HP$.>YP^S L9S^X+$%/!1H6J5/%MC 4SSJ?IIN8++".[:GL,-Z07H>M
M-SQ&UT<>*#EV\1L.@K_]\K12= RAF8:YM0.70Y@"%;!J9<M9@A?N3X^+LV5E
MS5ZH$!-N+J@YI&8;^-Y6*BT2Z'I7X&=MA<'/$S61>&Z)_C/P\=BASQ7@0]!#
M\5G5<0Z"18=P]J.;5G=[,VQO_7HQ/?3/[+M7GT+MMP(\4Z?_PXG(+#1&4(^U
M!2Z9#W3)3<142_K*S1KY??+P '&O3J7 %)=/X]I$E5T7[C=@U[^F-=FU8HX7
M?D(E\TC_'K3TK<Y^+8QR#D9G#O$<L+^/RN@:K3Q.C%-D#6:%A1Y>D'JE8B\7
MBCA2 O);QT],GT@@#+Y6DJ-??IP.__+R66;/@V"E/+]B18F#&K<#0G.NY91@
M1E#;)>UU*I1Q#.<2!+&FD;LZ:4E+EW>TJH42H+N(/X\2/32X56J-R,L^+)V\
MH;*8:KNFW9+:LY;1\LK!RR:4-0MFA#AV?V^6_ANG#,5^Q/.; ?X9H[DI$^9I
M677/6OB6%"E@9*_2=;'#45YPRJV#/W;)8YK5L9-\'@ A PE ,H"E]ZV9/]7O
MG,@VQLFW$T?@J&R&40DS;69XN;BV(]^+WV70I-?/_G"S<2A+S(VH@^(*$IA4
M\'38Q0Y4BT5=%/8*T('BA5.N4.85.=;]LWQIQL#SSJS]5JBZ]3J"((+=>8GM
M_0!M8:M;,1RQJ8.8YXZG\EY8M 5V/D,Q#*39+#Z]9]OM=:0_VMG<>OX])+R-
M$G;GMTS*M@(S5C&2\+Q83HVQ>50\,\#<0E29WUK\5LE#-@<V*JVT,;3PQR.\
M1#$TD 5]X>C]2ZV$3<;R;OW2QN/W=*>-?4.[QQ(3(RI3[FQ1$0I4>*K?OE)2
M'*S7 D%.UMV3)M3/JX)W86+MT_<OMJPW!CY+R[D;[07?Q0/EV)<Y*1Q1MW/0
M.HK@CTM(-RKS3CONTFWC&/ZO0D9)R??6FYOX20N+RRZ_.7HM[J[7Q>P&YM1D
M.BB-?,75OS5L9U[A2-4/Y/M9D)J:L8GR1YDK3=;](C.BF>TP?)L@T<.@]:%
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MF1[VZ9V[:7'^[7<<S",5T&-!F%<F\X_Q53]X;L(,@^O\N"#B!_ES.P#M##>
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M%39QB"$\MUV^S@?G#,:B!SI%SB:C%I8]Y48(UP*S&\_OW#JT\-)OX%W>2Q0
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M]O)X<UQ83N36+PJ%]168CSTOG4RD-_F?Y%*1(:,]EX+3W\W X'WSS"YKGJE
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M-<2YT%EM-9&FYNL$K;Y<XTY[U?\X7IG=0M<#T+?< $,ZQRW>";3&=T.60<
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M-]Z&1.P9.C5%N%="'0AIJ7609%W4%/OT<\+1?VT_R^B_&GRF>]A^^_I<4__
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MK"0&J'K%=H%Q87@9Z,\QTK)^=I"MM^M#1\# F__:6B5#&.%B[_FDH:P$8*]
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M>L**X16D4;NL#;9O#<W%JJZY]^UN9.G.%[OF5O72Q[;^E#6 =[<J-J$<MB\
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MZR9WT%5M3P6WI97AJA$L5@NS:B/<WNT<3*7O0KUO 2QF-+F&FA\K9(:><2Y
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M@P:WSW(!>+7%+]S<,3$S].V./KMJ-G//9R[K)\_,2!W-7IU$\^?*/XUMARX
MV28$+QB&F>X)<TIP*EKW M!<,AAY/?+'HBC)%0>*LXFKCBBUTUQ)I[$CA1$]
M-W+R]X1;K<U+%KC7%2NILRK4VZ<88V".K6IB.!X)PP3Y<Q@FV&8.K#B-++X[
MB2MF_!LC)S/SXKGGSW<9P@,T@'H6XPBE/GCC=.PG@FZ* O F),:XK?.7U**[
M3!.=ZO389)9V:E<QIY5^XP=F]B,:+LXZF/EYA73Y^>>_ G$V+WVU:,=O/Y]
MU#6"3][5_+C:2R5>]7EY[W I,/1$X^BQ\H?RLFG+8Z3J^3%R7HG?QEO&2^;
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M:VI1\M>> EV^<S2=7M,]&VOGU*2!I+?U/VINO+JN2<W=36H@[G<)4,.?F'"
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MR\QNC?]E-O4;7%>]R8HX3.U4O:N.S3,2&+)$4JY-(RQ&4Z'/"32X_J1&>$K
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M?+%?_8V)Q1J7L/MN#H,FI*8S70!\W.$SU]2ZJL[K@?7XK?:1!23_R1?T"I"
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M*]OA[\O"JRBLKM^U?-48(%K..#LK_0$=+PZ"B;?HA]N>+!$WT L_=B$<J1<
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M+0\II7DC,YEH9.8:_"I/.W@B:++#ZR@S@L^JM17+R>6-^EA#AX3# @@YUZX
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M)FS>S#]UY@!/_C*&OZ:0O,^ S!Y*$*VB-8,IG-;4R'#GRL;AR79(L*=S@7
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M-U33()=A74DAQUUH ;-?L!AR5Q:>UGEU1Z5]F1?2\/+8A\.DGX\G!:4(G4'
MWQPRX[;#%%.;/1IL98:$+3U@RC5IP&#&78OHF&TR1T O =F,$Z15$OH3"?;L
MQM27:7>RZ;*B6LH,XY.YOQYW0R0S!=D!7(F.UN!S[HT70-%(U[>!5U<#4@LK
MD:?E"K^D^+V^LAG_T5ASO563M/"7G;* TXLZ>4[WWKH=,DR;?]F!G>H<QWCP
MW#-0CAQ#OM+4E$ 8S(TGA;\P/<=Q6OC)A=KR <3(GI>M--(6:](U[<X,OE 9
M:R^W[/2+!7C2N%:MK3[&<<3134GWJ%-N)YZ(G1]F?\<"C*W3K<:%U\&.XRR
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MX$D\83B";0"*L/-F:+L!%;'I,J:&,0MH>-H89IQIE90CI_5K^6)7_U\U*8K
MU9[W=]DWZF6"5@]]60"-LC[YGZDYF)U=Y+YH\/2><\L=K?R-+]Z4F&&2?+E
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M:B+?\@NS-E/(U]V)]L:R@45+)R-JODZ)UQ<>?Y/2(?/FM_Z84]W0US[DS:N
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M6%UO$+2 F!$0N"/EY F3Q+>3KB1F9]/\NER$G>/,_=>1CF-/;(.5?-(KJUG
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M[C]FYHESKY,8OM/63_-1V[<E:27K 5$-+U60:H4UBZ5U8MM;+_&W*3)&H_N
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MICR\HHF;?XL,KV V^C#M(:DE%.Z:=;V@<;CB[2-BA0FY(4>6B^_Y[!U@ YH
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M#V;A0)S!%:"#(#6@66LL)<R]\JYQTC4[IBNG'GFTGN"KIWYDK'W4ZY/TZ@^
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MV)4>(!S,:,/0==&E=X#"_D5;)TJS@RTBN'X7PPHFE9OQJ=:.\]*!=G"ZS@=
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MX0J[&B6<Y4'!*(A+#LSZW'>?NJP[PJW"=7!XY$E=_<5_W-2[@SD:MFBSAY\
MX[G: XE-R(3QF;.EW(E]N:V";[Y-@N<[B GDV20>T@GV-+],F^M"4^U@ENB6
MG'YKD9?1FPO_.)07A)?>JS>TEMN^951):"YV9B#0"R9;*.BQU:XG82WDI8SF
M))D8^@VTJ+[::ZS])_9:XH37R*F4*%;91+!B_B+9%Y-:.#<WAY[KU1\2[Z'D
M>JNFAOW/1NX@K1]/T0:3BHWBX, OM!3QQ?YE4D;DAY%U_9*)%Q+7,..QR1EZ
M/$RS_%+)Z[X$(7^@NAG5!&\TF_A-ZC\D91&5*CR_3? 1@K&BH71$M3I\1E?M
MWE3H25=%L'92UHE#@OY0S**Z./N7M3N&\?9D/AKF\)H%.[@6%L),X-Y1)Z1C
MHQE4\18U,ZT?ZJK'+<#OP..OC-%FS CLAK_XZ8-B14I8YDS'.$Q^H(?II.4F
M##WEVAVC4TA=8AN0J=#V\?[[IW]+/X@P<XHK24&-%BE"5CH#'TR6;3 EGY-[
M=CW*Z8K;X;46(W-80S./;J!#79"/&GV%(8&7BAOS;J<@A;,]%Y^=T]P80EL%
M(;+#\C'!!O)35:0R %JBZ\)W_4RV(9O4BFN?Z[W4;I ]\0R;(Z<N^:&_06@K
M45WVOS34%NQHM*_,WY9P:OS!MA0VE)GAMDG&9#92+>[]K-=(K$BA@3+((C8<
MSGD%N$L;1GQ:?%FQ>P7X*U.U<*9H>* 44/,;/*PV[]M4'73J'N,A&^"P')C-
M7^/=S&DYL7=L.UWN#;M=D5N[5QKH=;^]W]H$:\,==EA%P;+8X70[>>\\4 :4
MWU5M2$K*/_\[@JO8>Y&_<TX]7.EN0\[F9?I@L?+15!*A,62M3(3WR[;LC\<T
MQ0/W-2F63+[MF7OZ0*+1\QP!1P0U\E&O5.&RVAWDE$;F,/9]^()59&_G%EVJ
M3!,P@-VYDJ68@32DY(([#9'<R6(8D#RW1$*++1<NP]]O2Y_*Z'I*Y3YQY:[^
M?J@&BRT$RIA??O?*4,>"#R*P$__?*=^[1C,E6*4[/44@P9R<^Q#HAIHUN=H=
MJ@2PM<8RMLSC: =)Y.P?7CA@WPHPKW 8N/2Z^-?JHED>L1B.%^TZ;;F+PTSN
MYHY^S_MLE]CI-W-B\$,S*-FI4R(.!J#^L?&K "Y B'3"F_U)0X2[3B]8-_AF
M6SEYB?P\XD[">C+^N2%DE\MG?J-!0Y:UZSTA'G?Z%A^8B]DS4I_\=REC.,:?
M;$Q342"=[0SO_-O96?U?^TO%G5"6 2JZ*7\,XK,=P1LCGCM2K%@MUXQJ23C&
MT*7X1Z8*0+[1WZ;*<]]"%TA7MUS>/C<[7R+=Z(VE(ZQ@$)_@4&PLRP 8^V"\
M3&!2R'7/A%LD/APT(%0919\CGL#.HA0)6@DLP80+*$KC2OUNH=*TAZNMT3YY
MD$SCY;^V(09BW3Q9] 4/WD0$NBH]/" &C.\?MWXF*4[\N_#=/RBO$?S[ 5D;
MU2<4,_K;0!60T!G_B<)T[4"1;-M2_G=3'?X@/'NF+$NM?LQUI6J\I7M,539V
M,!E\V%^M?9''>B_\M$4W_8:9^J47H@P56?/>:OM_>TZO &U'K!5P*)XVR&OH
M)2RH34RYO+M.?]:I,;#Z)+@Q!+NO8,YJ>N=$BUTC/]%%=+ ^;C6^(@^NA^<[
MB,W%U>Y_QES*;Z/1"AD:2F&VS\D_Z%QH1.=<%DC],?01MT)2/:0ZLGQT^;WL
M'YCMO%=E.9K?=[_F;/RT/9-:F]]0RZ5^_]X;U8ZS],'7$M*W>#,*\WTL)0@N
MI;"9;OD7:^NU^>J8/9%#P0M_R;&_VT^?T1C\_VQMP8GAXA5 T.L*$+2XP,"S
MVW*I1#M-2MFQX50AS)8Z@_[*3VT$@W=1M!4+ZBX%VWW%J2)7 #\-9(*_S;U2
M]WZ?3X8.5NO\[VWW8MN5V(\7 E<Z4M)B@WZ.HZ0J%@<*T);E%1L6I9M\7'G(
M0X-7NJO2T_35\(%OK+(I*@2!4J>EO_+"&Q%E!W#:GQ;JW@5;3_-9]J\ 7IK(
M&/_$YT+QG3YQ3(PV:P7&R_O3E035$R4JF)(Z:5KX"G"'E.=-"S3;>[[Z1MH&
MT4=J*M==V!JYVV2Z< 6@ECE: DM3--5-3\R .FRB\9P]36%$Y0J8_"GI_ISP
M:XOG;Y-[+A@ZEUPGK<3:A]FP<[U1<ZLW503KJ<1_+,^8%,&*-U0)5LOIIVG[
M9I%S&6QH$^L,0_7G _?$?;P"_APHA-S@>2R16._1*+J+*7$ZD5=,]<;./94,
M8$(?3K<OCKRZ %;=W5ODE-Y643B; ,Q%%G>S[/>O?08I3P<^O *X$&0ZTFA/
M0I,N8[T+YB]S>Q<V A*,5^>0'^=:![H]W#,)A>2Y? $5M VOS9>"7DTVM8HZ
MS:WG0KJ45&)K"#OENEZG$P1%]%R[.RQ"E[JO2+K<='-0E#K/([\^R"FL]RV]
M'56#J^ M\HWK9'<0 [;"1\)"7XZ7[V/Q+&->6L)*1M C/J^HL ST^(OX7S9<
M*31_%Z7A)4VEB*!T%*=(\&5%-$F @^="?;81T=D+\E6 7OCZ'Y&FES"EG"RD
M$8KNC[#,[@O]<8ADM)9AI&55Y>0_<5C=:418E "M]$"8,3^P.?[W_,>S-G*O
MI0E\Z I^CIC9^%ZS[Q ,A>CZ+?V D*P7X9[X!V6+&=D"0<("^*CS@<WJOR)5
M[?VW+Q@L>=M7YPX<(P!W#U5N&H-E-U["'2>[BT6R.GQ6VCH,V1AV[A:)UU\X
MI*\^JEO4H+Z3=6HVF%T]DA+C+$I.O!74KHUIL(EM/W^#UBE2S!=29,#]'1=V
M0Z+[W&Z$Z7)1D:>*F%374-'4QA<$#ISKA.,Y(/=GMQ;OUM>EZR<:.GDKW5'W
M+%7]N&]KPY2](3+*JY#B]:9?EOI/A\^Z12.)^5+C0K25J$2DC4^I(+KCAYMP
M^IV!HKC%<,S 4^')@'1H&(=9^KL$7K/OVO'&Y72[MQ_6D_\6D8Y>#,)>Z(;+
MYP6RIK]JG)"4F\QUD2X2:P@CD>8;NWCC;ENM4093U][]/YR]9SC;WQ__'Y\.
MM:IHS1HUV]IJ"UI;515%S=06$:D=A+1F[5441=4ND9HA@MJ;$J-B[Z*('02_
M?J__C?^]WXW?=;WOG?>-<[W.:SP?YSKG=41PUT(DG$DLY? 0>C;])6Y&L)?K
MY0,\TPL6"[&("4FMDH%>D<JF@2(PA9MS0%P^@':MR4PSTA S"K4?KT#!:@6>
MBHFYH3();-P-.IFZU/1VVT?Y^MS%1Y?!^8W&4.@%LAT1[[>$_KA"1(<E7PK6
MFRKF9$.SS(WD.B9_=/A[>V!N>\JNQ+Y_G=@>4TW:J##P_>=G:G/3;8;P*+*<
M8(&/YZ23+1S*ERH:QF'!]^"I;JJYYV]3:JK=2QZ2TB53RVVQU./A']O-54T'
M./232^6=;[GN4BHGJ1B%9=]W'J&#+:V#<_3I:I>375< I@2&B_R_LZI+#N*X
M[,8+7-/IO[B $?'A%0UU+8L[EU_FQ^.XA8MAM<BVX:/*I+TK0%=^6T!D"+0"
M%SQ_6SKN^=D2QZ"U12?5M-ON?5LT;YIDNN&(']?["8.P9FEX861$393WFZ.&
M7=21\*G,H-KZN8)J]3:,D;\!/L%\NAJAD?CX>ZGJC&G?65'+(O?V\%T2R/P<
ME'01)7W@SV6SJS3PX5O7W[CZV9Q(^6Y.5T[CGR.NS4K5>[23#_(B=;"C-CV=
M2;S#_&*6P?"?D?_?IB7UUK\YCEJW_.^R]_7^_--@UTM+4'#9BD<F2U><)Y$4
M:#2.X[N9N@ACE-!_?*;\>M";IF.T_;C,B[I<Q:[H9J]CNU1H[)YZJRJW3Y.7
M'M&W<8F;TI+DU:[R.,JB;T?4:M;JV0.,_\_ZF!Y-#<>X8VS/"KDQ5>^M]:@*
M'02+"+@74;;4XY- "X><9+[,9DZS;?35R90/'G_GY)-EA^'@31"Y^V4Y![90
MW/K/]E8(( E*&>O363\J;2U+M?"K8)1K8O\18:QS=?8Y_LZ2I,C[A]%2MZP[
MHP]>#NIW%Z*"A\Y/-_#ZN'Y33!/);[]%'S/I53@2++.5+OS5-1,3FH_'B2[Q
MLNCB,&.#G1NB3'JW&NHDOG6N/7[KEO;BR4/Y8<J(9DG('#\)YK\T-HH0@MY\
M12B?>^P8(J.ZQ;QO[*0R*(*X&6=J):L%'U12(\DLT=PD7D3D+],$Z;7GL-L*
M)CAA=:/7 S1&GKH7/ZD:XJ-+9)2O,M$5NK\$"AY6X1D_\B=K(I>RJ<BO8*)B
MR[*7'/##8A=&;]/Z&KG8 QW-=LY+ST3[F&LKK9P5VYB7QRT@Y=W1B;J"BO3M
M_9;TM(FMID.VQ?G8N#TE8Y)74/$LH9T#'GT%>#'&I#X>/&OK:?>CWJ/*YS53
M=Z[HAX<2[8G4$Y/=5P"&P84F%67()1,],RG@(6I%D@#W>QIC6)>FN2XGI?QE
M[OF7DGY=ZF6_ 0F=VL7<$$RF%JIH,S,AZF8I$H:>A1Q@W]PR,LL<1,7J--N[
MF<PFZMJ_I^CMY]SE('EU$2[&$EV"'X\<ZC,OT0LN<:"H]1I_O%27-J8I&7DY
M*MDL!(C]$O_8%<*ZO^MX,@WJ[CVC3DMV#[2^F/0EB_[^@WCD'U0"!VECQSKK
MQXJK(RR37,X7#\PI@N)24GOE%8!V]>*L9/LQH-+WK6';Q3\RJK?A#MH73:7]
M)9\%,;/L?6VW-$0$'S'EUZW'VKZ_$?]TGMB<6@Z'@*J)%]G?GRT$\:ECZFKK
M4]N'E7_:97DU\O![5.@:UO=)!!M;L<1> 9PX^3KF&="XUYE^(>BA4I$GKE1+
MZ%O=95;N<8RJA_X#(Y^?:=BP.5!$+"CP; BQ&&TM0B^#&BT/[S+%*OQ#^GUK
M),K=[0K0=LQ\*3T&?!*8IUQXG+X^[_J$(^1MZ/,W_9T!Z%7RG&W;+=*#--#G
MC_O#H.C+AS5$/.2L.-3M[U_Q\)H T7*+=KU +YF.CXG='MQ3XSQ#Q#?ER>$4
MV*6R7N)_PF@F*WC\EOG!$4H-\EE&M[G_X\YAPZNN.@HY<@PK0U6=P1!GY7G7
M/3,S$E,%O/%G]?\.0PJ.D-7S+&/LBV)R;^]D.(1HPN/6SB.C5W6>5I3=M?P
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M?MHJ$7<[.Y,,<],74*MXG;OK).ME?QD7G)OQTY0NW7*Q_(M86+$E!: J\!D
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M8-=((9,VHX?%XVZ'LQKFI;CW#OZ;IELNFO)B\1L/*7<<WKLA[$B&960UW)@
MOD(DSS*!9I.=-Z;8AQ>\@G&PKS7HN2Z:,IGT/A ,GUY$G423U4NLM;U@-PKG
MP]'2(I7VO/U/\LRZ)%[?4%A7EB\O),M M\7;,]#-(S8)HX1.0CYV=.^\:>QR
MJY?<!-- >*9-:XZLU!/-/E;XE*%4SY^?Z%8RPV1SH<G 4P,"HJG\V>./NWR
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MN["5>Q>^=M!.\)[C&\_''_X&*B^>9U0L"#C[L##.2#-4JFY<K_9_RJLYMOQ
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M>"5;I,?X@+OO.B"]?LLT_GULCNENO0%00(N4JL;X?V@2,-]%#&<L%R382KJ
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MT"B2!RIJ/K%[7"[9V4CS_:<%BJC?E,]<@]X^^ZX(YTL#_M[6\X_L"U6!G-A
M+4AW"U$1;M!O!RQO4M^8IO# H^X&\*+A;5+\LQ91'OPS5D^V>M)'6)H=]6&/
MH1ILH)]F#M98<O9S,/\,G>*9-ZLVM$<ELGAQN.3QTKC Q 4<"VLQO4+L%VP1
M<(Y=Y=\ 3E'^5_"3:YD52.A)$+FE PTSW_"!)^K>^Z;1O1,ZV\8ZHK/8I/O\
M'VWM66W$;N<U99F%QLG;Q"5BI9S6>!QL8UPA(':M0K\>1G>W;#-6(X2PE9V
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M8 ;"KB_=ZGN[<LW%L'3$\U9K4!L*."\'3>NPUN"?1:T=B^*W<M#\XL*97-D
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M^%"5)C.K_8%&C:<B_5E=TPT:#S;??WNL3U%3IF_!(:]IJ:G(09RP03E(Y0$
ME:7?2I6# )MP6QD8Q;%=TW3;)Y/DR4$9Y7_)'UM;T[F-M*URT.!Y@"U3JC$$
MQOT4Y: O57B<'*3H]9S,3:$ID@>MAZ"+S\CB-NA_IXJ.\ W\!GX#OX'?P&_@
M-_ ;^ W\!GX#_[?#_RJ>E)()>X SC)HKBTZ"N))/-3^CL'OKAZTI1_*#S4\O
M^A]*V[XYUU[AI4GZ@!R4E$@X](&F17KG8%@OV-*4JU=<"F&6C[^K#+IIO*_7
M>^O=":U+R6\FD]_83. =A:[BXQS[X-TH)W%\*3/L_"%\))K]'O_P>M"WG1$!
M_$/A8__^JE#_RW_.WR44Y.-_ E!+ P04    "  HA)Y<,$CI?#\7 @ R70(
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MAU7IMP![_3^S<Y>!,Q<=S+ (4$9_!ZU,#?+,O/$U/H_RU=LE7:;W@-KJH4X
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M%-ZT*>E25J?_DE^9/W>3KT]Q?'DXYB8R.]>]S,P^PW#$]_PGDW)[7CMLXA8
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M())S1X$L;KXH2SB9;>=[VZ-"^]@\,_MZD[K>IWN4/XC[]C7V_D<&&JDCT+/
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M(N67+JM8$KF)6B]J7J/![E6>4-4?;D_#5Z6G+U37!W/(S?2/'J(.S&<.Z\I
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M"G/>AU84X:;,VLN@Z]=EV?>QRJA1MK%/<V=WP7A!Y]&$0*SJRS2WF,TSEUO
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MSN$E2/9%?;(^-V#$:U"=KJLKE,ZTEI5Y.)KUTY"BP+?[GWY!YG'W8#$#"K>
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M3$\:!JU?U_X4%\+F2$$!B(VJ!4C_93L#.CS#>EV41P==F9#OU/SE<.%,#^K
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M=4P!/AO_'HG!R/1]'"I$5HT\\]\^MSF3WO+O[+8F)XEK38E^:R(L?2U[B8[
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M(9+RAT*2>0CY=XV)<NR7]G4LA;_E:'I>:Q\18BSE+&I3VAD&?ZZX&"X[DV&
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MTD]W-ZA3_E8.76WKY/WFQKH458%*5R2==++ZCN]+8F ,[MY'>^@\L<%O[0J
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M$-9J31(LL01_["W</#W<C=[E> 655)_&+S>PY^0I5B[4JP^OH77LGWQCHS!
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MMP^92MT#QC0VR@RV71.9I.B6Q&2B\"6]-V$A*YR!%+0%:FAN:(O7]11AZ.5
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MN#Z <@M!39"62G-]4^";5$>(^&\[6-P#=@B[DIM4S2:7R00QMX^#2>H0X"J
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M#-6?[K1#FR"&^_8?)]]2,#]U(^M_;:+=,6T(NESTP$#&!3=VMA0.-,N%TG_
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MW-+'(ZJJ2BH_&@"U&O]57(?AXP# I3E?KY""DPZ=Q&5\R<$&_DS1@GO3;ZA
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M9T34PHMEC0K6-!T19NE6'8ML<S])N ._Y<,S6T3$+_UVM?+;([?BD*J,EBG
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ME<RZ9&"Z;+F_'9B*!?JNR-=I%]WH*>PT'X%'\8TIE^,R%FT_"QG:?5G?YJ)
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MY;A-ZX^DO"9G';I]<DC8E&*0EY;6NW-<'[<2B37;78BJ%[M*[GCX_5U<)@;
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MM A.;H>RVUG*X$4J1- H4L1NQYY)_>@()$6X*CS=$)*<SB_'G.7T1MQM42_
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M*.#AIIM6N2;VG*J@L1*)ICN>$WO53[Z\5@IL$.A^I)\5Y_EQ5IB*?KD>14L
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MM[HUQ\5Z+'/7^PIZ/"69Y'M2)#1UZ&Z;N>8&V?S\!2VQ8_I__^O._GYDW5-
MT.-30'LW*0$WR(%L'Z4,4N;'RW[KG6F']KLK1_R(0:GDUFU(HQ/9ENKVSTL/
M+_H'Z4-36_$KK7^*3P%'CJ> 0PO@_Q*=L_9/_+<4-R@K<C&A%5_FS^M=U96)
MKSX%5(/+W=.:GYVIGE@?2V0<;=_R[O$S^%P5=UNWV[N1@$KPLS54&'@Q#KH'
M;Q$Z!534KIX"M+<VM_^<"T: C\&G@!\0_[MGJD $N&P+?6-T1D=GPH6<AUY:
M. EZ23%T/W=(_7^^?(>1\2\:PC!SN_X4()))4*2T29T"LD&O_;]!]^R ]*>
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MPF4W2)L*&Z*K5<<V!%I21#U^+!?=/3_I8G*L+,1[#(U9S0:CV6<^&?).)]0
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ML'#:F8II%7[T/:S<OP?7QT+C)<WK1DAZ6^@:R]08,X *<H:1F-?*"Z1BG%0
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M"9N'6RMDBE)Y=!=J../(S-OOKL2FCH3D'**BAY91_"H)W,>N6FAG9!E-G=&
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M#0YF$Q9B1C_9;2-4&+[%D*@S[)3F4\BSU2*Z(FKIPM!)8>KYP1+*$J2ZV=>
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M2Z)3<\WO N)]_B?]@<(G9MD:K3B6JC2GLI$6ACKT(QCWS!'[AL:NK9\X4:C
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M:.'-33?<2FHZIB"26H6QQ[.D36L9,A.\\4_,*</Z5BF[!?B_*J@ $M4!<%
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M]/5^F<&MSD:VV-'8_4;59SH3+PF?+""W=Q@5*R4-"Y<M;5;,/U_@WWO>!&H
MAS<"K$WZQ?G2@D\,2-Y854YH(%3]RRDHL?5,;A<(AA#Z,>G ]:3N%[P0-8?L
ME8*.Y9)/DY=L)"6]B>@L>RR(9O3Q%>$SEHY<.B_<74ZS_J[F+WJ"K<0>9<9P
MO0\,.7\IX?.4*R2[_1X#$ERP?N(/ "E5<VWZ%U=,_H,966UB;@*CCY=S@4DL
M,CF"1BB5;D4<57VN0L)7P09Z6Z]G5<%D/:G[*N8M#;A;B[*\AA1ZY4:X'E(8
M8[3- KR%5K_9OAV0365<$/D^J4?26%4E-VB91(Y2D/P-)O?M$-1XD/P[@7BS
M]6O"VEKW.2RUV%]J<PU;;KKT^ME0J?%!&LR&(:LV]!;#MIP/70C;K%LSQ+\(
MP44S,?(WB]/%%CE _9N:APMY_?\ET/HO+D/XOZLA?$_^GZ*)^Z/-8O]>-0 +
M_4]48LC_=+7!%,/'GSS_5J5=06_BV/J50Z/S1<%6]H:'YVKY/%-H#>_*HK-\
MX7H7E<%(LE>]5=@WBW?9N[_K%)JJXT+_/D+_J]\Y,[F\'U;F3P+-@6U0192:
M#490_!J%>B:?D -T-?%]F,,_&RD^PB&$HISC<#-PCZ]P!E&AK[T[_GFWQ 9X
M6%**IO[S+4&ZVYMWR5$U03W65)-H,42YHT_5$U!ACOSEQ,R!9QQ05HY-[NOZ
MH$S-C'L&97CF]:Z?\F0#<%U2$E]/T9A0NF&PAH+^;\G!9(>X0FIGG]=F;/QZ
M @L>'&_AOR4!M;>1%_7G=ROFP,L0:T:B=H,'L7!4..88'N=^4&90VL>ECODR
M..I-+O[N<?SS2H^%-%73@5#:\[M$*667<QUG[U!*M)*1$'6H-P78XZ5;0(+0
M*_$&]J+4%W.L!GM&Y79/GB01V+I.Z1,13:V:^VE(!LFLP*3I;Q-(I7H;S5')
M^H8&VFR'=*$T_Y?K]P'DWPXZ/49CCCD[C_4^SSA-IW$\/H4;.'B :@3-<\ 0
M027^"(&%00MW+M_?/K<':W9QJ &S2^YSN0GT,\</EK 8HVE-3_N/X*4'HGGP
MZ)9<]UB'I$0_HH'HH+G9!Z.YE]/>ZLZCE& ;:VNSA5U.E9-J^2R;N4N!*7=6
M?X2>4 #/RV8MYR4)[*!D(> &RWU4^?DU4G -)(1[4B&4&I*SG(U=$"S=]KN'
M5'</QP %K 6S7C7@V+M2WW@I 7J"]JD@L 8<9?X; LJ<V!=>4E<Z[S+I9B1I
MO <N2R.7C8)S4P%>KJ[=[:X5)F3A0QVK70R"RT@Z+^*J,.8* ?(HX,*VXM#=
ML,71XX]N7FR!CVFNT47L'>9%/6@XK<DD%/1P*H4K\%W%S'U7D0MU/WZUW6!C
MJ<\)1@HPT8%_B+ ? ZYHO] 0"J,66MLI:.@,4TAZ966]II7MZ=S"9JKN-%7S
M(7X[+)(R7VS]>8[Z3UA*ED ]Z_*"CR "<#AR]7@\>J$[GW$*;;IZ =;MF)$?
M4E!T?_!Y::''4?7;D7G%B*!L^1MFH7Z17B)*H#6A%C/;@WGNL,O+0>2-D1<@
M'H .^MZFC8/V5MOMNCW>Z8Y0?I'MHTY[V/3XP^%<4H+A_#-L5%XVTH;!TL"=
M/VU9S*,Q:'YF633>)5],,UTI+3&+Z4HJWO+SG:_E7+PB),I5&P[+Q>&JK8F5
M 5\EC%35BE$+:Y9Q<+ZRUR0XCL(X,YY]VK\<H^'8 ]3EY,XO/WL!L1#^<1P8
M$W[^ A+\$B6[<[R'D'S][B98)PV2[1'?&N!_/'H6G?G9#$I753@1P@\;A-'V
MQ%5R&:(\IB0E55)%L_X ^)3>+GA\9U@Z0MESX_NU7]T&=?[E1U<6YG<4\46+
MRZ$0"RNSY46;G2Q_4R6C14G:VVD!CA#NS$:4T;>^3+L7QH ^MR'"Z.,I>3"]
MDBEZVK=YK]&G6@NT_%&\S9(VICG)X7">(E5[7_%!5_^G._TKJ5X .(@4Q]!G
M0SE'RI_4GOH)IB5N8'0J)24DQ][2/&:])41FQDM^8_%58>*OQABL)^6V&FU=
M4_WXQ_R)KS-?Z=5H3=IRS.RB>9;-GON+5\?<;.9Z1TD'MEM[]9_S*Y@GGJ?*
MU1#W!Q!IS82:EO[9+MK;P9^V\!PJM:^OG/TQ?@(2Z:;RN%Z;]E/:TXRW,N^!
M#"VFF><>)$@-;-2$P!:+EC^%YXQ&-D:4Z]A7C JWMR]Z4KP=XD#<^>&R *2B
MKXMA%WP?=EVTW^(9G(LT1 B7ONZF)A@DS;B#"K0N=:R"Q?\!/(^&=0Q(ECU8
M,A 9,$W2=< $1KSUMM$RC7=59S@/( KB;,)\#U@A'=R$C2RLQ'">EL#XK]Q_
MF'81"O:4(1OB(:AUQ!'W>ZB+G3OG^%\B1X(TAY;/V@&F9*'[7G)=M3G):: [
MQEQ?E<VT=9(.91AH*RV$F- 1#(L%&"]HFZV)%*S:^JRJ8U)," K1M=4V,-?=
M;H);^"QXNL97*7S+6H_,9;TE38_%7''='_HU'+#1A'8DG/0=\W&#U 1)VBN:
M,]:&#'P,2]N!,X6*^2Q:H_GI.I)^1S_6LQ]E\,2J:NFMAL;D2[22)BO@.D0X
MIU3ZJU,Z-;Z&B9_ZOVLGA\$Q>>MID)L1&Y+=#R*[ 'D#=P"CEO]D1-/OZ@P_
M34@C1'W<&2P73!1-_>!&W.9TS$_!*5](T0;Y(J,?'EJ,L/LYI\;Y+P8"[@-,
MQZ>QIWQ_DV.L.EW(S7.-:17I$IA;;XY._*\[O[P4@CW6#)J1&> !VH'8O7V6
M69EH^DS!.S?7Y &=#=8M9<-5<!-"WW)Q< 7DDH.H/[==O^-O;&4YX'$\]D@
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M-;"]QVK'8[R/N=5Q49N#8E)C?9$MEM99=L%2NURQWSEN6D-<*U 8P/S4O$.
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M$&F7:++954#WLS96C1O]%Z5 I4'['GWO]&-_T=X:_YA86!.B(7E\Y/GP:V\
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M=/)#-M!*<=]L";$A&L^""+(CFY-]FAG(^:LS<H7)=A;.@IW$&5CT+_1FU8F
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MLTZOT3K6<YC%.\3@.^<E2@=<'4:_]<^31RZAF\!"WN:AP',. FK-9D!/_NR
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ML:%<NVILXQW,<PLPS0>MKT\L/!*<F6];6;HV;*>#OE(S(YD,(.Z ))Y8JPD
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MHL5@H) \BL$<5/$94[LA-NGT?/A)&L@7[V= C*UHC+(GI%RV56;:@]G32H+
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M1XV@F"E<5/-K((!5QU:H%MU_^EMHG\:HSI/+A-7?U-CIX2F+[N[,K20GK$(
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MF$WH;T5>9B'%3UE>K;A.]X RXG\6 VC50X7.LMH+L.VOW^J 68*[YDUH-"D
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M65&$[H/X>]T[K\.%1?_(^SE.NQ7-5-FD;N]([PCI%\8L+#U]>2<NV4J2XBW
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MHE]L\7 V<\*>Z@4#?4?-5>':C%E=S/U^@Q2D]VFFY8IRU(F\T"%+%0EL";N
M9C+O:QILPYCI1:FRM[/'KMT/=*:N;C,.LH8O&WP_[F+!>I 2NU_%!I6?/$R
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M-L5(1NAKV<6WW-=)O05(3L)!;$N9$V\O:^-+K4*]3]IE\1M >SO8<OHVUF'
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M4H=$6#O_/-"#O#S2RUH_,X3V+W :OB'0> ?(YM%GZIB[W\-1=JIQVUNKG]<
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MC(%DX?LLRCI;B+[7$E/"2+"4_[#1&VJ$O9_9E\3_&2*L&!VO1^;Y<D)*N^H
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M:"8>!C'5G[G$ ,S[*1>+S [(_P)02P,$%     @ *(2>7*/3NN#3<@  ))H
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M\UT]$?17;THMG;T7^A0DO"4PTOL_F\7U%IH$K<:KH%HTP2"C%*NKIY9LSW?
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MQ3?G=GDMKVY6V13+D&^E.7X 3-8"XXTR:;-F1S,.&7QQ?'6/N<;Y65<V_?6
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MC%1>_E@\%[N;T$/DD3#SIE6@>$N40_TK:B<1FN?H^?:7XU%9V*?J&I5P=NH
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M>J^Z&,WH$Q(:9+3_PH7&-_X]ED'N8H3PP&ELZ/PN! \(O\)D-4_@@:!8/%"
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M2KGSP^CVN]G@7.VVHQ*G$__.C*_*;\8Q&]8D:.J:!24CM^5>^]^RZ-VO"7B
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MY1UPM,");JD*Z?>,CH1^7]%[2X5?[KO,8]\DI)=/?_VU>#_[GOKEB$M%!:V
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MZ4YRJ.*2O&85D>7;/)P33$'7^KYS<J% FN"@Z\\6I'CGSUN,,8>+!HQP&8P
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MD6.;CH[W<N[_:.^[HYI8][6#*!V1WGM3 6E2I 4+3:1+1U"*]"8M2" (TIN
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M*,'86E^Z^1S($N0HM1B;OC@? F'W*@W%D/Z0 WX$N:/O$-3*9T;E=S@+54W
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MX*&X-;,NM/A@,&1M'&>M+IE$TSU3)U>?ZI<]-47WEH9EJ!WP_0.$/\$"8(?
M) S[ZK,CF8RA_23:(]=?_V,<RC8+Y\H'BR<PEZO8_^54=KV"6?8;AC@YNXJC
M]5W$_$4P+E<\-)D0^)N"2J8U?Q DYD\;F\P_47)T9FJC 47O*#'@\XJ!6+=Z
MNI;LX=D,+?(XH+1E&+VDRIF.+_P'F!3HD%7_3P!>C$>T\\O ,.78-"/PS:6&
M0KAFJ@W<-9H-_X?7N:R_2MO(E(.A@-7+(%._J&_M>%*=4P8"S'V]\5U]*IH
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M!J/,Z2O*JVO//4_4O7SDDRH-).GI]<S4\<7Z5SIHG';#=5YYZ0;'^C):6S"
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M;^R[#P@%BU&<N.)'."CLS?8!!X8#ZFT.#K[B2KWU,<M%?@-02P,$%     @
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M!)T_M5E@0(0W!9N7.;[?I*X-#9R&@)DM42(S%PBJX]0/K*-LMXXIF^762VB
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M[1:RY(XG1K]34(RA:3^KHUGEQ,-E-U4M86-YI63%3*:Q4K,)9[GG0S]J^+7
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M6GY-B[)]=Q4^98SSMA?.@09"XS2PV'[Y.XKT2SJ),22-/CAWXB/=>:1$;Z]
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MR5HK6N^,:-Z1/ZZ?1 F%I+>2U$8KZ_8-H,*A1F+5RH)0L?LX$JM^/I[=]S3
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MRL_>P\M@'/_4\<?_:V3?VPN!&X./?%XA/Q\9H)TI0J6LV@Z"-)NOR^%O\Y\
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M+KFDTBDBLRVJ+(ZTK9P_#VX7="[J_M0-$T6MJ7'D/8S_V(?'55/WC=R!9&5
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MM26+IU=SADY5(RIR9%Q554FOV7ZR,A"RN:,8]'X%LSERC%;8)MDX&$GYI'@
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M]I@V.$\8.];@1T+TB:M$MZN@71S[TV<BX6K%_DO-T5U%93E2:!/57V"(=)Z
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M$#3((=LOHW=*$24Z7@MB3!\?EM!'CQO*KM]2SB?< 13X[P!H^?-,^27UC3O
M,<6WZ_$[0%0U.+_Q\I3]8CIRXO,=H-]O^)JWC>4VU/ .D!E\(!;\/6OT#K#!
M&7Q1<@=X:!&GR&+1%2Q#5F9Y!T@]@I_K^LO?X%3? <3N ,L.=X!PR8([P(CJ
M'>!(\Y:KC3X:U/;^UH=%I_,.P+LN_[OX./B2X-6MXQV@Z\^:A&Y*=X"\M#O
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MW#<Z;U-MH5WF042T0 7;8H2?N-HC]O^4@R6.O=E.E;8;W";ETE2[%A'RQV0
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M:ZWR<>/8([(N7,Z 3>,TOH"F.GIC-'7%LL8!/*.?LY&ZS?-IFXK'O#0WNS*
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M)60;RCK,,&:.M]]ZG>N\U^^<<W^O^X_GNN_K>;Z?>WD^]T.9H'P'V'0TM#4
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M$)8+9^"\_2*WLH-11-YP"_30<XB)2Q0R+[;])[3?R/YWP"+^7\C^">Q?N*8
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M*C HJ42_6$]OFU*>^3FA9.;PL.W7"O5>CU$\GYE=?("3;3[.17EVRRUV--C
M@=>J_QP1O<&=LQ).P [WEWB3DE7,)4>+F^N"+&5CW!Y&5PD7D^@D4,[HC$>'
MW671NG_GKT8;0;A^L7](T5-PC5G]FY/+,61S)*>SZ1^3-J^:I"$5C6WD;$G*
MM&A!$X<)4X%ET"MK#NQ+ZZ%DDP?[Q6':V&/T9@BKS9?ZTGYWD_7V4!GY;](*
M*=U5[_SMQ5,/$^:BRP.CLE 6+N/LL^9:HK$8:UQ0Q'5VBX<2Q;77-O9/DO::
MV:I?V8N0OF!>AC[;,D1PO1?DN2[5WJ-S/+^>V%GK7";\4_1(P"@18AF4HY3\
M25LT.3!3+D0O!/#.4GKU\H&+MI)H9PLY!6$/;]MCK:$ ;=)D$ [AC"'J@X]D
M$)^"C[$HR!EE#IM;%."W2^UO%T[$ORU -E.N1 0[PD&7F)BS$Z+'J_+N0QBY
M;P2Q"H:?S$8PDL3)0E-/981,0A/N4P"X)E'S.!6Z+'^#6ZS[ T=ET#O?I%+;
M-L/FA+D14)L6< _@H0ZC=S'?69&!*T[CUS#)4HJM24_#&,4!GPLM=KV9!*Q"
M\OE'4Q9+PAB-F]^VR;=@>HN#7&4>_?EK.XYJ.]-:1;\2<*QH])*UDW4%-0MV
M4ZQ-K?>3AXO^).9Q[D_KG*U!;=G)Z9-YBL]NJ><%26@'P8&9MZ2++]0K=WD_
M>5O)E_B-7^K SGK3"0Z*?W/UO<Q$[KV2F\^L[<R']EW]B!QI]SQS:H*$ R7R
M6HQF!<0/5_[6[V[*?^MM[RFN=GM"].U(F^'L<<N+D<O(/T+&*0"K^4Z6O/'8
M#=XR7>I<*HM'^QNA)H)O3U)H/7DR3B-O2+LO2#_ZH1[ <SP]L4X>"$Q<LGKE
MLHWTQKER$_AY6N1?&\/A8H1TB!5"'UO^M,XSHCUX6Y$E>AIAG8JRIO>@*YS_
M:63'>.EQGA+,*"[Q7E"D54+\MIQI1$_I-^);CY7;@'M/(+@+5/B();U->X;W
MWB=8AYE9=KJZ YPL.H2_I3(0PJ%$IG,K)PJZFC18.G [E@4:O+%'<S_)0TKI
M,$F=>][L>HTT\#IF7G]3:UYSW;*N=)M#JY(E+6A33.#JZ1+69O#J:3B3T>L:
MXT\E)D5ZUH:5X\TE(O)5)1+]CM< 6!8!C<$9;T#@<EI3!VKU510@<6G=,KMQ
MH=7(ZF'UP)+%2HSP/ )LT_M^?;3+EM-&0<_&#M/C**.;EO:\S4!;+%%)' 4A
MY"7##25>9&O:EI3(:=]$N?U<;FI(8/:?,K/\><<@62\0^_0&KR"R-"B02W>?
M_TPIVYY@T=Q.18N&,*==:"L[)KKK;DM9'6Y Y<S6QU6^@&3;TWOMO!9'^56)
MZYM6"IRPP2^>*'')QX.%13J0A7R!) -U$%WD7[]W6'[:W*G$7@H=#&)XHK)X
MAE>_6&&9;S/,Y]*E3 M9=S=-)77B:! :47PL/2%1@>3)3*G[5CD0TVE47FH2
M,OAFTLP4U6?[1'41Y#D'&RUKYSK 7J'Z*EI&OY2Y_UF_*].D@K&E*KX NC.D
M<5(^'Z(5^F=)E^L\S0?N)5]6SU!C_?2P5<*N^+.YRUSLTOV!4M79,Q0@H_?R
M\Y9;^=3W&TBFX!4#W06WQT],] PW$E7/@S_6.Q+@Y1IS36GC!AL_$%>,$[OF
MV")[:C3GOMALE^<;,3<Y=PSW/!I1RG!(\[M\,5$DN^R3]CLOJV#HZ5J,2)!Y
M]_67YZ%]?!/5!',YOB-#43\M(S!AFP(P>?9\C9C[Q?G$/[;UP^X7*-_J'I06
MUS0B372<&L5GVFIH'HF@R-;XM2FGI]Y6$J4=CFBIO63WC \M6U! VK.A9/FF
M)/KU]>(E7[\2LE;/U^ K1:ML"Y.*7[I8Y>.J$6'[H%IUT/(7SY3&@E^#YFQQ
M(@,@>TX#=>T'ZISWJ/\Z.?])__5Z5^>\%":1AP3^DU(F_PM02P,$%     @
M*(2>7(&P^F@]F ( ,286 !<   !U<F=N,C R-C S,3)?9&5F,31A+FAT;>R]
M>5O;6+8W^G?WI]#-^_9I<A[C8" 32>5<!TB*Z@0X0'5.WW_.(UO;M@I9<FD
MW)_^KFD/DF6&)(!M=._;=8(M:T]KK;W&WWK_7U?CR+M0:18F\2]_[[0W_NZI
MN)\$83S\Y>_=T]V#@[__UX>_OA_E\!@\&F>_/!OE^63GQ8O+R\OVY58[28<O
M.F_?OGUQA<\\XX=V4C4H/7C52R-Z='-CX]4+^%8_J/J!>9 >RE2_/4PN7L 7
M\/#F*_T@?AF$Y6?-"_E+_6CLA_VL_JWTU<Q[P[ESW7H1QEGNQWUEGL^"NBV
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MJC^+,%5!HS7_!$\7[.?$#P-ODJJ+,"DRL)0OPWR$?QOOQ;BQ4W[NCO>3\:1
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M+IBMD;>UT?* #5[=IQ6]I_S4.QWYJ1HE$6Q':PF/NS3"OY+"@]7 Y90&8*&
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M-))?WI]!UVDO3 [93;<** 8J4OU<"Z./B9\&R#A[(;!BGJ19A6HS=0&L$"?
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MG2R)P@!1&DQ6Y74IU=NO[N$RN#D;Z\"4YAPR:9VHH9^:S('NA1]&OH1/R#Y
MIC>HCX8CW*P/C4 *NOY[C4VJ$W]RF_Q5S7HH 9E>5W!HL\0><*O.:BJK^*8A
MGDNIRQ@NK\3TR+X^;V%$;(J)._0:Y%M,U%F**^C),_8R5U)\G'I'N-/:]36;
M%='Z^=Q4FL&+[(6W.TKAFMQ30[!G[GFX!QT*"R0^&2-MB0HD?KQ2I":G^EX+
M9F\-,= @+RV"E%\FRK[)$ "-Y+8YSQ4EW%9/VY)=S*[U+E6O#UI-VZLIO597
M$\F#F_MB4]3[G77'+1SO#@72?F8*A(T]F,U40I/+%Q-?)CG6BV=H;62AH,,1
MW9=36U-;\\WAF5I+INWM8Z)?*(72_@67,@=FZEP]/_91.<.<8C='N=XVDG?-
MU+;7#7[,&PV' ]L[2B[5!=9;4TXPO\:4;%/>+>FVQMBC#APWUVC3B7%^=C:Z
MWJZ3Q0*9>DDO]RD=.0*E/9+#P"@O'Q%-+28 5J> -DTB'3(>P$G1")(/9:;=
M]AH@WV:,IKRR*:]<(")94H5B@:LS81KS"S0?83+7UFDN96G@+=9\<O0__^*F
MJE_W#\\>9=\_'9UX9[_NS[KA?JQ\=&G/9!6*4F]>Y7__OG]Z=G!TR,UTNX>G
MW^!,O>['H]_/D!I.]SVFS:] FB<'W2_\W#^/D!0685-^ LAG[\.W$>C>8^\
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M#\B-']$QG&&)PJ"(D'Y) QHH]-M5ZA]!F:]X^4P0H3$Y&[)]4+(]3 A6):'
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M,+AZHN@!Z.A,TOTP[1=CG"(;2O!J.PW)[##<48EB."F +L.U2D2N9IJ9D0]
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M?7-!"MW4PT&!^%GE"8BY _O"N$(P>@_OQY(OF7 &5_&\RSFD\UQ(R' &:7)
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M\<2?0@:5SVK!6-K>1S]C//-2,4"K=MK,1V+B67!PI\;V1G;B/%YLL%3IBN<
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MQ,%FDPH5YX)33]*?;MTDG;KO #U0X$L-.)!\ Q<.WK^<Z"Q0:AI^'FUY+ ;
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M?& :$1-^57 19BJKU!1H3P*, %0SG+;<*;78H=>"-6% JXC9+<%./^F#7-W
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MPTJ1K$BE0&4J9<E34_WS>YI\AJFC<P-L6#%5=(=I($AS@F$LE2?.>&#0X2-
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MN;#FW^^YT_^DHDJM<*(/&-U17N]O=(039^M.G>-IFB&WFA0V*F_\,$=W1JQ
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M$H7,"05XU/,0[P4)<*X'A%PN/@$<)![2'=%3T8DE/G-]A!I,&$XV]\:YLJ?
MX07(0_MIBT.ID0<R"./AXDM]C["R^4TA0277171E.7')L]))2E$,IR??.+=8
MI\OW#)O)>'9G=5#=@<=H9X6!P^T3-%%H%,2$(V[%P=[$L,'8Q\9NU)2SF5)
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M=4^ F19=73_2S1)<_ NG'LCC73\T;0NH:1=#I''O 386=<=W\IZ@R36@-AQ
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M:Q_***O647NIN,5$7%-6Y@HM.W+0%O$L^4F24;Z;*96A_BF3W-]VX\5@)Z1
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MC-*(31-M:M5%+98I68T[*?O_H=W:;)*)5T#/6:MD8KHLI>X/8&+D3>XC5 N
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M"J5>+K,>"4%U#Q4V"H'+S6W+D4"9F57[("B])A^<Y^T:1'6Z4(ED#%J72N;
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M,,T2ML()O7&>),M7R>M&UVK5M+>G&*/O7SN]P$N2_WEU\?[-OPRG*%0NV@R
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MO]KNPZ=;X[-L+-@+O_DE-<=_C78#3X<JVE1\+<5ZL%DUXMI)?")3V$<L_T<
MHI9S$?L1(<C\._)IM[_$T7MJ:Q2W9#@>)A\"3ZYNB&C 3[_W K@P6+,/]*!
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MG'N/"VK]>S)\Y21QK^KG/[]>J%/HLA?X5(->H:9/U9+$E_'!\;SJ YL]UEN
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MV@!6JO-G+EXS4QK./>2#2Z(U<QZ. K#*@_"IV(@D[RF5JFB#*K.7A+D%+&N
M8D-V(2+#U<$(( E)&8W6=D1:D2,3HX!V8/G,1Y(:?M)[6F8"YY87Y<IR[4%"
M+:7+&R&EJ#Y3?=A]_J793@4$45)F[\TC-(!(MZ<Z!)W"Y<2;&>E@D73*NJ+-
M(+JR\N[A6<&$3#<EUWD93Q%&EUHI*Y7@.".-DI$&RJ 2?#%-A&7(YDI(OLAU
MYG89>YTW:5Q;>E7>6)AMDJDO<HNB@V0X$I[C5%&>P3"$Q2<#&9$*!TB/I@9G
MN5/A^'('<$%]EQ.[U]ILV2*_9E;&'CNA5BU*X;G7$=VUL30*5,XH54ATTW,6
MX&3A!^E<17M56GOHAE43E2UM.3DL0G9(R,4FLWYGJ8]6EOS,B%A:60:CGB,G
M4QQUHT-NKVC#SY#A*@,H;:.@[/KR+FB6;AMIXS!\I?9*G9RP[>^$1S/TU*+!
MO/<<AR)F.$D:Q)%0@>#W#T'XO8"A,W&;A;8K+"GJ-C( 32$6#@,15B@O14KG
M*JM!RZANP'>AZ U(EM;-^2EU"^0X/!58R2<5_1*-;#'2YT;6O'9[6C*OS'\L
M/9MT!VEAM#RC4%:/Q$5"G.SQ5&^2,ZAF 2*7Q8?KX?G"Q)/\\ZL=.?;?C )N
MF.D(L'4HO6;W41"$^Q-2*?9>T*>9BRJ5$7ORC)!?(7+H:N&42,ET0C$N1)C#
MF B3NBI4-GK:F#)EZ[+//L:W^QJC)UH3^0$/DCW',J03C(%XO;149:<OY"^@
M>X0I'5=3-.;X!Z06A-D:)0U!Z?9$<IIH(.J*>T#9J$+I%_*;?BKNZ-M,N"J;
MPLX)8'%34H;V[3%(>$]6Z6(0\)Z#14+.10INWMDROP$XQML 4PP/D&-2DL$
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MD'^W"S?KN !W $06;9Z1OS!G\?<4>TX7IFF.'+#"R>]AE24L!BA;1#Q[//:
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M(;A5UZ,+%+,'Q/NQTY$<TQLX.)Y8WK7C2I3V@SA-!P*T)%JE+D#]D)@JW-O
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MHU1Y='/-+>N(4Q*A4KUR^NX5!EIH@ B"Z(EWC0(B$7C.$Y<C$>.)]WLH+UC
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M[9\EN^6#@:B6 4Z UJKNY8,56[D:"#S;'K"GIQ,@L1A4C20*>Y/4%K7+?<O
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M>4+ZN[N0X^P*=A?"(P<T_G=@NR&[M[TDG01<WN-;M'O7J"#W7=J]=AGV83$
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M>=LV.EU.IU,-WHU29Y0Z39?I'AX?&:5.,0RCTU7L6JJFR!A05$W),#K=2R$
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M&DE3DMZ#)+LW%GOMOF')6-(&T)7G OH#*>"?(9"#.X[QSV^'-X?P]UWBV7$
M<LP>C\, " QLI9!]<#_^OR1RDM#]\-:5U^F*-^8(-O"\X %5QHQJ@Y#^"/K]
M!)16/ ,L9C,0SOX=1X;0!U"$@8<;A9WB;^W^T.7W0MT4&Q4K#MPPBL4_224%
M*0W[BVR/WCEGC]\ 7L ?;F+@(/HNM>.7G-S"O<.F=/@5MM9/1OB4BS '?@3/
M.4D_IBTANY%X[W[\!_=&DSC(-I9JZMFN&7YKHW+B><BM$"ZNG\"^P6B]!Q:V
M][S/<>]9W[.CZ)=75[]^^CWE;<I-AQR+Z2Q+#"+/\2S\".@R_ZZOW[ZD+XOY
MCUA1=!^ND8>9'Q 6R+8$;\!-#=,\E*N37\\//EV?G_Q^</+Y]OP:N(#W8$^B
M]Y)=8]J#SW-O>\^&7&RK@3ZD?N %\+/_K-'_P'-V__M="(+3.<A_]>IM\0B_
MG5V7'@'A,.\ Z3G6Q:6TQ?^5@'TXF&@WRM3_'4W?[I-S3A;.,M'AH?:DIY[D
M=B5^[?H.QU<<')>B81$)W!]P?/]K CS'[1-EPDNN^>"75\[_(24=U.KPO^*?
M]<9!L_Z*^?8(SLK[SKN3!U#I;T=W7_RQ>^9&_5MX]I,'?/P5<YU?7O7KC5>,
M1WU[C%<;)AS1M\K ^M#[>!5X;M_E4<K,V%5H]T%:PL:N.7!$X:M CO2KD (#
M=@KBU :&?/YWXL831E")V*D71"0&\%3J&7@%)]MMP+[ NT)D\U\#?YST8%EV
MX9,X1!4T'1#Z/ QJ0VNL![U^"QX0PT[]R(&_BSC67M<RV1J?/?M.O;[SBHE+
M^>65^R-^-W!_< < Y$5\7>M>A=R)PY&?6[:[L6538H7+=3X'(0K6/VU/7_QH
MSN*?R711* W_M73QK"PGH<T%F=<"U#K&1V,OF'#T5KM^WTL<I4_AYAST3O03
MTCB"P0 (+HP.@2)(GEN@.S#'=<CT$MH7+I9;Q9)_HI+#07\B0XY$9X3J3N0"
M3MLA&69A(NPRLN_$XP>>^YVS ;?C!/THL&/T6<S>V&\NK!:B$NU-\A 8@DYR
MQWT>XE>I+\;G#P=#%_TGPL*T!9.0ZTRO@&H/[GH8A#&\)J]_IC^G/)WN>P5:
M4M[ [@RE2<G@>ED 3X2X/L/U 4PSMH)*U?2^I9Y)"BI< O^N%.P18-VPL"^U
MR&/;N@(<"FCMO+T]=PME"X[3%XD77^*=P64J3 .< 5R BXJ$1@P 1OL&66Q?
M+0KG<4&+=LEV=Y3]+G )E/$Q]R-;AY.P2T;VA/5X"AZ@%GQ1'NT!^#:^HN?Z
MX@U3O\ %KV^^_3?<BAT+HP,IB^P(M?44F.DNQ^/ ]6.AJ0/N>/ S?+L4,>1G
M$T?)OY*#BJ^.-^*<'.#R,B7NIDN1BCT,/-#]8&N -6-<XYXCKH^3,$J0 N5Z
M(+X.SA6\S^2FZ8TIY$BH3LA+.$A"PD<'](+0[<'U@H[(A24UY#:R!(OA/AJU
M]Z4O.UA\/7I-'911#BASR&XU(G4"(')D)D0=#^@3'8$()S&.WS^$;AQSGXVE
M.J"L$("E!)O$AN*5SN%"UI/9T"'[Q/MV IL#]D?VKPTH+]01<K[F:05WEA)W
M:H>-"\06"6>M K_="^XE#\\P1^%$"E'X8X00T>G3"0B"L?T=@2>5&:0^J<VX
MF3;#7LLK_?+UZD)>RQOX :"0W>^C?PW("L"M?,B*OA6X 3_@\RB#NZ6VF6XC
M0MXD19(P:/&'TR0'%QRB'J=13!'[Y?X=$)*@PR6A4-=@YWD<0D9/ $!!*IT.
MF78'/R<' [&I)!P'XG-[,$!2DN=+'>V9 -!9#IBQ.5'_\>E_C]%0RG]8;@CL
MLI;9^W@1\Q%KU1JO[]^P*V#-?P+C2B)VI3F8JJ!1K^H[0_33T%)H44I$NL"W
MI2B ?Z*339)X;\)NSD]9F*#O!NDFY7X^",4H@@6!G,ER$KQH&#SD5!J)QC,X
MPKW+Q<\]U_\.S#8&-<$O)RSM.G ?,]0K-K8G2&IP"OVP2+O DQUA@2&=P*YI
MOX+VP/H*N72X#QABA+@0B1;PV;5PA>'V;PY^1QX-=$YN:7BAY% 1 -V#/81\
M#*J7#!+#*4 ('"J!@FH5.J[Q3>3KSQ@=L-,D)IT.#D$,0#]T3I\8#UTX6C >
M3@@8"'1@\XJ/B>LHYPO9J>= &.7V "5K>K3S]&7Z3:I3[3IM@*F LB1T"-($
MH<=Q@ P+=(JZ#I>:G-(O-=0+^9T=DK4RXS[PGNG.0R!)=PPX,8W42@1>G5^F
M$I"( "0F?#;3UJ ?*4K4D4E)EP%L%%84CFK/I9B44'F>\4K7[5JZNA_?(F5.
MF?O'"[J45D4G$"K7@J4X#':2H-)VEM,(RN7,OH@9%?:,>(R8AG%\Q*EI=3U2
M["4G'D[Z<4):XI7M$K_.T)X06CYS<@_*Y%U!M.2?133_*FGD*]%(QL<N)8V\
M$C A%;F'T@<(HI\(;QUJ]*"?^J"V(A)&2""H;RH&P6;QAD/V3>ALI(F"_JDV
MG;<*U6;'L%EU0D7KIR=7F;8;*1E%$AE?"E(YY=R9= :UTD:;*_%4D"@]#BXX
MXO$P< (ON)N4O1 ,D*2?1:T==X!"@ +.Y?N6AG'Z#M<'^G4=^#)*;8'<DP[8
M-1'ITID5(>W@N8)& 4<I*61Y/">/>BX^N(NQ;K'7@UX0Q\'H701FK\/JXQ]I
M1*<0,A:_DYMH';9_WFC(&'CQ/T&ZI:QU1EA[E3,<'=;7?@8M("'C<<53W22C
M$:96Y=@?R3UV&\0R1 V,[T.4I)LJG )C]Z!X\P,9CZLW:C^KW$]XZN/^ >U1
M.;,$M!I["RTE81="M<?D[-Z"!P\F^?A<!%L(2$]'O^92Z$>@%4 .[WJO:Q;#
M_WWSGA7S>R2<TS*8P\Y\2"\0CIT;?579!WJ3A#EU&B@X<2^8%J#O1@_YEKR>
M[N]/Y4&[D-[QSQBL8C^!8(2/,%6(_.2?5"J)P/6;S+\-2E^<A#+>*BR7.7NI
M'];A?S#CH7Q#3[YZ. (E:^'J @-H#QNAK_5+Z<?IZRN8#Q<^Z(^<O?XCB*(W
M92C^A,K# BJ3ZE%^%XM6[A7>2&QHQNT*B_8S>>#1RX8&::/Q:C';%E/;Z!??
M;LYREBX/""F1ZYR,8M %87.<M$(]".LGHP,GB ]0^P;0OV+R'Q'^\F/+:M9K
M5@<;D.0W^?$Y0-!<'02*S2*770D2];IUU*I;S49W*Z!HK0@*$"X C:\ D/N[
MU=&B;M6/6H 6QUN!17N-L" P:#BR-$@:5NVH:1W7VNL "4G2<I#\5 Z3SHHP
M(9S0Q-=U["\'BHNOGW$ 0NNPMB:>,9,1__2Z'!3=%4"11 =WMCU^!^)%2!>4
M+4LA!(M@M[^\.@!B:3>MUG%+%&T6(/+FZ:)JXR;R(\+WB>VHMJZ+E^+(40F.
MM#(<:3V3<*VWCJVC]E$)H>PX?(]7A^_Z)+=UW&I:[7J9X-YM,#=K*X)YW5I!
MHPF:P1[B,\)P;8!>F\IQ7 >%HUNF@RU>HK.JXM$L,U.> IGU*AY@_1[6UJ2A
M/U7Q:):9*XN"8B.*1Z-C'77W2?%XTBR*%<V,9IG)U<RNL_E,.D*G>6RUCZ=O
M\#E 4&9I/1$$:Q/C':M9[X#=N16;LUEF7ST%$NN6M*UFRVIVUF)L/AD690;6
MLK!8FS $+:]]9!W5ZENQOYME!L538+)F,=@Y/JRO!1)+B,$RW7]14&Q$#-8:
M5J.UF!B<+N1\QD36Q1)J5ZL-<OYU&P#Q(=E]]HM)4*W:=!+4ZLNEY#YCT?KT
MHKN7YS"O]+US>)R&SA\E0'PPUP3JL1MHSKT!A#S\H6#=?/7QW'/_;?=X/%1-
MD8IH9U'*X57((Q>K&$6>X-#E@^F8I,4>L%(ZH60""F)2,0BF#,I$5^XL$8PI
M UYC*>#E]=/IN.%2=:(BD>VQ_$IK!CQ$+QU;5=5'[U:(6I4 :H7.$4Q2F"P5
M/U9:=_M=5D>O-<\2>"(PXPMW\-4*+]YG9:[_L"-,>\/66I;X%)_Z551[L-,@
M\2/N:3B&3,)S*1%5OJRR<&F]@SV';L3.^)UO^SH\/KOP 35;4!#) 8(]%08B
MN?$,7O"[.Q*/HR3D,]>K+-":[]C*>/1D\*V)!S77P(/6F;]63'38R")8E*"E
M@LNZV:FZC:F$*?P%\D>5ZVD_GI(KGWHT<SWD RQ.%,Q5IK)F"?:V@U7ZHF!C
M9#MIC7Q,*1KY9%69S9KR9IEO.B>I:5 *#GQKHK*"2ZH%9B8#S^+^6^PH\ISZ
MUU%W^VFFC6/ARYK-[%9Y>[W^#%FL)QK* [:?J99YC^6_8U+C!E/O*GWV97(2
MEW26*@S;'!S..+914B5#)Y*M72NVEA57O+JAJE712^05P,A+1G[*]DYO5W"P
MBMLN]Q64NPI:BV6U_!^9D>0I^N%&!^E903+)DZJ#?L-S@G).AQ1G%">\\/'3
MT]LOU,_I_]+;/K5C?A>$$WHQV$KB^]ENFFPG2_JI,K=$PZHW&E:CQ$VSB):Q
M!N OED;S7,!/O03/> 6=3LWJ;" X4B5Z%QU>"P0?;9[BRW%NL32EI^.<..6V
M*%XTLODW#X."4_I@&1?L$T7H6GI<Y3PC3[C/Q7*MGNT^U\I$GG2K.Z(G7/C]
MD%I)(-OXC*V9TT1WV5[L5]D=!QLL@C%%-@ZUJ+WFV,F$??-E>UK1(A'KIQCW
MG64S/"J.WV5AG4?Q^Y_AN>]\#@&REX/SO^/)R0, ]M?0CYT+__0^=/X97B9Q
MY/AW)SX@_'T4.UM72SZVK':]936Z91'%O;S9LBC5<]_L\^D\&#&NM<6\CA?(
MN_[$;K_:I_N)T^VR=,!'<?K/*/;OSN)2K 8TAJ]3Y-ZN+B7\,_K_?R&\JEV6
M??AL]_I,.M42MUMY3O76R9EIIVD';XU[40>%J]"%[U&7.N"^:$-$O;_C[+-I
M+B<>@M]F?(Y"BRB"8MNGOC+H?']1&EM[L;*Y JV<#OV["U^22E&$%P7]51C^
M,XRVK[*UK7JK975+B[#V\FH7*P?<\-4^H\YV5#NV&O7'L^GWF0_^*2=JG<FY
M0(_SP#\%L]M_;6\IY[E&#B?1Y4 J"9<#POR4')Y;Z7NDM+)I'=<?-USVY%J7
M<LNO^5J?D<EA9F:W658KNB-,+G/% WN::Y;.4M@^!^& NR^#:2T5 $CQ6J"S
M[TQ[7X3D_NPYA/JG@>]$9R'\P]BM6[SLI:(#&[UL8\PN[W838Y-HL!-]ABD7
MV!BGC.5]"1QWX+X(CK94B$ !E?H'?0.0:A!%@!(\+P<"F@J89P1+U(X-0]O.
M72\5--CD71M^MBH_@[L]P[ZD8&_29(U+&B-Q;H<^]:"E=#$]GC!62ERI9;J]
M3+IMTD5GJ<##V;WC1)<A #P\!^D=73F7?BKIO\;X^4-T/?#Z*/)O8ZJ8Q+E"
MNZ_2[3$F+!6JV!PF&/[XQ,)[2KJ>RK$5W0VU3-O'LH9W&(,7#"!LT1_6M=K-
MFM4M;;"UEU>RH.-_Z[ZLNM4]/K+:[<:BU+_5<N-='220SMMLM685*+6V6Z D
M %"Q*J7FRE5*XEBF2,@4";V8LYLBH16+A*JI9I17Q'3*(JK3#;SVM1RIVZY;
M]?)RI/V\[K)(Z_:N>QL%4'6KUL6NC:4E4'O'U2I5"M4IBX2N _M,*=26V$E9
MM'.+%[J5@LKCMM4XGO9+[ XW,0523W/-+-9(>P\*I.K64:>S4 '-GMSL8BV\
M]ZA JM'I6K7%?7=[Q;M>1H%4=[%^Z:9 :M?N=;'V[*9 JFJ<RA1(/;^=TEVL
M8_\>5$CI?HY6K6[5CZ>%^[XZM[J+#2/8FV*I[*Y;[6.P01=P8^XS=S1E4S-U
MA:6<_+M8-M4]MKJ=Q\V9/;G6I9SYNULVU;4:I9,H=X3%F:*II^#V4J$"4S2U
MFY>]5!C!%$U5B[^9HJGY2+Y4V, 43>WD72\52#!%4U7F9Z9H:G6Z.%HJ&&&*
MIO80$Y8*7YBB*5,T51EW\]&"084J! ,:5J/6L9JMEY/I>K1@,&#;7JWLCH[;
M=:O=["SLQ*]B(=6FBYR:ILAI T5.9LR2J: R%52F@LI44"VC:)0%5Z=G/^]K
M!56KT[(:[06*:?;ENLN"KMN[[FTHJD?'G<6N? ]XVCKKIW8*S<OBK^M \^V6
M:BV*X<T.F&+-E\/4R@*P6[SMK>30=8ZL5GNZL?SN<#53Q_4T%W190/91I-_%
M.JZF=7S4L!H+=)S>DYLM"[\^]\T^:QW7T5';JK6GO;LO@7>]C#JNX[+0Z:,X
M;>JX*G^O98'09[M7$_8T=5P[1"ME$==':647R[@^'K6/K5KMI8RY.BX+UC[[
MQ3[G!)BC#NALT['>E\0%3;W63')8*J2PB_5:]6;'JK=>2G^1XZ5B![M;L-5H
MU:U.R\RY>ADE6\=+A0Q,R=9N7O92$0-3LE4M_F9*MN8C^5(1 E.RM9-WO53,
MP)1L59F?F9*MU>FB7ELJ\&!JMO81%9:*59BB+5.T51T47C"$L-6NNYUNQ^J\
MF*Z[]=J"WO^M^[/J5JUU9!UUIQ,#JUFBM5*MC7[?JN%_K?:SNF915,.HAD9]
M),IJV&)U-06$C8.Q8H(SD746"A[ M?'0[6>HF/L6-$) Q0C^/>,'M@?HZ0-2
M13-^, XB%^]YU@*CX%_N##I8F,I>?7S=>DI^:0:P5O/PZ&5"3$BN:&B'?!AX
MF+0=\C@)??;ZO_[SJ-&HO;^]N:9_U=^_86[$ 'I]K'X3\7+,X :+;,!#CM5R
M/1X_<.ZG!8:V/\%GZ]WWD5@"[0/XG1W33WH<MNRK.#Q^(B/Y^,\10# 1AB ;
M Z #QX*ET!1Q6&_R]"5FOO;P"9Q'\*ROXN8_%O]^QBI ]8%DA;E]+#+U4.?J
MQ-!E!18:=']&A!0W&4Y<Q_XMO/"3%_2_OU(BI_6*<1 !8WA+'"8<B&='BV:%
M"O?!_7C-15EG-'3'[)/$Y3F%:HBU$@>9H",-9NR:Z APY&.J#.XPA&YS%;I]
M.&?,(AY'*/OC(9%6J(.O]SCXXH %"94Y6KDB8Z#4QY]ZK,[82GE*D4L 0V/!
MO:Q. <N) U,(HABVCTH6+(.EP!Y'#J>5"4>'SUOGJU8I50(%#_C@CH!S>J!W
MQ5%X%]KCX>&_QG>@@H3]PD=O/TI.D?YG*XQK/YCC5QY?^( C?)HE=A=DB=MC
M5[!Y]D<01<SPI6WR)?HE7(6'5R']I_O#CN!D+E%(D2F5?%%D38^O5J#N#0$
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M@3K5U_@1;,+66*QX9=8L"D>\QX'T86/W+>VXGFOW7$^,DJ<W]$"#L:6 SF
M*.]&Y!4ESC%UNOQO^UGW*]U4QLY8>4Z@!&;ZA(!^'H]2N0Y00)=SL]NRCEK-
M:3_Z(/^8AE7JLQOZ98I:R-G22Q:8$O(Q_$)T"\N<\&D?JI]:A[*2$6C)PR.
M[>$ZV5GOL94</W@@FP@/)%4'E!D(O_1-^E9OY %\\N!]M2/'_IO1'$WL+8;F
M-+G>\)%FC4"H) ) WQ&NZ0F6MP@M *4O*482:]\HKJE^FHE\D/:P([P%V4--
M;E,I/G@O$7GV+%UA02(EJ3*&EV7W+KX%"_$ ?3GB+_B%<A?\5&\7H8<XA.4W
M*K8 *PY1CJA';-9/1B1K[O4F>0]!Z#E@$8*8 ^!$-BAP#%X)2@BZ)!&K4-N4
MA!KI! R2H4?A6G01I]\+EY+?3V.WTIL<HH\ZI>Z,Y< G[$H^G?$=<J>S6<!A
M()TL5'7O/'[@N'=NC(H8&DF('V$PL;UX8N'M :_$%02DY#('O<G!U(<8S' C
M2SFEA>O7*H6.TOWTK>N-_N3Z)"N)Y_R+6A,&*:D#=2J%  1BYMJ76E#*MY5R
M>S^%*X+UI"\$'%0:9(X)E3*:C$VG'.<U\ 6!E!+RQ97[ 7%;*C"V=%4M%4%7
M2(SJ_O9 ,)]C=)6 "(JBYQ+W%RT8RT:@2BX[52"#?YQE-8:%@"!5@*MK 0I"
MV81""_1-GA<#2%22VFUIU<GPK]1_U6ZS6+"ET"DE=0NE81C\H&:(GGQ-X^BP
MF1IG^=O<^BUNQG-P =0P\MV!5 LTPZD*#H,-G!F=TJ@P]R7S N81]%W)MX%'
M ?=,"'/ C$^\,6&**X&D_ )1$O(9%;C",3UM\0DI.$@\E"6JE:58+RXJ-(BZ
M?]@/9/Z0?9A3>-V9-R9(\BG[L@0WC.WOQ*X#[:2PG=$BV[Z(0AM,-.;9((2*
MG3KM6+;RS#-B843V4?<0+R&08GY,=F:*$*2FWEGN()<*K.ES(J2GG;SD#DBA
MK4Q ;S/D3$$QI7*#-.Z#<$4-$,%S.V5)2G<A$^["2E#\ZFO\E0]OBA,*SY1N
M3*LX/B$I669"[4#D&><!1XX+!Z6*(CJTJNY=_F 5S XRA%"LW&/<"@PF.WM&
MQ$%G;2<ZQ)[!:!B,@R@KC)>;Q,:Y&/V6>L;LURBW$*9%Z9_#PV&( 4>A_X9B
M)[CNT!VG[KP(M":ITKEP&W:8VV'N'5'Q):0,9]Y4D=8T*9X8:%_V3E!^0/*,
M(#]VQ[;PJVJFM?"D%'VMT2S?*J6Q;,JY>I@G(+$GJ?F7-CZ($(^$#0=\,8ED
M'D+6E2'CSYEW36!/7B),ESZ5\5!RNJG.$B?EJ**C!SI2IAV Z8[@?WO<Y_ Q
MY9X\^.6>8GP-!=H4F.\#2FE"0S(D?J\;2?CK-+P[Y1X6WN0HQ1W2XR:TMG+V
M8:#<$^?5/,[/RLU-I-5$6K>?1:M28]'OGQ-K8+$(5[^26#(!:H[L*5*H_CKA
MP[9E3YEY\O1A"(L&@-\N)6N19$Q&HM6\E"\S7RS3MS O;.%=9_ZE="4Z"S(A
M *XM9=T(-"4F76^PS@"A2H^+;O.IFV+V.K(Y3Z'DA6%0#:!?_#@5_ZGC'^"!
MG\%VR9@@G[7PIZ*V/<:$)=@:YGKG^LI8)$N>KF>(;#UY8O%S@H&<<H Q-XIL
MC*528J&41<^<C+%EB;&I&V60^9DQ'A<I,2'-(?&'I>1N'I3P8R%'XDB*0?DS
M'<3X'L ?N8/\=Z[(-:902RHF"W&8-#:4Q6)$HR?, Z- BQ@$$7&9*(8NG=)
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MY@F\>^;"\G'I]"0IHZ^',0XW$GD:4:0/- !!(Z<,8P6[R@]5T?!AD$3T#G2
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M7C,"=9605,NA1H21G/_TSK Z[K9ZV]E1-ACL),C\A=C7&**6X 4/'%X(9BF
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MX]1Q'"FCH/L<I^X=:GT1TQJ03!#7$TQN\>@*/.H^G_>04F]ERZ,?K<K.R_M
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MX<O"@/<=AX3L2JZ.Z?Q1A'9>A :8<KAX0+.99'RKZ.#Y:_K6P?,WO<8G[J"
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M"Q[YC:5('>))-/[IE.E0]T(*GXZ'L+_IT6A5<I->]72=4)J%IY6+JMIP/5A
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MJ7BF]-_6*U6R$=Y[9;VU#UU9,JXNB['GS%(YG)[39^DE4**#(K;]"4F$24U
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MN/773$_8OX"XCSH]H2XC<OG\-B,;QD]@_R .&V%BCR7O^69(VN?'R4\GI^_
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MV$O2/&7#N/+=F+I'LG!&S*H33R2!MZ%(\,O)<+3!6R[)#8<&0S&(DE4O89;
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M^+]GYU>GYU=G[\]/?OGEG]'[7\^NKD[?_;_M7?G^Q^.]UE[?##_^^-,[<BG
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M5VY0/9L^T:NU@2#8QIW(C6_NC!/1RXKY=;MI)YGJ:':SC^]"NBF=[G7?1GB
MTZ@3HNCK)YCTC0Z^?24Y?0_[O!%T4YOKYK0!H^!!4BG+?.[L![8Q!^N@=QDZ
M<$1SM8F>,X4S@#N:U^J3JG0F#[B>C39BXO. G1<UR"?3D *E$_"U/@3_'S1C
MAGJ;).5?(:3'82*VS.$X?+OA1I8Y^U7)ADGK+2XE6#',!V1N]Q?6$?22)Q+O
MJ=+G,S>N7*N8]L1(]:UZ[E;?( H%4PZG#3+:L/NF  EK'^11U!)CC CMM00>
M()28O)Y[9+"$6!8HC,UU)JJF&696H%/(C#C_)+()D%B6R0B?6B08 IVEI3[3
M(#L =Z7ETA(,HBFV#(3?UBD/&%1?0W>8=GD,_)9ZZMY:4Q)%^7<C.&D$)SWZ
M,_J)T U<JNZV_MY40!;G$:R:_QP]/Z8$:?3?WO^!+@E^PU1TGC4?!-3T1?JM
M++3^B3[H7RR3Z)=Z?@AMF[#1NT0H?BU9:MW_3.C=EJ18[W^3ZLOZ\*_&G_5=
M,:3T@I9K3(G&8MM!@6VM$F,+'DC3@6^\%@23^X(X5%4G+6K@+_YDHN.G,!,N
M&.Q&%;,!>_CHYZGKZ+P\_B-/]#B#76XUMDAEP#GY.F=D+I/+CDB>)0#/<^\4
M_C=UO>:CN/5X_16H[J)7QY]3X/WLL0N\OSU\/22,XWEQ/U'"YE@W%QQ #28
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M5_/BRF*FU-S\L5@Q 2L&#!%MII95M$CKP^BLMD%/4YZ#C]:7J6R6EH9<*AZ
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MVW)MKC2#/Y=JV>3,!=^WNVQ@NYJ&W5-5WRGF3M^V+A?IMRN3K![']$/SF:?
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MQ'XO!1+VZ@9Y49P/^N\J<O< DF1=RAG[/%NXL* R^.V\!V@"Z.I+&E\[LGI
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M>H2Y6D&W>,"WP.>*<KP!^WP#!NA?7CDG&P\EU4#FV(%2"^! $,<.,*OK?#J
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MO%@<,(^IY;FE]NO"V*>]Q+%T5M7O8R0YV'NP^LLAWJDP\WN'6 C!RC"-R=P
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MYWE_ZS6YEOFL*?660M/%CE)AC\;=O%)N%.F SF*H'B%[UYEAQUWC;7/">>8
M_CF5PL<OAR3#TE92!W;;9CC0?2#5:Z6<?3543H,G3<(EL.]WA0DIO6?SPM@M
M5/:"C>VL0M^<6*)6G)U#GQ?Y$[&,[AD_3-G\Y12]+0^?]U/TIC%]N57+0?.P
M7&&$UKQY8?]O"8%Y(5'':5%+3V*'UP54ZUQ5VI"#H8WQZYFX=O2"Q*$AN0#
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MYV/J^7QF=J,GH##0Z9\D KE&A.QY!Y)-O.V!H(T3>9SP2=?@NJ5.485W*VV
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M=VZS4,*\_)ZWT:&=P_5@GRY[6J%_JC(G?U ?(X@IYS:!^^Z/YSY$DGIK-Z+
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M.$T;/A#31BK4DNC>0B4B.]:UR-N!\$- )B6ZDSQ:/$P3IBM:K8Y3E1<-5>U
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M==R=IV1I/I:9PJ:9<F1J2C1W"\?=9OJ6DD_  'L:J(%0&XNAP1V7)3*0XNU
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MCX5XO5=<MO2"19O461I@@(PQ;R$O_*:"[_,0>CC'LK?\!! 7QK1<#LT0*,^
MN=&U8>JT%]RX6/OX&5+V,JV0JUZP5)GF*6X9 C%C<^1F K\U=;4=64X S1:
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M(0VI[*I-*:QJ[8))&;.#!9_^$@-6WK +XBG@ZRG=#NJ"!LM98'1/W*C+90F
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M90L78?.OT:*JHJ<5*BB V4R5Y:=6H]IZ'%D)EP7+M2@3L^DHP/<.HEJXY0&
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MI@W1C'7[$X)E6,0&-/!^($%?0!UMS)RC& -P8S*:<^] $.#R+:)S;ZK26 *
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MGVG*:"M:=@+N;,"D(V9"(0#7\_H K5>ECZS"-HC&(C?>HK.F7F%E[::C5MV
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M40?PWA^XS;RAND*V8&-H(,4ZER_QT5O-5?9E]^I@SI#;JP?)6H[^@"I7OZM
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M)I[2/<].7Y\_<*HTJ>KO587+AYK_@+(Q(S 7F\OFQ_\/4$L! A0#%     @
M*(2>7(KJE,,"I0  LLH  !$              ( !     &-E;V1I<F5C=&-O
M;7 N:G!G4$L! A0#%     @ *(2>7'0-@-$-"0  \0D   D
M ( !,:4  &QB<VEG+FIP9U!+ 0(4 Q0    ( "B$GES5\_GC5GT  ,BG   2
M              "  66N  !N971I;F-O;65G<F%P:"YJ<&=02P$"% ,4
M"  HA)Y<EID*;I.0 @ PUP( $0              @ 'K*P$ <')O>'EC87)D
M8F%C:RYJ<&=02P$"% ,4    "  HA)Y<,$CI?#\7 @ R70( $@
M    @ &MO , <')O>'EC87)D9G)O;G0N:G!G4$L! A0#%     @ *(2>7*/3
MNN#3<@  ))H   P              ( !'-0% '1S<F=R87!H+FIP9U!+ 0(4
M Q0    ( "B$GEQ4&3&^>00  &P5   1              "  1E'!@!U<F=N
M+3(P,C4Q,C,Q+GAS9%!+ 0(4 Q0    ( "B$GES)U,^FKP(  )H,   5
M          "  <%+!@!U<F=N+3(P,C4Q,C,Q7V1E9BYX;6Q02P$"% ,4
M"  HA)Y<\6<8E$0#   0%   %0              @ &C3@8 =7)G;BTR,#(U
M,3(S,5]L86(N>&UL4$L! A0#%     @ *(2>7-Q_"T2* @  " L  !4
M         ( !&E(& '5R9VXM,C R-3$R,S%?<')E+GAM;%!+ 0(4 Q0    (
M "B$GEQPODM"81\  #@A   =              "  ==4!@!U<F=N,C R-# V
M,#9?9&5F,31A:6UG,# Q+FIP9U!+ 0(4 Q0    ( "B$GEQAH'P53%T  &-J
M   =              "  7-T!@!U<F=N,C R-# V,#9?9&5F,31A:6UG,# T
M+FIP9U!+ 0(4 Q0    ( "B$GEPZ\6(LO10  &(5   =              "
M ?K1!@!U<F=N,C R-# V,#9?9&5F,31A:6UG,# U+FIP9U!+ 0(4 Q0    (
M "B$GES/*<,?D1,  (H4   =              "  ?+F!@!U<F=N,C R-# V
M,#9?9&5F,31A:6UG,# V+FIP9U!+ 0(4 Q0    ( "B$GES'9ZR[0Q(  +03
M   =              "  ;[Z!@!U<F=N,C R-# V,#9?9&5F,31A:6UG,# W
M+FIP9U!+ 0(4 Q0    ( "B$GER!L/IH/9@" #$F%@ 7              "
M 3P-!P!U<F=N,C R-C S,3)?9&5F,31A+FAT;5!+!08     $  0 #,$  "N
%I0D    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>urgn20260312_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:urgn="http://www.urogen.com/20251231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="urgn-20251231.xsd" xlink:type="simple"/>
    <context id="d_2025-01-01_2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">urgn:DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2025-01-01_2025-12-31_RestatementDateAxis-RestatementDateAxis.domain-2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
                    <ecd:RestatementDateAxis.domain>2023-12-31</ecd:RestatementDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:AmendmentFlag contextRef="d_2025-01-01_2025-12-31" id="ixv-12294">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d_2025-01-01_2025-12-31" id="ixv-12295">0001668243</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d_2025-01-01_2025-12-31" id="c3">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="d_2025-01-01_2025-12-31" id="c4">UROGEN PHARMA LTD.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="d_2025-01-01_2025-12-31" id="c8">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:ErrCompAnalysisTextBlock
      contextRef="d_2025-01-01_2025-12-31_RestatementDateAxis-RestatementDateAxis.domain-2023-12-31"
      id="c9">
&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Clawbacks&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;As a public company, if we are required to restate our financial results due to our material noncompliance with any financial reporting requirements under the federal securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, certain covered officers, including the Chief Executive Officer and Chief Financial Officer, may be legally required to reimburse our Company for any cash bonus or other incentive-based or equity-based compensation they receive in accordance with the provisions of section 304 of the Sarbanes-Oxley Act of 2002.&#160;Additionally, we have adopted an incentive compensation recoupment policy (&#x201c;Clawback Policy&#x201d;) to comply with Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder and Nasdaq Listing Rule 5608. For more information, see the full text of our Clawback Policy, which is filed as an exhibit to our 2023 Annual Report on Form 10-K.&lt;/p&gt;
</ecd:ErrCompAnalysisTextBlock>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="d_2025-01-01_2025-12-31" id="c12">
&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"&gt;&lt;b&gt;Policies&#160;and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;From time to time, the Company grants stock options to its employees, including the named executive officers. In 2025, we did not grant any stock options, stock appreciation rights or similar instruments with option-like features to our named executive officers. Historically, the Company has generally granted new-hire option awards to our executive officers on or shortly following the executive&#x2019;s employment start date. For other new hires, new-hire option awards are generally granted in the first week of the month following the new hire&#x2019;s employment start date. Promotion option grants are generally granted in the month following the promotion date. Our non-employee directors receive automatic grants of initial and annual stock compensation awards which may be in the form of stock options or a combination of stock options and RSU's, at the time of a director&#x2019;s initial appointment or election to the Board and at the time of each annual meeting of the Company&#x2019;s shareholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under the heading, &#x201c;Director Compensation-Non-Employee Director Compensation Policy,&#x201d; below. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. Because we have a practice of generally granting new-hire and&#160;promotion options as described above, the Board and the Compensation Committee generally do not take material non-public information (&#x201c;MNPI&#x201d;) into account when determining the timing or terms of awards, and they do not seek to time the award of stock options in relation to the Company&#x2019;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.&lt;/p&gt;
</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="d_2025-01-01_2025-12-31" id="c15">From time to time, the Company grants stock options to its employees, including the named executive officers. In 2025, we did not grant any stock options, stock appreciation rights or similar instruments with option-like features to our named executive officers. Historically, the Company has generally granted new-hire option awards to our executive officers on or shortly following the executive&#x2019;s employment start date. For other new hires, new-hire option awards are generally granted in the first week of the month following the new hire&#x2019;s employment start date. Promotion option grants are generally granted in the month following the promotion date. Our non-employee directors receive automatic grants of initial and annual stock compensation awards which may be in the form of stock options or a combination of stock options and RSU's, at the time of a director&#x2019;s initial appointment or election to the Board and at the time of each annual meeting of the Company&#x2019;s shareholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under the heading, &#x201c;Director Compensation-Non-Employee Director Compensation Policy,&#x201d; below. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. Because we have a practice of generally granting new-hire and&#160;promotion options as described above, the Board and the Compensation Committee generally do not take material non-public information (&#x201c;MNPI&#x201d;) into account when determining the timing or terms of awards, and they do not seek to time the award of stock options in relation to the Company&#x2019;s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="d_2025-01-01_2025-12-31" id="c16">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:AwardTmgPredtrmndFlag contextRef="d_2025-01-01_2025-12-31" id="c17">false</ecd:AwardTmgPredtrmndFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="d_2025-01-01_2025-12-31" id="c18">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:PvpTableTextBlock contextRef="d_2025-01-01_2025-12-31" id="c19">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Required Tabular Disclosure of Pay Versus Performance&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;The amounts set forth below under the headings &#x201c;Compensation Actually Paid to PEO&#x201d; and &#x201c;Average Compensation Actually Paid for Non-PEO Named Executive Officers"&#160;have been calculated in a manner consistent with Item 402(v) of Regulation S-K. Use of the term &#x201c;compensation actually paid&#x201d; (&#x201c;CAP&#x201d;) is required by the SEC&#x2019;s rules and as a result of the calculation methodology required by the SEC, such amounts differ from compensation actually received by the individuals and the compensation decisions described in the &#x201c;Executive Compensation&#x201d; section above.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Summary Compensation Table Total for PEO&lt;sup style="vertical-align:top;line-height:120%;"&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation Actually Paid to PEO&lt;sup style="vertical-align:top;line-height:120%;"&gt;(2)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Average Summary Compensation Table Total for Non-PEO Named Executive Officers&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Average&lt;/b&gt;&#160;&lt;b&gt;Compensation Actually Paid for Non-PEO Named Executive Officers&lt;sup style="vertical-align:top;line-height:120%;"&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.6%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-variant: normal; text-align: center; margin: 0pt; font-size: 10pt;"&gt;&#160;&lt;/p&gt;

			&lt;div style="font-size: 10pt; text-align: center;"&gt;&lt;b&gt;Value of Initial Fixed $100 Investment Based on Total Shareholder Return&lt;/b&gt;&lt;/div&gt;

			&lt;div style="font-size: 11.1111px; text-align: center;"&gt;&lt;sup style="vertical-align:top;line-height:120%;"&gt;&lt;b&gt;(4)&lt;/b&gt;&lt;/sup&gt;&lt;/div&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Net Income (Loss)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: bottom; width: 4.5%; text-align: center;"&gt;2025&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.1%; text-align: center;"&gt;4,310,624&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.1%; text-align: center;"&gt;11,841,327&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.1%; text-align: center;"&gt;1,184,629&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.1%; text-align: center;"&gt;2,083,905&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 7.6%; text-align: center;"&gt;$264.04&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.5%; text-align: center;"&gt;$(153,494,000)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:4.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;2024&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:8.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;4,149,858&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:8.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;1,943,517&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:8.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;1,231,158&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:8.1%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;913,979&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 7.6%; text-align: center;"&gt;$120.07&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.5%; text-align: center;"&gt;$(126,874,000)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:4.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;2023&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.1%; text-align: center;"&gt;4,639,590&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.1%; text-align: center;"&gt;6,316,189&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.1%; text-align: center;"&gt;1,434,365&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.1%; text-align: center;"&gt;1,958,801&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 7.6%; text-align: center;"&gt;$169.11&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 8.5%; text-align: center;"&gt;$(102,244,000)&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="d_2025-01-01_2025-12-31"
      decimals="0"
      id="c22"
      unitRef="USD">4310624</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2025-01-01_2025-12-31"
      decimals="0"
      id="c23"
      unitRef="USD">11841327</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2025-01-01_2025-12-31"
      decimals="0"
      id="c24"
      unitRef="USD">1184629</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2025-01-01_2025-12-31"
      decimals="0"
      id="c25"
      unitRef="USD">2083905</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2025-01-01_2025-12-31"
      decimals="INF"
      id="c26"
      unitRef="USD">264.04</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2025-01-01_2025-12-31"
      decimals="0"
      id="c27"
      unitRef="USD">-153494000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c28"
      unitRef="USD">4149858</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c29"
      unitRef="USD">1943517</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c30"
      unitRef="USD">1231158</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c31"
      unitRef="USD">913979</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="INF"
      id="c32"
      unitRef="USD">120.07</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c33"
      unitRef="USD">-126874000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c34"
      unitRef="USD">4639590</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c35"
      unitRef="USD">6316189</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c36"
      unitRef="USD">1434365</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c37"
      unitRef="USD">1958801</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="INF"
      id="c38"
      unitRef="USD">169.11</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c39"
      unitRef="USD">-102244000</us-gaap:NetIncomeLoss>
    <ecd:AdjToPeoCompFnTextBlock contextRef="d_2025-01-01_2025-12-31" id="c40">

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;(1)&lt;/td&gt;
			&lt;td style="vertical-align:top;width:auto;"&gt;Elizabeth Barrett, our President and Chief Executive Officer, was our PEO for each year reported&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;(2)&lt;/td&gt;
			&lt;td style="vertical-align:top;width:auto;"&gt;
			&lt;p style="margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;The non-PEO named executive officers, for each year reported were as follows:&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; padding-left: 9pt;"&gt;2025:&#160;Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith,&#160;our General Counsel and Chief Compliance Officer&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; padding-left: 9pt;"&gt;2024: Chris Degnan, our Chief Financial Officer; Jason Smith, our General Counsel and Chief Compliance Officer; and Don Kim, our former Chief Financial Officer&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; padding-left: 9pt;"&gt;2023: Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith, our General Counsel and Chief Compliance Officer&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;(3)&lt;/td&gt;
			&lt;td style="vertical-align:top;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;For fiscal year 2025, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2025, computed in accordance with Item 402(v) of Regulation S-K:&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for PEO&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Stock Awards" Column in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.5%; text-align: center;"&gt;(2,122,211)&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.5%; text-align: center;"&gt;(660,600)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Option Awards" Columns in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.5%; text-align: center;"&gt;-&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;4,514,275&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,405,200&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Vest during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;5,144,729&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;809,218&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;23,910&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;244,734&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based upon Incremental Fair Value of Awards Modified during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;Total Adjustments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;7,530,704&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,798,552&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;"&gt;For fiscal year 2024, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:&lt;/p&gt;
&#160;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for PEO&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Stock Awards" Column in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(2,751,111)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(1,071,230)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Option Awards" Columns in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.5%; text-align: center;"&gt;-&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(695,294)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,866,200&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,267,052&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Vest during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(1,401,192)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(459,291)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;79,762&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;7,227&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based upon Incremental Fair Value of Awards Modified during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;Total Adjustments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(2,206,341)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(951,536)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;"&gt;For fiscal year 2023, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for PEO&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Stock Awards" Column in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(2,464,250)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(896,250)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Option Awards" Columns in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(836,533)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(468,459)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;3,982,234&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,885,051&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Vest during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;859,009&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;286,886&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;136,140&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;241,644&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based upon Incremental Fair Value of Awards Modified during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;Total Adjustments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,676,600&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,048,873&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="vertical-align:top;width:2.5%;"&gt;
			&lt;p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;(4)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:top;width:43.8%;"&gt;
			&lt;p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Total shareholder return (&#x201c;TSR&#x201d;) is calculated as the difference between the Company&#x2019;s share price at the beginning and the end of the measurement period, divided by the Company&#x2019;s share price at the beginning of the measurement period.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="d_2025-01-01_2025-12-31" id="c41">
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;(1)&lt;/td&gt;
			&lt;td style="vertical-align:top;width:auto;"&gt;Elizabeth Barrett, our President and Chief Executive Officer, was our PEO for each year reported&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;(2)&lt;/td&gt;
			&lt;td style="vertical-align:top;width:auto;"&gt;
			&lt;p style="margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;The non-PEO named executive officers, for each year reported were as follows:&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; padding-left: 9pt;"&gt;2025:&#160;Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith,&#160;our General Counsel and Chief Compliance Officer&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; padding-left: 9pt;"&gt;2024: Chris Degnan, our Chief Financial Officer; Jason Smith, our General Counsel and Chief Compliance Officer; and Don Kim, our former Chief Financial Officer&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; padding-left: 9pt;"&gt;2023: Mark Schoenberg, our Chief Medical Officer;&#160;and Jason Smith, our General Counsel and Chief Compliance Officer&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 6.9%;"&gt;(3)&lt;/td&gt;
			&lt;td style="vertical-align:top;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;For fiscal year 2025, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2025, computed in accordance with Item 402(v) of Regulation S-K:&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for PEO&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Stock Awards" Column in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.5%; text-align: center;"&gt;(2,122,211)&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.5%; text-align: center;"&gt;(660,600)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Option Awards" Columns in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.5%; text-align: center;"&gt;-&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;4,514,275&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,405,200&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Vest during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;5,144,729&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;809,218&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;23,910&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;244,734&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based upon Incremental Fair Value of Awards Modified during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;Total Adjustments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;7,530,704&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,798,552&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;"&gt;For fiscal year 2024, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:&lt;/p&gt;
&#160;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for PEO&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Stock Awards" Column in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(2,751,111)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(1,071,230)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Option Awards" Columns in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: 11.5%; text-align: center;"&gt;-&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(695,294)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,866,200&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,267,052&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Vest during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(1,401,192)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(459,291)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;79,762&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;7,227&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based upon Incremental Fair Value of Awards Modified during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;Total Adjustments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(2,206,341)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(951,536)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 44pt;"&gt;For fiscal year 2023, the Compensation Actually Paid to the PEO and the average Compensation Actually Paid to the non-PEO named executive officers&#160;reflect each of the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal year 2023, computed in accordance with Item 402(v) of Regulation S-K:&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:87%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:29.5%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for PEO&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Adjustments to Determine Compensation Actually Paid for Non-PEO Named Executive Officers&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Stock Awards" Column in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(2,464,250)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(896,250)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction for Amounts Reported under the "Option Awards" Columns in the SCT&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(836,533)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;(468,459)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Remain Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;3,982,234&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,885,051&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase for Fair Value of Awards Granted during year that Vest during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year end&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;859,009&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;286,886&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase/deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;136,140&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;241,644&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based upon Incremental Fair Value of Awards Modified during year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Increase based on Dividends or Other Earnings Paid during year prior to Vesting Date of Award&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;-&#160;&#160;&#160;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="vertical-align:bottom;width:29.5%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"&gt;&lt;b&gt;Total Adjustments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,676,600&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:bottom;width:11.5%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;1,048,873&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="vertical-align:top;width:2.5%;"&gt;
			&lt;p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;(4)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align:top;width:43.8%;"&gt;
			&lt;p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-variant-position: normal; font-variant-emoji: normal; margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;Total shareholder return (&#x201c;TSR&#x201d;) is calculated as the difference between the Company&#x2019;s share price at the beginning and the end of the measurement period, divided by the Company&#x2019;s share price at the beginning of the measurement period.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoName contextRef="d_2023-01-01_2025-12-31" id="c43">Elizabeth Barrett</ecd:PeoName>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c44"
      unitRef="USD">-2122211</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c45"
      unitRef="USD">-660600</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c46"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c47"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c48"
      unitRef="USD">4514275</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c49"
      unitRef="USD">1405200</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c50"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c51"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c52"
      unitRef="USD">5144729</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c53"
      unitRef="USD">809218</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c54"
      unitRef="USD">23910</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c55"
      unitRef="USD">244734</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c56"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c57"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c58"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c59"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c60"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c61"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c62"
      unitRef="USD">7530704</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2025-01-01_2025-12-31_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c63"
      unitRef="USD">1798552</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c64"
      unitRef="USD">-2751111</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c65"
      unitRef="USD">-1071230</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c66"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c67"
      unitRef="USD">-695294</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c68"
      unitRef="USD">1866200</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c69"
      unitRef="USD">1267052</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c70"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c71"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c72"
      unitRef="USD">-1401192</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c73"
      unitRef="USD">-459291</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c74"
      unitRef="USD">79762</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c75"
      unitRef="USD">7227</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c76"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c77"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c78"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c79"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c80"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c81"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c82"
      unitRef="USD">-2206341</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c83"
      unitRef="USD">-951536</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c84"
      unitRef="USD">-2464250</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheStockAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c85"
      unitRef="USD">-896250</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c86"
      unitRef="USD">-836533</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DeductionForAmountsReportedUnderTheOptionAwardsColumnInTheSCTMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c87"
      unitRef="USD">-468459</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c88"
      unitRef="USD">3982234</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c89"
      unitRef="USD">1885051</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c90"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c91"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c92"
      unitRef="USD">859009</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c93"
      unitRef="USD">286886</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c94"
      unitRef="USD">136140</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c95"
      unitRef="USD">241644</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c96"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c97"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c98"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-IncreaseBasedUponIncrementalFairValueOfAwardsModifiedDuringYearMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c99"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c100"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c101"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c102"
      unitRef="USD">1676600</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c103"
      unitRef="USD">1048873</ecd:AdjToCompAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="d_2025-01-01_2025-12-31" id="c104">
&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;Relationship Between Compensation Actually Paid and Company Total Shareholder Return&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our non-PEO named executive officers, and the Company&#x2019;s TSR over the three most recently completed fiscal years.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div style="text-align: center;"&gt;
&lt;div&gt;&lt;img alt="tsrgraph.jpg" src="tsrgraph.jpg"/&gt;&lt;/div&gt;
&lt;/div&gt;
</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="d_2025-01-01_2025-12-31" id="c107">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;&lt;i&gt;Relationship Between Compensation Actually Paid and Net Loss &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our non-PEO named executive officers, and our net loss during the three most recently completed fiscal years.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div style="text-align: center;"&gt;
&lt;div&gt;&lt;img alt="netincomegraph.jpg" src="netincomegraph.jpg"/&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="text-align: center;"&gt;&#160;&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;i&gt;The information provided above under the &lt;/i&gt;&#x201c;&lt;i&gt;Item 402(v) Pay Versus Performance&lt;/i&gt;&#x201d;&lt;i&gt; heading will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
</ecd:CompActuallyPaidVsNetIncomeTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
